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Abstract
Epithelial sheets create the forces which shape embryos during the development of all 
metazoans. The external epithelia, or hypodermis, of the nematode Caenorhabditis 
elegans plays an essential role in shape change during embryogenesis and also 
maintains body shape during postembryonic development. Embryonic shape change, 
known as elongation, is mediated by actin microfilaments in the hypodermis which 
align circumferentially and contract, causing the embryo to change from a ball of cells, 
to a long, thin worm shape. A prerequisite to elongation is the migration of the 
hypodermis around the embryo from the dorsal surface to completely cover the embryo 
in a layer of hypodermal cells, a process known as enclosure. At the end of 
embryogenesis, the hypodermis secretes a multi-layered, collagenous exoskeleton, 
known as the cuticle, which maintains the elongated worm shape postembryonically. In 
this thesis, I have characterised three elongation-defective mutants which arrest during 
embryogenesis, and have also looked at the pattern of a cuticular collagen, DPY-7, 
throughout development using a novel monoclonal antibody, DPY7-5a. One of the 
embryonic lethal mutations, w4, lies on Chromosome I, between positions 6.2 and 9.9 
on the genetic map. The majority of w4 homozygotes are defective in enclosure. The 
other two embryonic lethal mutations, ijDfl and ijDf2 are the result of large deficiencies 
which have been physically mapped. ijDf2 extends from around position -0.9 to 0.7 on 
chromosome V and is approximately 2.2Mb in size. ijDf2 homozygotes appear to have 
a pre-enclosure defect in cell adhesion. ijDfl extends from around position 18 to 23.5 
on the X chromosome and is approximately 1.6Mb in size. ijDfl homozygotes arrest as 
1.5-fold stage embryos and this early elongation defect was rescued by injection of the 
genomic overlap of cosmids K09A9 and K09E9, plus the whole of cosmid C02C6. 
However, inhibition of the function of predicted genes contained in these cosmids did 
not produce the mutant phenotype seen in the deficiency. The characterisation of the 
DPY7-5a antibody suggests localisation of DPY-7 in the cortical layer of the cuticle. 
The study of the antibody pattern in a dpy-7 mutant demonstrates a clear reduction in 
secreted DPY-7. These results suggest that there are many molecular components in the 
complex process of embryonic elongation and the DPY7-5a antibody provides a novel 
mechanism to study postembryonic shape change and mechanisms of cuticle 
organisation within the hypodermis.
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Chapter 1 
Introduction
1.1. Caenorhabditis elegans - a member of the Phylum Nematoda
Nematodes make up the majority of all living animals and, although around 
20,000 species have been described, estimates of the actual number range from 40,000 
to as many as 10 million (Platt, 1994; Blaxter, 1998). These nematodes, or 
‘roundworms’ as they are more commonly known, live almost anywhere. They inhabit 
all areas of the globe at all altitudes, from the tropics to the poles, and survive in salt­
water, freshwater, and both fertile and desert terrestrial environments. Although the 
vast majority of nematodes are free-living, many species have adopted a parasitic 
lifestyle and in this they are equally diverse, parasitising practically all groups of plants 
and animals. Despite this range of diversity, all nematodes are composed of the same 
basic body plan with a circular cross section, which consists of two concentric tubes 
separated by a fluid filled space known as the pseudocoelom. The outer tube comprises 
the muscles, nerve cells, epidermis (known as the hypodermis in Caenorhabditis 
elegans) and the collagenous extracellular cuticle which is secreted by the hypodermis 
and is probably one of the reasons why the phylum Nematoda is so successful. The 
inner tube consists of the intestine and its lumen and in adult worms, the pseudocoelom 
contains the gonads. Caenorhabditis elegans is a nematode worm of the Rhabditida 
order and the Rhabditidae family and as such is a member of a very diverse and 
successful group of animals.
1.2. The biology of C.elegans
C.elegans is the most extensively studied and best characterised species of the phylum 
Nematoda. It is a free-living soil microbivore with a 3V2-day life cycle and an adult 
length of 1.5mm. Sydney Brenner chose C.elegans as a model organism for the study 
of animal behaviour and development in 1965 for many reasons which will be discussed 
throughout this introduction, one being the ease of maintaining C.elegans in laboratories 
on agar plates or liquid culture using Escherichia coli as a food source (Brenner, 1974).
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There are two sexes, hermaphrodite and male, which are of similar size but can be easily 
distinguished in later stages of the life cycle by their different reproductive structures 
(section 1.2.2). Hermaphrodites make up the vast majority of C.elegans animals in 
normal populations with a male incidence of around 0.2%. The mode of reproduction is 
therefore predominantly self-fertilisation by hermaphrodites and each has the potential 
to produce around 300-350 progeny per generation if not mated with a male. The 
fecundity of hermaphrodites is limited by the number of germ cells which differentiate 
into sperm as these are produced before the oocytes. The life cycle of C.elegans, like all 
other nematode species consists of four larval stages, L1-L4, followed by a moult into 
the adult and the eggs are fertilised inside the adult hermaphrodite.
1.2.1. C.elegans development
The egg shell of C.elegans embryos and the body wall of larvae and adults are 
transparent, allowing the cell lineage of the embryo and postembryonic stages to be 
followed accurately using Nomarski microscopy, a non-damaging, high resolution light 
microscopy technique (Sulston and Horvitz, 1977; Sulston et al., 1983). It was found 
that the cell lineage was essentially invariant, producing a constant number of cells in 
the same positions in each animal. This has allowed the development of C.elegans to be 
studied in great detail and has resulted in an accurate description of the events that occur 
during the embryonic and postembryonic stages.
1.2.1.1. Embryogenesis in C.elegans
Embryogenesis in C.elegans takes around 14 hours (840mins) at 22°C and comprises 
three major stages (Figure l.l)(Sulston et al., 1983; Wood, 1988). The first stage 
occurs during the initial 2 hours after fertilisation and includes zygote formation and the 
generation of the founder cells. The second stage includes the majority of cell divisions, 
gastrulation, the beginning of organogenesis and the differentiation of cell types and 
continues until around midway through embryonic development. During the third stage 
of embryogenesis, organogenesis and cell differentiation are completed and the embryo 
changes shape from an almost spherical ball of cells to a thin cylindrical worm
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Figure 1.1
Stages, m arker events, and body elongation during embryogenesis in 
C.elegans
The timescale is in minutes from first cleavage and refers to embryogenesis at 
22°C. All embryos are approximately 50mm long and 30mm wide and before 
3-fold elongation are orientated with the anterior to the left and the dorsal 
surface to the top o f  the image. (Adapted from Sulston et a l., 1983)
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four times the original length. The third stage of development finishes at hatching 
when the pharynx of the embryo apparently pumps out enzymes which catalyse the 
breakdown of the eggshell from within (Wood, 1988). The timing of embryonic 
development is essentially invariant at any particular temperature and is usually 
measured from fertilisation or from first cleavage which occurs around 40 mins after 
fertilisation (Sulston et a l , 1983; Wood, 1988). Generally, early embryogenesis takes 
place in the uterus of the hermaphrodite and healthy wild type animals usually lay eggs 
when the embryos are undergoing gastrulation, around 120-180 mins after fertilisation.
The cell divisions which generate the founder cells and the tissues that arise 
from these cells are shown in Figure 1.2. The divisions that produce these founder cells 
are both asynchronous and unequal (Deppe et al., 1978). Each founder cell and the cells 
it produces exhibit a characteristic rate of division which is fastest in the AB lineage and 
slowest in the D lineage. While the E, D and P4 founder cells produce only gut, muscle 
and germline cells respectively, the AB, MS and C cells produce both ectodermal and 
mesodermal descendants (Sulston et a l, 1983).
Gastrulation is the process whereby mesodermal precursors migrate into the 
centre of the embryo from the surface through an opening known as the ventral cleft and 
thus form new cell-cell contacts which are essential for further development (Sulston et 
a l, 1983). This process begins around 140 mins after fertilisation at the 26 cell stage 
and continues until around 330 mins after fertilisation when the ventral cleft is closed. 
Gastrulation is discussed in more detail in section 5.1.2. Cell division and 
organogenesis occur during this stage and continue until around 390 mins after 
fertilisation. The terminally differentiated hypodermal cells are bom on the dorsal 
surface of the embryo around 330 mins after fertilisation after the ventral cleft has 
closed and begin migrating bilaterally around the embryo to the ventral surface (Sulston 
et a l, 1983).
The active process of body morphogenesis begins at the end of cell proliferation 
around 390 mins after fertilisation when the embryo consists of around 550 cells and the 
hypodermal cells are continuous around the whole surface of the embryo (Sulston et a l, 
1983; Wood, 1988; Williams-Masson et a l, 1997). From 390-690 mins the embryo 
elongates to a cylindrical shape which is three times narrower and four times longer than 
it was originally (Sulston et a l, 1983; Priess and Hirsh, 1986). The elongation of the
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Generation of the founder cells during embryogenesis in C.elegans
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shown at the top left and the different cell types produced by each founder cell is 
shown at the bottom. Founder cells which give rise to hypodermis are shown in 
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The life cycle of C.elegans
After hatching, development proceeds through four larval stages, L1-L4, to 
the adult. The entire process takes around 3 days at 20°C. The dauer stage is 
a developmentally arrested larva specialised to withstand adverse conditions. 
It is produced in response to environmental conditions at the LI and L2 
stages such as overcrowding or starvation.
worm and prior movements of the hypodermis are described in detail in section 1.7. 
The rate of elongation is invariant among wild type embryos and because there is a 
consistent relationship between age and shape of an embryo during elongation, the 
developmental stages can be described in terms of the physical length of the embryo 
(Sulston et a l, 1983; Priess and Hirsh, 1986; McKeown et a l, 1998). The main stages 
of elongation are shown in Figure 1.1 and are known as the precomma (or lima bean), 
comma, 1.5-fold, 2-fold, and 3-fold (or pretzel) stages of elongation and other 
increments of physical length are also used to denote development between these stages 
(Sulston et al., 1983; Wood, 1988). Although the embryo elongates to around four 
times its original length, a fully elongated worm was initially termed 3-fold in the 
literature and so I will also use this terminology (Sulston et al., 1983; Priess and Hirsh, 
1986). At around 690 mins post-fertilisation, a collagenous exoskeleton or cuticle is 
secreted by the hypodermal cells surrounding the body which takes over the role of 
shape maintenance and acts as a barrier to the external environment after hatching 
(Singh and Sulston, 1978; Sulston et a l, 1983; Priess and Hirsh, 1986).
1.2.1.2. Postembryonic development in C.elegans
The worm hatches as an LI larva and undergoes three more larval stages until it 
reaches adulthood, termed the L2-L4 stages of development (Figure 1.3). Each larval 
stage terminates in a moult when a new collagenous cuticle is secreted from the 
hypodermis underneath the old cuticle which is subsequently shed. Prior to the moult, 
when the new cuticle is being secreted, the pharynx of the larva stops pumping and the 
larva enters a developmental state known as lethargus (Singh and Sulston, 1978). Each 
of these larval stages differs in body size and the type of cuticle secreted although the 
morphology of the LI larvae is superficially quite similar to the adult. The hypodermal 
control of post embryonic development is discussed in section 1.7.6.3 and the control of 
body shape by the cuticle postembryonically is discussed in sections 1.7.6.1 and 3.1.4. 
It takes around 3 days for an embryo to develop into an adult and adults can survive for 
around 2 weeks although they are only self-fertile for 2-3 days. In conditions of 
overcrowding or starvation, L2 larvae moult into a specialised stage known as the dauer 
stage (Cassada and Russell, 1975). Dauer larvae are specialised for dispersal and long­
term survival. They do not feed but can survive for over 8 times the normal life span of
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C.elegans (Klass and Hirsh, 1976). When conditions become favourable again, the 
dauer larvae moult into the L4 stage and resume normal development.
At the time of hatching, the LI larvae contains 550 somatic nuclei, two of which 
will divide during larval development to produce the somatic gonad, and two of which 
will produce the germ line (Sulston et al., 1983). Due to the postembryonic 
proliferation of both non-gonadal somatic blast cells and the gonadal primordia, the 
number of somatic nuclei at the adult stage is 959 for hermaphrodites and 1031 for 
males of which around 140 in the hermaphrodite and around 60 in the male are somatic 
gonadal nuclei (Sulston and Horvitz, 1977). The extra nuclei of the male adult are 
mostly neuronal and function in the control of male mating behaviour. Although 
gonadal development occurs from the LI stage, gonadal structures are not visible until 
the L3 stage and their maturation concludes with the L4-adult moult when the 
hermaphrodite vulva is opened and the mail tail structures, which are used for 
copulation, become fully developed.
1.2.2. The anatomy of C.elegans
Each cell produced during the development of C.elegans which does not 
undergo programmed cell death has been followed to its terminal destination as part of a 
tissue or specialised structure in the body of the worm. The complete anatomy of the 
worm has been reconstructed using electron micrographs of serial sections and 
combined with the cell lineage data to produce a more complete picture (Sulston et al., 
1983; White, 1988). The basic nematode body plan has been mentioned in section 1.1 
and I will now discuss the individual tissues in more detail. The anatomy of an adult 
hermaphrodite and male is illustrated in Figure 1.4.
The shape of the nematode, embryonically and postembryonically, is determined 
by the hypodermal cells, the external epithelia of C.elegans, and the cuticle they secrete. 
The main features of hypodermal cells are common to all epithelial cells: distinct apical 
and basolateral surfaces, a complex cytoskeleton, and tight adherens junctions between 
cells. The cuticle is always secreted from the apical surface forming a barrier between 
the worm and the external environment, and a basement membrane lies on the 
basolateral side of the cells between the hypodermis and the underlying body wall 
muscles. The hypodermis extends along the length of the body and at openings, such as
7
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a Hermaphrodite anatomy
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the buccal cavity, the rectum, the vulva and the excretory cell, the hypodermis connects 
to specialised cells which act as interfaces between the hypodermis and the organ to 
which the opening leads. Most of the hypodermal nuclei are arranged into multinucleate 
syncytia, the largest of which is hyp7. Smaller syncytia are present in the head and tail 
regions and at lateral regions there is a row of mononucleate hypodermal cells known as 
the seam cells. These cells are responsible for the cuticular structures called alae, 
present in LI, dauer and adult stages. On solid surfaces, C.elegans travels on one side 
with the alae contacting the surface during stages in which they are present. The four 
bands of body wall muscles that run longitudinally beneath the hypodermis, attach to 
the cuticle through the basement membrane and hypodermal structures called 
hemidesmosomes. The muscles that are attached to each side of the body contract 
alternately and, together with the internal hydrostatic pressure of C.elegans, create the 
characteristic sinusoidal movement.
The nervous system of C.elegans makes up 37% of hermaphrodite and 46% of 
male somatic nuclei (Chalfie and White, 1988). All connections and positions of the 
nerves in the nervous system have been reconstructed (White et al., 1986). Most of the 
neuron cell bodies are organised into ganglia and the neuronal processes are organised 
into ordered bundles that run longitudinally (including the dorsal and ventral nerve 
cords) or circumferentially (the nerve ring). Synaptic contacts are made between 
adjacent neuronal processes within bundles. Most of the sensory neurons run from the 
nerve ring anteriorly and have their sensory endings in structures known as sensilla at 
the tip of the head. Motor neurons run posteriorly from the nerve ring and innervate the 
body wall muscle.
The alimentary canal is made up of the pharynx, the intestine, and the rectum. 
The pharynx is a self-contained system of muscles, epithelial cells and nerves 
demarcated by a basement membrane. Food is ingested through the most anterior 
section of the pharynx, the buccal cavity, and is concentrated and processed in the 
pharynx before being pumped into the intestine. During the life cycle, the pharynx 
pumps continuously except during the periods of lethargus prior to each larval moult. 
The complete structure of the pharynx has been described by Albertson and Thomson 
(1976). It is arranged into four regions (Figure 1.4c) termed the procorpus, the 
metacorpus, the isthmus, and the terminal bulb, all with a central lumen. The terminal 
bulb contains a structure known as the grinder and its function is to grind food as it
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passes through. The junction between the pharynx and the intestine is marked by the 
pharyngeal-intestinal valve. The intestine consists of a tube of 20 cells with a dense 
layer of microvilli on the apical surface. At the anterior end of the intestine, the lumen 
is surrounded by 4 cells (inti) and more posteriorly by 8 pairs of cells (int2-int9). 
Intestinal cells can undergo endoreduplication of DNA without nuclear divisions at each 
stage of lethargus (Hedgecock and White, 1985). The primary function of intestinal 
cells is to secrete digestive enzymes into the lumen and absorb the processed nutrients 
but they also function as storage cells and play a major role in the nurture of germ cells 
by producing yolk proteins (Kimble and Sharrock, 1983). Some intestinal granules are 
retractile under polarised light and strongly auto fluorescent under 300-400nm light 
which is very useful when identifying intestinal cells in living animals. The intestine is 
connected to the rectum by an intestinal-rectal valve, similar to the pharyngeal-intestinal 
valve. This valve is connected to hyp7 through endothelial cells which comprise the 
rectum. The rectum has 3 sets of associated muscles which control excretion. They are 
coupled together through gap junctions and innervated by a single neuron.
The excretory/secretory system consists of three cells: an excretory cell, a duct 
cell, and a pore cell which connects the excretory cell to hyp7. There are also excretory 
glands attached to the excretory and duct cells. The excretory cell is the largest 
mononucleate cell in C.elegans and is situated ventrally at the level of the pharyngeal 
terminal bulb.
The hermaphrodite reproductive structures comprise the gonad and the vulva. 
The gonad is bilobed and symmetrical with one arm extending anteriorly and one 
posteriorly from the centre of the worm (Hirsh et al., 1976; Kimble and Hirsh, 1979). 
Each arm bends ventrally and then doubles back to meet at a common uterus in a ventral 
position at the centre of the worm. Each arm of the gonad can be divided into the distal 
ovary, the loop, the oviduct, the spermatheca, the spermathecal valve, and the uterus. 
The ovaries contain germ line nuclei which progress through meiosis as they travel 
along the gonad while being enclosed by membranes and are in diakinesis by the time 
they reach the oviduct. These nuclei have now formed oocytes which pass through, and 
are fertilised in, the spermatheca which contain amoeboid sperm. The fertilised eggs 
pass into the common uterus where they begin embryogenesis before being ejected 
through the vulva, a structure protruding from the ventral surface of the hermaphrodite,
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made up of epithelial cells and muscles which connects the uterus to the outside 
environment.
The male reproductive structures are very different. The male gonad has one 
arm which is composed of the testis, the seminal vesicle, and the vas deferens. It begins 
in the central region of the worm and runs anteriorly before turning dorsally and running 
posteriorly until it meets the cloaca in the centre of the specialised reproductive 
structures at the male tail. The germ nuclei are mitotic at the beginning of the testis and 
become meiotic as they travel to the seminal vesicle. The sperm are stored in the 
seminal vesicle until copulation when they travel through the vas deferens and the 
cloaca. The mail tail is organised into a copulatory bursa which consists of many 
specialised neurons, muscles and hypodermal structures required for mating. A detailed 
description of the C.elegans anatomy is given in White (1988).
1.2.3. The genetics of C.elegans
In 1949, Nigon showed that wild type C.elegans hermaphrodites had five pairs 
of autosomes and one pair of X chromosomes while males contained five autosomes 
and just a single X chromosome. It has been shown that the primary sex-determining 
factor in C.elegans is the ratio of X chromosomes to autosomes by experimentally 
altering this ratio (Hodgkin et al., 1979; Madl and Herman, 1979). The haploid genome 
is relatively small, consisting of 97 megabases (Mb) of DNA, which is only around 
eight times that of the yeast, Saccharomyces or around one-half the size of the 
Drosophila genome (The C.elegans Sequencing Consortium, 1998).
Many of the genes in C.elegans have been isolated and studied using classical 
genetic analysis and this research has been greatly aided by the short life cycle and the 
mode of reproduction in this nematode. Normal populations of C.elegans consist 
largely of hermaphrodites with less than 0.2% of males arising from non-disjunction of 
the X chromosome during meiosis (Wood, 1988). This predominantly hermaphrodite 
mode of reproduction allows the isolation and maintenance of recessive mutations, as 
25% of the progeny of an heterozygous hermaphrodite will be homozygous for the 
mutation. It also allows easy maintenance of recessive lethal alleles, as 50% of the total 
progeny of an heterozygous hermaphrodite, or two-thirds of the viable progeny, will 
also be heterozygotes for the lethal mutation. At the same time, genetic crosses can be
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carried out with ease by mating hermaphrodites with males. Mutations are often 
generated in C.elegans using chemical mutagenesis or radiation in large scale genetic 
screens. This forward genetic approach is useful when studying mutations producing a 
noticeable phenotype such as abnormal shape, movement, or death, and the mutation is 
subsequently mapped and cloned to discover the gene involved, its relationship to other 
genes, and the protein it encodes. C.elegans was first proposed as a model organism for 
the study of animal behaviour and development in 1965 and, by 1974, over 100 genetic 
loci comprising behavioural and morphological markers had been identified (Brenner, 
1974). By 1997, Johnsen and Baillie reported that 1,503 loci had been genetically 
identified. The reverse genetic approach, which will be discussed in more detail in the 
next section, starts with a gene sequence and works backwards by attempting to 
elucidate the role of this gene, if any, in the worm. Clues of gene function can be found 
by comparing the sequence with known genes in other organisms and by observing the 
expression of the gene in the wild type worm.
1.3. C.elegans as an experimental system
Many features of C.elegans biology make it an excellent candidate for 
experimental analysis. Several of these, such as its size, short life cycle and 
transparency have been discussed above and the ease at which it can be maintained in 
the laboratory is another positive factor. The simplicity of this organism allows in- 
depth analysis of features such as the cell lineage and anatomy while it also shows many 
complex cellular, developmental and behavioural interactions. The constancy of cell 
number and the invariant cell lineage provide an ideal situation to enable the study of 
development. Virtually every cell in the body is accessible to laser microsurgery and 
the ability to selectively inactivate founder or blast cells and observe the effects on 
development provides an excellent opportunity to study the effects of cell positions, 
cell-cell interactions, and the determination of cell fate.
Initially, the study of the function and control of genes in C.elegans was 
restricted to the techniques available in the classical forward genetics approach 
(Brenner, 1974). However, many new techniques have become available over time 
which have increased the effectiveness of forward genetics while also allowing a reverse 
genetic approach to the study of C.elegans biology. Another reason for the increasing
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trend towards reverse genetics is the sequencing of almost the entire genome by the 
C.elegans genome sequencing consortium which is discussed in section 1.4.2.
A powerful tool developed for several different uses is DNA transformation, 
which can be utilised when attempting to rescue a mutant phenotype and thus clone the 
wild type copy of the mutant gene, or may be used to study the temporal and spatial 
expression pattern of a gene during development (Stinchcomb et al., 1985; Fire, 1986; 
Mello et al., 1991). The generation of a physical map comprising overlapping clones 
(see section 1.4.1) along with the DNA transformation technique has produced a way of 
identifying a gene which has been mutated to create an observable phenotype in a 
genetic screen. After the mutation has been mapped to a specific region of the genetic 
map, clones from the physical map corresponding to this region can be injected into the 
gonad of a mutant worm. These injected clones can form heritable arrays and if the 
wild type copy of the gene which is mutated in the genome is present in the transgenic 
array, it may rescue the mutant phenotype in subsequent generations (Mello and Fire,
1995). Mutant phenotype rescue by transgenic arrays is discussed further in Section
4.4.1. DNA transformation is also of considerable use in reverse genetics when 
attempting to elucidate the function of a gene or when examining the expression pattern 
of a cloned gene. The gene of interest along with its flanking sequences is fused in 
frame to a reporter gene such as lacZ or the gene encoding the green fluorescent protein 
(GFP) of a jellyfish, Aequorea victoria, and the reporter gene fusion is injected into a 
wild type worm (Fire et al., 1990; Fire, 1992; Chalfie et al., 1994). This is especially 
useful when the GFP reporter gene is used as it allows the temporal and spatial 
expression pattern of the target gene to be followed in living animals using a UV source 
to detect the fluorescence produced by GFP (Chalfie et al., 1994).
A technique which has proved to be invaluable in reverse genetics is gene- 
inactivation by insertion of the Tel transposon (Zwaal et al., 1993). Insertion of Tel 
into a gene can interrupt that gene and therefore inactivate it and the presence of the Tel 
transposon in or near a gene can be detected by the polymerase chain reaction (PCR) 
using specific primers. This technique makes use of so called mutator strains which 
have mobile transposable elements and which activate Tel transposition and excision in 
the germ line at high frequency (Zwaal et a l, 1993; Plasterk, 1995). Genomic DNA 
from different populations of a mutator strain is screened using PCR with primers 
specific to Tel and the target gene. Siblings of the screened worms are kept alive in
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order to maintain any Tel insertion found in the target gene. If an insertion is found in 
the target gene, further screening of sub-populations of the siblings is carried out until 
single worms carrying the Tel insertion are identified (Rushforth et al., 1993). One 
feature of C.elegans biology is the ability to withstand freezing at -70°C under certain 
conditions, and this has allowed the generation of frozen Tel insertion mutant banks 
which can result in the isolation of Tel insertions in most genes (Zwaal et al., 1993).
One of the most recent tools to be used in reverse genetics of C.elegans is RNA- 
mediated genetic interference (RNAi) which can specifically inhibit the function of a 
gene by the injection of double stranded (ds)RNA corresponding to a coding sequence 
of the gene and thus mimic the null phenotype of that gene (Fire et al., 1991; Guo and 
Kemphues, 1995; Fire et al., 1998; Tabara et al., 1998). This is an invaluable tool when 
studying the function of a specific gene in C.elegans as it produces a very rapid effect 
and more recently it has been shown that simply soaking the worms in dsRNA can 
induce specific interference (Tabara et al., 1998). RNAi is discussed in more detail in 
section 6.9.1.
These techniques, together with the extensive knowledge of C.elegans biology, 
an essentially completely sequenced genome, and experimental versatility make this 
organism an excellent experimental system for the study of gene function using both 
forward and reverse genetics and an ideal system for the study of development, both 
embryonically and postembryonically.
1.4. Genome Sequence of C.elegans
1998 was a landmark year in the history of C.elegans research with the 
announcement that the sequencing of the genome was essentially complete. It is the 
first multicellular organism genome sequence to be completed and the uses of such a 
resource of genomic information are manifold, not only for C.elegans biologists, but 
also for researchers interpreting other genomes, including the human genome.
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1.4.1. The C.elegans physical map
A starting point for the sequencing of the genome was the generation of an 
ordered physical map of clones covering the genome which allowed sequence data 
obtained from these clones to be accurately linked together. Initially, a restriction 
enzyme fingerprinting method was used to assemble random cosmid and lambda clones 
into large sets called ‘contigs’ (Coulson et a l , 1986). Although this resulted in the 
coverage of 90-95% of the genome by 17,500 cosmids arranged into 700 contigs, there 
were still gaps present between these contigs due to the absence or under-representation 
of the linking clones in the cosmid libraries used. At this time, newly developed yeast 
artificial chromosomes (YAC) clones were used to bridge these gaps by generating a 
YAC library of C.elegans genomic DNA and this method proved to be very successful, 
rapidly reducing the number of contigs to 346 (Burke et a l , 1987; Coulson et a l , 1988). 
The YAC clones alone also covered almost all of the genome, forming a YAC grid of 
958 clones, which enabled rapid screening of the entire genome using a hybridisation 
technique (Coulson et a l , 1991). At present, around 20% of the entire genome is only 
present in YAC clones (The C.elegans Sequencing Consortium, 1998).
Good alignment between the physical and genetic maps is also essential as this 
allows genes identified by sequence to be placed on the genetic map and mapped genes 
from mutant screens to be located in the physical map. Sulston et al. (1992) had 
positioned over 90Mb of sequence along the chromosomes using genetically mapped 
sequences and in situ hybridisation techniques and more recently a high resolution 
alignment of specific areas of the genetic, physical, and DNA sequence maps has been 
produced by the systematic rescue of lethal mutations in these areas using sequenced 
cosmids (Janke et al., 1997; McDowall and Rose, 1997).
1.4.2. Sequencing the C.elegans genome
The C.elegans sequencing project began with the sequencing of the centres of 
the chromosomes where there was good cosmid coverage and the density of genetic 
markers was high (Sulston et al., 1992). The sequencing process involved a shotgun 
phase where random subclones were sequenced and a finishing phase where gaps were 
closed and ambiguities solved using specialised techniques (The C.elegans Sequencing 
Consortium, 1998). Remaining gaps in the centres of the chromosomes were bridged by
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screening fosmid and YAC clones and using long-range PCR (Kim et al., 1992; Cheng 
et al., 1994). Fosmids are similar to cosmids but are maintained at a single copy per cell 
as opposed to the multi-copies of cosmids and were therefore potentially more stable 
(Kim et al., 1992). YAC sequencing recovered all the gaps in the outer regions of the 
chromosome and this also served as a check on the physical map arrangement as the 
YAC sequences were compared with previously made hybridisation links (The 
C.elegans Sequencing Consortium, 1998). 97Mb of sequence representing over 99% of 
the genome sequence is now represented by 2527 cosmids, 257 YACs, 113 fosmids, and 
44 PCR products (The C.elegans Sequencing Consortium, 1998).
Running parallel with the sequencing project, other groups have been 
sequencing and mapping randomly selected complementary DNA (cDNA) clones from 
C.elegans (Waterston et al., 1992; McCombie et al., 1992; Kohara, 1996 [cited in: The 
C.elegans Sequencing Consortium, 1998] ). These projects generate partial sequence 
from cDNA clones which have been mapped to the YAC grid to produce sequence tags. 
These can then be used to predict coding regions from the genomic sequence generated 
by the genome sequencing project. The Kohara group has produced 67,185 Expressed 
Sequence Tags (ESTs) which represent around 7432 genes and this information has 
been invaluable in identifying and elucidating the nature of genes in the genomic 
sequence (The C.elegans Sequencing Consortium, 1998).
1.4.3. The content of the C.elegans genomic sequence
In order to identify possible genes within finished C.elegans genomic sequences, 
the GENEFINDER program is used (P.Green and L.Hillier, unpublished software). 
These gene predictions are further adjusted or confirmed using information from 
protein, cDNA and EST matches. There are 19,099 predicted protein-coding genes in 
the 97Mb genomic sequence resulting in an average density of 1 predicted gene per 5kb 
(The C.elegans Sequencing Consortium, 1998). This number is around three times that 
found in yeast and around a third to a fifth of that predicted for humans (Goffeau et al., 
1996; The C.elegans Sequencing Consortium, 1998). Sequence comparisons of 
predicted protein products with known proteins has revealed that around 42% of 
predicted protein products show significant similarities to proteins in organisms outside 
the nematodes while 34% match proteins found only within the nematodes (The
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C.elegans Sequencing Consortium, 1998). Significantly, 36% of predicted protein 
products in C.elegans match with human proteins, which is higher than the percentage 
matching with either Escherichia coli or Saccharomyces cerevisiae as expected from 
evolutionary relationships (Sonnhammer and Durbin, 1997).
The predicted genes in C.elegans are not evenly dispersed across the 
chromosomes, with a higher gene density at the centres of chromosomes compared to 
the chromosome arms, and an overall higher gene density in chromosomes I-V than in 
the X chromosome where the genes are also more evenly distributed. There are also 
many repeat and inverted sequences present throughout the C.elegans genome, 
accounting for 6.3% of the genome, and these are much more frequent on the 
chromosome arms than in the central regions or on the X chromosome. Another feature 
of the chromosomal organisation for the autosomes, chromosomes I-V, is that the 
amount of genes with similarities to organisms other than nematodes is lower on the 
chromosome arms than in the centres (Barnes et a l , 1995). As the rate of meiotic 
recombination is much higher on the autosome arms, it is suggested that the DNA on 
the arms may be evolving much more rapidly than in the central regions of the 
autosomes (The C.elegans Sequencing Consortium, 1998).
As expected from the genome of a multicellular organism, the C.elegans genome 
is predominantly non-coding with just 27% of sequence comprising predicted exons. 
The importance of determining the entire genome sequence rather than just the coding 
sequence, however, is that much of the information about biological function is located 
in the non-coding sequences. The completed genome sequence also shows the 
relationships between genes and contains the structural and control elements necessary 
for their correct function which is essential for the biological understanding of the entire 
organism.
1.5. C.elegans as a model organism
The simplicity of C.elegans and the wide range of experimental tools available 
for C.elegans research has already resulted in the accumulation of a wealth of biological 
information regarding its biology. The idea that information gained from research on 
this nematode species is relevant to mammalian biology is strengthened not only by the 
substantial homology seen between the encoded proteins of C.elegans and higher
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eukaryotes but also by the discovery of several cellular pathways which appear to be 
shared between C.elegans and mammals. The detailed genetic analysis of these and 
other pathways which are clearly shared between C.elegans and mammalian pathways 
may eventually have an impact in the area of human health. This analysis may also link 
two pathways which were previously thought to be unrelated. I will discuss four such 
pathways as examples, two of which appear to be pathways important in aspects of 
human health.
The first example of a conserved pathway is the signalling pathway involved in 
the induction and development of the vulva in C.elegans. The vulva is the epithelial 
tube which connects the hermaphrodite uterus to the outside environment and which 
functions in egg laying and mating with males. It is generated by a special subset of 
ventral ectodermal blast cells and the induction pathway involved utilises molecules that 
are conserved between C.elegans and mammals as well as being present in many other 
organisms. The anchor cell present in the somatic gonad is the key organiser of vulval 
patterning and morphogenesis and it has been shown to be both necessary and sufficient 
to induce vulval development (Sulston and White, 1980; Kimble, 1981). The anchor 
cell produces an inductive signal, LIN-3, which is a transmembrane protein containing a 
single epidermal growth factor (EGF)-like motif (Sternberg and Horvitz, 1986; Thomas 
et al., 1990; Hill and Sternberg, 1992; Katz et al., 1995). The receptor for this signal is 
thought to be LET-23, a receptor tyrosine kinase of the EGF subfamily, which appears 
to positively regulate LET-60, a Ras protein, via an adapter, SEM-5 (Aroian et al., 
1990; Beitel et al., 1990; Han and Sternberg, 1990; Clark et al., 1992; Stem et al.,
1993). SEM-5 is a structural and functional homologue of the human GRB2 protein 
which functions as an adapter between receptor tyrosine kinases and Ras in humans 
(Clark et al., 1992; Stem et al., 1993; Greenwald, 1997). In turn, LET-60 activates a 
protein kinase cascade which includes LET-45, a Raf homologue, MEK-2, a MAP 
kinase kinase homologue, and MPK-l/SUR-1, MAP kinase homologues (Han et al., 
1993; Lackner et al., 1994; Wu and Han, 1994; Church et al., 1995; Komfeld et al., 
1995; Wu et al., 1995). Among targets of this signalling pathway are putative 
transcription factors, LIN-1 and LIN-31 (Miller et al., 1993; Beitel et al., 1995). LIN-1 
acts as a negative regulator of vulval induction while LIN-31 is involved in the 
specification of vulval and non-vulval fates. Each of the proteins in this pathway is 
homologous to a protein in the mammalian receptor tyrosine kinase signalling pathway
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which acts in the regulation of cell response to growth factors (Greenwald, 1997). The 
discovery of the LET-60 component in this system was also the first indication in any 
organism that Ras proteins are involved in specification and differentiation in addition 
to cell growth and proliferation.
During the development of the C.elegans hermaphrodite, 12% of generated cells 
undergo programmed cell death (Sulston and Horvitz, 1977; Sulston et a l , 1983). 
These deaths are highly reproducible and the same number of cells die in all individuals 
at the same developmental stage. The genetic pathway which controls programmed cell 
death results in the production of several proteins which have significant homology to 
proteins controlling cell death in vertebrates and so this appears to be another conserved 
pathway. Expression of the ced-3 and ced-4 genes are necessary for programmed cell 
death as mutations inactivating either gene result in the survival of almost all cells that 
normally die (Ellis and Horvitz, 1986). ced-3 encodes a protein which has significant 
similarity to a new family of cysteine proteases, of which the mammalian interleukin-lp 
converting enzyme (ICE) is a member (Thomberry et a l, 1992; Yuan et al., 1993). 
CED-3 exhibits a protease activity similar to that observed for ICE and it is thought that 
this protease activity is necessary for the ability of CED-3 to promote cell death (Xue 
and Horvitz, 1995; Xue et al., 1996). Overexpression of ICE was found to induce 
programmed cell death in rat fibroblasts and so it is possible that this or a related protein 
may be involved in mammalian programmed cell death (Miura et a l, 1993). The ced-9 
gene is necessary and sufficient to protect cells from undergoing cell death in C.elegans. 
ced-9 gain-of-function mutations or overexpression results in the survival of cells that 
would normally die and conversely, inactivation of ced-9 causes the programmed cell 
death of many cells that would normally survive (Hengartner et a l, 1992). CED-9 has 
sequence similarity to the product of bcl-2 the mammalian proto-oncogene involved in 
the control of mammalian programmed cell death and it has been shown that bcl-2 can 
substitute for ced-9 in C.elegans by preventing normal cell deaths and the extra cell 
deaths produced in ced-9 loss of function mutants (Vaux et a l, 1992; Korsmeyer et a l, 
1993; Hengartner and Horvitz, 1994). These results suggest that the genetic pathways 
controlling programmed cell death may be conserved between C.elegans and mammals.
The third example of a pathway showing homology between C.elegans and 
mammals is the lin-12 Notch-like signalling pathway which acts in the patterning of
19
equipotential cells by mediating cell-cell signalling (Levitan and Greenwald, 1995). 
Genetic analysis of the lin-12 Notch-like signalling pathway showed that a C.elegans 
orthologue of the human PS1 transmembrane protein implicated as having a role in 
Alzheimer’s disease, regulates lin-12 function (Levitan and Greenwald, 1995; Li and 
Greenwald, 1998; Greenwald, 1998). This placed the mammalian PS1 gene in a Notch­
like signalling pathway as well as a neural degeneration pathway, and vice versa, 
implicating the lin-12 pathway as a possible candidate for research into neural 
degeneration in Alzheimer’s disease.
Another example of a shared pathway between C.elegans and mammals which 
may be important in human health is the DAF-2/AGE-1/DAF-16 insulin-like metabolic 
pathway which regulates metabolism, development and longevity. (Morris et al., 1996; 
Kimura et al., 1997). DAF-2 is an homologue of the mammalian insulin receptor and 
AGE-1 encodes an homologue of the mammalian phosphatidylinositol 3-OH kinase 
[PI(3)K] catalytic subunit, daf-2 and age-1 mutants arrest development at the dauer 
stage although daf-16 null mutations can suppress this effect (Ogg et al., 1997; Riddle, 
1997). DAF-16 encodes members of the Fork head family of transcription factors and it 
is thought that it acts downstream of DAF-2/AGE-1 to regulate the transcription of key 
metabolic and developmental control genes (Ogg et al., 1997). DAF-2 and AGE-1 
appear to negatively regulate DAF-16. It is thought that in the absence of DAF-2/AGE- 
1 signalling, DAF-16 represses metabolic genes and that this repression is lost in daf-16 
null mutants resulting in the suppression of the daf-2 and age-1 mutant phenotypes 
mentioned above. This DAF-2 pathway normally acts synergistically with a pathway 
activated by a TGF-p-type signal, DAF-7, and it appears that the action of this pathway 
may account for the fact that animals with defects in insulin-receptor-like signalling can 
live normally if they are also lacking daf-16 (Ogg et al., 1997; Riddle, 1997). In 
mammals, PI(3)K signalling activates protein kinase cascades which regulate metabolic 
enzymes and glucose transport (Tanti, 1996; Toker and Cantley, 1997). Human 
orthologues of DAF-16, FKHR and AFX, may also act downstream of insulin signalling 
and co-operate with TGF-p pathway components in order to mediate metabolic 
regulation. These genes may be abnormally regulated in diabetic patients and there is a 
possibility that if  the DAF-16 homologues, FKHR and AFX are inhibited, the metabolic 
defects associated with a decline in insulin signalling may be lessened as is seen in age- 
1/daf-16 or daf-2/daf-16 mutants (Ogg et al., 1997). This pathway also has similarities
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to the vulval induction pathway discussed above as it involves a protein kinase cascade 
with a Fork head homologue as a suggested downstream target (Miller et al., 1993; Ogg 
et al., 1997).
These examples show to what extent pathways can be conserved between 
C.elegans and mammals and also how some of these pathways may be used to 
investigate new approaches to problems in human health. The high degree of homology 
between the systems supports the use of C.elegans as an important general model for 
metazoan biology.
1.6. Epithelial function and morphogenesis
C.elegans undergoes major body shape changes during embryogenesis and these 
changes are controlled and driven by the epidermis, the external epithelia, known as the 
hypodermis (Priess and Hirsh, 1986). Postembryonically, C.elegans larvae grow larger 
at each stage of the life cycle but do not undergo further body shape changes. The 
maintenance of the worm shape from the end of embryogenesis through the rest of the 
life cycle is performed by the exoskeleton, or cuticle, which is synthesised in, and 
secreted from, the hypodermis. I decided to study this dual function of the hypodermis 
in driving morphogenesis and maintaining body shape as it is an important 
developmental process in all metazoans. I will give a brief overview of the main process 
of epithelial shape change in metazoans and then look at the development and function 
of the hypodermis in C.elegans embryonically and postembryonically. Aspects of 
hypodermal function that are particularly relevant to individual chapters will be dealt 
with in the introductions to these chapters.
The shape of an organism is dictated by development of the epithelial tissue 
surrounding that organism which comprises a laterally continuous monolayer of cells 
with tight cell-cell junctions, a complex cytoskeleton, and apical basal polarity. Many 
factors are involved in the processes of cell signalling, cell adhesion and force 
generation in and between cells which mediate changes in the epithelial layer and 
transduce these changes into overall shape change or movement of the epithelium. 
There are four aspects of epithelial cells which practically all organisms have in 
common that are crucial for their function: apical-basal polarity, tight intercellular
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junctions, a complex cytoskeleton, and molecules which mediate cell-cell adhesion 
(Fristrom, 1988).
1.6.1. Apical-basal polarity
The apical surface of epithelial cells either faces the exterior or luminal spaces 
and is never closely apposed to other tissues. In nematodes and many other 
invertebrates the apical surface is covered by an extracellular matrix known as the 
cuticle which is secreted from the epithelial cells and acts as an impermeable protective 
exoskeleton. The basal surface is often in close contact with internal tissues and is 
covered by another type of extracellular matrix, the basement membrane, which is made 
up from components secreted by the epithelium (the basal lamina) and the underlying 
tissues (Fessler et al., 1984). The polarisation of these epithelial cells is also reflected in 
the distribution of cytoplasmic components and there are many molecules which act to 
maintain this polarity (Simons and Wandinger-Ness, 1990; Nelson, 1992; Mellman,
1996). The presence of two separate plasma membrane domains requires separate 
endocytic and biochemical pathways and a route for transport between the two cell 
surfaces (Rodman et al., 1990; Mostov et a l , 1992). In vitro studies on cultured kidney 
epithelial cells have highlighted a structure present at the apical surface and known as 
the apical recycling compartment, as having a major role in sorting molecules within the 
cell in a polarised manner (Barroso and Sztul, 1994; Apodaca et al., 1994). Small 
GTPases have been implicated in the function of polarised membrane transport and 
sorting within epithelial cells (Ltitcke et a l , 1993; Zacchi et a l , 1998). Although 
basement membrane and extracellular matrix have been shown to be essential for some 
morphogenetic events, many epithelial sheet movements occur without the presence of a 
well defined basal lamina or extracellular matrix, and in some systems, the extracellular 
matrices must be separated from the epithelium before morphogenetic changes can 
occur (Brenner, 1974; Higgins and Hirsh, 1977; Cox et a l , 1980; Kusch and Edgar, 
1986; Guo et a l , 1991; von Kalm et al., 1995; Williams-Masson et a l , 1997).
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1.6.2. Intercellular junctions
Epithelial cells are connected to their neighbours through circumferentially 
distributed apical junctions known as adherens junctions (Fristrom, 1988). These 
junctions perform an essentially adhesive role and are often associated with 
circumferentially distributed actin filaments and molecules involved in cell adhesion 
such as cadherins (Gieger and Ayalon, 1992; Gumbiner, 1996). The tight proximity of 
epithelial cells also serves to transmit local forces across the entire cell sheet which is 
essential for any morphogenetic process (Gumbiner, 1996).
1.6.3. The epithelial cytoskeleton
The cytoskeleton of epithelial cells comprises actin-based microfilaments, 
intermediate filaments and microtubules (Fristrom, 1988). Another component is a 
plasma-membrane skeleton which is often made up mostly of spectrin, an actin binding 
heterodimer, that assembles into an extensive network along with actin (Luna and Hitt, 
1992). It is linked to the plasma membrane on one side and to the cortical cytoskeleton 
on the other and has been implicated in stabilising the plasma membrane and 
maintaining cell shape (Elgasaeter et a l , 1986). Microtubules and intermediate 
filaments have also been implicated in maintaining cell shape and the tensile strength of 
the epithelial sheets (Joshi et a l, 1985; Janmey et a l, 1991; Fuchs and Weber, 1994). 
Microtubules also play a role in cell vesicle transport, polarity maintenance, and actively 
mediate certain cell shape changes while intermediate filaments also have roles in 
attachment of other tissues to the epithelium (Bamburg et a l, 1986; Francis and 
Waterston, 1991; Solnica-Krezel and Driever, 1994; Williams-Masson et a l, 1998). 
Apart from microtubules, the component of the cytoskeleton which has been implicated 
in many different aspects of epithelial motility and cell shape change is the actin 
microfilament network. Actin microfilaments polymerise and depolymerise rapidly in 
response to external signals and thus mediate cell movement (Schmidt and Hall, 1998). 
In response to activation by small GTPases, actin microfilaments organise into 
protrusions such as lamellopodia and filopodia during cell movement and they also 
assemble into contractile stress fibres along with myosin (Ridley and Hall, 1992; Ridley 
et a l, 1992; Kozma et a l, 1995; Nobes and Hall, 1995). They drive cell shape change
23
during Drosophila leg elongation along with myosin and during C.elegans embryonic 
elongation (Priess and Hirsh, 1986; Condic et al., 1991; von Kalm et al., 1995). I will 
discuss different aspects of actin-mediated epithelial shape change and movement later 
in this introduction.
1.6.4. Molecules involved in intercellular adhesion in epithelial sheets
As has been mentioned before, morphogenesis would be impossible without 
tight adhesion between the cells that make up the epithelium. There are many different 
adhesion molecules which maintain cell-cell contacts but one of the most important and 
ubiquitous types of adhesion complexes is made up of the classical cadherin molecules 
and their catenin counterparts. These have been found to play a major role in C.elegans 
embryonic morphogenesis and although they have been shown to have many roles in 
cell sorting during development, I will focus solely on their function in cell adhesion 
and actin cytoskeleton anchorage (Takeichi, 1991; Costa et al., 1998). Cadherins are 
transmembrane Ca2+-dependent adhesion molecules which are either present over the 
entire cell surface or localised to epithelial adherens junctions depending on the cell 
type and state and which maintain adhesion through homophilic interactions with the 
extracellular domains of cadherin molecules on adjacent cells (Takeichi, 1991; Shapiro 
et al., 1995). In order to function in this manner, cadherins must form intracellular 
connections with cytoplasmic catenin proteins and, through these, with the actin 
cytoskeleton (Figure 1.5) (Kemler et al., 1989; Gumbiner, 1993). a-Catenin has actin- 
binding activity and is thought to function in linking the actin cytoskeleton to the 
intracellular cadherin domain (Rimm et al., 1995). This is achieved through interaction 
with P-catenin which binds to cadherin and a-catenin although another protein, 
plakoglobin, may take the place of p-catenin in the complex (Aberle et al., 1994; 
Nathke et a l, 1994). The most important role of cadherin/catenin complexes in most 
systems is general cell adhesion. During C.elegans morphogenesis, however, it appears 
that this role may be performed by other molecules, while a putative cadherin/catenin 
complex performs the important role of anchoring the actin cytoskeleton to the adherens 
junctions (Laure et al., 1994; Costa et al., 1998). In any system that requires active 
organisation of the actin cytoskeleton for morphogenesis, especially when a contractile 
mechanism is involved, the anchorage of the active components must be essential.
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Figure 1.5
Possible models of cell adhesion and actin filament binding by the cadherin- 
catenin complex at epidermal adherens junctions
It is known that a-catenin binds to cadherin via p-catenin and that the cadherin- 
catenin complex is linked to the actin cytoskeleton but it is unknown whether a -  
catenin links directly to cytoplasmic actin filaments (model ii) or if  there is an 
unknown component which links the a-catenin-associated adherens junction 
filaments with cytoplasmic actin filaments (model i). The C.elegans homologues 
o f cadherin, a-catenin, and P-catenin are noted in brackets. They are thought to 
play a major role in the anchorage o f cytoplasmic actin filaments during 
embryonic elongation (see section 1.7.5.4).
The extracellular cadherin domain is thought to mediate cell adhesion through a 
zipper-like mechanism with extracellular cadherin domains on neighbouring 
cells.
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There clearly must be other adhesive molecules acting in C.elegans in order to maintain 
general cell adhesion but it is unknown whether these molecules are cadherin-related or 
of a completely different nature (Costa et a l, 1998). There are many other cell-cell 
adhesion molecules which may mediate general cell interactions in C.elegans and in 
other systems (Prieto and Crossin, 1995).
1.6.5. Mechanisms of epithelial morphogenesis
There are several mechanisms whereby an ectodermal sheet can change the 
shape of the organism or structure it covers and the main processes used to achieve 
morphogenesis are: cell shape change, cell rearrangements and the addition or deletion 
of cells (Fristrom, 1988). All of these mechanisms are dependent completely or in part 
on the aspects of epithelial structure and function outlined above.
The orientation of cell divisions in C.elegans and in the leech are very important 
in mediating cell-cell contacts and in this way could be considered as contributing to 
morphogenesis but cell divisions are essentially complete within the embryo when 
actual body morphogenesis occurs and so the addition of cells is not used as a 
morphogenetic process as it is in other systems (Sulston et al., 1983; Zackson, 1984; 
Hartenstein and Campos-Ortega, 1985). Cell death has also been shown to have a role 
in shaping epithelia in vertebrate neural tube morphogenesis and separating digits in 
developing limbs (Fristrom, 1988).
Cell shape change appears to be of paramount importance in the shaping of the 
C.elegans embryo and in the elongation of the Drosophila leg as well as in 
morphogenesis of many other tissues (Priess and Hirsh, 1986; Condic et al., 1991). As 
discussed above and in other sections of this introduction, this cell shape change appears 
to be almost entirely driven by actin microfilaments within the epithelial cytoskeleton 
which are often associated with myosin (Spooner et al., 1973; Priess and Hirsh, 1986; 
Young et al., 1993). The individual cell shape changes are often channelled in one 
direction by restricting movement in one plane, thus causing the cells to elongate. The 
force produced by this individual cell shape change is transmitted across the epithelial 
sheet via tight cell-cell junctions to produce an overall morphogenetic change. The 
mechanism of cell flattening has also been shown to be an essential component to 
epiboly in some organisms, where the epithelial cells spread around the embryo in order
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to cover it completely, and in the process of wound healing (Radice, 1980; Trinkaus, 
1984). Cell flattening is also a component of Drosophila wing imaginal disc 
development and sea urchin embryogenesis (Ettensohn, 1985; Milner and Muir, 1987).
Cell rearrangement is another mechanism resulting in the spreading of epithelial 
cells and in shape change in many organisms (Keller and Trinkaus, 1987; Schoenwolf 
and Alvarez, 1989; Wilson and Keller, 1991; Williams-Masson et al., 1998). This is the 
process whereby epithelial cells change position within the epithelial sheet while 
maintaining tight junctions and cell-cell contacts with neighbouring cells (Keller and 
Trinkaus, 1987; Fristrom, 1982). It is involved in the elongation of certain structures 
during sea urchin and Drosophila development and also is responsible for the first 
obvious shape change during C.elegans morphogenesis, the bending of the dorsal 
surface (Fristrom, 1976; Ettensohn, 1985; Hardin, 1989; Williams-Masson et al., 1998). 
The mechanism of cell rearrangement is not well understood although a recent report in 
C.elegans has implicated both actin microfilaments and microtubules as being involved 
(Williams-Masson et al., 1998).
1.7. Hypodermal development and function in C.elegans embryonic and 
postembryonic body morphogenesis
I will now look at the processes involved in C.elegans morphogenesis in detail from the 
cell fate specification of hypodermal cells through to the actual mechanisms that shape 
the embryo into the worm and maintain this shape throughout the life cycle.
1.7.1. Establishment and maintenance of the hypodermal cell fate in early 
embryos
1.7.1.1. Establishment of the hypodermal cell fate
Hypodermal cells are derived from two of the C.elegans founder cells, AB and C 
(Sulston et al., 1983). 72 hypodermal cells are descendants of the AB founder cell, 
while 13 are descendants of the C founder cell (Figure 1.2)(Sulston et al., 1983). The 
specification of cell fate in the AB lineage is quite complicated and arises from several 
binary switches early in development (Schnabel and Priess, 1997). These switches are
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a Possible anterior-posterior induction
b
AB
Anterior-posterior induction
2-cell stage
ABa ABp
4-cell stage
EMS
Left-right induction 
MS
ABala
ABprp
12-cell stage
ABara
ABi,rP ABpra 
Figure 1.6
Summary of the main inductions that occur in the early AB lineage to 
specify cell fate
a Possible anterior-posterior induction in the 2-cell stage embryo by the P, cell 
on the AB founder cell which may establish different identities in the anterior 
and posterior descendants o f AB.
b Anterior-posterior induction in the 4-cell stage embryo by the P2 founder cell 
which affects the ABp cell and establishes different identities in the previously 
equivalent ABa and ABp daughters o f AB.
c Left-right induction in the 12-cell stage embryo by the MS founder cell which 
establishes a pharyngeal fate in ABalp and ABarp descendants o f AB. (adapted 
from Schnabel and Priess, 1997)
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summarised in Figure 1.6. They all depend on cell-cell contacts, establish blastomere 
lineage fates and act to differentiate otherwise equivalent cells (Schnabel and Priess, 
1997).
There is disagreement as to whether there is an interaction between the AB and 
PI cells at the two cell stage in the embryo which polarises the AB cell and is involved 
in anterior-posterior patterning (Hutter and Schnabel, 1995b), or whether this anterior 
posterior asymmetry is already present in the AB blastomere by the first cleavage of the 
embryo (Gendreau et a l , 1994). However, it is generally agreed that at the 4 cell stage 
of the embryo, there is an interaction between P2 and ABp (the posterior daughter of 
AB) which changes the ABp blastomere from one equivalent to ABa (the anterior 
daughter of AB) to a blastomere with an unique fate (Priess and Thomson, 1987). This 
interaction depends on direct contact between ABp and P2 and it has been shown that if 
the orientation of cells in a 4 stage embryo is perturbed so that ABa contacts P2 and ABp 
does not, then ABa acquires the usual ABp cell fate and vice versa (Mango et a l , 
1994b; Hutter and Schnabel, 1994). This interaction has two main consequences: 
firstly it infers the ability on ABp to produce certain unique cells and products not 
produced by ABa, and secondly, it causes ABp to become largely unresponsive to the 
later induction from the MS founder cell which induces anterior pharynx in descendants 
of ABa (McGhee, 1995).
It has been proposed that each of the four granddaughters in the AB lineage has 
an intrinsic ability to produce one neuronal and one hypodermal precursor from each 
division and that the default state of cells in the AB lineage is neuronal (Gendreau et a l , 
1994). The hypodermal precursors produce mostly the major hypodermis: seam (lateral 
hypodermal cells), P cells (ventral hypodermal cells), and the major hypodermal 
syncytia. The minor epidermal cells (small head and tail hypodermal syncytia as well as 
neuronal support cells) are produced from both hypodermal and neuronal producing 
cells. It has been suggested that the ABa cell produces anterior granddaughters which 
are predisposed to become neurons and posterior granddaughters which are predisposed 
to become hypodermis and that this is reversed in the granddaughters of the ABp cell 
(Gendreau et a l , 1994; Moskowitz et a l , 1994). This fate disposition was thought to be 
an intrinsic feature of the AB blastomere at the first cleavage and it was reported that 
when P, was ablated at the 2 cell stage then this patterning remained (Gendreau et a l , 
1994). Hutter and Schnabel (1995b), however, have reported that when Pj is ablated at
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the 2 cell stage then the posterior granddaughters of both ABa and ABp change their 
fate to that of the anterior granddaughters, while the fate of the anterior granddaughters 
does not change. In both models, it was shown that the normal left-right asymmetry of 
the AB lineage was absent after P, removal for reasons explained below.
The interaction, involving the MS founder cell, which establishes left-right 
asymmetry is illustrated in Figure 1.6c. The MS founder cell which is a descendant of 
P, contacts three cells at the 12 cell stage of development and two of them, descendants 
of the ABa cell (shown in black in Figure 1.6c), are induced to form pharyngeal cells 
(Sulston et a l , 1983; Priess et al., 1987; Flutter and Schnabel, 1994; Moscowitz et al.,
1994). The third contacting cell is a descendant of the ABp cell and as mentioned 
before, is normally unresponsive to the MS induction due to an earlier interaction 
between ABp and P2. When the MS cell is removed, extra neuronal and hypodermal 
cells are produced from the cells which would have been induced by contact with MS 
(Priess et a l , 1987). This interaction between MS and two of the ABa granddaughters 
establishes a left-right asymmetry in the embryo which is modified by two later 
interactions (Schnabel and Priess, 1997). These final two cell-cell interactions affect 
ABp descendants on the left side of the embryo only, one occurring at the 24 cell stage 
between an ABa and ABp descendant, and one occurring at the 26 cell stage between an 
MS descendant and an ABp descendant (Hutter and Schnabel, 1994, 1995a). They 
specify further left-right asymmetries in the AB lineage.
In the C lineage, each daughter of the C blastomere also divides to produce one 
hypodermal and one non-hypodermal precursor although the non-hypodermal precursor 
produces body wall muscle rather than nervous tissue (Sulston et a l , 1983; Gendreau et 
a l , 1994). It also seems that the C founder cell has the intrinsic ability to produce 
hypodermis in isolation (Gendreau et a l , 1994). The genes involved in the induction of 
hypodermis appear to be completely separate in the two systems however and are 
discussed below.
I.7.I.2. Genes involved in specifying hypodermal cell fates
Many genes have been implicated as regulators in the inductions described 
above or as specifiers of hypodermal cell fate. Most events of C.elegans embryogenesis 
from fertilisation to gastrulation are thought to be controlled by maternally provided
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products and so most of the genes found to be involved in early cell-cell interactions in 
the AB lineage are maternally expressed (McGhee, 1995). glp-1 is a maternally 
expressed gene which is a homologue of lin-12 and the Drosophila Notch gene and 
which has been implicated in several cell-cell interactions during development (Austin 
and Kimble, 1987; Priess et al., 1987; Yochem and Greenwald, 1989). The protein 
encoded by glp-1 is present on the surface of AB but not P, descendants and has been 
implicated as the receptor in both the P2 and MS cell interactions. In the P2 interaction, 
the ligand for GLP-1 is thought to be APX-1 which is a homologue of the Drosophila 
Notch protein, Delta (Mello et al., 1994; Schnabel and Priess, 1997). APX-1 is 
expressed in P2 and is localised to the junction between P2 and ABp (Mickey et a l ,
1996). The ligand for GLP-1 in the MS interaction is unknown although it does not 
appear to be APX-1 or the product of two of its homologues (Schnabel and Priess,
1997). GLP-1 is also thought to function with LIN-12 in the minor left-right asymmetry 
interactions at the 24 and 26 cell stage (Schnabel and Priess, 1997).
The pal-1 gene is expressed both maternally and embryonically and appears to 
be involved in specifying the correct development of the C lineage and it seems that the 
expression of PAL-1 is regulated by the product of the mex-3 gene (Schnabel and Priess,
1997). In mex-3 mutants, PAL-1 is expressed ectopically in the granddaughters of the 
AB lineage whereby each of them produces body wall muscles and hypodermal cells as 
in the wild type C lineage (Draper et al., 1996; Schnabel and Priess, 1997). MEX-3 
contains two domains which are thought to mediate interactions with RNA and it has 
been suggested that MEX-3 binds to the pal-1 mRNA and prevents its translation in AB 
descendants in the wild type embryo but not in the P! lineage where PAL-1 is normally 
expressed (Schnabel and Priess, 1997).
Several genes have been implicated in the specification of hypodermis. These 
genes generally act later in embryonic development and are usually zygotically 
expressed although they are probably controlled by maternal products, elt-1 is an 
embryonically expressed gene which encodes a GATA-like transcription factor and is 
required for the production of major hypodermal cells from both the AB and C lineages 
(Spieth et al., 1991; Page et al., 1997). In elt-1 homozygous lethal mutants, cells that 
become epidermal cells in wild type embryos become either neurons (AB lineage) or 
muscle cells (C lineage) (Page et a l , 1997). ABp descendants differentiate into an as of 
yet unknown cell type which is neither hypodermal, neuronal or muscle. ELT-1 is
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expressed in hypodermal precursors from the 44 cell stage and in their hypodermal 
descendants and it appears that elt-1 is required for the specification of hypodermal cell 
fate. In the C lineage, it is possible that ELT-1 is regulated by PAL-1 which is 
expressed in the hypodermal precursors before and during the time of ELT-1 
expression. LIN-26, a presumptive zinc-finger transcription factor, is present in the 
nuclei of all non-neuronal ectodermal cells and appears to be involved in the 
maintenance of cell fate in this group which includes hypodermal cells (Labouesse et 
al., 1994; Labouesse et al., 1996). lin-26 expression is first seen in cells of the AB and 
C lineages that give rise to hypodermal cells around 2 cell divisions prior to the 
generation of these cells. In homozygotes of one mutant allele, lin-26(nl56), a subset of 
hypodermal cells, the P cells, differentiate into neurons rather than hypodermis, and in 
mutants homozygous for strong loss of function alleles mcl and mc4, hypodermal cells 
are abnormal and degenerate rapidly (Labouesse et a l, 1996). elt-1 mutants and 
chromosomal deficiencies deleting the elt-1 region prevent the normal expression of 
LIN-26 (Chanal and Labouesse, 1997; Page et al., 1997). Another GATA-like 
transcription factor, ELT-3, is localised to the nuclei of all hypodermal cells except the 
lateral seam cells immediately after the final cell division that gives rise to their terminal 
fate (Gilleard et al, 1999). elt-1 is required for the formation of most elt-3 expressing 
cells but lin-26 function does not appear to be necessary for elt-3 expression. Ectopic 
expression of elt-3 in early blastomeres produces additional hypodermal cells 
(J.Gilleard, pers. comm.). However, worms homozygous for a deletion which removes 
the DNA-binding domain of elt-3 appear to have a normal hypodermis which suggests 
that elt-3 has a redundant role in hypodermal differentiation (J.Gilleard, pers. comm.).
Several embryonically expressed genes also appear to specify the fate of a 
particular subset of hypodermal cell, the lateral seam cells, hln-2 encodes a zinc finger 
protein and is expressed exclusively in seam cells from the precomma stage until 
adulthood. This gene may play a role in specifying and patterning seam development. 
However, inhibition of the function of hln-2 by RNAi does not appear to give a 
noticeable phenotype which suggests that it could be redundant (K.Koh, pers. comm.). 
Another gene encoding a GAT A factor, elt-8, is expressed at high levels in seam cells 
and in lower levels in many other cells, mostly derived from the AB lineage. Inhibiting 
elt-8 function using RNAi resulted in lumpy worms with fewer than normal seam cells 
(K.Koh, pers. comm.). Another gene which acts in the seam cells is lin-22 (Wrischnik
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and Kenyon, 1997). Anterior seam cells (V1-V4) are blast cells which generate only 
hypodermis postembryonically in the wild type C.elegans, while a pair of seam cells to 
the posterior (V5 and V6) produce neuronal as well as hypodermal cells in males, lin- 
22 appears to act in VI-V4 to prevent them from following a more posterior-like fate 
and also seems to act in a branch of the V5 lineage to prevent excess neurons from 
being produced. In order to repress the production of excess neurons, lin-22 inhibits the 
expression of the posterior Hox gene mab-5 in both V5 and VI-V4 cells as well as 
inhibiting the activity of lin-32 and another as yet unidentified gene involved in the 
regulation of stem cell division in cells VI-V4. Interestingly, lin-22 is a homologue of 
the transcriptional regulator hairy and the Enhancer o f split complex genes of 
Drosophila (Wrischnik and Kenyon, 1997). These genes regulate multiple components 
of anterior-posterior patterning and neural development in Drosophila and some of the 
lin-22 activities are similar to those of its homologues.
1.7.2. Enclosure of the hypodermis in the C.elegans embryo
As cell divisions are occurring and cell fates are being specified, the precursors 
of the future internal structures of C.elegans migrate internally, a process known as 
gastrulation, producing novel cell-cell contacts and positioning the cells in the correct 
place within the embryo. Gastrulation is described in more detail in section 5.1.2. At 
the end of cell division, terminally differentiated hypodermal cells arise on the dorsal 
surface of the developing C.elegans embryo around 290 mins after first cleavage at 
20°C (Sulston et al., 1983). They organise into a monolayer of 6 rows of cells which 
then extends laterally around the embryo until the migrating edges meet at the ventral 
midline and form adherens junctions so that the entire embryo is enclosed in a 
continuous hypodermal layer. This process of epiboly, or spreading of epithelial sheets, 
is known as enclosure in C.elegans and occurs in two stages. The first stage involves a 
quartet of hypodermal cells, the leading cells, migrating around the embryo bilaterally 
towards the anterior using actin-rich filopodia to achieve movement (Williams-Masson 
et al., 1997). The other hypodermal cells are pulled around the embryo by this leading 
cell movement and eventually the leading cells from either side meet and fuse, forming 
adherens junctions, at the ventral midline. The second process of enclosure occurs at 
the ventral midline when the hypodermal cells from the anterior and posterior meet in a
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circular ‘pocket’. The cells at the edge of this pocket are known as the ventral pocket 
cells and appear to close in a ‘purse-string’ manner involving a contractile actin band 
similar to that employed in Drosophila dorsal enclosure or the healing of small wounds 
(Martin and Lewis, 1992; Young et a l, 1993). Enclosure is discussed in more detail in 
section 4.1.2.
1.7.3. Cell rearrangem ent during intercalation of the dorsal hypodermis in
C.elegans
Cells forming the two rows of the dorsal hypodermis undergo a process of 
intercalation which starts at around 330 mins after fertilisation as hypodermal cells are 
migrating around the embryo, and ends during ventral enclosure (Sulston et al., 1983; 
Williams-Masson et al., 1998). The tip of each intercalating cell produces a thin 
protrusion which wedges underneath and between the adherens junctions of its two 
contralateral cells and as the tip widens dorsoventrally and in the anterior-posterior 
direction, the cell pushes completely between the two cells resulting eventually in one 
row of dorsal hypodermal cells (Figure 1.7) (Williams-Masson et al., 1998). Prior to 
dorsal intercalation the embryo is a relatively spherical shape but this process produces 
a slight bend in the embryo by creating a longer dorsal surface with the merging of two 
hypodermal rows (Priess and Hirsh, 1986; Williams-Masson et al., 1998). The embryo 
is now at the precomma or lima-bean stage. This mechanism of cellular rearrangement 
is dependant on the presence of microtubules for its initiation and also requires actin 
microfilaments for successful completion. It is thought that the microtubules are 
necessary for the formation of the initial tip-protrusion and provide the rigidity needed 
for it to furrow between the two contralateral cells. The role of actin microfilaments in 
the process is less clear. There does not seem to be specific microfilament localisation 
or organisation in the intercalating tips like those seen in the leading edges of enclosing 
cells (Williams-Masson et al., 1997; 1998). Instead, it is possible that the disruption of 
the actin cytoskeleton of the cell may be enough to cause the defects seen in 
intercalating cells when cytochalasin D is used to interfere with actin filaments (Priess 
and Hirsh, 1986; Williams-Masson et a l, 1998). It has been suggested that the cue for 
dorsal hypodermal intercalation may come from signals produced by the basement 
membrane or underlying muscles (Williams-Masson et a l, 1998). This is because
34
Figure 1.7
Dorsal intercalation of hypodermal cells
The two rows of dorsal hypodermal cells are the central two rows in the diagrams, the 
cells of one side are shaded to illustrate intercalation into a single row. The anterior is 
towards the top of the figure. Cells are shown as if  the central region of the hypodermis 
was cut open along the ventral midline and viewed from above. Progression from a to c 
occurs as the hypodermal cells migrate ventrally around the embryo during hypodermal 
enclosure. The embryo illustrated in b would be a precomma embryo and in c would be 
a comma stage embryo. (Adapted from Podbilewicz and White, 1994).
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intercalation of the dorsal hypodermis is not blocked by the removal of neighbouring 
lateral hypodermal cells and it does not seem that the intercalating ability of individual 
dorsal cells is prevented by the ablations of any neighbouring cell of the dorsal 
hypodermis.
1.7.4. The relation of enclosure and dorsal intercalation to subsequent 
morphogenesis in C.elegans
It is obvious that complete hypodermal enclosure is necessary for subsequent 
elongation of the C.elegans embryo as embryos with enclosure defects rupture when 
elongation is initiated, probably because of pressure exerted on internal cells by the 
contracting hypodermis (Mango et a l , 1994a; Labouesse, 1997; Williams-Masson et al., 
1998; Costa et al., 1998). It is possible that the tension and hypodermal cell movements 
during enclosure help to organise the circumferentially oriented actin filaments 
responsible for elongation (Williams-Masson et al., 1998). It is also obvious that 
correct junctions must be formed along the ventral midline before morphogenesis can 
occur (Costa et al., 1998). Whatever the function of enclosure relating to subsequent 
morphogenesis, it is evident that it is an essential prerequisite to normal elongation.
The intercalation of the dorsal hypodermis also appears to be necessary for 
subsequent normal elongation. Mutants homozygous for a mutation in the die-1 gene 
show incomplete dorsal intercalation and arrest at the 1.5 to 2-fold stage (P.Heid, 
pers.comm.). Enclosure and fusion do occur in these mutants, although fusion appears 
to be initiated prematurely and enclosure is not completely normal, die-1 encodes a zinc 
finger protein which is interesting as several putative transcription factors in Drosophila 
are involved in cell rearrangement in ovary and embryo development (Godt and Laski, 
1995; Oda et al., 1998; P.Heid, pers.comm.). It is possible that the intercalation of the 
dorsal hypodermal cells is necessary for the alignment of the microtubule framework 
which in turn may allow the circumferential alignment of actin microfilaments and 
subsequently elongation of the worm (Priess and Hirsh, 1986; Williams-Masson et al.,
1998).
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1.7.5. Elongation of the C.elegans embryo
1.7.5.1. Mechanism of elongation in wild type embryos
During mid-embryogenesis, from around 390-690 mins after fertilisation, the 
C.elegans embryo elongates from a relative spheroid to a cylindrical worm shape four 
times the original length and with a decrease in width of around threefold (Sulston et a l, 
1983; Wood, 1988). Active elongation begins after the intercalation of the dorsal 
hypodermal cells produce a slight bend in the embryo and is thought to be driven by the 
contraction of actin-rich microfilament bundles which circumferentially align 
throughout the hypodermis prior to elongation (Priess and Hirsh, 1986). Microtubules 
in the hypodermal cells also align circumferentially and are thought to maintain the 
tensile strength of the cells during elongation. There is also an extracellular sheath 
present over the surface of the embryo from the beginning of elongation which may act 
to transmit stresses across the hypodermis. Actin-mediated elongation is described in 
detail in section 6.1.1.
1.7.5.2. Hypodermal cell fusions during embryonic elongation
There are 78 hypodermal nuclei in the C.elegans embryo at the end of elongation 
but only 42 hypodermal cells (Sulston et a l, 1983; Podbilewicz and White, 1994). This 
arises due to the extensive cell fusions which occur in the hypodermis prior to and 
during embryonic elongation. After dorsal intercalation, 17 cells from the dorsal 
hypodermis fuse with 4 cells at the anterior of the ventral hypodermis and 2 cells at the 
posterior anus to form hyp7, the largest hypodermal syncytium (Figure 
1.8)(Podbilewicz and White, 1994). To the anterior of hyp7, hypodermal cells fuse to 
form 6 smaller syncytia, hypl-hyp6 with 3,2,2,3,2 and 6 nuclei respectively (White, 
1988). To the posterior of hyp7, hypodermal cells fuse to form 4 smaller syncytia, 
hyp8-hypll, containing 1,1,2 and 1 nuclei respectively (White, 1988). The 10 lateral 
hypodermal cells on either side of the embryo and the 6 pairs of P cells on the ventral 
surface of the embryo do not fuse during embryogenesis but remain mononucleate 
(Podbilewicz and White, 1994). Recently, a cold sensitive mutant with defects in dorsal 
fusion of the hypodermis has been characterised and homozygous embryos arrest at a
Anterior
hypl
hyp2
hyp3
hypl 1
hyplO (dorsally)
hyp8
hyp9
hyplO (ventrally)
Posterior
Figure 1.8
Hypodermal cell positions at hatch
This diagram is a representation o f an embryo hypodermis at hatch which has 
been cut open along the ventral midline and viewed from above. It illustrates the 
fusion o f the hypodermis into 11 syncytia (hypl-hypl 1), which contain 3, 2, 2, 3, 
2, 6, 23, 1, 2, 2 and 1 nuclei respectively. The ventral P cells (1-12) and the 
lateral paired seam cells (HI,  H2, V I-V 6, and T) remain mononucleate during 
embryogenesis. (Adapted from Podbilewicz and White, 1994).
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1.5- to 2-fold stage of elongation indicating that normal hypodermal fusion is necessary 
for the completion of elongation (B.Podbilewicz, pers. comm.). Viral-induced cell 
fusion and invasion are cold-sensitive processes and the nature of this duf-1 mutation 
suggests that hypodermal cell fusion is also a cold-sensitive process. It has also been 
reported recently that cell fusion between hypodermal cells occurs by a similar 
mechanism to virus-cell fusion (Mohler et a l, 1998). Hypodermal cell fusion initiates 
at a single point or pore restricted to the adherens junctions, and then widening basally 
and laterally in a radial wavefront as the fusing membranes are internalised by 
vesiculation.
1.7.5.3. Hypodermally expressed genes involved in embryonic elongation
Despite the evidence implicating the hypodermis as the tissue responsible for 
driving cell shape change and elongation in the C.elegans embryo, there remain very 
few elongation defective mutants which show mutations in hypodermally expressed 
genes. Most of the elongation defective mutants characterised to date have mutations in 
genes expressed in the body wall muscle which is attached to the hypodermis, or in 
genes encoding proteins present in the basement membrane between hypodermal and 
muscle cells. These observations indicate that the presence of normal body wall 
muscles, muscle-hypodermis basement membrane, and muscle-hypodermis attachments 
are essential for complete elongation of the embryo although the role of the muscle in 
elongation is still unknown (Guo et a l, 1991; Lundquist and Herman, 1994; Sibley et 
a l, 1994; Williams and Waterston, 1994; Gupta et a l, 1997). I will discuss mutations 
in genes expressed in both hypodermis and body wall muscle which result in an 
elongation-defective phenotype.
Priess and Hirsh (1986) proposed that the circumferentially oriented 
microfilaments within hypodermal cells were connected to the adherens junctions at 
each side of the cell they traversed and recently this idea has been reinforced by the 
characterisation of mutations in the genes hmp-1, hmp-2 and hmr-1 which encode 
homologues of the cell adhesion proteins a-catenin, p-catenin/Armadillo, and classical 
cadherin respectively (Costa et a l,  1998). Mutants homozygous for hmp-1 and hmp-2 
arrest as embryos with severe defects in elongation although all other tissues and 
structures show terminal differentiation. This is also true for around 40% of hmp-2
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homozygotes and 2% of hmr-1 homozygotes. The other hmp-2 homozygotes arrest with 
less severe elongation defects while 98% of hmr-1 homozyogtes undergo abnormal 
ventral hypodermal enclosure as discussed in section 4.1.2.2. The elongation defective 
mutants begin to elongate as normal although subsequently only the ventral cells are 
seen to elongate significantly and dorsal folds appear as the dorsal hypodermis retracts 
along with the ventral elongation. Immunofluorescence studies have shown that the 
actin microtubule bundles align as normal and appear to be anchored to the adherens 
junctions on either side of the hypodermal cells. However, during elongation, actin 
microfilaments in the dorsal hypodermis detach from the adherens junctions and retract 
towards the dorsal midline so that further contractions no longer draw opposing sides of 
the hypodermal cell together and therefore do not result in elongation of the cell. 
Detachment of actin microfilaments does not occur in the much smaller lateral or 
ventral hypodermal cells and it is thought that the attachments are under much more 
stress in the dorsal hypodermis which is mostly made up of the single large hyp7 
syncytium. In lateral and ventral cells there are adherens junctions between unfused 
cells which run parallel to the circumferential actin microfilaments down the length of 
the embryo while in the dorsal hypodermis there are only two adherens junctions 
parallel to the contractile microfilaments, one at either end of the hyp7 syncytium. 
These adherens junctions may help withstand the stretching forces created by 
microfilament contraction in lateral and ventral hypodermal cells. HMP-1, HMP-2 and 
HMR-1 all localise to adherens junctions between hypodermal cells. Wild type hmr-1 is 
required to localise HMP-1 and HMP-2 to adherens junctions and wild type hmp-2 is 
required to localise HMP-1 to adherens junctions.
From the characterisation of these mutations it appears that the actin 
microfilaments are anchored to the adherens junctions via a putative cadherin/catenin 
system (see Figure 1.5)(Costa et al., 1998). This system is used extensively in both 
vertebrate and invertebrate epithelial cells for cell-cell adhesion, signal transduction and 
the organisation of the actin cytoskeleton and so it seems that it plays a similar role in 
C.elegans during embryonic elongation (Aherle et a l , 1996; Gumbiner, 1996). Another 
cadherin-related gene in C.elegans, cdh-3, shares homology with the Drosophila 
dachsous gene (see below) and has been shown to have a role in the morphogenesis of a 
single hypodermal cell, hyplO (Pettitt et al., 1996). It is expressed in developing 
hypodermal and neuronal cells throughout development and null mutations in cdh-3
result in an abnormal tail phenotype. It was proposed that cdh-3 acts to maintain the 
connection between hyplO and hypl 1 cells during elongation of the tail in embryos and 
that disruption of this connection results in abnormal tail morphogenesis. Because cdh- 
3 is expressed in many more hypodermal cells than are affected in a cdh-3 null 
mutation, there must be other cadherin-related or general adhesion molecules which can 
substitute for cdh-3 function in these cells. Severe mutants of the Drosophila dachsous 
gene, which encodes a protein with 27 cadherin domains, have abnormal legs with 
shorter, thicker leg segments (Clarke et a l , 1995). The mechanism of Drosophila leg 
elongation is also thought to be driven by cell shape change caused by the contraction of 
an apical actin-myosin belt and so would also require a mechanism to transmit this 
contractile force across a sheet of epidermal cells in order to cause shape change on a 
larger scale (Condic et a l , 1991; von Kalm et a l , 1995). It is thought that the 
contractile actin-myosin belt is connected to the adherens junctions via a 
cadherin/catenin system as in vertebrates (von Kalm et a l , 1995).
Another gene which is involved in elongation and is expressed in the 
hypodermis is sma-1 which encodes a PH-spectrin homologue, a novel isoform of P- 
spectrin which was first identified in Drosophila (McKeown et a l , 1998). sma-1 
homozygotes are viable and elongate for the same length of time as wild type embryos 
but they have a decreased rate of elongation and result in short, wide larvae with a blunt 
anterior, abnormally elongated pharynx, and a twisted tail. Different sma-1 alleles 
elongate at different rates specific to each allele and sma-1 RNA is located in 
hypodermal cells from the start of hypodermal migration around the embryo prior to 
enclosure. As embryos elongate, the level of sma-1 RNA in hypodermal cells rapidly 
decreases and cannot be detected after the 2-fold stage. Spectrin is a heterodimeric 
actin-binding protein which is composed of a - and p-spectrin subunits and forms a 
cytoskeletal network with the plasma membrane (Bennett and Gilligan, 1993). PH- 
spectrin differs from P-spectrin in that it does not contain an ankyrin binding sequence 
that is present in p-spectrin and it does contain SH3 domains which are not present in P- 
spectrin (Thomas et a l , 1997). In polarised epithelia, a-spectrin is generally distributed 
on plasma membranes while p-spectrin is restricted to the basolateral surface and pH- 
spectrin is localised at the apical surface at the adherens junction (Lee et a l , 1993; de 
Cuevas et a l, 1996; Thomas et a l, 1997). A pair of a-spectrins can form tetramers with 
a pair of either P- or PH-spectrins and both can crosslink actin (Dubreuil et a l, 1990). It
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is proposed that SMA-1 acts as a component of the hypodermal actin cytoskeleton to 
regulate the elongation of the C.elegans embryo (McKeown et al., 1998). SMA-l/oc- 
spectrin tetramers could link the actin fibres in the hypodermis to each other and to the 
apical membrane thus stabilising the actin cytoskeleton during elongation. SMA-1 may 
play a regulatory role as well as a structural role in embryonic elongation as indicated 
by the decreased rate of elongation of sma-1 mutants. It is suggested that SMA-1 may 
play a role in the interaction between muscle and hypodermis at the attachment sites, 
possibly as a binding site for signal transduction molecules. In Drosophila, PH-spectrin, 
encoded by the karst gene, co-localises with DE-cadherin (Thomas et al., 1998). It is 
thought to play a role in mediating tight cell-cell adhesion in order to facilitate cell 
signalling through the close association with the cadherin cell adhesion complex and is 
essential for eye development. pH-spectrin is associated with regions of apical 
contraction resulting in cell shape change and movement during morphogenesis of the 
Drosophila embryo although no karst mutants have shown matching morphological 
defects to date (Thomas and Kiehart, 1994; Thomas et al., 1998). Interestingly, a 
mutation in the gene encoding an homologue of a-spectrin, spc-1, has recently been 
isolated in C.elegans and it produces a phenotype of 1.5- to 2-fold arrest (K.Norman, 
pers. comm.). There appears to be no disorganisation in the hypodermal actin filament 
pattern but instead these mutants show abnormalities in the body wall muscle and 
overlying basement membrane, which are twice as wide as normal, and in pharyngeal 
muscle, resulting in abnormal pumping (K.Norman, pers. comm.).
The third C.elegans hypodermally expressed gene with an apparent function in 
embryonic elongation is let-502, which encodes a Rho-binding serine/threonine kinase 
and which interacts with mel-11, a gene encoding a protein similar to regulatory 
subunits of smooth muscle myosin-associated phosphatase (Wissmann et al., 1997). 
LET-502 is expressed in the hypodermal seam cells and the gain of function mutations 
in let-502 resulted in embryonic arrest with no elongation although other tissues and 
structures appeared to have differentiated terminally (Wissmann et al., 1997; A.Piekny, 
pers.comm.). These results may implicate a myosin component of the microfilament 
contraction which drives elongation.
Smooth-muscle myosin II is composed of two heavy chains and two pairs of 
light chains (Allen and Walsh, 1994). In smooth muscle, and non-muscle cells, 
phosphorylation of either muscle or non-muscle myosin light chain (MLC), one of the
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pair of two myosin light chains, results in the formation of myosin cross-bridges along 
actin filaments and subsequently either contraction of the smooth muscle, or the 
assembly of contractile acto-myosin stress fibres in non-muscle cells (Allen and Walsh, 
1994; Giuliano and Taylor, 1995; Huttenlocher et al, 1995; Kimura et al, 1996; Gong et 
al, 1996). Phosphorylation of MLC is carried out by Myosin light chain kinase 
(MLCK) and Myosin light chain phosphatase (MLCP) reverses this effect by 
dephosphorylating MLC resulting in the relaxation of muscle cells or inhibition of stress 
fibre formation depending on the cell (Allen and Walsh, 1994; Giuliano and Taylor, 
1995). The process of MLC phosphorylation is regulated mainly by intracellular Ca2+ 
levels as Ca2+ regulates MLCK activity. However, it has been found that the state of 
MLC phosphorylation can be altered while Ca2+ levels remain constant and therefore 
there must be other regulatory mechanisms involved (Bradley and Morgan, 1987). 
Many studies have since implicated small GTPases such as Rho in the regulation of 
MLC phosphorylation and thus the control of myosin contraction in smooth muscle 
(Kimura et al., 1996; Gong et al., 1996). Rho activates several serine/threonine kinases 
including rho-binding kinase which inactivate MLCP by phosphorylating their myosin- 
binding subunits thus preventing the dephosphorylation of MLC (Kimura et al., 1996). 
In this way, activation of Rho can trigger or maintain myosin contraction. Rho, and 
Rho-binding kinases have also been implicated in non-muscle cells in cytoskeletal 
reorganisation of actin and myosin to form contractile stress fibres which run 
throughout the cytoplasm and are anchored at the plasma membrane by cell adhesion 
molecules in sites known as focal adhesions (Ridley and Hall, 1992; 1994; Hall, 1998).
A possible model was proposed for the function of the let-502 and mel-11 genes 
which suggested that a small GTPase could activate LET-502 which would then 
phosphorylate MEL-11 preventing dephosphorylation of non-muscle MLC (nmMLC) 
and may in fact phosphorylate nmMLC itself, leading to myosin contraction and thus 
elongation. In the absence of Rho activation, MEL-11 would dephosphorylate nmMLC 
and result in myosin relaxation. However, all the let-502 alleles identified by Wissmann 
et a l (1997) were gain of function alleles with a maternal component and it has been 
subsequently shown that both RNAi for let-502 and loss of function alleles produce 
variable phenotypes which are near wild type (A.Piekny pers.comm.). Although this 
strongly suggests that the let-502 and mel-11 pathway is redundant, it does not remove 
the possibility that other serine/threonine kinases or MLCP homologues may be
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interacting in a similar pathway active in C.elegans elongation. The mutant LET-502 
protein which results in a blockage of elongation may disrupt the function of another 
Rho-binding kinase in an active contractile pathway.
An embryonic morphogenetic process which apparently utilises an actin-myosin 
mechanism to drive cell shape changes and thus elongation is the morphogenesis of the 
Drosophila leg (Condic et al., 1991; von Kalm et al, 1995). During the prepupal period 
of Drosophila morphogenesis the leg imaginal disc evaginates from its larval position 
on the inner surface of the epidermis, and the femur and tibia undergo significant 
elongation via changes in the epidermal cell shape (Condic et al., 1991). Several 
mutations in two genes, zipper and spaghetti squash, result in abnormally elongated 
and malformed leg and wing discs (Gotwals and Fristrom, 1991). These two genes 
encode homologues of non-muscle myosin heavy chain (nmMHC) and nmMLC 
respectively and the zipper protein localises to the actin-myosin belt present around the 
apical edge of many epithelial cells forming the Drosophila leg (Gotwals and Fristrom, 
1991; Young et al., 1993). This suggests that Drosophila leg elongation results from 
the cell shape change caused by the contraction of a myosin motor in the actin-myosin 
belt (Condic et al., 1991; von Kalm et a l, 1995).
1.7.5.4. Genes encoding proteins present in basement membrane and muscle 
which are involved in embryonic elongation
Muscle cells arise in two lateral rows adjacent to the lateral hypodermal cells at 
around 290 mins after first cleavage and migrate dorsally and ventrally until there are 
two longitudinal rows to each side of the embryo midline on both the dorsal and ventral 
surfaces immediately underlying the hypodermis (Hresko et al., 1994). A basement 
membrane forms between adjacent muscle cells and between the muscle cells and the 
hypodermis. The embryo is at the precomma stage when the muscle cells have arranged 
in this way and the muscle and hypodermal cells remain in close contact during 
embryonic elongation with muscle cells forming attachments to the hypodermis as the 
embryo elongates from the comma to the 1.5-fold stage (Goh and Bogaert, 1991; 
Hresko et al., 1994). As the embryo continues to elongate, the myofilaments of the 
muscle cells attach through the basement membrane to hemidesmosome structures in 
the hypodermis containing intermediate filaments. It is thought that these
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hemidesmosomes are formed in response to signals from the underlying muscle cells as 
they do not form in hypodermal cells when the precursors of the underlying muscle cells 
have been ablated (Hresko et a l, 1994). Around the 3-fold stage of wild type 
elongation, the hemidesmosomes attach the muscle cells through the hypodermis to the 
cuticle so that their contractions will be manifested as body movements (Francis and 
Waterston, 1991). At the 1.5-fold stage of elongation the muscle cells are organised 
into sarcomeres and as elongation progresses, they become flattened and more closely 
aligned to the hypodermis (Guo and Bogaert, 1991; Hresko et al., 1994). Muscle cells 
usually begin contraction as the embryo elongates from 1.5- to 2-fold and result in the 
embryo vigorously rolling around inside the eggshell during the latter stages of 
elongation.
Both the correct assembly and organisation of muscle components and the 
formation of adequate connections between the body wall muscle and hypodermis 
appear to be essential for the normal completion of elongation. Mutations in genes 
encoding basement membrane proteins have also shown that this plays an essential role 
in the attachment of muscle to the hypodermis during elongation. Mutations in various 
genes encoding proteins present in the muscle and basement membrane produce severe 
defects in body wall muscle organisation and attachment leading to what is termed the 
Pat phenotype (Gilchrist and Moerman, 1992; Rogalski et al., 1993; Williams and 
Waterston, 1994). This phenotype is the paralysed arrest of embryos at a two-fold stage 
of elongation and is lethal. Embryos do not start muscle contractions as normal but 
instead exhibit irregular twitching around the 1.5- to 2-fold stages and cease elongation 
and movement around the 2-fold stage. These mutants often hatch but are inviable. 
Genes which can be mutated to produce this phenotype include myo-3, which encodes 
myosin heavy chain A, unc-52, which encodes a homologue of the mammalian 
basement membrane protein perlecan; and pat-3, which encodes a homologue of P- 
integrin, a protein involved in the attachment of muscle structures to the membrane as 
well as many other genes which have not been studied at a molecular level (Waterston, 
1989; Rogalski et a l, 1993; Williams and Waterston, 1994; Gettner et al., 1995). 
Certain alleles of the mec-8 gene also show a variably penetrant cold sensitive Pat 
phenotype and mec-8 has been shown to encode a protein with two RNA binding motifs 
which regulates alternative splicing of the unc-52 gene (Lundquist and Herman, 1991; 
Lundquist et a l, 1996).
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Mutations in other genes affecting muscle or basement membrane function show 
arrest at an equivalent or slightly longer stage of embryonic elongation with variable 
defects in muscle contraction. Certain mup-1 mutant alleles produce inviable short and 
lumpy 3-fold embryos or LI larvae as a result of abnormal or ectopic muscle- 
hypodermis attachments (Goh and Bogaert, 1991). Mutants homozygous for null 
mutations in the hlh-1 gene, which encodes a homologue of the vertebrate myoD DNA- 
binding protein have defects in muscle sarcomere organisation and muscle cell 
placement and arrest as lumpy 2-fold embryos or larvae with weak muscle contractions 
and uncoordinated movement (Chen et al., 1994).
Type IV collagen forms a branched network that is a major component of the 
basement membranes which surround the pharynx, intestine, gonad, and is present on 
the basolateral surface of the hypodermis, between muscle-muscle and muscle- 
hypodermis junctions (Albertson and Thomson, 1976; Francis and Waterston, 1991; 
Kramer, 1994a). Temperature sensitive point mutations in the genes emb-9 and let-2, 
which encode two different chains of type IV collagen, result in a vast reduction of 
collagen secretion into basement membranes and a build up of the collagen in the 
producing muscle cells at the restrictive temperature (Guo et al., 1991; Sibley et al., 
1994). This is manifested as a lethal phenotype with embryonic arrest at around the 2- 
fold stage of development. At the permissive temperature the phenotype is less severe 
with a higher proportion of secreted collagen and less retention of the mutant collagen in 
muscle cells (Gupta et al., 1997). The phenotype of homozygous null emb-9 embryos is 
embryonic arrest at around the 2.5- to 3-fold stage. In these null mutants, body wall 
muscles are seen to detach from the hypodermis as elongation progresses indicating that 
type IV collagen is essential for normal muscle attachment to the hypodermis (Williams 
and Waterston, 1994; Gupta et al., 1997). The temperature sensitive mutants show a 
semi-dominant embryonic lethal phenotype with embryonic arrest at an earlier stage and 
it appears that this phenotype is due to the accumulation of collagen within the muscle 
cells (Waterston, 1989; Williams and Waterston, 1994; Gupta et al., 1997). This 
collagen build-up may be disrupting the muscle cell function to some degree by 
interfering with the synthesis or processing of other proteins.
Clearly there is a relationship between muscle and hypodermal tissues which is 
essential for normal embryonic elongation. The mechanism of muscle-hypodermis 
attachment appears to be involved in the later stages of elongation when there appears to
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be a stronger pull from the muscles as the embryos elongate. The role of this muscle- 
hypodermal interaction in elongation is still unknown as the longitudinal contraction of 
muscles would oppose the direction of elongation. However, it has been proposed that 
the hemidemsomes, apparently recruited in the hypodermis by signals from the 
underlying muscle cells, may act to stabilise the actin cytoskeleton during elongation 
and so defects in the signalling cells or the attachment structures themselves may disrupt 
elongation in this way (Costa et a l , 1998; McKeown et al., 1998).
1.7.5.5. Genes involved in pharyngeal organogenesis which may play a role in 
embryonic elongation
The pha-4 and glp-1 genes will be discussed in connection with embryonic 
enclosure by the hypodermis in section 4.1.2.2. Mutations in glp-1 have been shown to 
result in extra hypodermal cells due to the failure of the pharyngeal fate induction in the 
AB lineage (Priess et a l , 1987). As well as producing variable defects in hypodermal 
cell enclosure, these embryonic mutants also have variably penetrant defects in 
elongation and prominent bulges often form along the length of the embryo. In many of 
these embryos the hypodermis does not divide into the usual dorsal, lateral and ventral 
rows and in those embryos which do show hypodermal subdivisions, the extra 
hypodermal cells are always present in the lateral rows. Another gene involved in the 
development of the pharynx is pha-1 which encodes a transcription factor (Granato et 
a l, 1994). Mutant embryos homozygous for certain pha-1 alleles are often shorter than 
wild type embryos and have hypodermal bulges although there do not seem to be any 
abnormalities in the number or arrangement of hypodermal cells (Schnabel and 
Schnabel, 1990). It has been proposed that the morphogenetic defects in the body shape 
of these mutant embryos are secondary effects of the absence of a pharynx. Since the 
pharynx usually fills the anterior third of the developing embryo, the absence of a 
normal pharynx may indirectly influence anterior body shape. However, certain pha-4 
mutants which completely lack a pharynx can elongate relatively normally and so the 
general morphogenetic defects seen in pha-1 mutant embryos may be the result of a 
more direct effect (Mango et a l , 1994a).
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1.7.6. The maintenance of body shape after embryonic elongation
1.7.6.1. The role of the cuticle
During the life cycle of C.elegans the cuticle, the impermeable exoskeleton, is 
synthesised 5 times, once at the end of embryogenesis and once at each subsequent 
moult with the final cuticle secreted at the L4 to adult moult (see Figure 1.3)(Singh and 
Sulston, 1978; Cox et al., 1981c). Starting at the precomma stage of embryonic 
development, structural proteins that will form the multi-layered cuticle are transcribed 
and translated in the hypodermis (Singh and Sulston, 1978; Johnstone and Barry, 1996; 
Gilleard et a l , 1997). These proteins are known as cuticular collagens and are 
expressed in temporally distinct waves throughout embryogenesis and each subsequent 
stage of the life cycle (Cox et al, 1981b; Johnstone and Barry, 1996). After elongation 
of the embryo is complete, cuticular collagens and other components of the cuticle are 
secreted from the apical membrane of the hypodermal cells forming the extracellular 
cuticle and after this stage the cuticle takes over the role of shape maintenance in the 
embryo (Sulston et a l, 1983; Priess and Hirsh, 1986). Genes that encode cuticular 
collagens and the mutations found in these genes which have uncovered their various 
roles in the maintenance of body shape are discussed at length in section 3.1.4. The 
actin microfilaments which drive the process of elongation and the embryonic sheath 
which covers the embryo during elongation are both thought to play a role in the 
formation and patterning of the first cuticle and actin microfilaments have also been 
implicated in cuticle patterning at each moult during post embryonic development 
(Costa et a l, 1997). The external layer of each cuticle is patterned into a series of rings, 
known as annulae, by shallow circumferentially oriented furrows (Cox et a l, 1981a). 
These furrows correspond to the pattern of actin filament bundles during elongation and 
are first manifest in the embryonic sheath (Costa et a l, 1997). The sheath furrows and 
ridges are found at close proximity to the hypodermal membrane and patches of 
electron-dense material are present in regions of the hypodermis underneath sheath 
ridges which may represent the secretion of extracellular materials from the hypodermis 
at these points. At the end of embryogenesis, prior to hatching, the sheath appears to 
separate from the hypodermal membrane and develops a trilaminar appearance which is 
identical to the external layer of the cuticle in hatched LI larvae. Thus, the sheath,
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which is patterned by the hypodermal actin filaments during elongation becomes the 
outermost layer of the first secreted cuticle of the life cycle resulting in the annular 
patterning of the cuticle. Annulae extend along the dorsal and ventral sides of the LI 
cuticle but do not traverse the lateral areas which instead have longitudinally arranged 
ridges known as the alae (Cox et a l , 1981a,c). Although the actin microfilaments also 
align circumferentially in the lateral seam cells during elongation, they do not appear to 
be closely associated with the apical membrane as the dorsal and ventral microfilaments 
are and therefore do not pattern the sheath and thus the cuticle at these areas (Costa et 
a l , 1997). Postembryonically, during each moulting period, actin microfilaments again 
align circumferentially in the hypodermis but only in the dorsal and ventral regions. 
These actin bundles appear to join the adherens junctions on either side of the 
hypodermal cells they traverse as during embryonic elongation, and the pattern of these 
filaments is coincident with the pattern of annulae in each subsequent cuticle. It is 
thought that the actin filaments contract at postembryonic moults as the hypodermal 
cells add new cuticle material to the surface between the bundles thus allowing the new 
cuticle to form beneath the old cuticle but have a larger surface area to accommodate the 
increase in growth between each stage.
During normal moults, after the new cuticle is synthesised underneath the old 
cuticle, the old cuticle is expelled from the anterior half of the pharynx and then the 
whole anterior cuticle separates from the body (Singh and Sulston, 1978). The animal 
rotates inside the old cuticle rupturing it at the anterior and subsequently emerges in its 
new cuticle. The molecules that control the process of moulting in C.elegans are not 
well understood as yet but recently there have been reports of two genes which may be 
involved in cuticle shedding, nhr-23 is a gene encoding CHR3, an nuclear hormone 
receptor, which is homologous to the Drosophila ecdysone-inducible DHR3 protein 
involved in metamorphosis (Koelle et a l, 1991; Lam et a l, 1997; Kostrouchova et a l, 
1998). During late embryogenesis, nhr-23 transgene fusion constructs are expressed in 
hypodermal cells. CRH3 function was inhibited using RNAi and the phenotypes 
produced included small size, dumpyness, and an inability to shed or degrade old cuticle 
properly after moulting. It has been proposed that CHR3 plays a role in cuticle 
detachment although, as with the Drosophila DHR3 protein, this involvement in 
moulting may be indirect.
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A second gene lrp-1 has also been implicated as having a role in moulting 
(Yochem et a l , 1999). lrp-1 encodes a lipoprotein receptor-related protein homologous 
to megalin, a membrane protein which is expressed on the apical surface of epithelia 
and which regulates lipid homeostasis and the activity of extracellular proteases 
(Strickland et a l, 1995). Animals homozygous for mutations in lrp-1 produce 
phenotypes with high similarity to nhr-23 RNAi (Kostrouchova et a l , 1998; Yochem et 
a l, 1999). Many of these mutants are slow growing or dumpy and they often arrest at 
the L3-L4 stages encased in old cuticles or with pieces of old cuticle still attached to 
their bodies (Yochem et a l, 1999). lrp-1 mutants do not appear to rotate inside the old 
detached cuticles or be able to degrade them. These mutants are also very slow moving 
and are thought to have feeding defects due to the obstruction of old cuticle at the buccal 
cavity and pharynx. LRP-1 is present at the apical surface of hyp6 and hyp7 and is 
thought to endocytose dietary sterols which are needed for an as yet unknown function 
during moulting. Another possible role for LRP-1 could be the activation of 
collagenases or other proteases that might be secreted during moults. As the study of 
moulting control in C.elegans is in its infancy, many of the proposed roles for these 
genes are highly speculative and a clearer picture of the molecules involved in cuticle 
moulting awaits the characterisation of further genes.
1.7.6.2. Postembryonic hypodermal cell fusions
The lateral seam and the ventral P cells are blast cells which go through several 
stages of cell divisions after hatching throughout post embryonic development (Sulston 
and Horvitz, 1977). The postembryonic fate of these cells differs between the 
hermaphrodite and the male because different sets of sex organs must develop in each, 
so I will only describe hypodermal postembryonic lineage in the hermaphrodite. At 
each round of cell divisions one of the daughter cells generally fuses with hyp7, the 
largest hypodermal syncytium, and the other daughter cell either remains as a blast cell, 
as in the case of the seam, or V, cells or becomes neuronal or a vulva precursor cell, as 
in the case of the P cells depending on their position (Sulston and Horvitz, 1977; 
Podbilewicz and White, 1994). P cells 1,2 and 9-12 undergo a cell division at the end of 
the LI stage after which the anterior daughters fuse to hyp7 and the posterior daughters 
eventually migrate into the ventral nerve cord. At the end of the L3 stage, the posterior
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daughters of P3-P8 divide once and while half of these cells fuse with hyp7 also, the 
other half become vulva precursor cells (Podbilewicz and White, 1994; Sharma-Kishore 
et al., 1999). The lateral seam cells undergo a stem cell division at the beginning of 
each larval stage and half fuse to hyp7 at each division. Around the middle of the L4 
stage, the seam cells to either side fuse longitudinally, in the final postembryonic cell 
fusion event, forming two continuous lateral syncytia and cease cell division 
(Podbilewicz and White, 1994). Overall, 12 P cell descendants and 98 seam cell 
descendants fuse to hyp7 throughout postembryonic development (Sulston and Horvitz, 
1977).
The significance of these fusions is not well understood although it is known 
that the cells stop cell division once they have fused and certain genes have been 
discovered which appear to be involved in this fusion process. lacZ fusion constructs 
containing two genes encoding novel transmembrane tyrosine kinases were shown to be 
expressed in hyp7 from the LI stage and in each subsequent cell which fused to hyp7 
during postembryonic development at the time of fusion (Morgan and Greenwald, 
1993). It was proposed that these genes, kin-15 and kin-16 which appear to have arisen 
from a gene duplication event, may regulate the fusion of mononucleate cells with hyp7 
throughout postembryonic development or may function in maintaining the nuclei of 
these cells in a mitotically quiescent state after fusion. The transgene constructs showed 
expression in all hyp7 nuclei from the LI stage, when there are 23 hyp7 nuclei, to the 
adult stage when hyp7 comprises 133 nuclei.
I.7.6.3. Postembryonic control of hypodermal function
The pathway that controls many aspects of postembryonic hypodermal cell fate 
including hypodermal gene fusions and the transcription of several stage-specific 
cuticular collagens is known as the heterochronic gene pathway and to date comprises at 
least 6 genes: lin-4, lin-14, lin-28, lin-42, lin-58 and lin-29 (Figure 1.9)(Ambros, 1989; 
Abrahante et al., 1998). lin-29, which encodes a zinc-finger type transcription factor is 
the most direct regulator of the larval to adult switch, which comprises the fusion of 
lateral hypodermal cells, secretion of the adult specific cuticle, and cessation of the 
moulting cycle (Liu et al., 1995; Rougvie and Ambros, 1995; Bettinger et a l , 1996). 
LIN-29 accumulates in the hypodermis during the L4 stage of development (Rougvie
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and Ambros, 1995; Bettinger et a l , 1996). lin-14, lin-28, lin-42 and lin-58 all act 
upstream of lin-29 and act as negative regulators of lin-29 activity, restricting LIN-29 
production to the L4 stage (Abrahante et a l , 1998). The associations between these 
genes has been elucidated by the study of many heterochronic mutants which either 
precociously moult into adults, or never undergo the larval to adult moult depending on 
the mutation. Null lin-4 mutants reiterate the LI hypodermal pattern at each moulting 
stage and never moult into adults (Chalfie et a l , 1981; Ambros and Horvitz, 1987). 
Null lin-14 mutants conversely adopt precocious L2 hypodermal patterns at the LI stage 
and subsequently moult into adults one stage early (Ambros and Horvitz, 1984; 1987). 
lin-4 encodes two small RNAs which interact directly with the 3 'UTR region of the lin- 
14 transcript and negatively affect its translation therefore actively downregulating lin- 
14 (Lee et a l , 1993). Null mutations in lin-28 result in mutants which undergo a moult 
straight from the LI to L3 stage, completely skipping the L2 stage of hypodermal 
development, and subsequently moult to adult one stage early (Chalfie et a l , 1981; 
Ambros and Horvitz, 1984). As expected, lin-29 null mutants develop to the L4 stage 
but never moult into adults, instead moulting into successive L4 stages (Ambros, 1989). 
It is thought that lin-14 and lin-28 do not directly regulate lin-29 and it is unknown 
whether lin-42 or lin-58 control lin-29 directly although it is known that lin-42 prevents 
the early expression of the adult hypodermal program and that lin-14 requires the action 
of lin-58 in order to prevent the larval to adult switch (Abrahante et a l , 1998).
As mentioned above and described in detail in section 3.1.2, hypodermal cells 
synthesise collagens during each larval stage (Cox and Hirsh, 1985). These collagens 
are expressed in temporally distinct waves within each stage and many collagens have 
been found to be specific to a particular larval or adult stage (Cox and Hirsh, 1985; 
Kramer et a l , 1985; Johnstone and Barry, 1996). The expression patterns of certain 
larval or adult-specific collagen reporter transgenes have been examined in 
heterochronic mutants. These have shown that heterochronic mutations which cause 
precocious formation of the adults cuticle also cause precocious transcription of the 
adult-specific collagen genes col-7 and col-19 (Liu et al., 1995; Abrahante et a l , 1998). 
They also showed that heterochronic mutations which prevented the larval-adult switch 
caused continued expression of a larval collagen gene col-17 and prevented the 
activation of col-7 and col-19 transcription (Liu et a l , 1995). It is not known whether 
lin-29 directly controls the transcription of these collagens although it is thought that
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cuticle collagen genes are controlled largely by tissue specific transcriptional enhancers 
rather than repressors in other tissues (Liu et al., 1995; Gilleard et al., 1997; Abrahante 
et al., 1998). It is possible that other heterochronic genes also have a role in regulating 
cuticular collagens specific to different stages of the life cycle.
Figure 1.9 The heterochronic gene pathway
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During wild type development these genes are up- or down-regulated depending 
on the larval stage in order for the correct sequence of hypodermal developmental 
events to occur. However, an interesting discovery was made when observing 
heterochronic mutants that had passed through the dauer stage instead of the normal L2 
stage (Liu and Ambros, 1991). lin-4, lin-14, and lin-28 mutants which had gone 
through a dauer stage in response to lack of food exhibited wild type post-dauer 
development (Cassada and Russell, 1975; Liu and Ambros, 1991). During wild type 
development, lin-14 activity must decrease between the LI and L2 stages of 
development in order to specify the proper timing and sequence of events which 
ultimately lead to the larval/adult switch (Ambros and Horvitz, 1987; Ambros, 1989). 
Since lin-4 and lin-28 interact with lin-14, they too are likely to be under precise 
temporal control (Liu and Ambros, 1991). Dauer development is a period of indefinite 
developmental arrest and so it may be that lin-4, lin-14, and lin-28 are rendered 
ineffective due to this period of arrest and are no longer of use in post-dauer 
developmental control.
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1.8. Aims of the project
It is clear that there are many factors involved in the process of hypodermally- 
mediated body shape change in C.elegans. The mechanism of morphogenesis relies on 
correct cell fate specification in the very early embryo, through correct cell migrations at 
the time of gastrulation and enclosure, to correct cell-cell contacts during the active 
process of elongation between hypodermal cells and between muscle and hypodermal 
cells, and correct synthesis and secretion of an extracellular cuticle which takes over the 
role of body shape maintenance from the end of embryogenesis onwards. Each stage in 
the control of this process may involve several pathways which must co-ordinate 
properly in order for the correct series of events to take place and as yet the molecules 
involved in elongation are largely unknown. My aim in this project was to elucidate 
some of the molecules involved in the enclosure and elongation of the C.elegans 
embryo by characterising embryonic lethal mutants defective in these processes and to 
examine postembryonic shape change using an antibody specific to a cuticular structural 
protein which is essential for the maintenance of body shape.
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Chapter 2 
Materials and Methods
Unless otherwise stated, all chemicals / reagents were purchased from BDH 
(Merck House, Poole, Dorset, UK), Fisher Scientific (Fisher Scientific UK Ltd., 
Loughborough, Leicestershire, UK). GibcoBRL (Life Technologies Ltd., Paisley, 
Renfrewshire, UK) or Sigma (Sigma-Aldrich Company Ltd., Poole, Dorset, UK). 
Restriction enzymes were obtained from New England Biolabs (New England Biolabs 
[NEB], Ltd.,Hertfordshire, UK).
2.1. Chemical abbreviations and common names
BSA: Bovine Serum Albumin
BME: p-mercaptoethanol
DABCO: 1,4-diazabicyclo-2,2,2-octane
DEPC: Diethyl pyrocarbonate
DTT: Dithiothreitol
diH20: Deionized water
FITC: Fluorescein isothiocyanate
IPTG: Isopropyl-P-D-thiogalactoside
Na^DTA: Ethylenediaminetetraacetic acid disodium salt
NajEGTA: Ethyleneglycoltetraacetic acid disodium salt
Pipes: 1,4-piperazinediethanesulphonic acid
RITC: Rhodamine B isothiocyanate
sdiH20: Sterile deionized water
SDS: Sodium dodecyl sulphate
Tris-HCl: 2-Amino-2-(hydroxymethyl)-1,3-propanediol-hydrochloride
Tween-20: Polyoxyethylenesorbitan monolaurate
X-gal: 5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside (Boehringer 
Mannheim, Ltd., Diagnostics and Biochemicals, East Sussex, UK)
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2.2. Commonly used stocks, solutions and media
Antibody Buffer A (AbAk lx  PBS, 1% BSA, 0.5% Triton X-100, 0.05% NaAzide and 
ImM EDTA in diH20 . Stored at 4°C.
Antibody Buffer B (AbB): As AbA but with 0.1% BSA. Stored at 4°C.
Ampicillin (1.000x1: lOOmg/ml solution in sdiH20 . Aliquoted and stored at-20°C.
Blocking solution (lx ): 1% milk powder in lxPBST. Made fresh before use.
BO, buffer (20x1: 1M H3B 0 3, 0.5M NaOH in diH20 . Stored at room temperature.
Chitinase solution: 20mg/ml chitinase in 50mM NaCl, 70mM KC1, 2.5mM MgCl2. 
Aliquoted and stored at -20°C.
Chloramphenicol (1.000x1: 17mg/ml solution in sdiH20. Aliquoted and stored at-20°C
DEPC Treated diH,0: DEPC added to diH20  to a final concentration of 0.1%, mixed 
vigorously for lOmin and autoclaved. Stored at room temperature.
DTT: 1M stock in 0.01M Na acetate, adjusted to pH 5.2. Aliquoted and stored at - 
20°C.
Egg Salts: 118mM NaCl and 48mM KC1 in diH20. Stored at room temperature.
Ethidium Bromide: lOmg/ml stock in diH20 , final concentration 0.5pg/ml in agarose 
gels. Stored, protected from light, at room temperature.
Injection mix (TOxk 20% Polyethylene glycol (MW 6000-8000), 200mM KP04, pH7.5 
and 30mM C6H5K30 7 in DEPC Treated diH20 . Stored at room temperature.
IPTG: 0.5M stock in sdiH20 . Aliquoted and stored at -20°C.
Kanamvcin (1 .OOOxk 50mg/ml in sdiH20. Aliquoted and stored at -20°C.
L-Broth: 1% Bacto tryptone (Difco, Michigan, USA), 0.5% yeast extract (Difco), 0.5% 
NaCl, in diH20. Autoclaved and stored at room temperature.
L-Broth Agar: as for L-Broth + 1.5g/100ml bacto-agar (Difco). Autoclaved then
allowed to cool (antibiotics were added at this stage, if required) poured with sterile 
technique on to plastic plates, allowed to set, dried by inversion in sterile flow hood 
(microflow) and stored, for short periods, at 4°C.
M9 Buffer flxh 0.3% KH2P 0 4, 0.6% Na.HPO,, 0.5% NaCl, lmM M gS04, in diH20. 
Autoclaved and stored at room temperature.
Mounting Solution: 50% glycerol, lxPBS, 2.5% DABCO. Made fresh prior to use.
NaoEDTA: 0.5M stock in diH20  pH8.0 with NaOH. Autoclaved and stored at room 
temperature
NGM Agar: 0.3% NaCl, 1.7% agar (Difco), 0.25% peptone (Difco), 0.0003%
cholesterol (lml/L of 5mg/ml stock in ethanol), in diH20 . Autoclaved and then lml/L 
of 1M CaCl2, lml/L of 1M MgS04 and 25ml/L of 1M potassium phosphate buffer 
pH6.0 added. Poured with sterile technique on to plastic plates, allowed to set, dried by 
inversion in sterile flow hood (microflow) and stored at room temperature.
Phenol: Purchased liquified and pre-equilibrated at pH8. Stored at 4°C.
Phenol / Chloroform: Mix of equal volumes of phenol and chloroform. Stored at 4°C.
Phosphate Buffered Saline fPBSl (TOOmML 7.31g NaCl, 2.36g N a^PO ,, 1.31g 
NaH2P 0 4 2H20  in 1L diH20 , adjusted to pH 7.2. Autoclaved and stored at room 
temperature.
PBST: As PBS but with the addition of 0.2% Tween 20. Stored at room temperature.
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Potassium Phosphate Buffer (1MV Prepared from 1M KH2P 0 4 and 1M K2HP04, mixed 
in appropriate ratio for desired pH. Autoclaved and stored at room temperature.
Proteinase K: lOmg/ml stock in diH20 . Aliquoted and stored at -20°C.
Ruvkun Fixation Buffer TRFB1 (2x1: 160mM KC1, 40mM NaCl, 20mM Na^GTA, 
lOmM spermidine-HCl, 30mM NaPipes (pH7.4) in 50% methanol. Stored at -20°C.
Single Worm Lvsis Buffer fSWLBV 50mM KC1, lOmM Tris (pH 8.3), 2.5mM MgCl2, 
0.45% Tween 20, 0.01% (w/v) gelatin. Autoclaved and stored in aliquots at -20°C. 
Proteinase K (Boehringer-Mannheim) added to 60pg/ml just prior to use.
SDS: 10% stock solution in sdiH20 . Stored at room temperature
SOC medium: 20g Bacto-tryptone, 5g Bacto-yeast extract, 0.5g NaCl in 950ml diH20. 
10ml of 250mM KC1 added and pH adjusted to 7. Autoclaved and then 5ml of 2M 
MgCl2 and 20ml of 1M glucose added before use. Stored at room temperature.
Sodium Phosphate Buffer (\M ): Prepared from 1M NaH2P 0 4 and 1M NajHPO^ mixed 
in appropriate ratio for desired pH. Autoclaved and stored at room temperature.
TE: ImM EDTA, lOmM Tris-HCl, (pH as required) in diH20 . Autoclaved and stored 
at room temperature. TE at pH 8.0 was used for all DNA manipulations, unless 
otherwise indicated.
Tetracycline (1 .OOOx): 12.5mg/ml in 50% sdiH20 , 50% ethanol. Aliquoted and stored 
at 4°C.
TBE nOxk 0.9M Tris-HCl, 0.9M Boric acid, 25mM N a^D TA  pH8.0, in diH20. 
Stored at room temperature.
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Tris-Triton buffer TTTB1: lOOmM Tris-HCl, pH7.4, 1% Triton X-100, ImM EDTA. 
Stored at room temperature.
X-Gal (100x1: 2% in dimethyl formamide (DMF). Stored in aliquots, protected from the 
light, at -20°C.
Note: All media and most heat insensitive solutions were autoclaved using the 
following conditions: 120°C, 151bs/in2 for 15min.
2.3. C.elegans, yeast and bacterial strains
C.eleeans: All Obtained from the Caenorhabditis Genetics Center
(University of Minnesota, St Paul, Minnesota, USA)
N2: Wild-type Bristol stock (Brenner, 1974).
BA671: spe-9(hc88)\
BC1785: dpy-18(e364)/eTl III; unc-46(el77) sDf30/eTl V
CB88: dpy- 7(e88)X
CB151: unc-3(e!51)X
CB458: dpy-13(e458)IV
CB224: dpy-1 l(e224)V
CB1410: unc-84(el410)X
CX51: dyn-l(ky51)X
DR210: dpy-5(e61) daf-16(m26) unc-75(e950)\
DR293: dpy-5(e61) unc-101(ml)l
MT309: lin-15(n309)X
MT465*: dpy-5 (e61)\; bli-2(e768)11; unc-32(e!89) III
SP219: mnDpl (X;V)/+V; unc-3(el51)X
SP511: mnDpl (X;V)/+V;mnDf43 X
SP261: mnDpl (X;V)/+V;mnDf2 X
SP262: mnDpl (X;V)/+V;mnDfl X
SP268: mnDpl (X-y)/+V;mnDf7 X
SP275: mnDpl (X;V)/+V;mnDfl 7 X
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SP277: mnDpl (X;V)/+V;mnDf.19 X
SP278: mnDpl(X;V)/+V;mnDf20 X
RW7000: RW subclone of Bergerac BO
*MT465 was previously known as CB4166
Other strains:
IA022 dpy- 7:: GFP fijls9) (Generated by I Johnstone).
IA023 egl-23(n601)TV\ dpy- 7::GFPfijls5) (Generated by I.Johnstone).
IA060 ijDfl/+ X (Generated by I.Johnstone).
IA061 ijDf2/+ V (Generated by I.Johnstone).
IA105 unc-76(e911)\\dpy-7\:G¥¥, unc-76(+)(ijIsl2) (Generated by E.Stewart).
MQ375: dpy-7(qm63)X (Gift from S.Hekimi).
Alleles:
w4\ Gift from J.Rothman. No designated strain name.
dyn-l(cq4) Gift from A.van der Bliek. No designated strain name.
E.coli strains:
Name Genotype
OP50 The strain used in the our laboratory is a variant of the uracil requiring
OP50 strain (Brenner, 1974) which has been transformed 
with a plasmid containing the Tetr marker (I.L. Johnstone, pers. comm.).
NovaBlue endAl, hsdl7(rkI2~mkI2+), supE44, thi-1, recAl, gyrA96, relAl, lac [F',
proA+B+ laclqZ-M15::TnlO] Obtained from Novagen,Inc.via R&D 
systems Europe, Abingdon, UK.
XLl-Blue recAl, endAl, gyrA96, thi-1, hsdRl7, supE44, relA l, lac [¥\proAB,
lacFZ-M l5, TnlO (Tef)] Obtained from Stratagene Ltd., Cambridge, 
UK.
60
2.4. Vectors and clones
2.4.1. Plasmid vectors
pBluescript II SK-: pUC19 derived phagemid. Obtained from Stratagene Ltd.
pTAe: pUC derived phagemid. Obtained from Novagen, Inc.
2.4.2. Clones
pRF4:
PMWQ002:
pMW00Q3:
Contains the dominant rol-6(sul006) C.elegans cuticular 
collagen mutation (Mello et al., 1991). Gift from J.Kramer. 
Consists of the dpy-7 cuticular collagen gene promoter in frame 
with the GFP coding sequence contained in the pPD95.67 Fire 
Vector (A.Fire, pers.comm.). Constructed by M.Watson.
Consists of the col-12 cuticular collagen gene promoter in frame 
with the GFP coding sequence contained in the pPD95.67 Fire 
Vector (A.Fire, pers.comm.). Constructed by M.Watson.
Cosmid Clones:
Chromosome I: W02B9, F36D1, F56G4, T02A8, W06H12, F46A8, AA2, F28D9,
C27D12.
X Chromosome: C11G10, T10B10, F46F2, C02D4, C33A11, F47C8, F39D8,
R03A10, C02C6, K09A9, K09E9, H08J19, F59D12, ZK662, 
ZK678.
Gifts from J.Sulston and A.Coulson.
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2.5. Culture maintenance
2.5.1. C.elegans culture
2.5.1.1. Wild type culture
Bristol N2 wild-type strains carrying non-temperature sensitive mutations and 
transgenic C.elegans strains were maintained in a 20°C incubator (Jencons LT3, Jencons 
Scientific Ltd., Leighton Buzzard, UK) on NGM agar plates (3.5 or 5cm in diameter- 
Griner Labortechnik Ltd., Stonehouse, Gloucestershire, UK) with E.coli OP50 as a food 
source according to standard methods (Sulston and Hodgkin, 1988).
2.5.1.2. Culture of strains carrying temperature sensitive or lethal mutant alleles
Strains carrying temperature-sensitive (ts) alleles were maintained at the 
permissive (16°C) or restrictive (25°C) temperature, in Jencons LT3 incubators (Jencons 
Scientific Ltd.), depending on what they were being used for. If males hemizygous for a 
ts allele on X which prevented mating were required for crosses, the cross was generally 
carried out at 15°C and the progeny then moved to 20°C or 25°C. Strains carrying 
recessive lethal mutations were maintained as a heterozygous stock and at each 
generation individual hermaphrodites from the strain were left to self fertilise separately 
on agar plates (3.5cm in diameter - Griner). As soon as the embryos laid began to hatch, 
the hermaphrodites were removed. After around 24 hours, the plates were scored for 
embryonic death and larvae from plates which contained carriers of the mutant allele 
were plated out separately as before to maintain the mutation. All worms were viewed 
and scored using an Olympus SZ40 dissecting microscope (Olympus Optical Co. (UK) 
Ltd., London, UK).
2.5.2. Bacterial culture
2.5.2.I. Bacterial culture on plates
All E.coli bacterial strains were grown at 37°C (in a Heraeus incubator; Heraeus
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Equipment Ltd., Brentwood, Essex, UK) on L-agar plates (9cm - Griner), supplemented 
with the appropriate antibiotic at the appropriate concentration. The final concentrations 
of the antibiotics used were as follows:
i) E.coli strains transformed with plasmids: 100pg/ml ampicillin or
12.5 pg/ml tetracycline
ii) E.coli strains transformed with cosmids: lOOpg/ml ampicillin,
25 fig/ml kanamycin or 
17pg/ml Chloramphenicol
2.5.2.2. Bacterial liquid culture
Unless otherwise stated, all liquid cultures were grown at 37°C with vigorous 
shaking. The media, antibiotics and antibiotic concentrations used in these cultures 
were as follows:
i) E.coli strains transformed with plasmids:
L-broth supplemented with lOOpg/ml ampicillin or 12.5pg/ml tetracycline.
ii) E.coli strains transformed with cosmids:
L-broth supplemented with lOOpg/ml ampicillin, 25pg/ml kanamycin or 
17pg/ml Chloramphenicol.
2.6. DNA preparation
2.6.1. Plasmid and Cosmid DNA mini preparation
Qiagen plasmid Mini DNA Preparation kits (Qiagen Inc., via Hybaid Ltd., 
Teddington, Middlesex, UK), were used for cosmid and plasmid DNA mini 
preparations from an appropriate volume of overnight culture of E.coli cells, according 
to the manufacturer’s protocols supplied with these kits. To get an equivalent DNA 
yield from cosmid preparations, 9mls of overnight culture were used per column instead 
of the recommended volume. Approximately 5pg of DNA was recovered from each 
column for cosmids and 15-20pg for plasmids. The cosmid or plasmid DNA was
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resuspended in an appropriate volume of TE or sterile deionized water, usually 15-20pl 
for cosmids and 50pl for plasmids.
2.6.2. Cosmid and plasmid DNA medium scale preparations
Qiagen Plasmid Midi DNA Preparation kits (Qiagen Inc.) were used for medium 
and large scale plasmid DNA preparations respectively, from an appropriate volume of 
overnight culture of E.coli cells according to the manufacturer’s protocols. I used 
150mls of overnight culture for cosmids per column to obtain a higher DNA yield. 
Cosmid preparations yielded around 30pg of DNA, and plasmid preparations, around
66jag.
2.7. Standard molecular biology techniques
2.7.1. Restriction endonuclease digests
Single enzyme digests were carried out at 37°C in lx enzyme reaction buffer 
supplied with the restriction endonuclease for 3 hours to overnight. Double digests 
were performed in the recommended buffer for that specific double digest (yielding over 
75% activity for each enzyme - NEB). In situations where the enzymes used required 
incompatible reaction conditions single digests were done sequentially with 
phenol/chloroform extraction and ethanol precipitation steps between the two digests 
using standard protocols (Sambrook et al., 1989) and adding 0.5pg of 20mg/ml 
glycogen (Boehringer Mannheim) to each extracted sample to aid ethanol precipitation. 
After precipitation, the DNA was resuspended in sterile deionized water containing lx 
reaction butter appropriate for the next restriction endonuclease to be used. In some 
cases heat inactivatable enzymes were used first and the organic extraction step above 
was replaced by inactivation of the enzyme by heating at the recommended temperature 
for that enzyme, usually 65°C, for lOmin on a heating block (Grant instruments, 
Cambridge, England). The quantity of enzymes used varied depending upon the source 
of the DNA and also upon its required usage, however a general rule was observed 
which states that 1 unit of enzyme digests 1 pg of lambda DNA in 1 hour in a 20pl 
volume at the appropriate temperature.
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2.7.2. Agarose Gel electrophoresis of DNA and RNA samples
Restriction endonuclease digested DNA and PCR amplified DNA samples were 
electrophoresed through agarose gels. Samples of purified single- and double-stranded 
RNA was visualised in the same way. DNA samples from STS marker PCRs were 
electrophoresed through special MetaPhor agarose (FMC corporation, via Flowgen, 
Lichfield, Staffordshire) to allow greater separation of the STS marker bands. Gels 
ranging from 0.6% to 2% agarose were prepared by dissolving the appropriate amount 
of agarose in lx TBE. MetaPhor agarose gels were prepared according to the 
manufacturer’s protocol and 3% gels were used for separation of STS bands. These 
gels, which were normally 15cm in length, were run in lx  TBE using gel 
electrophoresis tanks from GibcoBRL or Pharmacia (Milton Keynes, UK). The gels 
were generally run at a voltage equivalent to 3-10V/cm. All DNA samples were loaded 
into the wells of these gels using DNA sample buffer (see below). Gels were post­
stained by placing in a container of lxTBE plus 0.2pg/ml ethidium bromide on a 
moving platform for 20-40 mins and then washed in deionized water before visualising. 
The electrophoresed DNA or RNA was visualised using a UV transilluminator 
(Appligene Oncor, Durham, UK) and a record of the gel made using a digital imaging 
system (Appligene). Each gel contained at least one lane of DNA size standards, either 
1 kb ladder or 50bp ladder (both from GibcoBRL).
Fragment Sizes
lkb ladder 12.216 11.198 10.180 9.162 8.144
(in kilobases) 7.126 6.108 5.090 4.072 3.054
2.036 1.636 1.018 0.517 0.506
0.396 0.344 0.298 0.220 0.201
0.154 0.134 0.075
50bp ladder 800-50 in multiples of 50bp. The 350bp band is 2-3 times
(in bases) brighter than the other bands for internal orientation.
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lOx DNA Sample buffer
20mM EDTA 
25% Ficoll
0.2% Bromophenol blue 
in diH20
2.7.3. Gel and PCR purification
DNA fragments generated from restriction endonuclease digests or PCR 
reactions were purified in two ways. Specific fragments from restriction endonuclease 
digests or PCR reactions resulting in non-specific fragments as well as the target DNA 
fragment were electrophoresed through agarose gels run in lx TBE. Where there were 
high molecular weight fragments that required extra separation from surrounding
fragments before they could be excised cleanly, a 0.7% gel 30cm in length was used to
separate these fragments. The appropriate fragments were excised using a scalpel blade 
and the DNA extracted from the gel using the QIAquick Gel Extraction kits ( Qiagen 
Inc.) according to the manufacturer’s protocol. The PCR purification method allows 
separation of lOObp-lOkb products from primers, nucleotides, polymerases and salts. If 
a clean PCR fragment of the correct size was obtained, it was purified using the 
QIAquick PCR purification kit ( Qiagen Inc.) according to the manufacturer’s protocol.
2.7.4. Ligation reactions
Ligation reactions were performed in a lOpl volume using lx T4 DNA ligase 
buffer (NEB) and 1-2 units of T4 DNA ligase (NEB). Generally, 250ng of vector DNA 
were used in each ligation. The amount of insert DNA used varied with the molar 
concentration of free ends in the reaction and I used the following equation as a 
guideline with a molar ratio of around 1:1:
ng of vector x kb size of insert x molar ratio of insert = ng of insert
kb size of vector vector
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Ligations were performed overnight at 16°C.
2.7.5. Transformation of E.coli
Transformations were performed using either E.coli XL 1-blue (Stratagene, Ltd.) 
or Novablue (Novagen, Inc.) supercompetent cells and 25-100ng of ligated DNA 
according to the manufacturers protocols with the following exceptions: only 25pi of 
supercompetent cells were used for the transformations with XL 1-blue and the volumes 
of all solutions required for the transformation were adjusted accordingly; also, when 
transforming with Novablue, 200pi of SOC medium was added to each transformation 
rather than 80pl.
The transformed cells were selected using the antibiotic resistance marker 
carried by the plasmid (Amp1). Where applicable, blue / white colony selection was also 
used to select transformants with plasmids containing inserts. This selection makes use 
of a-complementation of the lacZAM15 mutation in appropriate E.coli strains. In these 
instances, the agar media was also supplemented with 0.004% X-gal and 34pM IPTG 
(final concentrations).
2.8. Preparation of slides for observations of living embryos and adults
2.8.1. Slide preparation for short-term Nomarski and fluorescence microscopy of 
live embryos
Slides used for microscopy of living embryos were overlaid with an agarose pad 
to prevent squashing of the specimens. A 0.4mm thick pad of agarose was prepared by 
flattening a large drop of a molten 2-5% agarose solution on a microscope slide (BDH) 
with a second slide placed across it at right angles to its longitudinal axis. The 
flattening slide was supported on either side by another slide perpendicular to the 
mounting slide resting on 2 layers of autoclave tape (approximately 0.4mm thickness) 
which raises it the required amount above the mounting microscope slide with the 
agarose overlay. The agarose pad was usually around 15 mm in diameter and was left 
sandwiched between these two slides while preparing the specimens. Embryos were 
washed off the surface of an agar plate onto a watchglass using M9 buffer. A 1mm
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capillary was drawn out to 0.1-0.2mm and used to transfer embryos from the watchglass 
to the mounting slide using a mouth pipettor. Once the transfer was complete, a 
22x22mm coverslip ( thickness 1, BDH) was carefully lowered over the agarose pad 
using a scalpel blade. Care was taken to transfer enough M9 along with the embryos so 
that they would not be squashed when the coverslip was lowered (around 10-20pl). 
After the specimens were mounted, slides were kept in closed humid boxes at 20°C until 
viewed under the microscope. These humid boxes were plastic boxes with close fitting 
lids, containing tissue paper soaked in deionized water.
2.8.2. Slide preparation for short-term Nomarski and fluorescence microscopy of 
live larvae and adults
The preparation of slides for microscopy of live larvae and adults was essentially 
the same as for embryos but the problem of movement across the agarose pads had to be 
overcome. To enable microscopy of stationary worms, lOmM sodium azide was added 
freshly to the agarose when molten. This anesthetises the worms so that they can be 
examined at length. Worms were washed off plates, mounted, and stored in the same 
way as for embryos.
2.8.3. Slide preparation for time course observations of live embryos
Embryos examined over a longer period of time, such as for timecourse 
microscopy were prepared in a different manner. A small drop of 5% agarose was used 
to make the agarose pad on a microscope slide in the same manner as before, although 
for time course microscopy a smaller pad was used, around 10mm in diameter. 1ml of 
the 5% agarose was prepared in an eppindorf and was placed on an heating block at 
80°C to melt. In this way, each slide could be prepared individually without the agarose 
solidifying. Gravid hermaphrodites were washed off plates onto a watch glass with M9 
buffer and cut open using two sharp needles (microlance 26G1, Becton Dickinson S.A., 
Madrid, Spain) so that the embryos were released into the buffer. Embryos of a 
particular age were selected to synchronise the observed population, usually 2- or 4-cell 
embryos were chosen. Capillaries were drawn out to a diameter just wider than that of 
an embryo and the selected embryos were transferred to the centre of the agarose pad
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along with a small amount of M9. A 22x22mm coverslip (thickness 1, BDH) was then 
lowered carefully on top using a scalpel blade. For preliminary timecourse observations 
which were carried out at a lower magnification, it was preferable to view groups of 
embryos at a time. To position embryos close together, 22x22mm coverslips (thickness 
1, BDH) were subbed by immersing in 0.1% Poly-L-lysine for 5-10 mins and leaving to 
dry at room temperature. Embryos were transferred from the watchglass to the centre of 
the coverslip in a small amount of M9 and, once they had settled onto the surface, it was 
lowered carefully using a scalpel blade onto the microscope slide with the 5% agarose 
pad. To prevent the slides drying out, the edges of the coverslip were sealed with 
molten soft paraffin. White soft paraffin BP (Pinewood laboratories, Clonmel, Ireland) 
was melted in a 1.5ml eppindorf tube on a heating block (Grant instruments) at 80°C 
and loaded into a 1ml syringe with a 26G3/8 microlance needle (Becton Dickinson S.A.). 
This allowed the soft paraffin to be precisely placed underneath the edges of the 
coverslip without any damage to the specimens.
2.8.4. Nomarski and Fluorescence optics used in microscopy of living embryos and 
larvae
The live embryos, larvae and adults were viewed using a Zeiss Axioplan 
microscope (Carl Zeiss, Oberkochem, FRG). Embryos were examined at lOOOx 
magnification using the 100x/1.5 Zeiss Plan-Neofluar air objective. For embryos 
containing a reporter GFP transgene, the GFP fluorescence was viewed using a 
Tungsten halogen lamp (240V 500W, Osram) UV source and Zeiss filter set 09 
(487909-0000). Larvae and adults were examined at 200x, 400x, and lOOOx 
magnification, using the 20x/0.5, 40x/0.75, and 100x/1.5 Zeiss Plan-Neofluar air 
objectives respectively. For timecourse microscopy, embryos were viewed at 40x or 
lOOx magnification using the objectives detailed above and photographed across a 
period of around 10 hours at hourly or half-hourly time points depending on the onset of 
the defect seen (estimated from preliminary low-resolution time course observations). 
Between time points, slides were kept in a humid box at 20°C. Images were taken with 
either a Panasonic wv-CL700 colour digital camera and Digitalvision 1.0.6 video 
capture software or a Hamamatsu C4742-95 (Hamamatsu photonics, Hamamatsu City, 
Japan) monochrome digital camera and Openlab 2.0.2 software.
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2.9. Fluorescence microscopy of embryos and adults
Except where noted, all these protocols are variations on staining protocols 
obtained from J.Ahringer, and M.Labouesse (pers. comm.) and from Albertson (1984). 
Mutant embryos were stained with each antibody at least twice and always along with a 
wild type control slide. The DPY7-5a staining pattern was examined in over 50 wild 
type embryos, over 50 larvae of various stages and in over 20 adult specimens. When 
examining the DPY7-5a staining pattern in CB88, CB458 and MQ375 strains, I 
observed more than 30 embryos and over 30 larvae and adult stages.
2.9.1. Preparation of slides for fluorescence microscopy of embryos, larvae and 
adults
Slides used for fluorescence microscopy were first cleaned with 70% ethanol 
and subbed by immersing the slide in a 0.1% poly-L-lysine solution for 5-10 mins and 
then allowing the slide to dry at room temperature. Embryos, larvae or adults were 
washed separately off agar plates into eppindorf tubes using M9 buffer and pelleted at 
5000rpm for 30 seconds in a Heraeus microfuge. Depending on the amount of bacteria 
washed off with the worms, they were washed and pelleted 1-3 times and then 
transferred to a watchglass. Capillaries drawn out to around 0.2-0.3mm for embryos 
and around 0.4-0.5mm for larvae or adults were used to transfer large numbers of 
embryos, larvae or adults onto the subbed slide. Large amounts of embryos were 
transferred in around 30pl of M9 and allowed to settle on the subbed surface of the 
slide. A 22x22mm coverslip (thickness 1, BDH) was lowered over the buffer using a 
scalpel blade and the excess M9 buffer was wicked off the edge of the coverslip under a 
dissecting microscope until the embryos were seen to be under a slight pressure but not 
rupturing (J. Ahringer, pers. comm.). Larvae and adults were transferred in around 10- 
20pl of M9 buffer and overlaid with a 64x22mm coverslip (thickness 1, BDH). 
Pressure was applied to the coverslip using forceps until the larvae or adults were 
slightly ruptured (otherwise they do not stick to the slides) and excess M9 buffer was 
again wicked off at the edge of the coverslip.
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2.9.2. Permeablisation of embryos, larvae and adult specimens on slides
Immediately after preparing the embryos, larvae or adults under pressure on the 
slides they were snap frozen by placing on an aluminium block pre-cooled and 
maintained at -20°C on dry ice. After 5-10 mins, the coverslip was ‘popped’ off using a 
clean scalpel blade while the slides were still frozen.
2.9.3. Fixation of embryos and adults on slides
Freeze-cracked slides were immediately placed in coplin jars filled with 
methanol at -20°C and left at -20°C for 10 mins. The slides were then transferred to 
acetone at -20°C for 10 mins and rehydrated in lxPBS.
2.9.4. Antibody staining protocol for embryos, larvae and adults fixed on slides
For all washing steps in the staining protocol, embryos were usually washed in 
coplin jars filled with lxPBST while slides containing larvae or adults were washed by 
carefully pipetting lxPBST onto the slide placed flat in a humid box and then removing
it by tilting the slide gently onto a tissue. This is because embryos generally adhere to
the slides strongly whereas larvae and adults tend to be loosened easily. The staining 
protocol is as follows:
i) Excess lxPBS was removed from slides containing fixed and rehydrated 
specimens using a tissue and the slides were placed in humid boxes. Around 
500pl of blocking solution was placed on the slides and they were left at 20°C 
for 20-30 mins.
ii) The blocking solution was removed by tilting the slides at an angle onto some 
tissue and primary antibody dilutions were prepared in fresh blocking solution. 
The dilutions differed slightly for each primary antibody used. Table 2i details 
the antibodies used with their localisation, and staining conditions. lOOpl of 
antibody + blocking solution was placed on each slide in the humid box and the 
slides were placed at 4°C overnight.
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iii) The antibody + blocking solution mix was removed by wicking it off the tilted 
slides using a tissue and the slides were washed 2x15 mins with lxPBST.
iv) Excess PBST was removed using a tissue and secondary antibody dilutions were 
prepared in blocking solution. Fluorescent secondary antibodies were used at 
1/100 dilution and around lOOpl of antibody + blocking solution was placed on 
each slide. The slides were placed in an humid box at 37°C for 2-3 hours.
v) Again, the antibody + blocking solution mix was wicked off the slide and the 
slides were washed 2x15 mins with lxPBST. This time, the washing receptacles 
were covered in foil to prevent exposure of the slides to light.
(vi) After washing, the slides were allowed to dry completely and around 5 pi (for
embryos) or 20pl (for larvae/adults) of mounting solution was placed on top of 
the specimens. A 22x22 (thickness 1, for embryos) or 64x22mm (thickness 1, 
for larvae/adults) coverslip was placed over the mounting solution and lowered 
very carefully with a scalpel blade to avoid the production of bubbles. The 
edges of the slide were sealed with clear nail polish and the slides stored in a 
covered box at 4°C.
2.9.5. Alternative protocol for permeabilsation, fixation and staining of adults in
tubes
An alternative protocol to freeze-fracturing for larvae and adults, is the Finney 
and Ruvkun method (Finney and Ruvkun, 1990). This allows larvae and adults to be 
stained completely intact without rupturing on a slide. I used the modified Finney and 
Rufkun method (Miller and Shakes, 1995). Fixation was performed by incubating in 
4% formaldehyde for an hour and incubation with 1% P-mercaptoethanol was carried 
out at 37°C for 1 hour. Antibody staining times were the same as indicated above.
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Table 2i Monoclonal antibodies used in immunofluorescence microscopy
Antibody
name
Antibody
type
Localisation Dilution 
used in 
staining
Secondary
antibody
used
Notes and 
References
3NB12 monoclonal a subset of 
pharyngeal 
muscles from 6 
hours of 
development
1/10
(ascites
fluid)
goat-anti-
mouse
FITC
A gift from 
J.Hodgkin. 
(Okomoto 
and
Thomson, 
1985; Priess 
and
Thomson,
1987)
DM5.6 monoclonal myosin A within 
the central region 
of body wall 
muscle thick 
filaments
1/100 goat-anti-
mouse
FITC
A gift from 
M.Coutu.
(Miller et al.., 
1983)
DPY7-5a monoclonal DPY-7 collagen 
present within or 
secreted on the 
apical surface of 
hypodermal cells
1/50 goat-anti-
mouse
FITC
Produced by 
I.Johnstone
anti-LIN-
26
polyclonal LIN-26 nuclear 
protein present in 
all epithelial cells
1/100 goat-anti- 
rabbit 
FITC or 
TRITC
A Gift from 
M.Labouesse 
(Labouesse et 
al., 1996)
MH3 monoclonal UNC-52 in 
junctions between 
adjacent muscle 
cells, and 
between muscle 
cells and the 
hypodermis
1/50 goat-anti-
mouse
FITC
A gift from 
M.Coutu
(Francis and
Waterson,
1991)
MH4 monoclonal intermediate 
filaments 
(components of 
the
hemidesmosome) 
within the 
hypodermis
1/200 goat-anti-
mouse
FITC
A gift from 
M.Coutu
(Francis and 
Waterson, 
1991; Hresko 
et al., 1994)
MH27 monoclonal A component of 
adherens
junctions between 
hypodermal cells 
and within the 
intestine
1/500 goat-anti-
mouse
FITC
A gift from 
R.Waterson 
(Francis and 
Waterson, 
1991)
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2.9.6. Fluorescence microscopy of stained specimens
Stained specimens were viewed 400x or lOOOx magnification using a Zeiss 
Axioplan microscope and Zeiss Plan-Neofluar 40x/0.75 or 100x/1.5 air objectives. The 
UV source was a tungsten halogen lamp (240V 500W, Osram) and Zeiss filter sets 09 
(487909-0000) or 15 (487915-9901) specific to green and red excitation/emission 
spectra specifically. Images were taken using either a Panasonic wv-CL700 colour 
digital camera with Digitalvision 1.0.6 software or Hamamatsu C4742-95 monochrome 
digital camera plus Openlab 2.0.2 software.
2.10. Expression of collagen: :GFP transgenes in mutant strains
The Aequorea victoria green fluorescent protein (GFP) is a widely used 
fluorescent marker which is active in many prokaryotic and eukaryotic organisms 
(Chalfie et a l , 1994; Dopf and Horiagon, 1996). GFP can acquire fluorescent activity 
without exogenous substrates or cofactors and is therefore a valuable tool which can be 
used to monitor gene expression or protein localisation in living specimens. Gene 
fusions can be made by placing the gene under observation, or its promoter sequence, in 
frame upstream and in cis to the GFP primary sequence. These transgene fusions can be 
injected into worms using the methods described in section 2.14 and the pattern of 
fluorescence can be examined in the transgenic lines obtained. I examined the 
expression of cuticular collagen::GFP reporter transgenes in mutant embryos by either 
crossing the mutant chromosome into a strain carrying an integrated collagen::GFP 
transgene, or injecting the collagen::GFP construct directly into the mutant strain.
2.10.1. Crossing mutant strains with integrated lines carrying collagen::GFP 
transgenes
IA022 and IA105 are strains carrying integrated copies of the col-12 
promoter::GFP (IA022) or the dpy-7 promoter::GFP reporter construct (IA105). 
Chromosomes carrying either w4 or ijDf2 were crossed into the collagen: :GFP 
transgene integrated background and homozygous lethal mutants carrying the 
transgenes were examined for their expression patterns.
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2.10.2. Injecting collagen::GFP transgenes into mutant strains
Because I could not cross the ijDfl carrying X chromosome into the integrated 
strains, I injected the pMW0003 plasmid into hermaphrodites heterozygous for ijDfl. 
pMW0003 was injected at lOng/pl along withlOOng/pl pRF4 (see section 2.14). ijDfl 
homozygote embryos from transgenic lines were examined for col-12::GFP expression.
2.11. Classical genetic mapping
2.11.1. Generation of males
Male worms (carrying only one X chromosome) occur spontaneously in the wild 
type population of C.elegans at a frequency of around 0.2% (Sulston and Hodgkin, 
1988) but this frequency can be increased 10 fold or more by heat shock to produce 
males for mating. 6-10 L4 hermaphrodites were incubated at 30°C for 4-6 hours on a 
small NGM agar plate (5cm diameter) seeded with OP50 and then were left to self at 
20°C. The progeny usually contains 2-5% males. To generate a male stock for mating, 
these males are mated with wild type hermaphrodites. Generally around 10-15 L4 
males and 2-3 L4 hermaphrodites were placed on a 5cm plate containing NGM agar and 
an approximately 2cm diameter spread of OP50 in the centre of the agar at 20°C. These 
are the normal conditions for all crosses and unless noted otherwise, other crosses 
mentioned were carried out in this way. L4 males are transferred for crossing in all 
cases as the male mating apparatus is enclosed in cuticle until the adult stage and is 
therefore not damaged when transferring between plates. These plates were maintained 
at 15-20°C and FIs were almost 50% males depending on the success of the mating. L4 
males from each subsequent generation were mated with wild type L4 hermaphrodites 
as before to maintain the male stock.
2.11.2. Setting up crosses to map mutations
Initial crosses were carried out between old adult hermaphrodites heterozygous 
for the lethal mutant allele and 10-15 wild type males, using the same conditions as the 
cross above. To obtain hermaphrodites heterozygous for the recessive lethal alleles
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being mapped, individual animals from the strain carrying the lethal mutation were left 
to self fertilise on separate plates. As soon as the resulting embryos began to hatch, the 
parent hermaphrodites were transferred separately onto fresh plates which were marked 
in the same way as the original plates. After about 24 hours, the original plates were 
scored and the hermaphrodites transferred from that plate were used in crosses. Male 
FIs from the mutant/wild type cross were picked and used to cross the mutant allele into 
mapping strains. Where the mutant allele was found to be linked to the X chromosome, 
as in the case of ijD fl, subsequent crosses were carried out by crossing the mapping 
strain with wild type males, and crossing the FI males produced with an hermaphrodite 
heterozygous for the mutant allele under study.
2.11.3. Using the results from mapping crosses to position mutant alleles
These mapping crosses rely on the generation and detection of recombinant 
animals in order to position the mutant alleles genetically in relation to other genes 
contained within the genome.
2.11.3.1. Chromosome assignment crosses
For the initial chromosome assignment cross, males heterozygous for the lethal 
alleles (not linked to the X chromosome) were crossed into the triply mutant strain, 
MT465 ( dpy-5 (e61)l; bli-2(e768)ll; unc-32(el89) III) and the FI hermaphrodites were 
allowed to self. The progeny of hermaphrodites carrying the w4 or ijDf2 alleles were 
then examined for recombinants homozygous for only one of the visible marker 
mutations. These recombinants were then allowed to self on individual plates and their 
progeny were scored for the presence or absence of the lethal mutant allele. If the allele 
was unlinked to the marker mutation, then 2/3 of the recombinants should be positive for 
the lethal mutation. This is because the homozygous ijDf2 or w4 progeny are dead 
therefore, of the living progeny, 2/3 will be heterozygous for ijDf2 or w4 and V3 should 
be homozygous for the wild type chromosome. If the lethal mutation was linked to the 
marker mutation, however, then the number of marker recombinants which carry the 
lethal mutation would be significantly reduced. I calculated whether the differences
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were significant or non-significant using a x2 test with 1 degree of freedom (Parker, 
1991).
2.11.3.2. Two-Factor crosses
In order to measure the genetic distance between two genes I used a formula 
which allows for the production of recombinant classes of progeny and also takes into 
account that certain classes of progeny may be subviable (Sulston and Hodgkin, 1988). 
Mutants that were heterozygous for the lethal allele and a marker allele present in cis on 
the same chromosome, were allowed to self on individual plates. If the two mutations 
are known as a and b, where a is the visible marker mutation and b is the lethal mutation 
to be mapped, and p is the recombination distance, then the gamete proportions will be 
as shown below:
ab ++ a+ b+
.LE E E
2 2 2 2
And subsequently, the proportion of each type of progeny produced will be as follows:
W(wild type) A(marker phenotype) B(lethal) AB(lethal)
3_-2p+pi 2 ^  2 ^  O iE£
4 4 4 4
This gives the equation :
(A+B)______ = 2n-p2
(W + A + B + AB) 2
where p is the total frequency of recombinant phenotypes. But where progeny classes B 
and AB are both lethal, they cannot be distinguished and are removed from the viable 
population so it is better to calculate p from the modified equation:
A = I2p -p21 
(A + W) 3
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I calculated p separately for each brood scored and then looked at the deviations of the 
means of each brood to see if the results could be pooled (Parker, 1991). In each case, 
the means were shown to be from within the same population and the results could be 
pooled.
2.11.3.3. Three-factor crosses
The main aim of three-factor crosses is to order the mutant allele with respect to 
two other known mutations. These crosses are less informative about the genetic map 
distance of the mutant allele from any particular gene. Males heterozygous for the 
lethal allele (/) under study (not linked to the X chromosome) were crossed into a strain 
homozygous for two visible marker mutations (a and b) on the same chromosome and 
the resulting FI hermaphrodites heterozygous for all mutations with the lethal allele in 
trans to the marker mutations (<a + b/+ I +), were allowed to self on individual plates. 
Recombinant F2 hermaphrodites homozygous for only one of the marker mutations {a + 
b/ a ? + or a + b/ + ? b) were picked separately onto plates and each was scored for 
presence or absence of the lethal allele. The proportion of these recombinants carrying 
or not carrying the lethal ailele indicated the position of the lethal allele relative to the 
marker alleles and the genes were positioned in this way. For example, if 8 
recombinants homozygous only for marker a carried the lethal allele I {a + b /a  I +) and 
4 did not (a + b/ a + +), and if 6 recombinants homozygous only for marker b carried 
the lethal (a + b/ + I b) and 12 did not (a + b/ + + b), then the genes would be 
positioned thus:
with I being between the two genes and lying approximately twice as close to b as it is 
to a.
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2.11.4. Complementation tests
For complementation tests with the ijDfl allele, wild type males were first 
crossed into a strain (CB224) homozygous for dpy-ll(e224). The resulting FI males 
were crossed with old adult hermaphrodites heterozygous for ijDfl and the progeny 
were examined for visible phenotypes.
For complementation tests with ijDfl, a different approach had to be taken. The 
unc-3(el51) allele on X was balanced by the duplication mnDpl (strain SP219) and 
when wild type males were crossed into this strain, only FI males appearing wild type 
(that is carrying the duplication) were picked to cross with old adult hermaphrodites 
heterozygous for ijDfl. Males hemizygous for unc-3(el51) without the balancing 
duplication were unable to mate. Iin-15(n309) homozygotes, used in the 
complementation test, have the multivulva (Muv) phenotype and did not carry a 
balancing duplication but the lin-15(n309) allele is temperature sensitive and could be 
crossed at the permissive temperature of 15°C. At 25°C, wild type males cannot mate 
with lin-15(n309) hermaphrodites as none of their vulvas function normally and 
hemizygous Iinl5(n309) males have a significantly reduced mating efficiency. At the 
permissive temperature (15°C ), however, mating can occur both between wild type 
males and lin-15(n309) hermaphrodites, and between lin-15(n309) hemizygote males 
and other hermaphrodites. Iin-15(n309) hemizygote males and ijDfl heterozygote 
hermaphrodites were crossed at 15°C and after 1-2 days, the plates were moved to 25°C 
so that any visible phenotype would be seen in the FI generation.
2.12. Sequence tagged sites (STS) mapping
STS mapping is a PCR-based mapping system which utilises known Tel 
insertions in the genome of the Bergerac strain, RW7000, as dominant markers to map a 
mutation (Williams et al., 1992; Williams, 1995). The principle of STS mapping is 
outlined in section 5.3.2.
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2.12.1. Preparation of custom made primers
Custom oligonucleotide primers for Polymerase Chain Reaction (PCR) in this 
section and elsewhere, were supplied ready to use by Genosys (Genosys 
Biotechnologies Europe Lts., Pampisford, Cambridgeshire, UK).
2.12.2. STS mapping protocol
I carried out STS mapping of the mutant alleles ijDfl and ijDf2 using essentially 
the same protocol as Williams et al., 1992, but with several changes. The differences in 
the mapping crosses due to ijDfl being present on the X chromosome are detailed in 
chapter 6.3.2.. I used a slightly modified PCR reaction mixture and slightly different 
PCR conditions. These are both detailed below:
STS PCR reaction mixture
Reagent Final Concentration
\QxTaq polymerase buffer (made up as in Williams et al., 1992) lx
dNTPs (Promega Corporation) 0.1 mM
Tel primer 618 (Table 2ii) 125pM
Each STS specific primer used (Table 2ii) 25pM
Taq polymerase (NEB) 0.5U/25pl
The reactions were made up in a final volume of 25 pi using sdiH20 . Each reaction was 
overlaid with an approximately equal volume of mineral oil and the PCR was performed 
using a Crocodile III thermocycler (Appligene) using the following conditions:
Step Cycles Temp°C Timetmm)
1 1 94 3
2.1 38 94 0.5
2.2 38 58 1
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Step
2.3 38
Cycles Temp°C
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Timefaiin)
1
STS-specific primers used for mapping ijDf2 on chromosome V and ijDfl on the X 
chromosome are shown in Table 2ii. lOpl of each reaction was run on a 3% MetaPhor 
agarose (FMC corporation) gel as detailed in section 2.7.2.
2.13. Physical mapping of deficiencies using PCR
In order to physically map deficiencies, I designed primers specific to small 
regions of the genomic sequences within the cosmids tested and then used PCR to detect 
the presence or absence of these cosmid sequence markers (CSMs).
2.13.1. Design of cosmid sequence marker (CSM) primers
Primers were designed to amplify between 100 and 400bp of genomic sequence 
within each cosmid tested. I used Vector NTI to design primers specific to each cosmid 
genomic sequence and the sequences are listed in tables 2iii and 2iv
2.13.2. Preparation of embryos and PCR conditions for CSM assay
ijDfl or ijDf2 homozygote embryos and wild type controls were lysed in SWLB 
in the same way as in Williams et a l,  1992 with one exception: I lysed each embryo in 
12.5pl of SWLB rather than 2.5pl so that I could use the DNA from one embryo to test 
several CSMs at one time, including positive and negative control markers. The PCR 
reaction mixture and conditions were the same as detailed above for STS mapping. 
Each CSM was tested using at least ten mutant embryos on at least two separate 
occasions and many more repetitions were carried out where there was ambiguity with 
the results obtained. For each CSM tested, I carried out a positive and negative control 
at the same time on the same mutant embryo DNA and on wild type embryo DNA.
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Table2ii Primer sequences for STS assays
Primer Polymorphism Band size (bp) Sequence (5'-3')
618* GAACACTGTGGTGAAG
TTTC
Chromosome I
734 hP4 130 CGGAAATATT ATC AGC 
ACAGC
Chromosome II
723 maPl 234 CCAATTTTCCGGAAGTT
TTCG
Chromosome III
587 mgP21 165 GGAACAAAAGTGCCTT
GGG
Chromosome IV
653 sP4 179 TTTCTGTTTTGTGCTTA
GACG
Chromosome V
813 stP3 153 GTCGCATTTCCATTCAT
GCAG
440 stP192 290 GCACGCTGAGAGTAAG
TGC
997 stP23 135 TT GT C AACT ATTTT AC A 
GCGAG
736 Bpl 119 AACACATTTAGGTAAT
GTAGCAC
998 stP6 170 TCACAATCGATGACTA
AGTACTGG
862 stP18 203 TTGAACTTCTCCCACTC
CTC
438 stP108 135 AAAGATAAACGCGCTT
TTTGG
439 stP105 152 GGGTAGTTGTTCATGTC
TCG
652 stP128 200 GCAACGCTTTGTGGAT
CTG
Chromosome X
930 stP41 193 TGTCTACTTACCTTAAC
TTACC
888 stP40 229 GTATGAGCTAATTGTA
CCCTC
112 stP33 260 CGTCTAGTCGTGTGTTT
CC
454 stP129 160 CCACTTATTGCCACTTT
TTGG
452 stP72 112 CTTGAAAATACCATGG
CATAC
887 stP2 127 CAAAACGGTATACTCT
GGTG
*618 is a primer speci:ic  to Tel which is used in all reactions
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Table 2iii CSM primers for physical mapping of Chromosome V deficiencies
CSM
Primer
name
Primer (Read 5'-3') Sense of 
primer
Position of 5' and 
3' end bases of 
each primer in 
published cosmid 
sequence
Fragment 
size produced 
by each 
primer pair 
(bp)
5' end y  end
C52A10-S GCGGCGACCAGC
AAAAC
sense 93 110 210
C52A10-A TTCCCCACATCCC
CAAC
antisense 303 286
C35A11-S TCATTCTTGTCCC
GCCC
sense 3668 3685 280
C35A11-A TGGTTGTGCT GGT 
CTCGC
antisense 3948 3930
M03E7-S TGTCGTCCTCCAC
CACCG
sense 12435 12453 150
M03E7-A ATGCTCCGCCAAA
GTCG
antisense 12585 12568
F29G9-S TCCGTTGTCTTTTC
ATTTCG
sense 6113 6133 153
F29G9-A TCCTTCTACTCCC
TTGTTTCTTC
antisense 6266 6243
K08B12-S ATTTGGCAGACCG
AGCG
sense 19909 19926 129
K08B12-A GGCGACGATTTCA
CTGG
antisense 20037 20020
W01A11-S CGATGGTGGTTCC
TTGTTCC
sense 24377 24397 333
W01A11-A AT GAT GT GAG ATT 
TTATTCCCG
antisense 24710 24688
K04A8-S AGGAGCCGCACTT
TTCTTCACAC
sense 720 743 208
K04A8-A CGCGTATTTCGGA
TTCATCACAGTC
antisense 928 903
F44C4-S GCGGTTTGATGGA
GGATAGTGGAAG
sense 16180 16205 210
F44C4-A CGGTGTTTTTGGC
GAGAAGGTG
antisense 16390 16386
W02F12-S GACCAGATTCATA
CTCAAACCACC
sense 4489 4513 220
W02F12-A TCTTCTACCCCAA
CATTTCTCC
antisense 4709 4687
K11C4-S TTGGTTT AGGGGT 
TAGAAGGG
sense 24833 24854 330
K11C4-A TCATTTACTCAGC
GGTGGAA
antisense 25163 25143
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Table 2iii CSM primers for physical mapping of Chromosome V deficiencies
(continued)
CSM
Primer
name
Primer (read 5' to 3') Sense of 
Primer
Position of 5' and 
3' end bases of 
each primer in 
published cosmid 
sequence
Fragment size 
produced by 
each pair (bp)
5' end y  end
F10G2-S ATCCCAACCACCA
ACGG
sense 132 149 333
F10G2-A CCTGAGCCACCAA
AGCC
antisense 465 448
C12D5-S ATCACTTCTCATT
TCTATTCTCCCAT
C
sense 6869 6896 217
C12D5-A CCCATTCATCACC
ATCACTCTG
antisense 7086 7064
T05B11-S GGTGCCCCATCAA
AATCAG
sense 2897 2916 332
T05B11-A TCAAACTTCCGCC
AACAAC
antisense 3229 3210
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Table 2iv Cosmid primers for physical mapping of X Chromosome deficiencies
CSM
Primers
Primer (Read 5'-3') Sense of 
primer
Position of 5' and 
3' end bases of 
each primer in 
published cosmid 
sequence
Fragment size 
produced by 
each primer 
pair (bp)
5' end 3' end
K02B9-S ATTACTGTAAGTT
GAGCGCGGCTGA
sense 18118 18143 238
K02B9-A TGACGGATGGCA
GTATACTTCGAGG
antisense 18356 18331
E02H4-S TGATTCTCCGTGT
AAGGAAGAGGCC
sense 21123 21148 208
E02H4-A AACTGACGACCA
CCCATAGAAACC
G
antisense 21331 21306
T14C1-S AAACCCAACCAA
TCGCC
sense 11570 11587 239
T14C1-A GCAAATGAATAG
CAGAACAACAAG
antisense 11809 11785
T24C2-S TGACCAGGTAGC
GGAAAACG
sense 7758 7778 239
T24C2-A GGTAGAGGGGGA
AAGGAGTATTGTG
antisense 7997 7972
F54E4-S ACTCTTTATGTCT
GTGTTGCCC
sense 16034 16056 194
F54E4-A ACTGTATCCTTCG
CTCCCC
antisense 16228 16209
F42D1-S CCCACAATCAGCT
CACTCCAAGAAC
sense 14589 14614 299
F42D1-A CGGAGGCAAGAA
CGACATCATC
antisense 14888 14866
C18B12-S TGGACAACAAGC
GATGAATAG
sense 3852 3873 293
C18B12-A AGAAACGACGAC
AGGAGGG
antisense 4145 4126
T10B10-S AAAACACCCAGG
CAGCAACAGGT
sense 708 731 155
T10B10-A GGTTATCGAGCGC
TTTGTGGTCAAC
antisense 863 838
F39D8-S GTAGGAAATAAT
GGTGATAGCGATG
sense 16414 16439 161
F39D8-A AACTGTAGGGGTA 
AT GAT AACGAC
antisense 16575 16551
ZK662-S CGAGAAGAGTTC
AACTACCGAGTGC
sense 22113 22138 235
ZK662-A CACTTTGATGGGA
AGATTTCTGAAA
antisense 22323 22298
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Table 2iv Cosmid primers for physical mapping of X Chromosome deficiencies
(continued)
CSM
Primers
Primer (Read 5'-3') Sense of 
primer
Position of 5' and 
3' end bases of 
each primer in 
published cosmid 
sequence
Fragment size 
produced by 
each primer 
pair (bp)
5' end 3' end
ZK678-S AT GC AATGCTTGC 
AAACTGTTTT
sense 15741 15764 218
ZK678-A TCAAATCATAAAT
TCGATCGGAAGT
antisense 15959 15934
E03G2-S TCTCCAGGGATTC
CGTCCTC
sense 4754 4774 305
E03G2-A GGCCAACGTCAA
CTTCTATGCC
antisense 4996 4974
F09C8-S TCTAATGTCTTGT
CACCTCCGGC
sense 27271 27295 227
F09C8-A TCTTCTGGCGGCT
TGGTAGTT
antisense 27498 27477
F52E10-S CTTGAATGATGTC
GTGC
sense 10958 10975 181
F52E10-A TTTCGCAAGCTCA
TCTG
antisense 11139 11122
C11G6-S ACATTGACTCTGC
TCCG
sense 14120 14137 166
C11G6-A ATCAGCGGCAAC
AGATG
antisense 14224 14207
F01G12-S GTCGGTGGACTTG
ACGCAAACTTG
sense 21123 21148 208
F01G12-A T GGCTT ACC ACC A 
TCGACAATGACT
antisense 21331 21306
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2.13.3. Visualisation of PCR results
lOpl of each PCR reaction was loaded onto a 2% agarose gel and run according 
to the conditions detailed in section 2.7.2.
2.14. Generation of transgenic C.elegans lines
2.14.1. Preparation of materials and worms for microinjection
Cosmid and plasmid DNA for microinjection was extracted and purified using 
the Qiagen Plasmid Mini or Midi DNA kits (Qiagen Inc.) and was resuspended in TE. 
In some cases additional organic extraction and ethanol precipitation steps were carried 
out if the DNA was suspected of containing impurities. One or both of two marker 
plasmids were used in cosmid rescue injections, pRF4 which carries the dominant rol- 
6(sul006) mutation, and pMW0002 which carries a dpy-7 promoter::GFP transgene 
fusion. The rol-6(sul006) mutation causes animals that carry the pRF4 plasmid to have 
a helically twisted cuticle and body resulting in rolling about the longitudinal axis and 
movement in circles which is easily detected using a dissecting microscope (Mello et 
al., 1991). Animals carrying the pMW0002 plasmid express the dpy-7 promoter::GFP 
transgene fusion in hypodermal cells from the comma stage of elongation and so its 
presence could be detected by observations using a tungsten halogen lamp (240V 500W, 
Osram) UV source and Zeiss filter set 09 (487909-0000). The pRF4 marker plasmid 
was diluted to a final concentration of 100ng/pl in sterile deionized water and the 
pMW0002 dpy-7 promoter::GFP marker transgene was diluted to 5ng/pl where used. 
Concentrations of cosmids and plasmids used in rescue experiments of w4 and ijDfl are 
shown in Tables 2v and 2vi. pTAg (Novagen, Inc.) is a vector containing both 
ampicillin and kanamycin resistance providing areas of homology to cosmids carrying 
ampicillin or kanamycin resistance.
Needles for microinjection were prepared from Borosilicate glass capillaries 
(Clark Electromedical Instruments, Pangboume, Reading, UK) which possessed glass 
filaments along their internal length to aid loading of the injection solution to the tip of 
the needle. Needles were pulled to the desired shape using a model 773 electrode puller 
(Campden Instruments Ltd., Sileby, Loughborough, UK). Immediately before use, the
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Table 2v Concentration of cosmids and plasmids used in the 9 cosmid mix to 
attempt cosmid rescue of w4.
Cosmid or plasmid 
name
Antibiotic
resistance
marker
Stock concentration 
of cosmid DNA 
(pg/pl)§
Final concentration of 
DNA in mix (ng/pl)
W02B9 Kan 0.349 23
F36D1 Kan 0.986 66
F56G4 Kan 0.483 32
T02A8 Kan 0.082 5
W06H12 Kan 0.033 2
F46A8 Kan 0.090 6
AA2 Amp 0.205 14
F28D9* Kan 0.100 7
C27D12* Amp 0.100 7
pTAg Amp and Kan 500 50
pRF4 Amp 400 100
§ These concentrations were OD readings from a Beckman DU 650 Spectrophotometer
which appears to be inaccurate at low concentrations. Because of this, the cosmid 
stocks were diluted so that 1 pi of each stock run out on a gel gave an approximately 
equivalent band concentration.
* These cosmids concentrations were estimated only from gels.
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injection solution was centrifuged at 15,000rpm for 5-10 mins in a microcentrifuge 
(Heraeus Equipment Ltd.) and loaded into hand pulled borosilicate capillary tubes 
(Clark Electromedical Instruments) by drawing the injection solution up using a mouth 
pipettor. The DNA was then loaded into the needles by inserting the hand pulled 
capillary tube down the wide bore of the needle and depositing the injection solution 
just behind the needle tip, using gentle pressure with a mouth pipettor.
Worms to be injected were immobilised on dried agarose pads under paraffin oil 
essentially as described by Fire (1986). The dried agarose pads were prepared on 64mm 
x 22mm glass coverslips (Thickness 1, BDH), by placing a single drop of a 3% agarose 
solution onto the coverslip, placing a 22mm x 22mm glass coverslip (Thickness 1, 
BDH) on the drop and applying gentle pressure. The smaller coverslip was removed 
and the agarose plug dried by baking at 80°C for lOmin.
Young adult C.elegans hermaphrodite worms heterozygous for w4 or ijDfl 
(Table 2vii) were transferred to a partially desiccated NGM agar plate prior to injection. 
When the injection apparatus was ready, a sharpened platinum wire pick was used to 
transfer 5-12 of these worms to a dried agarose plug, overlaid with 2-3 drops of paraffin. 
The picked worms were allowed to touch the dried agarose plug and the pick was gently 
removed once a portion of the worm had adhered to the surface of the dried agarose. 
The immobilised worms were placed on the microscope stage and the injection 
procedure started immediately.
2.14.2. Microinjection procedure
The microinjection procedure and apparatus are essentially the same as that 
described by Mello et a l , 1991. Needles containing the injection solution were loaded 
into the microtool collar of a Narishige MO-202 Joystick Hydraulic Micromanipulator 
(Narishige Co Ltd., Tokyo 157, Japan) and were pressurised using an attached bottled 
nitrogen source. A pressure regulator and solenoid valve attached to the nitrogen 
cylinder were used to obtain the desired rate of flow of the injection solution. Pressure 
was activated by means of a foot operated switch linked to the solenoid valve.
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Table 2vi Concentration of cosmids and plasmids used in the cosmid rescue of
ijDfl
Cosmid or plasmid 
name/group
Antibiotic resistance 
marker
Final concentration of 
DNA in mix (ng/pl)
pRF4 (in all mixes) Amp 100
pMW0002 (in all mixes) Amp 5
15 cosmid mix 1 all Amp, Kan or Chlor 5 (each cosmid)
6 cosmid group L2 all Amp, Kan or Chlor 5 (each cosmid)
6 cosmid group L3 all Amp, Kan or Chlor 5 (each cosmid)
F29D12 Kan 10
H08J19 Chlor 10
K09E9 Kan 10/5 4
K09A9 Kan 10/5 4
C02C6 Amp 10
ZK678 Kan 10
5 cosmid group 5 all Amp, Kan or Chlor 5 (each cosmid)
K09A9 + K09E9 Kan 5 (each cosmid)
K09A9 + C02C6 Kan, Amp 5 (each cosmid)
K09E9 + C02C6 Kan, Amp 5 (each cosmid)
pKAl,pKA2,
C02C6
Amp 1 (each plasmid), 5 
(C02C6)
pKEO and C02C6 Kan, Amp 5 (each cosmid)
pKENO and C02C6 Kan, Amp 5 (each cosmid)
The 15 cosmids injected in this mix were, from left to right: Cl 1G10, 
T10B10, F46F2, C02D4, C33A11, F47C8, F39D8, R03A10, F59D12, 
H08J19, K09E9, K09A9, C02C6, ZK662, ZK678.
The cosmids in the 6L mix were, from left to right: C33A11, F47C8, F39D8, 
R03A10, F59D12, H08J19.
The cosmids in the 6R mix were, from left to right: F59D12, H08J19, K09E9, 
K09A9, C02C6, ZK678.
K09A9 and K09E9 were both injected singly at 5 and 10 ng/pl 
The cosmids in the 5 cosmid mix were :F59D12, H08J19, K09E9,
C02C6, ZK678.
Table 2vii Genotype of worms used in cosmid rescue injections
Lethal allele under 
study
Genotype of injected worms ts alleles present
w4 spe-9(hc88)/w4,unc-75(e950) spe-9(hc88) is ts. Strain 
maintained at 25°C
ijDfl ijDfl/unc-84 or 
ijDfl/+
unc-84 is ts. Strain 
maintained at 25°C 
ijDfl/+ strain maintained at 
20°C
90
Each large coverslip, carrying worms immobilised on the agarose plugs, was 
taped to the free sliding oil cushioned stage of a Zeiss Axiovert 100 inverted microscope 
fitted with Nomarski optics. Microinjections were performed at 400x magnification 
using a Zeiss Achroplan 40x air objective lens. Pressure was applied to the needle 
containing the injection solution using the foot operated switch. The micromanipulator 
was used to open the sealed needle by repeatedly touching the tip of the needle onto a 
piece of capillary tube placed on the agarose plug until a suitably high flow rate was 
observed, indicating that the needle possessed a sufficiently large bore to reduce 
blocking. Injections were performed by first focusing on the grainy cytoplasm in the 
centre of the distal gonad. The needle was then brought into the same focal plane and 
the microscope stage moved by hand to push the worm into the needle tip. Once the 
needle was touching the surface of the worm, the microscope stage was tapped and this 
usually resulted in the needle penetrating the cuticle and gonad. Nitrogen pressure was 
then applied to force the injection solution into the gonad immediately after penetration. 
The needle was rapidly withdrawn from the worm without reducing the nitrogen 
pressure, once the gonad had swollen visibly.
After injection, the worms were recovered by adding a drop of lxM9 buffer onto 
the agarose pad, causing the worms to float off the pad. The injected worms were then 
collected from the drop using a platinum wire pick and approximately 10 worms seeded 
onto a fresh NGM agar plate supporting an E.coli OP50 food source, by floating the 
worms onto a drop of sterile lxM9 buffer. The injected worms were incubated for 3-4 
days at 20°C (or overnight at 20°C and 2 days at 25°C in cases where the injected 
hermaphrodites carried the lethal mutation, w4 or ijD fl, balanced by a ts allele -see 
Table 2vii) until FI progeny with the rol-6 phenotype were observed.
2.14.3. Isolation of transgenic lines and examining for signs of cosmid rescue
FI progeny from the injected worms which exhibited the rol-6 phenotype, 
conferred by the pRF4 marker plasmid, were seeded to fresh NGM agar plates 
supporting an E.coli OP50 food source (3 worms/plate). These plates were incubated 
for 3-4 days at 20°C (or 2 days at 25°C in cases where the injected hermaphrodites 
carried the lethal mutation, w4 or ijD fl, balanced by a ts allele - see Table 2vii) until F2 
progeny with the rol-6 phenotype were observed. Around 10 F2 roller progeny were
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picked from each FI plate that transmitted the rol-6 phenotype to the F2 progeny and 
these worms were seeded onto fresh NGM agar plates supporting an E.coli OP50 food 
source (1 worm/plate). This process generated at least 10 populations of worms derived 
from a single animal from each original plate of transmitting FI progeny. Each of the 
populations generated from each FI plate were scored for the presence of the lethal 
allele under study and these populations were examined for signs of rescue. For cosmid 
rescue of w4, signs of rescue were observed by scoring the progeny of the transformed 
lines and noting any changes in the percentages of Uncs seen that did not correspond to 
recombination between w4 and unc-75(e950). The signs of rescue for the ijDfl 
deficiency, however, were more subtle. Because I was only adding back a small number 
of cosmids to a large deficiency which deletes several essential genes, the ijDfl 
homozygotes would still be arresting as embryos but, if  rescued by a gene involved in 
elongation, the arrested embryos would have a noticeably longer end phenotype. The 
dpy-7::GFP transgene was co-injected to act as a marker in the arrested embryos so I 
could distinguish between transformed and untransformed embryos under UV light. 
ijDfl homozygote embryos from transmitting lines were examined at 1000X 
magnification using a Zeiss Axioplan microscope and Zeiss Plan-Neofluar 100x/1.5 air 
objective, with Tungsten halogen UV source (240V 500W, Osram). Images were taken 
using a Panasonic wv-CL700 colour digital camera and the Digitalvision 1.0.6 program.
2.15. Diagnostic restriction digests of injected cosmids
The usual method of testing that cosmids are intact before injecting is to prepare 
DNA from at least 2 separate colonies containing the cosmid using a Qiagen plasmid 
Mini kit (Qiagen Inc.) and compare the restriction patterns of a common restriction 
endonuclease, for example EcoRl. However, when I began looking at the digest 
fingerprint in detail for cloning purposes, I realised that many of these cosmids were 
deleted significantly and in order to be certain that an intact cosmid was being injected, 
it appeared to be necessary to examine the digests in detail. Before the restriction 
endonuclease digests of each injected cosmids could be analysed properly, I had to 
determine what cosmid backbone was present and the full genomic sequence contained 
within the cosmid. A. Coulson et a l , 1995 lists the cosmid backbones for all cosmids 
used and the full genomic sequence was determined from details within the separate
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published sequences. I used Vector NTI version 4.0 to construct the entire cosmid 
backbone plus contained genomic sequence and thus calculate what fragments any 
diagnostic digest should yield.
2.16. Subcloning of Cosmids involved in phenotype rescue of ijDfl
2.16.1. Restriction digests of Cosmids
The complete genomic plus cosmid backbone sequence was determined for each 
cosmid as in section 2.15 and the restriction endonuclease enzymes required to cleave 
fragments of the correct size were selected. Digests were carried out as in section 2.7.1.
2.16.1.1. Fragments containing gene clones and vector digests
In order to isolate the fragment containing the predicted gene K09A9.1, cosmid 
K09A9 (accession number Z79601) was digested with Pvull and Kpril. These digests 
were carried out sequentially as in section 2.7.1 and a sample was taken at the end of the 
initial digest to ensure that the DNA was cut completely. The digest reaction was run 
out on a 0.7% agarose gel (see section 2.7.2) and a 4701bp fragment, corresponding to 
the sequence between positions 36409bp and 41113bp in the complete genomic 
sequence contained within K09A9, was excised and purified as in section 2.7.3. 
K09A9.1 is predicted to run from 37183bp (ATG)-40467bp (TAA) in the complete 
genomic sequence within the K09A9 cosmid and so the excised fragment also contained 
774bp of upstream flanking sequence and 646bp of downstream flanking sequence from 
the predicted gene. Since there are two Pvull sites within the pBluescript pSK- plasmid 
used to clone the gene, both outwith the polylinker, another blunt cutting restriction 
endonuclease, EcoRV, was used along with Kpril to cut this vector. The digest was run 
on an agarose gel and the correct fragment gel purified as before.
A fragment containing the predicted gene K09A9.2 was isolated from cosmid 
K09A9 by digesting with BamHl and Xhol. The digest reaction was run out on a 0.7% 
agarose gel as before and a 4492bp fragment containing sequence between positions 
33279bp and 37770bp of the complete genomic sequence within cosmid K09A9 was 
excised and purified. The predicted gene K09A9.2 runs complementary from 36864bp
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(ATG) to 3553 lbp (TAG) and so the fragment containing K09A9.2 also has 906bp 
upstream flanking sequence and 2252bp downstream flanking sequence from the gene. 
The pBluescript SK- vector was also cleaved with Xhol and BamRl within the 
polylinker. The digest was run out on an agarose gel, excised and gel purified as before.
2.16.1.2. Specific deletions of cosmids
I wanted to subclone the K09E9 cosmid (accession number: Z79602) so that I 
was only injecting the genomic overlap between K09A9 and K09E9, or the non-overlap 
genomic region. In order to do this I used restriction endonucleases to specifically 
delete the area of the genomic DNA I did not want and then re-ligated the rest of the 
cosmid sequence plus the backbone to produce a new smaller cosmid clone containing 
the genomic sequences of interest.
The pKEO cosmid subclone was produced by deleting the non-overlap 
sequences containing predicted genes and leaving the overlap sequence which contained 
predicted genes K09A9.1 and K09A9.2. In order to create this subclone, I digested 
cosmid K09E9 with AvrU., ran the digest reaction and gel purified the 15625bp fragment 
corresponding to the region containing the K09A9/K09E9 genomic overlap plus the 
LoristB cosmid backbone. This fragment comprised the 555 lbp LoristB cosmid 
backbone, the genomic sequence from lbp to the Avrll sites at 8312bp in the complete 
K09E9 genomic sequence, and the sequence from the Avrll site at 37447bp to the end 
(39209bp) of the K09E9 genomic sequence.
The pKENO cosmid was produced as a result of deleting the genomic sequence 
contained in the K09E9/K09A9 genomic overlap from cosmid K09E9 and re-ligating 
the linearised deleted cosmid so that only the non-overlap genomic sequence remained. 
The K09E9 cosmid was digested with Pmel and BamRl endonucleases and the digest 
run out on an agarose gel as before. The 38246bp fragment containing the 555lbp 
LoristB cosmid backbone, genomic sequence from lbp to the BamHI site at position 
478bp in the complete K09E9 genomic sequence, and genomic sequence from the Pmel 
site at position 6992bp to the end (39209bp) of the complete K09E9 genomic sequence 
was gel purified as before. This fragment contained the cosmid backbone and the 
genomic sequence that was not shared between cosmids K09A9 and K09E9. Before I 
re-ligated this fragment, I used klenow DNA polymerase I (NEB) in the supplied
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EcoPol buffer plus recommended amounts of dNTPs (Promega Corporation) to fill in 
the BamRl 5 ' overhang and then heat-inactivated the enzyme according to the 
manufacturer’s instructions.
2.16.2. Ligation reactions for gene and cosmid deletion subcloning
Ligation reactions between genomic inserts and pBluescript vector DNA were 
carried out with molar ratios and conditions as section 2.7.4 (using around 20ng of both 
insert and vector). To ligate the pKENO fragment I cleaned up the klenow reaction 
using a Qiaquick PCR clean-up kit (Quiagen, Inc) to remove unused dNTPs and other 
impurities. This reaction was resuspended in around 8jnl of deionized water, to which 
T4 ligase (NEB) and T4 ligase buffer (NEB) were added as in section 2.7.4.
2.16.3. Transformation of subcloned plasmid and cosmids
The ligations involving fragments containing predicted genes plus pBluescript 
SK- (Stratagene Ltd.) vectors were transformed using Novablue (Novagen, Inc.) 
supercompetent cells. Of the deleted cosmid self-ligations, pKEO was transformed 
using Novablue (Novagen, Inc.) supercompetent cells and pKENO was transformed 
using XL 1-blue (Stratagene Ltd.) supercompetent cells. Transformations were carried 
out as in section 2.7.5.
2.16.4. Screening of Transformed colonies
2.16.4.1. Colony Lysis
Colony lysis is a method used to screen transformed E.coli colonies during the 
generation of subclones for genes K09A9.1 and K09A9.2. The same buffer and 
protocol was used in all cases and is outlined below:
Colony lvsis buffer
2% Ficoll
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1% SDS
0.2% Bromophenol Blue 
in lx  TBE buffer
1) Isolated colonies from transformation plates were picked using a wooden 
tooth pick.
2) The pick was dipped into 30pl of lysis buffer in a 0.5ml eppindorf and left at 
room temperature for 15-20 min.
3) Samples were microfuged at 13,000rpm for 25 min
4) Samples were then placed at 4°C for at least 30 min to enable subsequent easy 
loading of an agarose gel
5) The sample supernatant was loaded onto a 1.2% agarose gel, being careful to 
avoid loading the loose pellet, and the gel was run at around 5V/cm
Colonies containing an insert ran more slowly than control colonies containing the 
vector only.
2.16.4.2. DNA preparation from colonies and diagnostic digests
DNA was prepared from transformed colonies using Quiagen plasmid Mini 
DNA preparation kits (Quiagen, Inc.). Blue-white selection was used to identify 
positive colonies where pBluescript SK- (Stratagene Ltd.) was used as a vector (see 
section 2.7.5). Diagnostic digests were performed on around 200ng of prepared DNA 
using suitable endonucleases for each subclone with conditions as 2.7.4.
2.17. RNA interference (RNAi)
j
i
i
j  RNAi information and general protocols were taken from the Fire lab website
| (http://elegans.swmed.edu/Worm-labs/Fire/) version 1.0, 1 February, 1998 (also Fire et
a l , 1998; Tabara et al., 1998). The protocol I used differed in many respects from the 
protocols outlined on the website so I will describe it in detail.
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2.17.1. Generating the target DNA fragment using PCR
Primers were designed specific to each cloned or predicted gene used in the 
RNAi analysis. K09A9.1, K09A9.2, C02C6.2 and C02C6.3 are predicted genes from 
the published sequences of the C.elegans genomic DNA contained within cosmids 
K09A9 and C02C6, and C02C6.1 is dyn-1 which has been cloned (Clark et al., 1997). 
RNA prepared from genomic DNA inclusive of intron sequence is effective, as long as 
there is also an exon sequence present, and for most genes, any RNA segment of around 
200-1000 nucleotides or more seems to be capable of inducing interference (Tabara et 
al., 1998). Each of these primers also had either T3 or T7 sequences at their 5'end to 
enable RNA synthesis of the amplified fragment after PCR. Primer sequences, cloned 
and predicted genes, and intron/exon sequences amplified are shown in Table 2viii. 
Reagents and conditions used in PCR are shown below. Genomic fragments were 
amplified from K09A9 or C02C6 cosmid DNA which had been prepared using Quiagen 
Mini or Midi plasmid DNA preparation kits (Quiagen, Inc.).
PCR reaction mix
Reagents Final concentrations
Taq Polymerase lOx buffer (NEB) lx
Taq Polymerase (NEB) lU/25pl
The reactions were made up in a final volume of 25°C using sdiH20 . Each reaction was 
overlaid with an approximately equal volume of mineral oil and the PCR was performed 
using a Crocodile III thermocycler (Appligene) with the following conditions:
MgCl2
dNTPs (Promega Corporation) 
gene T3 oligo (Table 2viii) 
gene T7 oligo (Table 2viii) 
cosmid DNA
2.5mM
O.lrnM
4ng/pl
4ng/pl
0.8ng/pl
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Table 2viii Primers for the amplification of gene sequences for RNA synthesis
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Step Cycles Temp°C Timefmin)
1 1 94
2.1 35 52
2.2 35 72
2.3 35 94
3.1 1 52
3.2 1 72
4
0.5
gels as in section 2.7.2 and targetThe PCR reactions were run out on 0.7% agarose 
fragments were gel purified as in section 2.7.3.
3
1
4
5
2.17.2. T3 and T7 polymerisation
RiboMAX large scale RNA production systems (Promega Corporation) were 
used for T3 and T7 synthesis of single stranded RNA from around l-2pg of the purified 
PCR fragments. The manufacturers protocol was followed except that I used 50pl 
reactions rather than 1000pi reactions and all the reagents were scaled accordingly. I 
also added 80U extra rNAsin ribonuclease inhibitor (Promega Corporation). After RNA 
synthesis, the DNA template was removed by DNase treatment. The RNA was cleaned 
by an organic extraction and isopropanol precipitation according to the RiboMAX 
protocol. All reagents and tips used were RNase free.
2.17.3. Annealing reaction
Equal amounts (around 25 pg) of sense RNA and antisense RNA were incubated 
in 12pl of lx injection buffer along with 40U rNAsin ribonuclease inhibitor (Promega 
Corporation) at 68°C for lOmin and 37°C for 30min. The annealing was checked by 
running a sample from each reaction on a 0.7% agarose gel as in section 2.7.2. Clean 
tanks and RNase free TBE were used. The reactions were stored at -70°C until needed 
for microinjection
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2.17.4. dsRNA microinjections
Injection mixes with double stranded (ds)RNA specific to different combinations 
of predicted genes were made as in Table 2ix. The injection procedure used was 
identical to that in section 2.14.2, with the same needles and equipment. Young adult 
wild type hermaphrodites were injected with each of the dsRNA mixes, except for mix 
10 which was injected into hermaphrodites heterozygous for the dyn-l(null) allele, and 
were placed 10 to a 5cm plate (Griner) for 6-12 hours at 20°C to recover.
2.17.5. Examination of the phenotype produced by RNAi
Wild type worms that appeared healthy after the recovery period were plated out 
separately on 3.5cm plates (Griner) at 20°C and the plates were numbered. These 
hermaphrodites were transferred around every 12 hours to similarly numbered plates 
and around 14-20 hours after transfer, the original plates were examined. Any visible 
phenotype such as lethality (Let), dumpy (Dpy), uncoordinated (Unc) etc. was scored 
quantitatively and arrested embryos were viewed on agarose mounted slides using 
Nomarski optics were scored quantitatively also. The plates were all followed through 
to adulthood for any later death or visible markers which only became obvious at later 
stages.
2.18. Statistics
A number of statistical tests were used to determine whether the percentage 
death from hermaphrodites heterozygous for a mutation or deficiency could be 
attributed to homozygote death alone and to compare results from classical genetic 
mapping crosses with expected results for unlinked genes. An analysis of variance 
(ANOVA) test was carried out comparing the deaths in 33 broods from hermaphrodites 
heterozygous for w4, ijDfl and ijDf2 (Appendices 4.1,5.1 and 6.1)(Parker, 1991). This 
gave an F value of 1.13 which was not significant at 2 numerator (k-1) and 66 [k(n-l)J 
denominator degrees of freedom for 3 (k) treatments and 33 (n) replicates for each 
treatment. This showed that there was no significant difference in the percentage of 
deaths for each mutation and suggested that the deaths were unlikely to be due to
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Table 2ix Genes and dsRNA used in RNAi injections
Gene
specific
dsRNA
Abbreviations 
used in mixes
Concentration 
in all mixes 
except mixes 2 
and 9 (ng/pl)
Concentration 
in mix 2 and 
9
(ng/pl)
Mix dsRNA
present
K09A9.1 K1 315 32 1 all genes
K09A9.2 K2 307 31 2 all genes
C02C6.1 
0dyn-1)
Cl 285 29 3 K1,K2,C1
C02C6.2 C2 296 30 4 K1,K2,C2
C02C6.3 C3 292 29 5 K1,K2,C3
6 K1,C1,C2,
C3
7 K2,C1,C2,
C3
8 Cl
9 Cl
10 K1,K2
anything other than homozygosity for the recessive lethal mutation. For each classical 
mapping cross, a %2 test was carried out with the appropriate degrees of freedom as 
detailed in Parker (1991) as in section 2.8.1.
2.19. Computer programs
All images were taken using either Digitalvision software version 1.0.6 © 1993- 
1994 Graphics unlimited, or Openlab 2.0.2 software © 1998 Improvision (Coventry, 
UK) for Macintosh computers. Primers and subclones were designed using Vector NTI 
software, version 4.0 © 1994-1996 InforMax Inc.. The ACeDB C.elegans was used for 
all C.elegans genetic and physical map computer analyses (Thierry-Mieg and Durbin, 
unpublished software). DNA sequence comparisons were done using the WU-blast 1.4 
BLASTN search. WU-BLAST 1.4 is based on NCBI-BLAST version 1.4 (Gish and 
States, 1993; Altschul and Gish, 1996). C.elegans clone sequences were obtained from 
EMBL or genbank sources using either <http://www.sanger.ac.uk/Projects/c_elegans/ 
Genomic_Sequence.shtml> or <http://www .ncbi.nlm.nih.gov/Entrez/nucleotide.html>.
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Chapter 3
Localisation of the cuticular collagen, DPY-7 in wild type and mutant 
animals using a novel monoclonal antibody, DPY7-5a
3.1. Introduction
3.1.1. Cuticular collagens of C.elegans and the structure of the cuticle throughout 
the life cycle
Caenorhabditis elegans is covered by a cuticle which acts as a barrier between 
the worm and the environment, and an exoskeleton which maintains and defines the 
shape of the nematode (Johnstone, 1994). The predominant constituents of this cuticle 
are the extensively crosslinked cuticular collagens which are synthesised and secreted 
by the underlying hypodermal cells (Singh and Sulston, 1978; Cox et a l , 1981a; 
Kramer, 1994a). Collagens are the most abundant and ubiquitous extracellular proteins 
of metazoans although nematode collagens are notably smaller than vertebrate collagens 
being around 30-40kDa compared to >150kDa in size (Adams, 1978; Kramer et a l , 
1988; Johnstone, 1994). The structure of C.elegans cuticular collagens are most similar 
to the non-fibrillar FACIT collagens of vertebrates (Shaw and Olsen, 1991). The 
genome of C.elegans contains 170 collagen genes and most of these are thought to be 
cuticular collagens (Johnstone, 1994; The C.elegans sequencing consortium, 1998). It 
is clear therefore that in C.elegans many collagens must be assembled from the 
hypodermal cytoplasm into a complex macromolecular extracellular structure, the 
cuticle, and the mechanism by which this happens is not well understood.
C.elegans nematodes, in common with other nematodes, undergo 4 larval stages 
between hatching from the egg and becoming adults, named the L1-L4 stages (Singh 
and Sulston, 1978; Cox et al., 1981c). During embryogenesis and at each of the 
transitions from one larval stage to the next, a new cuticle is synthesised in the 
hypodermal cells and secreted from them. In all stages after embryogenesis this new 
cuticle is secreted underneath the old one which is then sloughed off from the worm 
(Singh and Sulston, 1978). To allow for growth at each stage, it has been proposed that 
the hypodermal surface contracts during cuticle secretion forming a folded surface under 
the old cuticle so that a new cuticle can be synthesised beneath the old one but have a
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larger surface area (Costa et al., 1997). Under conditions of overcrowding or lack of 
food, L2 stage larvae moult into a specialised L3 stage called the dauer stage (Cassada 
and Russell, 1975). These longer, thinner larvae are specialised for withstanding harsh 
environments and they do not feed. They can survive for 8-16 weeks and only moult 
into an L4 larvae when better conditions are presented, such as the addition of food 
(Klass and Hirsh, 1976). Each of the larval and adult stages has a different cuticle 
structure adapted to its needs, for example, the dauer cuticle is thicker in proportion to 
its circumference and the adult cuticle allows it to grow considerably larger without an 
additional moult (Cox et al., 1981c).
The cuticle is composed of several layers differing at every stage. The main 
layers characterised in the adult cuticle are the epicuticle, external cortical, internal 
cortical, medial and basal layers (Figure 3.1a)(Cox et al., 1981a,c; Peixoto and Souza, 
1992). The adult-specific medial layer is fluid-filled and contains filamentous struts 
which connect the cortical and basal layers (Figure 3.1a)(Kramer, 1997). The cuticles 
of L2-L4 larvae are all very similar and contain an epicuticle, external cortical, internal 
cortical, and basal layers (Cox et all, 1981c). LI and dauer cuticles have a striated layer 
in place of the basal fibre layer of other stages (Cox et al., 1981c). The localisation of 
collagens and other components of the cuticle is largely unknown. Exceptions are the 
SQT-3 collagen which is thought to localise to the basal layer, and the BLI-1 and BLI-2 
collagens which are thought to be components of the medial layer struts in the adult 
cuticle (Priess and Hirsh, 1986; J.Kramer, pers.comm.). There are also insoluble 
components of the cuticle known as cuticlins which are localised to the cortical layer 
(Ristoratore et al., 1994; Favre et al., 1995). These proteins are discussed in more detail 
below.
The external cortical layer of the different cuticles secreted throughout the life 
cycle of C.elegans contain circumferentially orientated furrows, named annulae (Figure 
3.1), which are coincident with the organisation of actin filaments in the underlying 
hypodermis during embryogenesis and at each moult (Cox et al., 1981c; Costa et al.,
1997). These annulae are present on the dorsal and ventral cuticular surfaces but not at 
the lateral surfaces overlying the specialised hypodermal cells known as seam cells. 
This can be explained postembryonically by the fact that, at each moult, membrane 
associated actin fibres in the hypodermis align only in dorsal and ventral regions and in 
embryos the aligned actin filaments in the seam cells are never found on the apical
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Figure 3.1
Structure of the cuticle in C.elegans
a Schematic diagram of the adult cuticle of C.elegans showing the different
component layers. The outermost layer, the epicuticle, is not shown. The 
predominantly collagenous layers are the internal cortical, struts, and basal 
layers.
b Cross section of the adult worm showing the cuticle and underlying hypodermis.
This shows the difference in the thickness of the hypodermis at different places. 
The thickest regions of the hypodermis are at the seam cells and the dorsal and 
ventral cords. In other regions the hypodermis is very thin. Hypodermal nuclei 
tend to lie in thick areas of the hypodermis.
(Johnstone, 1994)
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surface and so do not influence the patterning of the cuticle above in the same way as 
the dorsal and ventral hypodermis (Costa et al., 1997). Seam cells are responsible for 
another structural aspect of the cuticle. In three different life cycle stages; LI, dauer and 
adult, there are additional surface cuticular structures, known as alae, which are 
thickenings of the cuticle running longitudinally along the lateral regions of the worm, 
above the seam cells (Figure 3.1b)(Singh and Sulston, 1978; Cox et al., 1981c). These 
are produced by the seam cells at each of these specific stages and differ in their 
structure between each stage. They are apparently generated by circumferential 
contraction of the seam-specific cuticle after secretion at these stages (Singh and 
Sulston, 1978; Sulston et al., 1983). C.elegans nematodes travel across substrates on 
their lateral surfaces and so the alae contact the substrate directly when they are present 
(Cox et a l , 1981a). As yet, none of the collagen genes are known to be alae-specifie 
although the col-7 collagen gene is expressed only in the lateral hypodermal cells (Liu et 
al, 1995). However, there are two insoluble cuticle proteins, CUT-1 and CUT-2, which 
are present in high amounts within a 2 pm-wide band underlying the alae of the dauer 
stage (Sebastiano et a l , 1991; Lassandro et a l , 1994). These proteins, known as 
cuticlins (Fujimoto and Kanaya, 1973), are present in very low amounts in the cortical 
layers of the cuticle in all stages but are not concentrated at the alae region in any stage 
other than dauer (Ristoratore et a l , 1994; Favre et a l , 1995).
3.1.2. Stage specific and temporal expression of cuticular collagens
It was originally thought, from radiolabelling studies, that the cuticular collagens 
in C.elegans were synthesised just prior to moulting between each developmental stage 
(Cox et al., 1981b) but looking at the mRNA abundance of 6 different collagen genes 
this was found not to be the case (Johnstone and Barry, 1996). Instead, it was 
discovered that there are several different, temporally distinct, waves of collagen gene 
expression during each developmental stage (Johnstone and Barry, 1996). Some 
collagen genes, including dpy-7, are expressed at the start of the cycle four hours before 
the next cuticle is secreted. Others, including dpy-13 and col-1 are expressed two hours 
before the next cuticle is secreted while col-12 and col-14 are expressed coincident with 
the secretion of the new cuticle (Johnstone and Barry, 1996). This is thought to be a 
possible mechanism of restricting the number of collagens being translated and
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processed at any time, to facilitate a more straightforward assembly into a multi-layered 
cuticle (Johnstone and Barry, 1996). Another interesting finding was that some 
collagen genes, sqt-1 and col-12, were also expressed during the adult stage while 
others, dpy-7, dpy-13, col-1 and col-14, were not. Adults of C.elegans increase 
significantly in length and circumference without moulting and this is also seen in 
nematodes such as Ascaris (Figure 3.2) (Watson, 1965). The mechanism of adult 
growth is not understood in C.elegans but it is possible that the synthesis of certain 
collagens at the adult stage relates to growth of the adult cuticle and also may indicate 
that only a restricted set of collagens are responsible for adult cuticle growth (Johnstone 
and Barry, 1996). There have been several studies examining collagen gene expression 
throughout development which have identified other stage-specific collagens. Certain 
collagens, col-2 and col-6, are expressed only during the specialised L3 dauer larval 
stage and other collagens, col-7 and col-19, are primarily adult specific (Cox and Hirsh, 
1985; Kramer et al., 1985).
3.1.3. Structural and sequence similarities among C.elegans cuticular collagens
Collagens are all rich in the amino acids: glycine, proline and the hydroxylated 
form of proline, hydroxyproline, and are characterised by blocks of Gly-X-Y amino acid 
repeats where X and Y can be any amino acid but are often proline and hydroxyproline 
respectively (Bomstein and Traub, 1979). Collagens typically form a triple helical 
structure (Ramachandran, 1967; Ramachandran and Ramakrishnan, 1976). Gly-X-Y 
repeats form a helix in the collagen monomer with the glycines being stacked on top of 
one another down one side of the helix. These helices then join with two other helices 
by hydrogen bond interaction so that the glycine residues all face into the centre of the 
newly formed triple helix (Figure 3.3b). Spatial constraints in the centre of the helix 
restrict the size of the side chains of amino acids present here while no such constraints 
are placed on the side chains of amino acids elsewhere in the helix. This results in the 
necessity of a glycine, which has a side chain of hydrogen, as every third residue to 
form the centre of the helix. Nematode collagens contain a number of cysteine residues 
at conserved positions which are thought to stabilise this triple helical structure, via 
disulphide bonding, and possibly maintain the correct positioning of different collagen 
chains (Cox et al., 1981a; Johnstone, 1994; Kramer, 1994). Although the
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Figure 3.2
Young and old adult wild type hermaphrodites
Image showing the difference in size between a young, gravid hermaphrodite 
(left) and an old hermaphrodite past the reproductive age (right). The old 
adult is both broader and longer than the young adult. The anterior is to the 
top and the dorsal surface to the left o f the image.
Scale bar is 0.1mm
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Figure 3.3
The general structure of C.elegans cuticular collagens and the coiled structure of 
the collagen triple helix
a General structure of C.elegans cuticular collagens derived from the sequences of
38 collagen genes. The dashed lines indicate the regions that show the greatest 
length and sequence divergence among the collagens. The number of amino 
acids in different domains are indicated above the lines at the top of the figure. 
(Kramer, 1997).
b The coiled structure of the collagen triple helix. Three chains, labelled 1,2 and 3
are indicated. Size constraints of amino acid side chains in the core of the triple 
helix (R1 and R4) dictate that every third residue of the collagen chains (Cl and 
C4) must be glycine. There are no size constraints on the side chains (R2 and 
R3) of the other residues in the Gly-X-Y repeats and they are usually proline and 
hydroxyproline(C2 and C3).
(Johnstone, 1994).
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overall structures of the cuticular collagens are very similar (Figure 3.3a), they differ in 
the organisation and lengths of the Gly-X-Y repeat blocks, the number and spacing of 
cysteine residues and the sequence of the non-repetitive amino- and carboxy-terminal 
domains (Cox et al., 1989). The collagens fall into groups based on the differences 
between the Gly-X-Y blocks and the cysteine residues. Interestingly, there are some 
similarities between the groupings of collagens based on structure and those based on 
temporal expression. Two of the genes expressed mid-cycle, dpy-13 and col-1, belong 
to the same structural group, as do the collagen genes expressed at the moult, col-12, 
col-13 and col-14 (Johnstone and Barry, 1996; J.Muriel, pers.comm.). There are also 
specific sequence homologies in the presumptive promoter regions of collagens 
expressed at the same stage in the life cycle. The dauer larva-specific genes, col-2 and 
col-6, and the primarily adult-specific genes, col-7 and col-19, show two distinct 
conserved sequences in the 5' flanking sequence presumably involved in stage specific 
regulation (Cox et a l, 1989). However, genes within a particular structural group do 
not always share similar temporal or developmental patterns which suggests that 
structural and regulatory regions of these genes evolve separately.
In addition to the Gly-X-Y repeats and the conserved cysteine residues, there are 
also 4 blocks of homology in the amino-terminal domain (Figure 3.3a), one of which 
(HBA) contains two highly conserved arginines that are thought to function as a 
subtilisin-like proteinase cleavage site (Yang and Kramer, 1994). There is a C.elegans 
gene, bli-4 which encodes a protein with strong similarity to the subtilisin family of 
endoproteases and certain mutations in this gene result in disruptions to the cuticle as 
described below (Peters et a l, 1991; Kramer, 1994a).
3.1.4. Mutations in C.elegans cuticular collagens and their affect on body shape
During embryogenesis in C.elegans, the embryo elongates from a ball of cells to 
a cylindrical worm shape more than four times longer and three times narrower (Sulston 
et al., 1983). It is thought that contractions of actin microfilaments within the 
hypodermal cells drive the elongation process until the worm is fully elongated and at 
what is known as the 3-fold stage of development (Priess and Hirsh, 1986). Structural 
elements that can effect organism morphology are often found in the extracellular 
matrix. There is strong evidence that the extracellular cuticle of C.elegans plays a role
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in maintaining the shape of the body from the end of embryogenic elongation onwards 
(Kusch and Edgar, 1986; Priess and Hirsh, 1986; Kramer et a l, 1988). Mutations in the 
sqt-3 gene, which encodes a collagen, cause mutant embryos to initially elongate 
normally but then retract significantly in length as they cannot maintain the elongated 
shape (Priess and Hirsh, 1986; van der Keyl et a l , 1996). Also, many cuticular 
collagens have been shown to alter the postembryonic body shape drastically when 
mutated, resulting in phenotypes such as roller (rol-6, sqt-1: Cox et al., 1980; Kramer et 
al., 1988; Kramer et al., 1990), dumpy (dpy-7, dpy-13\ von Mende et al., 1988; 
Johnstone et a l, 1992), and long (sqt-1: Kramer et a l, 1988). Roller mutants have a 
helically twisted cuticle and internal organs and move in circles, rotating about their 
longitudinal axes (Brenner, 1974; Higgins and Hirsh, 1977). Dumpys are short and fat, 
and the long mutants are abnormally long and thin (Brenner, 1974).
It has been suggested that the dumpy phenotype could arise from a cuticle that 
had greater inherent extensibility and would therefore become more spherical when 
subjected to the high internal hydrostatic pressure of the worm resulting in a short, fat 
animal (Kramer et a l, 1988). This may indicate that collagens which can be mutated to 
produce the dumpy phenotype have a function in maintaining the strength or relative 
rigidity of the cuticle. Conversely, the long phenotype could arise from a cuticle which 
had a more restricted radial extensibility resulting in a longer, narrower worm than 
normal (Kramer et a l, 1988). The roller phenotypes are interesting as mutations in 
different genes can result in either a right roller or left roller phenotype (Kusch and 
Edgar, 1986; Kramer et a l, 1988; Levy et a l, 1993; Park and Kramer, 1994). The basal 
layer of the C.elegans cuticle has two fibrous sublayers containing helically oriented 
fibres that spiral in opposite directions offset from the anterior-posterior axis by 65°C 
(Cox et a l, 1981a; Bergmann et a l, 1998). The outer fibre layer has a right-handed 
screw direction while the inner fibre layer has a left-handed screw direction. It has 
previously been proposed that the roller phenotypes were due to defects in these layers 
and that the handed-ness of the roller phenotype seen depended on which layer was 
disrupted. However, there is not a wide body of evidence for this view (Peixoto et a l,
1998). Certain rol-6 mutants which exhibit the roller phenotype have unchanged 
orientations of the apparently normal fibre layers while other mutants seem to have 
clearly altered fibre orientations (Bergmann et a l, 1998; Peixoto et a l, 1998). 
Bergmann et a l (1998) have proposed a model in which the assembly of the first (outer)
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fibre layer involves interactions of the fibres with each other and with other cuticle 
components while the assembly of the second (inner) fibre layer is affected by 
interactions with the overlying fibre layer. In this model, mutations which alter the first 
layer by interfering with the self assembly or interactions with other cuticle components 
would affect the orientation of both layers while mutations which alter the interaction 
between the two fibre layers should only change the orientation of the second layer. In 
this way, different mutations could be expected to produce either left or right roller 
phenotypes. There are also mutations in the collagen genes bli-1 and bli-2 which cause 
blistering of the adult cuticle due to the production of fluid-filled swellings (J.Kramer, 
pers.comm.). The blister phenotype is only seen in adult cuticles due to the stage 
specific fluid-filled medial layer (Cox et a l, 1981c). The dense columns or struts of 
material which traverse the fluid-filled medial layer connecting the outer layers, are 
absent or abnormal in bli-1 and bli-2 mutants causing the fluid to flow out into 
swellings on the surface of the cuticle (J.Kramer,pers.comm.).
Mutations in certain collagen genes, including sqt-1, rol-6 and dpy-10, result in 
completely different phenotypes depending on whether the mutation in the gene is 
dominant or recessive (Kramer et a l, 1990; Kramer and Johnson, 1993). This suggests 
that the different types of mutation may produce mutant phenotypes for completely 
different reasons, for example, a recessive mutation may result in a phenotype due to the 
absence of the wild type collagen in the mutant cuticle while a dominant mutation could 
result in a phenotype caused by the presence of an aberrant collagen in the mutant 
cuticle. The different mutations also interact in unpredictable ways both intra- and 
intergenically. These observations are typical of genes encoding structural components 
which interact with each other forming complex multimeric structures (Kusch and 
Edgar, 1986; Kramer et a l, 1988).
3.I.4.I. Null mutations in C.elegans cuticular collagen genes
The effects of null mutations are the most easily interpreted for these genes and 
they appear to fall into two different classes. Null mutations in certain collagen genes, 
for example sqt-1 and rol-6 (Kramer et a l, 1988; Kramer and Johnson, 1993), show a 
very weak or apparently wild type phenotype while null mutants of other collagen 
genes, such as dpy-7 (Figure 3.4c)(J.Ewbank, pers. comm.), dpy-10 (Levy et a l, 1993)
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Figure 3.4
Size differences between egg-laying wild type and dumpy adult 
hermaphrodites
In all images, the anterior is to the left and the dorsal region to the top o f the 
page
a wild type hermaphrodite
b homozygous dpy-7(e88) hermaphrodite
c homozygous dpy-7(qm63) hermaphrodite
d homozygous dpy-13(e458) hermaphrodite
Scale bar is 0.1mm
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and dpy-13 (Figure 3.4d)(Kramer, 1994a) can cause severe morphological defects. This 
indicates that the wild type copies of SQT-1 and ROL-6 may have partially overlapping 
functions or functions that are not easily detected by the observation of phenotypes 
under laboratory conditions, whereas the wild type DPY-7, DPY-10 and DPY-13 
collagens are clearly required to achieve or maintain normal cuticle function.
3.1.4.2. Glycine substitutions in the Gly-X-Y repeats of cuticular collagens
Studies of mammalian fibrillar collagens have shown that mutations causing the 
substitution of glycine residues in Gly-X-Y repeats result in a dominant phenotype 
(Prockop et al., 1989; Engel and Prockop, 1991). These dominant glycine substitution 
mutations cause the inhibition of triple helix assembly and, as a result, mutant and wild 
type collagen chains are subsequently degraded intracellularly. This is a common effect 
of glycine substitutions and as a result, a reduced amount of abnormal collagen is 
secreted into the matrix (Kramer, 1997). The dominant effects seen in these mutants 
could therefore either be due to a reduced amount of wild type collagen in the cuticle or 
the result of small amounts of mutant collagen incorporated into the closely packed 
fibrillar collagen matrix. In contrast, glycine substitutions in Gly-X-Y repeats of 
nematode cuticular collagens often result in recessive phenotypes similar to the null 
phenotype (Johnstone et al., 1992; Levy et al., 1993; Kramer, 1994a, J.Ewbank, 
pers.comm.). This suggests that the presence of mutant glycine substitution cuticular 
collagens does not prevent the production and secretion of wild type collagens, allowing 
the formation of an apparently normal cuticle. It also strongly suggests that the 
recessive nature of these mutations in cuticular collagen genes is due primarily to the 
absence of the wild type collagen in the secreted cuticle rather than the presence of any 
mutant collagen within it. In two cases, however, the recessive phenotype resulting 
from glycine substitutions in cuticular collagens differs from the null phenotype. Two 
sqt-1 glycine replacement mutations, scl07  and sc99, result in a weak long or weak left 
roller phenotype compared to a very weak abnormal tail phenotype or wild type 
phenotype for the null (Kramer et al., 1988; Kramer and Johnson, 1993). Also, several 
recessive glycine substitution alleles of dpy-10 result in a dumpy phenotype which 
differs from the null dumpy LRol phenotype (Levy et al., 1993). These results suggest 
that the incorporation of a glycine replacement mutant collagen into the mutant cuticle
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can contribute to the phenotype seen. An interesting effect is seen in dpy-2 glycine 
substitutions as identical amino acid substitutions at sites in close proximity can result 
in different phenotypes (Levy et al., 1993). For example, dpy-2(e489) which creates a 
Gly to Arg substitution at position 247 in dpy-2 results in a temperature sensitive dumpy 
left roller (DpyLRol) phenotype whereas the same substitution at position 253 [dpy- 
2(q292)] results in a dumpy phenotype alone.
C.elegans glycine substitution collagens do not noticeably disrupt the cuticle in 
animals heterozygous for the mutation which indicates that either there is a mechanism 
which completely blocks secretion of these mutant collagens, or small amounts of the 
mutant collagen incorporated into the cuticle do not disrupt the normal function of this 
complex matrix. An explanation for the absence of glycine substitution collagens in the 
cuticle could be that mutant collagens do not trimerise normally due to the disruption of 
the triple helix caused by the missing glycine and as a result are degraded 
intracellularly, as happens with the vertebrate collagens discussed above (Johnstone et 
al., 1992; Johnstone, 1994). However, due to the recessive nature of cuticular collagen 
glycine substitution mutations, any triple helix disruption among mutant collagens does 
not appear to prevent the trimerisation of wild type collagen chains and secretion of 
sufficient wild type collagen to produce a functioning cuticle.
3.1.4.3. Dominant mutations in the HBA domain of cuticular collagens
One set of typically dominant mutations in C.elegans cuticular collagens are 
point mutations resulting in the substitution of one of two highly conserved arginine 
residues at positions 1 and 4 in a block of homology at the amino-terminal domain 
known as HBA (Yang and Kramer, 1994; Kramer, 1994b). Dominant mutations have 
been discovered in the HBA domain of sqt-1, rol-6 and dpy-10 (Kramer and Johnson, 
1993; Levy et al., 1993). These were all found to be arginine to cysteine substitutions at 
one of the two conserved arginines and it was thought that the mutant collagens 
produced could form ectopic disulphide bonds because of the extra cysteine residues. 
However, transgenic analysis of rol-6 and sqt-1 genes mutagenised in vitro indicated 
that the substitution of other nonbasic amino acids for arginine at these conserved 
positions also produced a dominant effect (Yang and Kramer, 1994). The phenotypes 
produced by these synthetic mutations differ from the null phenotype in the type of
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morphological abnormality produced and therefore seem to result from the 
incorporation of mutant collagen into the cuticle rather than, or in addition to, the 
absence of wild type collagen in the cuticle (Kramer, 1994a). It seems that even a small 
amount of mutant collagen is enough to disrupt the cuticle structure by being 
incorporated into it. An exception was seen where the arginine residues are replaced 
with another amino acid with a strong positive charge such as lysine as these mutant 
collagens produce a wild type phenotype (Yang and Kramer, 1994). In fact some wild 
type collagen genes that have been sequenced encode collagens with lysine at positions 
1 or 4 rather than arginine (Kramer, 1994b; Yang and Kramer, 1994). An arginine to 
histidine replacement at the conserved Arg-4 site in rol-6(el87) results in a recessive 
phenotype which, together with the lysine data suggest that a strong basic residue is 
required at the conserved arginine positions (Yang and Kramer, 1994). A closely 
related motif to the HBA homology block functions as a cleavage site for subtilisin-like 
serine proteinases which are involved in endoproteolytic processing of proproteins and 
prohormones (Barr, 1991; Yang and Kramer, 1994). The HBA motif could therefore be 
the cleavage site for a subtilisin-like protease with cleavage required for normal 
functioning of the cuticle (Yang and Kramer, 1994). One explanation for the different 
severity of phenotypes seen could be that the substitution of arginine with a non- 
positively charged residue completely blocks cleavage at the HBA site while 
substitution with His, a weakly positively charged residue, only partially blocks 
cleavage (Yang and Kramer, 1994). It seems likely that the incorporation of incorrectly 
cleaved cuticle collagens could dominantly disrupt collagen function and lead to the 
phenotypes seen in rol-6 and sqt-1 arginine substitution mutants.
The bli-4 gene of C.elegans has been shown to encode a subtililsin-like protease 
as mentioned above (Peters et al., 1991; Yang and Kramer, 1994). Mutations in bli-4 
usually cause early larval lethality but one viable mutation causes incompletely 
penetrant blistering of the adult cuticle indicating a role for the wild type gene involved 
in cuticle function (Peters et al., 1991). These two defects are independently mutable 
suggesting that bli-4 plays more than one role during the life cycle of C.elegans. Unlike 
mutations in cuticular collagens which are structural components of the cuticle, the 
mutations of bli-4 do not produce many different morphological phenotypes and are all 
recessive (Peters et al., 1991). This points more to an enzymatic function of cuticle 
assembly or maintenance which agrees with the idea that bli-4 may be involved in
116
cleaving collagens prior to their assembly into the cuticle (Kusch and Edgar, 1986; 
Yang and Kramer, 1994).
3.1.5. Background of DPY7-5a production and DPY-7 expression
DPY7-5a is a mouse monoclonal antibody which reacts against the carboxy 
terminal domain of DPY-7 (Figure 3.5) (I. Johnstone, pers.comm.). The target epitope is 
within the protein region shown in Figure 3.5b. Blastp searches using WU-Blast 1.4 
suggest that the DPY-7 carboxy terminal is not similar to other C.elegans collagens and 
so the DPY7-5a antibody should specifically recognise DPY-7. Previous studies using 
GFP and lacZ reporter constructs have shown that dpy-7 is expressed in hypodermal 
cells from the precomma stage of embryogenesis before elongation begins (Johnstone 
and Barry, 1996; Gilleard et al., 1997). Also, mRNA studies using RT-PCR indicate 
that this is the first collagen expressed among those studied (Johnstone and Barry, 
1996). The majority of animals expressing the dpy-7 \\G¥¥ or lacZ reporter constructs, 
showed expression in all hypodermal cells except the lateral seam cells, although in 
around 20% of animals, much fainter expression was also seen in seam cells (Gilleard et 
al., 1997). More recently, dpy7::GFP transgenes have been constructed in our 
laboratory that are expressed in the seam cells as brightly as in the dorsal and ventral 
hypodermis (E.Stewart, pers.comm.). Figure 3.6 shows the early onset of dpy-7v.GFP 
transgene expression during embryogenesis.
3.2. Specificity of the DPY7-5a monoclonal antibody
The dpy-7(qm63) allele is a deletion of approximately 6.6kb which removes the 
dpy-7 locus although it has not been accurately characterised (J.Ewbank, pers.comm.). 
The dpy-7(qm63) homozygotes are dumpy, as expected from the phenotype of the GLY- 
X-Y glycine substitution mutants (Figure 3.4c)(Johnstone et al., 1992; Johnstone, 1994; 
Kramer, 1997). No staining was found at any embryonic or postembryonic stage in dpy- 
7(qm63) homozygotes indicating that the DPY7-5a antibody was indeed specific to the 
DPY-7 collagen (Figure 3.7). Control wild type slides were prepared and stained under
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Figure 3.5
Schematic representation of the predicted DPY-7 protein and the amino 
acid sequence of the carboxy terminal domain
a Schematic diagram of the predicted DPY-7 protein. Numbers refer to amino 
acid residues. The dpy-7(e88) mutant allele has a residue substitution of glycine 
to arginine at position 156 which is indicated. Cysteine residues are indicated as 
vertical bars denoted by the letter C. The lengths of the Gly-X-Y repeat domains 
are indicated within the boxes.
b Amino acid sequence of the carboxy terminal domain of the predicted DPY-7 
protein which contains the epitope recognised by the monoclonal antibody 
DPY7-5a. The conserved cysteine residues are indicated in boxes.
(Adapted from Johnstone et a l , 1992).
118
Figure 3.6
dpy-7 promoter::GFP reporter gene expression in an embryo of strain 
IA105 which contains an integrated copy of a dpy-7 promoter::GFP/«cZ 
construct.
The embryo is positioned with the anterior to the left and the dorsal surface to 
the top o f the image. In this and in all subsequent images, embryos are 
approximately 50pm in length and 30pm wide.
a DIC image o f a 1.5-fold IA105 embryo
b UV image o f a 1.5-fold IA105 embryo showing expression o f a dpy-7:: GFP 
reporter gene construct long before the first cuticle is secreted.
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Figure 3.7
Illustration of the specificity of the DPY7-5a antibody
All embryos are orientated with the dorsal region to the top and the anterior to the 
left o f the page.
a dpy-7(qm63) homozygous comma stage embryo
i DPY7-5a staining (showing bleed-through o f anti-LIN-26 staining).
ii anti-LIN-26 staining
iii DIC image
b dpy-7(qm63) homozygous 3-fold stage embryo
i DPY7-5a staining
ii anti-LIN-26 staining
iii DIC image
c Section from a dpy-7(qm63) homozygous adult hermaphrodite
i DIC image
ii DPY7-5a and MH27 staining
The scale bar in c is 1 Opm and applies only to the images in c
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the same conditions as the dpy-7(qm63) homozygote slides and usually the dpy-7(qm63) 
embryos and postembryonic stages were also co-stained with the anti-LIN-26 polyclonal 
antibody, which recognises the nuclear protein LIN-26 present in all epidermal cells in 
C.elegans, or the MH27 monoclonal antibody which recognises a component of 
epidermal adherens junctions, to ensure that they were completely permeabilised (Priess 
and Hirsh, 1986; Waterston, 1988; Labouesse et al., 1996). The wild type DPY7-5a 
staining pattern in each case was as described below and for dpy-7(qm63) homozygotes 
that were co-stained with DPY7-5a and either anti-LIN-26 or MH27 respectively, the 
anti-LIN-26 or MH27 patterns were as wild type.
3.3. Spatial and temporal pattern of DPY7-5a during embryogenesis
The intracellular spatial and temporal localisation of DPY-7 was observed 
extensively during embryogenesis as this is the only stage of the life cycle where there 
is not a secreted cuticle to obscure the pattern of the collagen within the hypodermal 
cells. The timing of each embryonic stage, from precomma through to comma, 1.5-fold, 
2-fold and 3-fold has been well documented and so the onset of antibody staining is 
easily estimated with respect to the stage of embryo elongation (Sulston et al., 1983; 
Wood, 1988). Intracellular staining of DPY-7 was observed easily using the 
monoclonal antibody DPY7-5a and could be followed from before the initiation of 
elongation through to the secretion of cuticle at the end of embryogenesis.
3.3.1. Temporal occurrence of DPY-7 during embryogenesis
DPY7-5a staining was first observed at the early comma stage of embryogenesis 
at around 350 mins after first cleavage (Figure 3.8a) . The time was not measured 
absolutely but estimated by comparing the stage of embryogenesis with previously 
published results (Wood, 1988). The staining was quite faint at this time but grew more 
intense as the embryo developed (Figure 3.8b,c). Extracellular staining was first seen at 
the 3-fold stage of embryogenesis, around 650mins, and was clearly different from the 
fainter intracellular staining pattern (Figure 3.8d). Extracellular staining was observed 
in every postembryonic stage including the adult stage (results shown later) although 
this brighter staining of secreted DPY-7 obscured the intracellular staining and so the
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Figure 3.8
Localisation of DPY-7 in wild type embryos
DIC images are shown in column i
a precomma stage embryo (anterior to the left, lateral sides to top and bottom o f the 
page)
ii Internal DPY7-5a staining o f the dorsal region
iii Internal DPY7-5a staining o f the ventral region
b 1.5-fold stage embryo (anterior to the left, dorsal region to the top o f the page) 
ii and iii Internal DPY7-5a staining on either side o f the embryo 
c 2.5-fold stage embryo (anterior to the left)
ii and iii Internal DPY7-5a staining o f either side o f the embryo 
d 3-fold stage embryo (anterior facing the bottom right o f the image)
ii and iii) External DPY7-5a staining on either side o f the embryo 
Scale bar in d is 10pm and only applies to the images in d.
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timing of intracellular DPY7-5a staining was not followed after embryogenesis.
3.3.2. Spatial localisation of DPY-7 during embryogenesis
DPY7-5a staining was observed only in hypodermal cells. The monoclonal 
antibody, MH27, and the polyclonal antibody anti-LIN-26, were used to visualise the 
cell junctions or nuclei of hypodermal cells respectively. The easiest stage to see the 
staining clearly was the comma stage of development as the 3 rows of hypodermal cells 
are seen clearly on each side of the embryo. DPY7-5a staining is present in the 
cytoplasm of hypodermal cells and is brightest around the nucleus although it is absent 
within the nucleus. The anti-LIN-26 and DPY-7 co-staining is shown in Figure 3.9a for 
an embryo homozygous for the dpy-7(e88) point mutation (see section 3.5). There was 
no detectable difference in these staining patterns between dpy-7(e88) and wild type 
embryos (not shown). It was initially difficult to determine if  there was staining in both 
hypodermal syncytia and seam cells as the nuclei of hypodermal cells which will form 
the hyp7 syncytia to the dorsal side and the P cells to the ventral side, lie very close to 
the borders of the seam cells (see Figure 3.1b). From further observations, however, it 
appears that there is DPY7-5a staining within the cytoplasm surrounding the nuclei of 
the seam cells as well as in the cells to either side. Co-staining with MH27 helped to 
clarify the matter (Figure 3.9b) although the majority of intracellular DPY7-5a staining 
is observed on a more internal focal plane than distinct MH27 staining and is only 
present faintly towards the apical surface of the hypodermis where MH27 lies. It 
appears therefore that the DPY-7 collagen is localised predominantly to a subapical 
position in the hypodermal cell. DPY7-5a staining appears to be present throughout the 
cytoplasm of mononucleate hypodermal cells and is brightest around the nucleus. In 
hypodermal syncytia such as hyp7, DPY7-5a staining is only apparent at regions where 
nuclei are present and there are two dark bands where staining is absent to each side of 
the dorsal midline (Figure 3.10). The DPY-7 protein may be translated near nuclei in 
thicker regions resulting in an absence of DPY7-5a staining where the hypodermis is 
thin (see Figure 3.1b).
The transition from internal to external staining is abrupt and occurs after the 
embryo has elongated to the 3-fold stage (Figure 3.8c-d). External DPY7-5a staining is 
much brighter than internal staining which is why it is so difficult to see intracellular
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Figure 3.9
Localisation of DPY-7 within hypodermal cells of dpy-7(e88) and wild type 
embryos
Both embryos are positioned with the anterior to the left and the dorsal region to the top 
of the page. DIC images are shown in row i.
a Homozygous dpy-7(e88) 1.5-fold embryo showing DPY7-5a and anti-LIN-26 co- 
staining
ii Anti-LIN-26 staining which recognises the LIN-26 nuclear 
protein present in hypodermal and other epithelial cells.
iii DPY7-5a staining showing that DPY-7 localises to the cytoplasm 
around the nucleus of hypodermal cells.
b Wild type comma stage embryo showing DPY7-5a and MH27 co-staining
ii and iii DPY7-5a and MH27 co-staining of lateral sides of the embryo.
Arrows point to either side of the row of seam cells which runs 
from right to left in each image. DPY7-5a staining can be seen 
within the row of seam cells at each side. The boundaries of the 
seam cells are stained by the MH27 antibody which recognises a 
protein in the adherens junctions of hypodermal cells.
a b
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Figure 3.10
The absence of DPY7-5a staining from either side of the dorsal midline 
where hypodermal nuclei are present
The embryo is positioned with the anterior to the left and dorsal region to the top 
o f the page.
DPY7-5a staining o f a wild type 1.5-fold stage embryo showing an absence of 
staining to either side o f the dorsal midline. The embryo is positioned with the 
dorsal region tilted out o f the page and so the bands showing an absence of 
staining are not symmetrical about the top o f the image.
i DIC image
ii View o f the left side o f the embryo showing DPY7-5a staining
iii View o f the right side o f the embryo showing DPY7-5a staining
Arrows indicate the regions where DPY7-5a is absent.
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staining in later stages. Co-staining with MH27 suggests that DPY-7 is present 
extracellularly everywhere but above the seam cells (Figure 3.11). This is a surprising 
result as the internal staining shows the presence of DPY-7 within the cytoplasm of the 
seam cells. Because the longitudinal ridges, or alae, are positioned above the seam cells 
at the LI stage, it is clear that DPY-7 collagen is not present in these structures and it is 
possible that it is the presence of the alae which prevents the localisation of DPY-7 in 
this region. It is also possible that DPY-7 is present above the seam cells but the 
epitope recognised by DPY7-5a is masked by the presence of the alae. The time of 
secretion of DPY-7, taken as the switch of DPY7-5a staining from an intracellular to an 
extracellular position, is consistent with the assumption that the cuticle is secreted at the 
3-fold stage of elongation (Sulston et a l , 1983; Priess and Hirsh, 1986; Wood, 1988).
3.4. Postembryonic localisation of secreted DPY-7 cuticular collagen
3.4.1. Spatial localisation of DPY7-5a in postembryonic stages
After the 3-fold embryonic stage and postembryonically, cuticular annulae are 
obvious as alternate fluorescing and dark bands running circumferentially around the 
worm at regular intervals in animals stained with DPY7-5a antibody. The fluorescing 
bands coincide with the annular ridges while the dark bands coincide with annular 
furrows (Figure 3.12). This may indicate a subcuticular localisation of DPY-7 in the 
annular ridges. Measurements taken of the distance between annular ridges of a fixed 
adult under Nomarski optics also correspond to measurements taken of the distance 
between DPY7-5a bright bands in the same region (Table 3.1; Appendix 3.1). The 
pattern of secreted DPY-7 is very similar in each developmental stage but there are 
some interesting differences. As has been mentioned, the cuticular structures known as 
alae, which run longitudinally along the worm above the hypodermal seam cells, are 
only present in the LI and adult stages in the normal life cycle. While the pattern of 
DPY7-5a staining in LI and Adult stages clearly shows that DPY-7 localisation is either 
outwith the alae or undetectable where the alae are present (Figure 3.13a,b), DPY7-5a 
staining in L2-L4 stages indicates that DPY-7 is localised above the seam cells (Figure 
3.13c,d). This can be seen more clearly using the MH27 monoclonal antibody to 
highlight the boundaries of the seam cells (Figure 3.14). The DPY7-5a staining pattern
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Figure 3.11
Absence of extracellular DPY7-5a staining over the lateral seam cells 
in wild type 3-fold embryos
The anterior o f the embryo is facing to the left o f the page at the top o f 
the image
a DIC image
b and c DPY7-5a and MH27 antibody staining on both sides o f the 3-
fold embryo. DPY7-5a staining is absent from above the lateral 
seam cells. Hypodermal cell boundaries are visualised by the 
MH27 antibody. The row o f seam cells is indicated with white 
arrows
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Figure 3.12
A section from a larval stage of a wild type hermaphrodite showing the 
coincidence of DPY7-5a bright bands with cuticular annulae ridges.
a DIC image o f a wild type larval section showing cuticular annulae 
ridges as stripes running longitudinally down the plane o f the image, 
b UV image o f a wild type larval section which has been stained with the 
DPY7-5a monoclonal antibody and an FITC-labelled secondary antibody 
showing bright bands coincident with the annular ridges.
Scale bar is 10pm
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Figure 3.13
Postembryonic extracellular localisation of DPY-7 in wild type hermaphrodites
In all cases i shows the DIC image and ii shows DPY7-5a staining, 
a Lateral view o f an LI larva showing an absence o f DPY7-5a staining where the 
lateral alae are present. The extent o f the alae dorsally and ventrally is indicated by 
arrows.
b Lateral view o f an adult showing an absence o f  DPY7-5a staining where the 
lateral alae are present. Again the extent o f the alae is denoted by arrows, 
c and d Postembryonic stages between the LI and adult stage which do not possess 
alae along their lateral surfaces. These images show lateral views o f the larvae and 
indicate that DPY7-5a staining is not absent from above the lateral hypodermal 
seam cells in these stages.
Scale bars are all 10pm
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Figure 3.14
Postembryonic localisation of DPY-7 in wild type adults and in larval stages 
without alae
a Lateral section o f an adult hermaphrodite
i DIC image. Alae indicated with an arrow.
ii DPY7-5a and MH27 staining. MH27 denotes the boundaries o f the lateral 
seam cells running from right to left across the page which are fused in the adult. 
The seam is indicated with an arrow. The DPY7-5a bright bands o f staining 
which is running from the top to the bottom of the page is clearly absent from 
within the seam cells.
b Lateral section o f a larval stage without alae
i DIC image
ii DPY7-5a and MH27 staining. MH27 again denotes the boundaries o f the 
lateral seam cells running from right to left and is indicated with an arrow. The 
DPY7-5a bright bands o f staining, which run from top to bottom, can be seen to 
traverse the boundaries o f the seam cells and interdigitate above the centre o f 
this row o f cells.
Scale bars are 10pm
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in postembryonic stages without alae shows a pattern coincident with the annulae which 
traverses the borders of the seam cells as visualised by MH27 and almost interdigitates 
rather than stopping clearly to either side of them. This difference in DPY7-5a pattern 
between the stages with and without alae seems to suggest that it is the presence of the 
alae that completely prevents DPY-7 localisation or the detection of DPY-7 localisation 
above the seam cells rather than the presence of the seam cells alone. Johnstone and 
Barry, (1996) have shown that dpy-7 is not expressed in adults. However, it is 
expressed in the L4 larvae which synthesise the adult cuticle and so it is not surprising 
that DPY7-5a is seen in the adult cuticle as well as the other stages.
Table 3.1 Coincidence of DPY7-5a bright band staining with annular ridges
Measurements made 
between:
Distance between annular ridges 
(mean ± standard error)
Number of annulae 
measured
Annular ridges viewed 
under Nomarski optics
1.474±0.02pm 22
DPY7-5a bright staining 
bands
1.505±0.03|im 22
One of the staining methods used to visualise DPY7-5a staining, the modified 
Ruvkun method (section 2.9.5), caused damage to the cuticle so that individual ‘threads’ 
of DPY7-5a staining were seen to peel away from the animal (Figure 3.15). The 
Ruvkun method uses freeze-fracture to permeabilise the worms and then consists of a 
series of fixation, reduction and oxidation reactions. The ‘threads’ of DPY7-5a staining 
could be another indication that the DPY-7 protein is localised to structures within the 
annular ridges. However, it may be a result of reducing disulphide bonds in the cuticle 
between annular ridges so that any material in the furrows is degraded more easily 
during the staining process.
3.4.2. Annular spacing in young and old N2 adults
Measurements were made in several pre-egg-laying and egg-laying adults 
(‘young’ adults) between the bright DPY7-5a staining bands and compared with old 
adults that had stopped egg laying (Table 3.2; Appendix 3.1). Because the wild type 
adult increases considerably in size, both in length and width, between the L4-adult 
moult and death, I would expect to see an increase in the spacing of annular ridges
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Figure 3.15
Damaged cuticle of a wild type adult hermaphrodite showing DPY-7 
localisation
a DIC image
b DPY7-5a staining. The cuticle has been damaged by oxidation and 
reduction stages and the DPY7-5a staining bands appear to be peeling off 
as ‘threads’ rather than sheets o f stained tissue.
Scale bar is 10pm
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between young adults and very old adults. This is because the annular ridges are 
thought to arise from actin filament patterning at the L4-adult moult and would 
therefore be fixed in number throughout the adult stage (Costa et ah, 1997). If the 
annulae were fixed in number but the worm increased significantly in length, the 
annulae width should increase, which would be reflected as an increase in the distance 
between annular ridges. Although these measurements were made on fixed animals and 
therefore may not indicate a true spacing of annular ridges in living animals, the results 
were comparable with the annular widths given by Cox et ah (1981c) and therefore do 
seem to be indicative of the actual annular spacing. There was as much variation in 
annular width among the group of ‘young’ N2 adults as there was between the ‘young’ 
and ‘old’ N2 adults. However, this variation among the ‘young’ adults may have arisen 
as some of them had just moulted into adults and contained no eggs, while others were 
slightly older and were egg-laying. There does seem to be a general increase in annular 
width between adults just after the L4-adult moult and adults which have passed 
reproductive age but a more tightly controlled comparison would need to be carried out 
before the significance of this difference can be tested properly.
Table 3.2 Comparisons between young and old N2 adults and between N2 and 
dpy-13(e458) homozygote adults of a similar age.
Adult age and strain Distance between annular ridges 
(mean ± Standard error)
number of annulae 
measured per 
animal
N2 young adults
young adult A 1.249±0.022pm 40
young adult B 0.825±0.020pm 51
young adult C 0.927±0.020pm 48
young adult D 1.050±0.015pm 48
young adult E 1.127±0.018pm 48
N2 old adults
old adult A 1.505±0.026pm 22
old adult B 1.526±0.019pm 47
old adult C 1.697±0.028pm 47
CB458 (dpy-13fe458J) old adults
old dumpy adult A 0.676±0.12pm 29
old dumpy adult B 0.766±0.09pm 44
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3.5. Embryonic spatial localisation and temporal pattern of DPY7-5a in a Gly-X-Y 
glycine substitution mutant, dpy-7(e88)
The dpy-7(e88) point mutation is at base 648 from the ATG initiation codon in 
dpy-7 resulting in the substitution of the fourth glycine with arginine in the second Gly- 
X-Y repeat block of the encoded DPY-7 mutant collagen, dpy-7(e88) homozygous 
mutants have a dumpy phenotype slightly longer than the dpy-7(qm63) homozygotes 
(Figure 3.4b,c). homozygous dpy-7(e88) embryos were stained with DPY7-5a and 
compared with wild type embryos. DPY7-5a staining was detected from the same time 
in mutant embryos and wild type embryos and there was no detectable difference in the 
intracellular pattern observed (Figures 3.16 and 3.9a). It was not until the 3-fold stage 
of embryogenesis that a difference in the staining pattern was observed (Figure 3.17). 
While wild-type embryos have a clear secreted collagen pattern showing annulae, dpy- 
7(e88) homozygotes show very speckled surface staining which is significantly different 
to the wild type pattern. This speckled staining appears, in places, to be arranged into 
an annular pattern.
3.6. Postembryonic localisation of DPY-7 collagen in dpy-7(e88) mutants
The speckled appearance of DPY7-5a staining within the secreted cuticle 
appears similar in postembryonic stages (Figure 3.18a). The pattern of staining seen in 
this mutant is consistent with the idea that the mutant DPY-7 collagen resulting from a 
glycine substitution in a Gly-X-Y repeat block is predominantly degraded within the 
hypodermis and not secreted into the cuticle (Johnstone et al., 1992). Because the 
DPY7-5a staining shows the same speckled pattern in later dpy-7(e88) stages as in LI 
larvae, intracellular DPY-7 localisation can be seen clearly (Figure 3.18b). The spatial 
organisation of the intracellular pattern appears to be the same as seen in embryogenesis 
with cytoplasmic staining of hypodermal cells and an absence of nuclear staining.
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cFigure 3.16
Intracellular localisation of DPY-7 in homozygous dpy7(e88) embryos
In all cases the DIC image is shown in column i and DPY7-5a staining is 
shown in column ii. All embryos are positioned with the anterior to the left 
and the dorsal surface to the top o f the image.
a 1.5-fold homozygous dpy7(e88) embryo 
b 2-fold homozygous dpy7(e88) embryo 
c 2.5-fold homozygous dpy7(e88) embryo
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Figure 3.17
Extracellular localisation of DPY-7 in homozygous dpy-7(e88) and wild type 
3-fold embryos
In both embryos, the anterior o f the worm is facing the bottom right o f the image 
a homozygous dpy-7(e88) 3-fold embryo
i DIC image
ii DPY7-5a staining o f the two sides o f the embryo showing a speckled 
appearance unlike the bright bands seen in the wild type 3-fold embryo
b DPY7-5a staining in a wild type 3-fold embryo
i DIC image
ii DPY7-5a staining showing the bright bands running 
circumferentially around the embryo. There is a clear difference between 
the extracellular localisation o f  DPY7-5a in the wild type and dpy-7(e88) 
3-fold embryo.
The scale bar in b is 10pm and refers only to image b
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Figure 3.18
Postembryonic localisation of DPY-7 in dpy-7(e88) mutants
a Adult dpy- 7(e88) homozygote
i) DIC image
ii) DPY7-5a staining showing the speckled pattern o f extracellular 
DPY-7 secretion clearly different to the wild type pattern (Figure 3.16).
b Homozygous dpy- 7(e88) larva
i) DIC image
ii) DPY7-5a staining showing intracellular localisation o f DPY-7 
postembryonically. This can be seen clearer in dpy7(e88) 
homozygotes due to the reduction in extracellular staining.
Scale bars are 10pm.
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3.7. Spatial localisation of DPY-7 collagen in mosaic dpy-7(e88) mutants carrying a 
wild type dpy-7 transgene
In order to measure the difference in secreted DPY-7 staining observed between 
animals with and without wild type DPY-7 more directly, I stained a mixed population 
of larvae from an unstable line of dpy-7(e88) homozygotes which carried a wild type 
copy of the dpy-7 gene as a transgenic array. Transformed lines containing unstable 
transgenic arrays are commonly used in C.elegans to generate somatic mosaics where 
some cells of an individual animal are genotypically mutant and others are 
genotypically wild type (Herman, 1995). There was a high proportion of array loss in 
this line and consequentially dpy-7(e88) mosaics should be produced. Since the dpy- 
7(e88) mutation was not dominant, the presence of the mutant DPY-7 collagen in the 
strains also carrying a wild type copy of the dpy-7 gene should not interfere with the 
function of wild type DPY-7. I found that the results obtained by staining these larvae 
on the same slide was consistent with the DPY7-5a pattern already seen as some larvae 
exhibited a wild type pattern of secreted DPY-7 while others showed the speckled 
appearance (Figure 3.19a). I co-stained with the anti-LIN-26 polyclonal antibody to 
check that all animals examined had been fixed and permeabilised properly (Figure 
3.19b). Since I was not using another marker of array presence or absence, I could not 
say which animals on the slide carried the array and which did not, but the results 
coincided with the differences seen between wild type and dpy-7(e88) larvae and so 
suggested that the animals which stained normally contained the array while animals 
showing a speckled staining appearance had lost the array.
I also looked for the presence of mosaic animals in which some hypodermal 
cells showed a normal pattern of DPY-7 secretion and others did not. This was 
problematical as hypodermal cells are mostly multinucleate syncytia. Syncytia make 
mosaic analysis difficult as one wild type nuclei in a multinucleate cell will result in the 
production of wild type collagen which will be secreted normally. However, there are 
several tri-, bi- and mononucleate hypodermal cells at hatch which secrete DPY-7: 
hypl-hyp5,hyp8-hypll and the ventral P cells, and so the absence of the wild type 
transgene would be detected in these cells. Hypl-hyp5 are present in the head and 
hyp8-hypll in the tail, which are regions where it is more difficult to see local 
differences in staining due to the closer proximity of the annulae and the smaller cells.
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Figure 3.19
Extracellular localisation of DPY-7 in mosaic dpy-7(e88) embryos carrying a 
transgene which contains the wild type copy of dpy-7
Embryos are in various orientations with lateral views showing in the images 
a DPY7-5a staining o f mosaic 3-fold embryos
i DIC image
ii DPY7-5a staining showing wild type-like staining in the embryo on the 
left and dpy-7(e88)-iike staining in the embryo on the right.
b DPY7-5a and anti-LIN-26 staining o f mosaic 3-fold embryos
i DIC image
ii DPY7-5a staining
iii anti-LIN-26 staining
The embryo to the base o f the image has a very speckled DPY7-5a 
extracellular staining pattern although the wild type anti-LIN-26 staining 
pattern shows that the embryo has been permeabilised.
The scale bar in a is 1 Opm and refers only to image a.
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The P cells are in two rows just ventral to the seam cells at hatch but during the LI stage 
the nucleus of each P cell enters the ventral cord and the cells rotate to form a single row 
(Podbilewicz and White, 1994). A large number of larva were observed from this 
transgenic dpy-7(e88) line but no mosaicism was observed.
3.8. DPY7-5a staining pattern and annulae spacing in dpy-13(e458) mutants
In order to check that the altered DPY7-5a extracellular staining seen in dpy- 
7(e88) mutants was not simply due to dumpyness, larvae and adults homozygous for 
dpy-13(e458) were stained with the DPY7-5a monoclonal antibody, dpy-13 encodes 
another cuticular collagen and the dpy-13(e458) allele is a 673bp deletion which is 
considered to be a null allele of dpy-13 (ACeDB). Costa et al., 1997 have shown that the 
pattern of actin filament bundles in the hypodermal cells is coincident with the furrows 
in the secreted cuticle between the annular peaks. They have suggested that it is the 
presence of the membrane associated actin filaments at each stage in the life cycle that 
creates the furrowed pattern of the cuticle. Because the shape change seen in dpy- 
13 (e4 5 8) homozygotes is a result of an abnormal cuticle rather than a hypodermal 
defect, the number of annulae in these mutants, visualised with DPY7-5a, should be 
equal to the number of annulae in wild type animals. Consequentially, the adult pattern 
of DPY7-5a should show a decreased spacing between annular rings in dpy-13(e458) 
hermaphrodites compared to wild type as the overall body length is reduced.
dpy-13(e458) homozygotes show an embryonic DPY7-5a staining pattern which 
appears to be equivalent to the wild type pattern (Figure 3.20). The switch from 
intracellular to extracellular staining occurs at the same stage as in wild type embryos 
and the annular spacing also appears equivalent at this stage. These results show that 
the absence of a wild type amount of DPY-7 collagen becoming incorporated into the 
cuticle is not a general aspect of the dumpy phenotype. At later postembryonic stages 
the DPY7-5a pattern shows bright staining circumferential rings coincident with the 
annular ridges as in wild type. However, these annular ridges appear to be much closer 
together than in the equivalent wild type stage and this is especially evident in the adult 
stage when dpy-13(e458) mutants have an annular spacing of almost half the distance of 
wild type adults (Figure 3.21 and Table 3.2). These results suggest that the number of 
annulae is indeed equivalent in wild type animals and the much shorter dpy-13(e458)
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Figure 3.20
Localisation of DPY-7 in homozygous dpy-13(e458) embryos
In all cases image i is a DIC image and ii shows DPY7-5a staining. Both 
intracellular and extracellular staining appears as wild type embryos (see 
Figure 3.10). All embryos are positioned with the anterior to the left and the 
dorsal region to the top o f the page.
a Lateral view o f a dpy-J3(e458) 1 5-fold stage embryo
b Lateral view  o f a dpy-13(e458) 2-fold stage embryo
c Lateral view o f a dpy-13(e458) 3-fold stage embryo
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Figure 3.21
Difference in the distance between annular ridges in dpy-13(e458) homozygote and 
wild type old adult hermaphrodites
Alae are indicated with arrows in all the images. Images to the left are DIC images and 
those to the right show DPY7-5a staining
a DPY7-5a staining in a section of a dpy-13(e458) homozygote old adult
hermaphrodite
b DPY7-5a staining in a section of a wild type old adult hermaphrodite
Scale bars are 10pm
mm i l l  i,.
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homozygotes indicating that the actin filaments in the hypodermis are not affected by 
the collagen mutation and in turn they appear to have no have no influence on this 
postembryonic defect in body length.
3.9. Discussion
The spatial and temporal expression of many cuticular collagen genes have been 
examined extensively and the subsequent results show an high level of complexity in 
the control of cuticle formation. In order to elucidate some of the components of this 
process, it is valuable to follow the synthesis of the encoded collagens and their 
localisation in the secreted cuticle. This will not only provide further information on 
any particular collagen, but may also help in understanding the overall structure of the 
secreted cuticle at each stage of the life cycle. We have developed a monoclonal 
antibody against the non-conserved carboxy domain of the DPY-7 cuticular collagen 
and the pattern of localisation observed at different stages has strengthened previous 
ideas about synthesis and secretion and provided new information about cuticle 
organisation. This antibody was shown to be specific to the DPY-7 collagen by its 
complete absence in dpy-7(qm63) mutants which are homozygous for a 6.6kb deletion 
at the dpy-7 locus.
DPY7-5a is first seen at the early comma stage of embryonic development and is 
localised to the cytoplasm of hypodermal cells until the end of embryonic elongation 
(the 3-fold stage) when it is present extracellularly in circumferential bands 
corresponding to the cuticular annulae. DPY7-5a staining can be seen within the lateral 
seam cells before cuticle secretion but is apparently absent above the seam cells once 
the staining switches to an extracellular location. The extracellular staining of DPY7-5a 
is seen throughout post embryonic development, although intracellular staining is much 
more difficult to detect in these stages due to the overlying cuticle. In all stages, the 
bright bands of DPY7-5a staining correspond to the ridges of the annulae running 
circumferentially around the surface of the worm and I will henceforth refer to these 
fluorescent bands as annulae. The extracellular DPY7-5a staining is absent above the 
seam cells only when the special cuticular structures known as alae are present, in LI 
and adult stages. In L2-L4 stages, the DPY7-5a staining extends over the boundaries of 
the seam cells, as visualised by MH27, and almost interdigitates with annulae crossing
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the other side of the seam. It therefore appears that it is the presence of the alae and not 
the presence of the seam cells per se which prevents DPY7-5a staining, and thus either 
DPY-7 localisation or the detection of DPY-7 localisation, above the seam cells. Costa 
et al. (1997) reported that annulae were not present above the seam cells as the aligned 
microfilaments in the seam are not associated with the cell surface and therefore do not 
pattern the cuticle. It is interesting, therefore, that in postembryonic stages without alae, 
DPY7-5a staining is seen above the seam in a continuation of the bright bands 
coinciding with the annulae of the dorsal and ventral surfaces.
The fact that DPY7-5a staining showed a pattern coincident with annulae ridges, 
and that damaged cuticles showed that DPY7-5a stained material did seem to be in 
threads rather than sheets suggests two things. Firstly, since the external cortical layer 
is the only layer of the cuticle to be patterned into annular furrows and ridges, it seems 
likely that the DPY-7 collagen is present in the cortical layer of the cuticle. Secondly, 
the staining pattern suggests that DPY-7 collagen is not present evenly throughout a 
layer of the cuticle but is possibly localised to structures within the annular ridges.
The staining pattern of DPY7-5a was examined in a glycine substitution DPY-7 
mutant carrying the mutation dpy-7(e88). The embryonic intracellular staining is 
indistinguishable between wild type embryos and dpy-7(e88) homozygotes. However, 
at the switch from intracellular to extracellular localisation, homozygous dpy-7(e88) 
embryos show a quantitatively different staining pattern with a speckled surface 
appearance rather than the bright circumferential bands normally seen. This speckled 
extracellular staining is seen throughout postembryonic development also. Intracellular 
staining is present during each larval stage as normal. Although a greatly reduced 
secreted staining pattern is seen in these mutants, the intracellular staining disappears at 
the same time as in wild type. These results agree with the idea that the mutant 
collagens are mostly prevented from being incorporated into the cuticle in glycine 
substitution mutants although it would appear that more mutant collagen is secreted than 
previously thought and therefore this could possibly be a factor in the phenotype 
produced (Johnstone, 1994; Kramer, 1997). The absence of intracellular staining after 
the normal intracellular to extracellular switch also seems to indicate that the mutant 
collagen synthesised within hypodermal cells is mostly degraded quite efficiently once 
the cuticle is secreted and there is no evidence that mutant collagens are retained within 
the cells. These results may indicate a mechanism in hypodermal cells which results in
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the swift degradation and removal of unsecreted mutant collagens from the cell. This 
would prevent disruption of the synthesis or function of other proteins in hypodermal 
cells as is thought to happen in muscle cells due to a build up of non-secreted type IV 
basement membrane collagens (Gupta et ah, 1997). A ‘clean-up’ mechanism such as 
this would not be surprising in a group of cells which synthesised a cuticle at five 
separate stages during the life cycle especially when collagens are synthesised in 
temporal waves during each larval stage (Johnstone and Barry, 1996). With such a high 
turnover of wild type collagens, a clean-up process would be a means of preventing 
untrimerised collagen chains from one wave of synthesis from trimerising with different 
collagen chains from the next wave of synthesis, potentially disrupting cuticle 
formation.
When observing the DPY7-5a staining pattern in dpy-7(e88) transformed 
homozygotes carrying the wild type dpy-7 gene in an unstable extracellular array, no 
animals showing mosaic staining were found. This may simply have been due to not 
finding any animals which had lost the array in nuclei present in mononucleate cells or 
in all the nuclei of a multinucleate cell. Since most of the hypodermis consists of 
multinucleate syncytia this is certainly a possibility. However there is also a chance that 
an animal showing mosaic staining was not found because of the nature of DPY-7 
secretion. If there is a mechanism whereby DPY-7 can move across the cell surface 
during cuticle formation then it could possibly travel to, and be incorporated into the 
cuticle above, the surfaces of cells which do not secrete it directly. Because of this, 
cells which had lost the wild type dpy-7 array may still have DPY-7 incorporated into 
the cuticle above them and no interruption to the extracellular DPY7-5a staining pattern 
would be seen.
The clear embryonic and postembryonic DPY7-5a staining pattern of dpy- 
13(e458) homozygotes shows that the greatly reduced incorporation of DPY-7 into the 
secreted cuticle is not an aspect of all dumpy mutants. dpy-13(e458) homozygotes are 
as short as dpy-7(e88) homozygotes yet show an apparently wild type DPY7-5a staining 
pattern. The only observable difference is that the annular ridges stained by the DPY7- 
5a antibody in dpy-13(e458) homozygotes are almost twice as close together than in 
wild type animals of the same stage. Actin microfilament alignment in hypodermal 
cells should be independent of collagen synthesis and therefore the number of annulae 
in a dumpy animal, homozygous for a collagen mutation, should be equivalent to the
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number of annulae in a wild type animal of the same stage. As dumpy adults are much 
shorter than wild type adults, it follows that the spacing between the annular ridges 
should be less in dumpy adults.
The staining pattern of a DPY-7 cuticular collagen-specific monoclonal antibody 
has been characterised and has elucidated several previously held ideas about cuticle 
secretion and patterning. The beginning of antibody staining in the embryo mirrors the 
onset of collagen gene expression previously shown from other studies as does the 
switch of the staining pattern from an intracellular to an extracellular location 
(Johnstone and Barry, 1996; Gilleard et al., 1997). The noticeable reduction of secreted 
DPY-7 when there is a Gly-X-Y glycine substitution in the collagen is consistent with 
the previous idea that certain mutant collagens could not assemble normally and 
therefore would not be secreted as wild type collagens (Johnstone et al., 1992; 
Johnstone, 1994; Kramer, 1997). However as some mutant collagen is secreted, this 
may have an effect on the phenotype produced rather than the phenotype resulting 
simply from the absence of wild type collagen in the cuticle (Johnstone et al., 1992; 
Levy et a l , 1993). The DPY7-5a staining pattern shows that the distance between 
annular ridges in dpy-13(e458) mutants is around 50% less than the spacing in wild 
type. This suggests that there are an equivalent number of annulae in the wild type and 
dpy-13(e458) mutants indicating that the annulae do indeed appear to originate from a 
non-cuticle component such as the actin microfilaments suggested by Costa et al. 
(1997). The production of an antibody specific to a cuticular collagen has been shown 
to be a very useful tool, in examining cuticle synthesis and secretion in wild type 
animals and when investigating the cause of mutant phenotypes due to alterations in the 
collagen. Observations of the staining pattern of a cuticular collagen in mutants of other 
collagens expressed at the same time during each developmental stage may uncover 
previously unknown interactions at different stages of cuticle formation such as the 
trimerisation of collagen chains and may help to explain the reason for these temporal 
waves of collagen expression.
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Chapter 4
Characterisation of a zygotic embryonic lethal mutation, w4
4.1. Introduction
4.1.1. Zygotic lethal screens used to generate mutants defective in embryonic 
elongation
During C.elegans development, embryonic transcription begins as early as the 4 
cell stage for some genes although components from maternally expressed genes appear 
to be sufficient to allow normal embryonic development until around the 26 cell stage 
when gastrulation begins (Edgar et al., 1994; Powell-Coffinan et a l , 1996). In embryos 
where zygotic transcription is blocked by the inhibition of RNA polymerase II activity, 
embryos continue cell division until around the 100 cell stage when they arrest although 
development after the 26 cell stage is not as wild type (Powell-Coffinan et al., 1996). It 
seems therefore that early events in the C.elegans embryo are controlled by maternal 
factors while later events rely on the transcription of zygotic genes for their control and 
execution. I was interested in the processes of body shape change (elongation) and 
body shape maintenance in the C.elegans embryo, driven by the hypodermis, which 
occurs from mid- to late-embryogenesis after cell division has been completed, 
producing 558 cells (Wood, 1988). I therefore concentrated on finding zygotic lethal 
mutants which had apparently completed cell division and gastrulation but were 
defective in enclosure of the hypodermis, elongation, and/or cuticle synthesis and 
secretion. I focused on embryonic lethal mutants because shape change is a vital 
process in development and thus morphogenetic defects usually result in embryonic 
arrest. Several mid- to late-zygotic lethal mutants were generated in a mutant screen 
performed by J.Rothman and were kindly given to us as gifts. The screen identified late 
embryonic zygotic lethal mutants with a view to isolating genes involved in hypodermal 
or cuticular defects.
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4.1.2. Enclosure of the hypodermis in the C.elegans embryo
4.I.2.I. The process of enclosure in wild type embryos
The hypodermal cells arise on the dorsal surface of the embryo and organise into 
a monolayer of six rows, and before elongation can occur, this sheet of cells must first 
migrate laterally around the embryo and meet at the ventral midline in a process known 
as enclosure. Initially, a quartet of hypodermal cells, known as the leading cells, from 
the two outer rows of hypodermal cells migrate around the embryo bilaterally, two on 
each side, using the underlying neuroblasts as the substratum (Williams-Masson et a l, 
1997). There is no evidence for the presence of a basement membrane at this stage. 
The two anterior leading cells migrate by extending actin-rich filopodia across the 
substratum towards the ventral midline while the two posterior leading cells extend 
actin-rich filopodia which connect to the anterior leading cells. It appears that the two 
anterior most leading cells migrate actively and the two posterior leading cells migrate 
partially by adherence to the anterior cells. The other marginal cells may be pulled 
around the embryo due to the tension set up by the leading cell migration. When the 
leading cells meet at the ventral midline they form adherens junctions and eventually 
fuse. Experiments with cell inactivation or the inhibition of actin function indicate that 
the leading cells are necessary for the initiation of enclosure as are the actin filaments in 
the filopodia. However, the leading cells from only one side of the embryo are 
sufficient to complete enclosure apparently normally as they have the ability to migrate 
past the ventral midline and form proper adherens junctions with their contralateral 
inactivated neighbour.
The second process of enclosure occurs at the ventral midline when the 
hypodermal cells from the anterior and posterior meet in a circular ‘pocket’. These cells 
are known as the ventral pocket cells and appear to close in a purse string manner 
similar to that employed in Drosophila dorsal enclosure or the healing of small wounds 
(Martin and Lewis, 1992; Young et al., 1993). The pocket cells form tight lateral 
junctions and there is a thick actin cable running around the apical surface of all these 
cells even without the presence of apical adherens junctions (Williams-Masson et al., 
1997). It is thought that the contraction of these cells is actin mediated as the inhibition 
of actin function at this stage also causes retraction of the hypodermis. After the
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circular gap is closed in this way, the cells form adherens junctions with their 
contralateral neighbours at the ventral midline and ventral enclosure is complete. 
Hypodermal cells also enclose separately in a more anterior region but the processes 
involved in this anterior enclosure have not been reported.
4.I.2.2. Genes involved in C.elegans ventral enclosure
Although the hypodermal leading cells migrate over the underlying neuronal 
precursors and the hypodermal filopodia seam to follow grooves between these neuronal 
cells, ablation of individual or small groups of neuronal precursors does not appear to 
prevent normal enclosure (Williams-Masson et al., 1997). However, mutants of the 
vab-1 gene which is expressed only in neuronal precursor cells at the time of enclosure, 
show variable defects in hypodermal enclosure with the leading cells in some mutants 
migrating too far towards the anterior (George et al., 1998). vab-1 encodes an Ephrin 
(Eph) receptor tyrosine kinase and appears to have both kinase dependent and kinase 
independent functions as none of the vab-1 alleles with alterations in the kinase domain 
cause complete loss of vab-1 function. Modulation of cell shape change and adhesion 
are common features of Eph-mediated signalling in vertebrates (Holder and Klein, 
1999). It is possible that in wild type C.elegans embryos, VAB-1 could function by 
sending inhibitory signals from the neuronal precursors to the leading cells which stops 
them migrating too far to the anterior and in the mutants this inhibitory signal is blocked 
(George et al., 1998). Another idea which may act in tandem to the inhibitory signal, is 
that disruption to the neuronal precursors seen in some vab-1 mutants where the ventral 
cleft is not closed normally, may inhibit the migration of hypodermal cells as there is an 
abnormal substratum. The ablation experiments carried out by Williams-Masson et al. 
(1997) suggested that specific neuronal precursors were not necessary for normal 
enclosure, however, studies on vab-1 seem to indicate that a properly organised 
neuronal precursor layer with normal VAB-1 function does seem to be necessary for 
normal hypodermal enclosure (George et al., 1998). A further morphogenetic defect is 
seen in many vab-1 mutant alleles which enclose normally and elongate but have 
deformed head and tail regions. The number of hypodermal cells in these regions 
appear normal and so the defects seen must be as a result of abnormal morphogenesis of 
these regions after the time of enclosure.
Other genes which have recently been implicated with a possible role in 
hypodermal enclosure are hmr-1, hmp-1 and hmp-2, C.elegans homologues of cadherin, 
a-catenin and (3-catenin respectively (Costa et a l, 1998). 98% of hmr-1 homozygotes 
arrest with abnormal enclosure and embryos that are deficient in both maternal and 
zygotic hmp-1 or hmp-2 also fail to enclose. HMR-1, HMP-1 and HMP-2 are all absent 
from, or at very low levels in, the leading edge of enclosing hypodermal cells. Instead it 
is thought that these proteins may function at the time the cells meet and form adherens 
junctions at the ventral midline. Although it has been shown that these proteins are not 
required to form general adherens junctions between adjacent cells in C.elegans, they 
appear to have a function in stabilising contacts and increasing adhesion between 
contralateral pairs of hypodermal cells during the final stages of ventral enclosure.
mup-4 is a gene essential for the hypodermal functions of morphogenesis and the 
maintenance of body wall muscle position and two classes of mup-4 homozygote 
mutant phenotypes result in arrest at the precomma or 2-fold stage with abnormal 
enclosure of the hypodermis (Gatewood and Bucher, 1997). In the more severe 
precomma arrest, the hypodermis appears to be arranged into clumps rather than rows 
and only extends over small areas of the embryo surface while in the 2-fold arrest 
embryos, hypodermal cells are abnormally shaped and there are hypodermal lesions on 
the dorsal surface through which internal cells are exuded. This may indicate a defect in 
the integrity or adhesion properties of the hypodermal sheet.
Mutations in another gene, pha-4, which encodes a transcription factor 
homologous to the Fork head protein in Drosophila and HNF-3 in mammals, prevent 
the formation of a pharynx and also show defects in hypodermal enclosure (Mango et 
a l, 1994a; Homer et a l, 1998; Kalb et a l, 1998). pha-4 is present in all cells of the 
pharynx from the earliest stages and acts as an ‘organ identity factor’. It is unknown 
whether there is a direct requirement for pha-4 during hypodermal migration or whether 
incomplete enclosure is an indirect consequence of the absence of a pharynx. As one of 
the pharyngeal precursors from the AB lineage is switched from an hypodermal to a 
pharyngeal cell fate by the MS founder cell, the absence of pha-4 may prevent this 
switch and produce extra hypodermal cells which could result in morphogenetic 
abnormalities (Hutter and Schnabel, 1994; Mello et a l, 1994). Certain mutant alleles of 
another gene, glp-1, which encodes a member of the Notch family of transmembrane 
receptors, also result in a percentage of embryos undergoing incomplete hypodermal
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enclosure (Priess et al., 1987). glp-1 is also involved in the pharyngeal inductive switch 
in the AB lineage and mutants show supernumerary hypodermal cells resulting in 
morphogenetic defects.
4.1.2.3. Mechanisms of epiboly and wound healing in other systems
The spreading, or epiboly, of epithelial sheets is seen in many other 
developmental systems. It occurs during the embryogenesis of many organisms when 
epidermal sheets originate at a small area on one side of the embryo and subsequently 
migrate around the embryo enclosing it completely, and also during wound healing 
when epidermal cells bordering the wound move into the area left uncovered and reseal 
it. The epithelial sheets have an advancing margin, known as the free edge and various 
mechanisms are utilised in the movement of the epidermal cells at this free edge. In 
certain systems, actin-rich lamellipodia are extended from the marginal cells across their 
substrate and the cells migrate, pulling the submarginal cells with them. This is seen in 
the healing of large wounds in cell monolayers where the border cells subsequently 
migrate into the wound to seal the epithelial gap (McCormack et al., 1992; Nusrat et al., 
1992). It is also seen during epiboly of the outer layer of the chick blastoderm when a 
small group of free edge cells adhere strongly to the vitelline membrane, which is the 
substratum that they move along, and extend actin-rich lamellipodia which pull the 
submarginal cells behind them (Downie and Pegrum, 1971). The epiboly of the 
blastoderm in several other vertebrates does not appear to follow the same mechanisms. 
Epiboly in teleost fish comprises the movement of the enveloping layer (EVL) of the 
blastoderm, and the deep cells of the blastoderm, over the yolk cell. The EVL travels 
with the yolk syncytial layer (YSL) around the embryos of Fundulus heteroclitus and 
the zebrafish (Danio rerio) and due to the tight junctions between these two layers, the 
ability of the YSL to complete epiboly independently of the EVL and the organisation 
of microtubules in the YSL, it has been suggested that the EVL is passively towed 
around the embryo by the underlying YSL (Trinkaus, 1951; Betchaku and Trinkaus, 
1978; Strahle and Jesuthasan, 1993). The migration of the YSL is thought to be driven 
by microtubule motors and is halted when microtubule function is inhibited (Betchaku 
and Trinkaus, 1978; Strahle and Jesuthasan, 1993; Solnica-Krezel and Driever, 1994). 
However, there are constant orderly cell rearrangements in the cells of the EVL free
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edge in response to changes in the size of the spherical embryo in Fundulus (Keller and 
Trinkaus, 1987) and it has also been postulated separately that the EVL can move 
independently of the YSL in Danio (Solnica-Krezel and Driever, 1994) and that a 
possible contraction at the blastoderm marginal cells after the equator can aid 
blastoderm closure (Strahle and Jesuthasan, 1993).
Other developmental systems seem to use a mechanism of contraction at the free 
cell margin to close the final epithelial breach. Honey bee epiboly occurs by blebbing 
of the free edge cells of the spreading preserosal epithelium which do not adhere to any 
substratum (Fleig and Sander, 1988). This migration appears to be driven by the 
rearrangement and flattening of cells at the free edge rather than active migration and 
when the free edges almost meet, the final circular opening closes by contraction. 
Actin-driven contraction has been seen to function in the closure of small wounds in 
both chick epidermis and a cultured human intestinal cell line (Martin and Lewis, 1992; 
Bement et al., 1993). Also, in the dorsal closure of the Drosophila epidermis, a 
contractile ‘purse string’ mechanism is utilised to close the gap in the epithelium 
(Young et al., 1993). Actin and Myosin co-localise at the leading edge of the epidermis 
and homozygous zip mutants, which have mutations in the non-muscle myosin heavy 
chain, fail to undergo normal dorsal closure.
4.2. Phenotypic Characterisation of w4 homozygotes
Of the mutants received from J.Rothman, four were selected for initial study, 
and from this group, one mutant with the allelic designation w4 was chosen for 
characterisation. w4 was selected for study due to several features implicating 
hypodermal or cuticular abnormalities. The mutant did not elongate past 2-fold, 
although a percentage of embryos hatched and arrested as lumpy-dumpy LI larvae. 
There were also visible structures in the cuticle, the lateral ridges, or alae, which showed 
abnormalities, and most of the unhatched arrested embryos were ruptured at the ventral 
posterior surface.
In order to characterise the phenotype of the w4 mutation, both Nomarski optics 
and fluorescence microscopy were used. Because of the transparent nature of the 
C.elegans embryo, much tissue detail can be seen using Nomarski microscopy alone, 
although in situ detection of subtle defects in structure can be visualised using
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antibodies against specific molecules and labelling with fluorescent secondary 
antibodies.
4.2.1. General characteristics of w4 homozygote mutants
Using Nomarski, also known as differential interference contrast (DIC), 
microscopy, it can be seen that w4 embryos range from very abnormal arrested embryos 
at around the 2-fold stage of elongation which are quite wide and lumpy with a ruptured 
ventral posterior region, to lumpy-dumpy larvae which usually have a detached buccal 
cavity (Figure 4.1ai,bi). The mutant strain was outcrossed at least three times before a 
phenotypical characterisation was undertaken and all w4 mutants studied were the 
w4/w4 homozygote progeny of w4/+ heterozygote hermaphrodites. The percentage of 
LI death compared with embryonic death varies widely in each brood raised at 20°C, 
from 0% to 53%, with an average of 25.70±2.77% (st.dev.=15.9, n=33 broods). The 
raw data is shown on Appendix 4.1. Despite the wide variation in the percentage of LI 
death per brood, the mean percentage determined from pooling the individual progeny 
from all these broods together is very similar 28.63% (n=2961 progeny). The 
homozygote w4 mutants will henceforth be referred to as either ‘unhatched’ or 
‘hatched’.
The hatched mutants die within around a couple of days without growing larger, 
presumably due to starvation as most have a detached and fused buccal cavity and 
therefore cannot feed (Figure 4.lei). They seem to move relatively well and there is 
definite pharyngeal pumping although the contractions are not regular and seem to occur 
in groups. The pharynx may not contract for several minutes and then it will contract 
around 10 or more times in a row within 10-30 seconds. These hatched mutants also 
have clear alae along each lateral surface although these alae are often abnormally 
branched towards the anterior at regions where the larvae are very flaccid and have a 
slack shape with dorsal and ventral bulges (Figure 4.lei).
Most homozygotes arrest as unhatched 1.5- to 2-fold stage embryos with a 
ruptured ventral posterior region, although the severity of the rupture varies between 
arrested mutants. The buccal cavities are usually detached and most unhatched mutants
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Figure 4.1
DIC (Nomarski) images showing the terminal arrest phenotypes of w4 homozygous 
mutants, fully elongated wild type embryos, and wild type LI larvae.
Mutants are shown on the left column (i), wild type embryos and larvae on the right 
column(ii). In all images, the anterior is to the left and the dorsal region is to the top.
a i Unhatched w4 homozyogte
ii 3-fold, fully elongated wild type embryo 
b i Hatched w4 homozygote with an arrow pointing to the gut autofluorescence
ii Hatched LI wild type larva 
c i The anterior of an hatched w4 homozygote with an arrow indicating
the detached buccal cavity
ii The anterior of a wild type LI larva with an arrow indicating the normal 
attached buccal cavity 
d i An unhatched w4 homozygote with arrowheads indicating the position of the
four regions of the pharynx: the procorpus, metacorpus, isthmus, and terminal 
bulb. An arrow points to the gut autofluorescence.
ii A wild type 3-fold embryo with arrowheads indicating the position of the four 
regions of the normal pharynx. It can be seen that the mutant pharynx is much 
shorter with the four regions positioned much closer together, 
e i A section of an hatched w4 homozygote with an arrow indicating branched
alae.
ii A section of a wild type LI larva with an arrow indicating normal alae.
All scale bars are 10pm
1
•  •
11
MgQM
Ifitll
154
appear wide and lumpy at the anterior and amorphous towards the posterior (Figure 
4.1ai). No alae are visible inside the eggshell but a cuticle can be seen covering the area 
where the body shape is intact i.e. the non ruptured region. Internal cells of the embryo 
burst out from the ruptured region and lie loose within the eggshell outside the embryo. 
Some embryos are very disrupted and very little evidence of intact body shape can be 
seen. Although the pharynx is well developed in unhatched mutants (Figure 4.1di), I 
have not observed pharyngeal contractions.
I have looked at mutants maintained at 16°C, 20°C and 25°C and have seen no 
reproducible difference in the percentage of hatched versus unhatched death or in the 
terminal phenotypes of each class. Unhatched mutants at each temperature are shown in 
Figure 4.2. However, one w4 homozygote which hatched and developed at 13°C (due to 
a faulty incubator) was viable and produced 100% dead progeny (Appendix 4.1). This 
points to a possible maternal component, although the conditions were not within 
normal temperature limits for C.elegans and no other evidence of a maternal element 
has been observed under normal conditions.
From time course microscopy observations, it seems that embryogenesis 
proceeds normally to around the 1.5-fold stage and then, while wild type embryos 
elongate further, w4 embryos begin to rupture at the ventral surface towards the 
posterior of the embryo (Figure 4.3a). Elongation decreases significantly and the 
mutant embryos continue growing much more slowly until around 2-fold while further 
tissue is exuded from the ventral surface(Figure 4.3b). This can also be seen in a mixed 
embryo population of developing mutant embryos. If a selection of embryos are viewed 
at different stages of development, estimated by the development of the pharynx and 
buccal cavity, some are at an early stage of tissue differentiation and are already exuding 
tissue from their lower ventral surface. Later mutant embryos with a fully developed 
pharynx are much more severely ruptured, possibly as a result of attempted elongation 
pushing cells through a break in the hypodermis. The lower ventral surface is the site of 
ventral enclosure within the developing C.elegans embryo.
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Figure 4.2
DIC images showing terminal arrest phenotypes of unhatched w4 
homozygotes at various temperatures.
In all images, the anterior is to the left and the dorsal region is to the top. 
a 16°C 
b 20°C 
c 25°C
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Figure 4.3
DIC images showing ventral rupture of unhatched w4 homozygotes at 
various stages during development
a w4 homozygote (upper embryo) and wild type (lower embryo) at various 
stages o f development. w4 mutant is shown with anterior to the left and dorsal 
region to the top, wild type embryos is shown with the anterior towards the 
bottom left comer and dorsal region to the top right corner o f the image.
i w4 embryo is at comma stage, wild type embryo is at precomma stage
ii w4 embryo is rupturing at the ventral surface, wild type embryo is at 1.5-fold 
stage
iii w4 embryo is very ruptured and deformed while the wild type embryo has 
elongated completely to the 3-fold stage.
b Magnification o f the area denoted by a box in aii show ing the rupture at the 
ventral surface o f the w4 mutant. Arrow points to the site o f rupture.
Scale bar is 10pm
/
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4.2.2. Specific characterisation of tissues and structures within w4 homozygote 
mutants.
I used fluorescence microscopy to study tissues within the mutant embryos. The 
most obvious markers to test were hypodermal and cuticle specific reagents as the 
hypodermis drives and maintains shape change (Priess and Hirsh, 1986; Costa et al, 
1998). Different components of the body wall and pharyngeal muscle, and the 
connections of muscle to the hypodermis including basement membrane components 
were also visualised. Another tissue that undergoes shape change and development 
during this time in morphogenesis is the pharynx which was observed using several 
tissue-specific antibodies. In all cases, the markers used showed patterns equivalent to 
wild type patterns in hatched mutants and so only images of unhatched mutants will be 
shown in this section.
4.2.2.I. Hypodermis
MH27 is a widely used monoclonal antibody which recognises a protein within 
adherens junctions, both between adjacent hypodermal cells and within the intestine 
(Priess and Hirsh, 1986, Waterston, 1988). The staining pattern of the monoclonal 
MH27 antibody during embryogenesis has been extensively characterised and every 
individual hypodermal cell fusion has been followed (Podbilewicz and White, 1994). In 
w4 mutants, the MH27 pattern indicates that the correct number of terminal hypodermal 
cells are present although in unhatched mutants, intestinal staining extends past the 
intact edge of the embryo right through the exuded tissue at the site of rupture, while 
hypodermal staining ceases at the edge of the embryo (Figure 4.4 and Figure 4.11b). 
This leads strongly to the idea of incomplete enclosure of the hypodermis at the lower 
ventral region of the embryo, at least in unhatched mutants. Another defect leading to 
rupture would be the presence of a weak cuticle at a specific region of the embryo. If 
this was the case the embryo should elongate normally to 3-fold and then collapse back 
as the defective cuticle is secreted. This phenotype is seen in certain sqt-3 alleles which 
have a mutant col-1 gene and secrete an abnormal cuticle (Priess and Hirsh, 1986; van 
der Keyl et al., 1994).
158
ab
c
Figure 4.4
Hypodermal cell shapes and positions in n'4 unhatched embryos and wild 
type embryos.
Embryos were stained with the monoclonal antibody MH27 to visualise the 
adherens junctions between hypodermal cells. In all images, the anterior is to 
the left and the dorsal region is to the top. A lateral seam cell is indicated with 
an arrowhead in image ii o f all embryos. DIC images are shown in column i.
a Unhatched w4  homozygote
ii and iii MH27 staining showing lateral views o f the hypodermis. The 
hypodermal cells appear to be o f approximately wild type shape and 
position although they are not as elongated as a wild type 3-fold embryo 
due to the overall body elongation defect, 
b l 5-fold wild type embryo
ii and iii MH27 staining showing lateral views o f the hypodermis 
c 3-fold wild type embryo
ii and iii MH27 staining showing lateral views o f the hypodermis
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The nuclear protein LIN-26 is expressed in all hypodermal cells of C.elegans 
and is required for their development (Labouesse et a l , 1996). The polyclonal anti- 
LIN-26 antibody which recognises the LIN-26 protein can be used in conjunction with 
MH27 to look for specific defects such as abnormal fusion patterns. Although I did not 
have the equipment necessary to count the number of hypodermal nuclei accurately in 
the mutant embryos, it could be seen that the seam and P-cells were mononucleate and 
that the other hypodermal syncytia were multinucleate (data not shown). This indicates 
that basic fusions have occurred normally within the hypodermis during w4 
embryogenesis although minor abnormalities would not have been detected and I cannot 
say definitely whether all hypodermal nuclei were present.
4.2.2.2. Cuticle
To examine the synthesis and secretion of the cuticle I used the DPY7-5a 
monoclonal antibody which recognises the cuticular collagen DPY7. DPY7 is one of 
the proteins which make up the structural framework of the C.elegans cuticle. In both 
unhatched and hatched w4 mutants, the antibody clearly shows that the cuticle has been 
secreted on the surface of the embryo (Figure 4.5). This is evident from the alae on 
hatched mutants. However, their lumpy-dumpy shape may indicate a cuticular defect 
which is unseen in the ruptured unhatched embryos or may reflect other hypodermal 
abnormalities. Again, it can be clearly seen that the DPY7-5a staining extends in the 
unhatched embryos only as far as the body remains intact. Where tissues have been 
exuded from the body, there is no DPY7-5a staining. The presence of extracellular 
DPY7-5a staining is an indication of terminal hypodermal differentiation, at least with 
respect to cuticle formation, as cuticle secretion is the final role of the hypodermis 
during embryogenesis.
4.2.2.3. Muscle
DM5.6 is a monoclonal antibody which recognises a component of the body 
wall muscle myosin heavy chain, myosin A (Figure 4.6)(Miller et al., 1983; Hresko et 
al., 1994; Moerman et al., 1996). I used this antibody to identify body wall muscle cells 
in order to observe sarcomere organisation in this mutant. Myosin staining in wild type
160
1
•  •
11
Figure 4.5
The localisation of a cuticular collagen, DPY-7 in \v4 unhatched mutants and 
wild type embryos indicating presence or absence of a secreted cuticle.
Embryos were stained with the monoclonal antibody DPY7-5a which visualises 
the carboxy terminus o f  the DPY-7 collagen Only one side view o f each embryo 
is shown. In all images the anterior is to the left and in images a and b the dorsal 
region is to the top. DIC images are shown in column i 
a Unhatched w4 mutant
ii DPY7-5a staining o f one lateral view o f mutant a showing the extracellular 
localisation o f the antibody indicating that a cuticle has been secreted, 
b 1.5 fold stage wild type embryo
ii DPY7- 5a staining o f one side view o f the embryo showing internal localisation 
o f DPY-7
c 3 fold wild type embryo
ii DPY7-5a staining o f one side view o f the embryo showing the extracellular 
localisation o f DPY-7 indicating that a cuticle has been secreted
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Myosin thick 
filaments:
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Body M-Tine
Basement membrane: 
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Hemidesmosomes:Muscle cell membrane
\____ I Basement membrane
I I Hypodermis
i i  M i l  1 1 1 Cuticle
MH4 antibody
Figure 4.6
Schematic model of a C.elegans body wall muscle sarcomere showing the 
localisation of antibodies: MH3, MH4 and DM5.6
Thin filaments are anchored to dense bodies and, at the other end, overlap with 
thick filaments. The alignment o f thick filaments is maintained by the M-Line 
components. Contractile force is generated by myosin heads which pull on 
adjacent thin filaments, bringing the dense bodies closer together. This 
contractile force is transferred to the outside through the basement membrane and 
hemidesmosome attachments to the cuticle. DM5.6 is a monoclonal antibody 
which recognises myosin A in the centre o f the thick filaments. MH3 recognises 
a protein, Perlecan, in the basement membrane. MH4 recognises a component o f 
the hemidesmosome intermediate filaments.
(Adapted from Hresko et al., 1994)
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embryos is tightly arranged in four longitudinal rows along the developing embryo 
(Figure 4.7b). w4 embryos appear to have the four muscle quadrants which are stained 
with the DM5.6 monoclonal antibody. The staining is usually very regular in mutant 
embryos within the intact body region but staining is absent outside the site of rupture 
(Figure 4.7a). Irregular staining could reflect some defect in muscle-hypodermis 
attachment which would definitely occur at a site where enclosure is incomplete.
4.2.2.4. Muscle-hypodermis attachments and basement membrane
MH4 is a monoclonal antibody which recognises areas of the hypodermis 
associated with the attachment of the underlying body wall muscle cells, called 
intermediate filaments within structures called known as hemidesmosomes. It also 
stains areas of the pharynx, the excretory cell, and the amphid sensory neurons (Figure 
4.6)(Francis and Waterston, 1991; Hresko et a l , 1994). In mutant embryos, MH4 is 
clearly present in the correct positions, although hypodermal staining is less clear than 
in 3-fold wild type embryos and staining does not extend past the intact body surface at 
the edge of posterior rupture (Figure 4.8). At the site of rupture, staining is more 
disorganised and diffuse. Elsewhere, it looks as if  the hemidesmosomes are present in 
the correct positions within the hypodermis and consequently the underlying muscles 
seem to be in the correct position also.
The monoclonal antibody MH3 recognises several isoforms of the basement 
membrane protein UNC-52, a homologue of vertebrate perlecan, which has a primary 
function in anchoring the muscle myofilament lattice (Figure 4.6)(Francis and 
Waterston, 1991). It is present at both muscle:muscle and muscle:hypodermal cell 
junctions. In unhatched w4 homozygote embryos, MH3 is present and appears to lie in 
the correct positions where the body is intact (Figure 4.9a). Outside this area, where the 
embryos have ruptured, staining is again irregular and diffuse and does not extend past 
the site of rupture. This corresponds to the MH4 data and the position of DM5.6 
sarcomere staining.
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Figure 4.7
Position of muscle sarcomeres in n>4 unhatched mutants and wild type embryos
Embryos were stained with the monoclonal antibody DM5.6 to visualise myosin A 
within the muscle sarcomeres. In both images, the anterior is to the left and in 
image a the dorsal region is to the top o f the image.
a unhatched w4 mutant
i DIC image
ii and iii DM5.6 staining showing different views o f  the mutant embryo 
muscle sarcomeres. Sarcomeres appear to be organised in an 
approximately wild type manner.
b 3-fold wild type embryo
i DIC image
ii and iii DM5.6 staining showing two views o f the embryo muscle 
sarcomeres
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Figure 4.8
Association of the hypodermis and underlying muscle in w4 unhatched 
mutants and wild type embryos
Embryos were stained with the monoclonal antibody MH4 which recognises 
intermediate filaments, part o f the hemidesmosomes, present in hypodermal cells 
overlying muscle sarcomeres. Bands o f MH4 staining are denoted with 
arrowheads on the images. Both embryos are positioned with the anterior curving 
down to the bottom centre o f the image. MH4 also stains the pharynx, the 
secretory cell, and several sensory neurons which can be seen on more internal 
focal planes. DIC images are shown in row i. 
a unhatched vr4 mutant
ii and iii MH4 staining showing hemidesmosome positions at two lateral 
views o f the mutant embryo. The MH4 staining pattern in w4 mutants 
appears equivalent to the wild type staining pattern, 
b 3-fold wild type embryo
ii and iii MH4 staining showing normal hemidesmosome positions at 
two lateral views o f the wild type embryo.
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Figure 4.9
Positions of muscle:muscle and muscle:hypodermis junctions in w4 unhatched 
mutants and wild type embryos
Embryos were stained with the monoclonal antibody MH3 which recognises several 
isoforms o f the protein UNC-52 present in the basement membrane between 
adjacent muscle cells and muscle:hypodermal cells. In all images the anterior is to 
the left and the dorsal region is to the top and right.
a w4 unhatched mutant
i DIC image
ii and iii MH3 staining pattern at the two sides o f the mutant 
embryo.
b 3-fold wild type embryo
i DIC image
ii and iii MH3 staining pattern at two sides o f the wild type embryo.
166
4.2.2.5. Pharynx and intestine
The monoclonal antibody 3NB12 stains a subset of pharyngeal muscles (from 6 
hours of development) and shows clearly the differentiation and morphogenesis of the 
pharynx in wild type embryos (Okomoto and Thomson, 1985; Priess and Thomson, 
1987; Mango et al., 1994a). MH27 and MH4 also stain specific areas of the marginal 
cells in the terminally differentiated pharynx. In unhatched mutants, all antibody 
staining showed that the pharynx is differentiated fully but is shorter than wild type 
probably due to the shorter body length and internal rupture (Figure 4.10a,c,e). 
Together, 3NB12, MH27 and MH4 stain muscle, adherens junctions, and 
hemidesmosomes respectively within the pharynx and so it seems that apart from some 
shortening resulting from a detached buccal cavity, several representative cell types 
within the pharynx are present as normal.
MH27 staining also showed that intestinal adherens junctions appear normal in 
w4 mutants (Figure 4.10c). The refractile gut granules of the intestine can also be seen 
clearly in Figure 4.1bi and di.
4.3. Mapping
As a first step towards cloning the wild type copy of the w4 allele, I mapped the 
mutant allele using classical genetic methods. Initially the chromosome assignment 
cross was performed using a triply mutant strain and then the mutant allele was 
positioned relative to other genes on that chromosome using a variety of two- and three- 
factor crosses. Whilst three-factor crosses are used to order the genes, two-factor 
crosses are more important in calculating the distance of the mutant allele from a marker 
gene. Because of this, it is important to perform two-factor crosses with marker genes 
that have been accurately mapped or cloned. A big factor in mapping an allele is the 
marker genes that are chosen to map it and how accurately these have previously been 
positioned on the genetic map. The area of study, the right arm of chromosome I, 
turned out to be very sparse in good marker genes and, at the time of characterising this 
mutant, had many gaps in the physical sequence. The genes used as markers in the 
mapping of w4 were dpy-5(e61) position 0.00±0.008 on chromosome I, unc-75(e950) 
position 9.48±0.077 (chromosome I) and unc-lOl(ml) position 13.30±0.196
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Figure 4.10.
Pharynx and intestine position and shape in w4 unhatched mutants and 3-fold wild 
type embryos.
Embryos were stained with the monoclonal antibodies 3NB12, MH4 and MH27 (see 
text for details). DIC images are in the left column (i) and UV images showing 
antibody staining are shown in the column to the right (ii). In all images the anterior is 
towards the left and in images of mutant embryos (a, c, and e) the dorsal region is to the 
top. In all images, arrowheads denote the four main regions of the pharynx as in Figure 
4.Id.
a u'4 unhatched mutant
ii 3NB12 staining of the mutant embryo showing the position of pharyngeal 
muscles which appears to show differentiation equivalent to wild type but much 
less elongation of the pharynx, 
b 3-fold wild type embryo
ii 3NB12 staining of the 3-fold embryo showing the normal position of 
pharyngeal muscles, 
c w4 unhatched mutant
ii MH27 staining of the mutant embryo showing the position of pharyngeal and 
intestinal adherens junctions which again appears differentiated as wild type but 
shows much shorter structures, 
d 3-fold wild type embryo
ii MH27 staining of the 3-fold embryo showing the normal position of 
pharyngeal and intestinal adherens junctions, 
e w4 unhatched mutant
ii MH4 staining showing the position of intermediate filaments within the 
marginal cells of the mutant embryo pharynx. Again these structures appear 
differentiated as wild type but are not as elongated, 
f 3-fold wild type embryo
ii MH4 staining of the 3-fold embryo showing the normal position of 
intermediate filaments within the marginal cells of the mutant embryo pharynx.
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(chromosome I). dpy-5(e61) is a strong dumpy, unc-75(e950) is sluggish, short and coils 
if touched on the anterior tip of the head, but moves forward well, and unc-101(ml) 
resembles unc-75(e950) but is also slightly egg-laying defective (Egl) and moves less 
well. A problem with comparing results from crosses in which strong dumpys are 
scored with crosses in which Uncs are scored, is that the dumpy phenotype is much 
more obvious and will be scored more easily. Care must be taken in interpreting the 
results as mis-scoring of Uncs, especially less strong Uncs, may occur and this may 
effect the map distance calculated.
4.3.1. MT465 Chromosomal Assignment Cross
I crossed the heterozygote mutant strain carrying the w4 mutation with N2 males 
to produce male FIs carrying the mutation. These FI males were then mated with 
hermaphrodites of the MT465 strain which are homozygous for three recessive mutant 
marker genes: dpy-5(e61) I, bli-2(e768)II, and unc-32(el89) III. I scored the FI 
generation of this cross (which were phenotypically wild type) for segregation of lethal 
mutants. All of these FIs were heterozygous for each of the three marker genes and 
approximately 50% carried the w4 mutation and so it was evident that w4 did not lie on 
the X chromosome. If w4 did lie on X, hemizygous males which have only one X 
chromosome would be lethal and therefore the mutant allele could not be passed on to 
the next generation via males. I selected recombinant Dpy-non-Unc-non-Bli, Unc-non- 
Dpy-non-Bli, and Bli-non-Dpy-non-Unc F2 progeny from the FI hermaphrodites 
carrying w4 and scored the progeny of each of these classes for the number of F2s 
carrying the w4 mutation. If w4 is unlinked to the marker gene then approximately 2/3 of 
the animals should segregate w4 lethality (12 out of 18 animals). Results are shown in 
Table 4.1 and raw data in Appendix 4.2.. There is a significant deviation from the 
expected ratio in the dumpy recombinants which indicates that w4 is linked to dpy- 
5(e61) on chromosome I (pO.OOl, x2 test, ldf, n=18).
169
Table 4.1
Mapping data from MT465 Chromosomal Assignment Cross
Recombinant type adults carrying w4 
allele
adults not carrying 
w4 allele
Total number of 
adults
Bli-non-Dpy-non
Unc
16 2 18
Unc-non-Dpy-non-
Bli
14 4 18
Dpy-non-Bli-non-
Unc
2 16 18
4.3.2. dpy-5(e61)/dpy-5(e61)w4 two-factor cross
I used the dpy-5(e61) homozygote/ w4 heterozygote (dpy-5(e61)+/dpy-5(e61) 
w4) mutants obtained from the MT465 cross to perform a cis two-factor self-cross. This 
cross should give the frequency of recombination between w4 and dpy-5(e61). I crossed 
these dpy-5(e61) +Idpy-5(e61)w4 hermaphrodites with N2 males, picked FI 
hermaphrodites clonally and allowed them to self before removing the parent. I scored 
the number of dumpy recombinant, phenotypically wild type, and total number of 
progeny of the FIs that carried the w4 mutation, transferring the parent hermaphrodites 
several times so that the entire progeny was scored. The results are shown in Table 4.2. 
In order to measure the recombination distance between dpy-5(e61) and w4, I used a 
formula which allows for the production of recombinant classes of progeny and also 
takes into account that certain classes of progeny may be subviable (see section 2.11.3.2 
for full derivation). Because both w4 and dpy-5(e61),w4 homozygotes are lethal, the 
recombination frequency was calculated using only the numbers of viable dumpy and 
phenotypically wild type progeny. The formula used was:
A = (2p-p2l (Sulston and Hodgkin, 1988).
(A+W) 3
Where A= number of viable dpy-5(e61) homozygote progeny, W= number of wild type 
progeny and p= the recombination frequency.
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The mean value of p=0.099±0.00527 (n=3 broods). Therefore, the best estimate of w4 
position from dpy-5(e61) is 9.9map units, which corresponds to position ± 9.9±0.527 on 
chromosome I.
Table 4.2
Mapping data from dpy-5(e61)/dpy-5(e61)w4 two-factor cross
Brood number dead progeny dpy-5(e61)
recombinants
wild-type
progeny
P
1 56 12 206 0.086
2 43 15 203 0.109
3 54 15 220 0.101
4.3.3. dpy-5(e61)unc-101(ml)/w4 three-factor cross
In order to decide whether w4 mapped to the left or right arm of chromosome I, I 
carried out a three factor cross using dpy-5(e61) and unc-lOl(ml) as marker mutations. 
dpy-5(e61)unc-101(ml) homozygotes were crossed with w4 heterozygote males and the 
FI hermaphrodites were allowed to self. From FI broods carrying the w4 mutation 
(parental genotype: dpy-5(e61)+unc-101(ml)/+w4+), Dpy-non-Unc and Unc-non-Dpy 
recombinant hermaphrodites were picked out clonally and allowed to self. The progeny 
of these hermaphrodites were scored for the presence (indicated by 25% death) or 
absence of the w4 mutation. The results are shown in Table 4.3 and the raw data can be 
found in Appendix 4.3. These results indicated that the w4 locus lies between dpy- 
5(e61) and unc-lOl(ml) at a ratio of 50:28. unc-lOl(ml) is at position 13.3 on 
chromosome I and so this would place w4 at around position 8.5, slightly closer to dpy- 
5(e61) than the two-factor cross predicted. However, three-factor crosses are not as 
accurate as two-factor crosses and are of use in predicting position relative to other 
genes rather than actual distance from a marker gene. So the most valuable information 
gained from this cross was that the w4 locus lies on the right arm of chromosome I, 
between dpy-5(e61) and unc-lOl(ml).
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Table 4.3
dpy-5(e61)unc-101(ml)/w4 three-factor cross
The table below shows the number of recombinant Dpy-non-Unc and Unc-non-Dpy F2 
hermaphrodites carrying the w4 mutation
Recombinant
phenotype
carrying w4 
mutation
not carrying w4 
mutation
total number of 
recombinants
Dpy-non-Unc
recombinants
30
(dpy-5(e61)+ unc- 
101(ml)/ dpy- 
5(e61)w4+)
13
(idpy-5(e61)unc- 
101 (m l)/ dpy- 
5(e61)+)
43
Unc-non-Dpy
recombinants
15
(dpy-5(e61)+ unc- 
101(ml)/+ w4unc- 
101 (ml))
20
(dpy-5(e61)unc- 
101(ml)/+ unc- 
101 (ml))
35
4.3.4. dpy-5(e61)unc-75(e950)!w4 three-factor cross
From previous data, it would seem that the w4 locus is situated to the right of, 
and is very closely linked to unc-75(e950) which has a genetic map position of 
9.48±0.077. A three-factor cross between dpy-5(e61),unc-75(e950) homozygotes and 
w4 heterozygotes was carried out in the same way as the three-factor cross described 
above. The results are shown in Table 4.4. This cross positioned w4 between dpy- 
5(e61) and unc-75(e950) with the ratio 20:7, giving the w4 allele an approximate 
position of 7. Again this differs from the dpy-5(e61) two-factor cross data but it 
coincides with the positioning of w4 relative to the marker genes. The distance of w4 
from dpy-5(e61) may have been over-estimated from the previous two-factor cross.
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Table 4.4
dpy-5(e61)unc-75(e950)lw4 three-factor cross
The table below shows the number of Dpy-non-Unc and Unc-non-Dpy recombinant F2s 
which carry the w4 mutant allele:
Recombinant
phenotype
carrying w4 
mutation
not carrying w4 
mutation
total number of 
recombinants
Dpy-non-Uncs 9
(dpy-5(e61)+ unc-
75(e950)/
dpy-5(e61)w4+)
3
(dpy-5(e61)unc-
75(e950)/
dpy-5(e61)+)
12
Unc-non-Dpys 4
(dpy-5(e61)+ unc- 
75(e950)/+ w4unc- 
75(e950))
11
(idpy-5(e61)unc-
75(e950)/+
unc-75(e950))
15
4.3.5. spe-9(hc88)/w4 unc-75(e950) two-factor cross
A second two-factor cross was performed to measure the distance of w4 from 
unc-75(e950). This was scored in a slightly different way to the dpy-5(e61) two-factor 
cross as there was a third mutation, spe-9(hc88), present in the mapping strain, although 
it was not used as a marker mutation. This strain [+ spe-9(hc88)+/w4+unc-75(e950)] 
was constructed as a balanced strain which enforces maintenance of heterozygotes as 
spe-9(hc88) homozygotes are sterile, and w4,unc-75(e950) homozygotes are lethal. In 
addition, spe-9(hc88) and unc-75(e950) are at positions 9.41±0.779 and 9.48±0.077 
respectively, only 0.07 map units apart on chromosome I, therefore there is a very low 
recombination frequency between these two loci. I carried out the two-factor cross 
using essentially the same steps as before although the initial outcross was not necessary 
as the balanced strain was already heterozygous for both unc-75(e950) and w4. + spe- 
9(hc88)+/w4+ unc-75(e950) hermaphrodites were allowed to self and the entire brood 
was scored for uncoordinated (Unc) recombinants and w4 death (Table 4.5).
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Table 4.5
spe-9(hc88)/w4 unc-75(e950) two-factor cross
Brood number dead progeny Unc progeny total number of 
progeny
P
1 47 2 181 0.022
2 24 4 125 0.064
3 23 1 99 0.020
4 50 5 181 0.055
5 42 3 173 0.035
6 31 2 157 0.025
7 36 2 161 0.025
8 36 2 166 0.024
9 68 2 256 0.016
10 42 4 214 0.037
11 44 3 231 0.036
12 48 3 231 0.026
13 41 1 192 0.010
14 38 4 158 0.051
This time I could not calculate the recombination frequency, p, using the 
equation (2p-p2)/3=(A/A+W) because of the spe-9(hc88) mutation in the unc- 
75(e950)/w4 heterozygote parent. The sterile spe-9(hc88) homozygotes could not be 
separated easily from the wild type progeny (W). Instead, p was calculated using the 
equation:
p = Uncs present x2 (recombinant Unc chromosomes) 
total expected Unc chromosomes (if unlinked)
The number of viable Unc recombinants are multiplied by two because half of the 
recombinant unc-75(e950) chromosomes will pair with spe-9(hc88) and remain unseen. 
The results are shown in Table 4.5. The mean value of p= 0.032±0.004 (n=14 broods). 
These results place the w4 locus further left (at around 6.2 on the right arm of 
Chromosome I). There is a high range of p values and unc-75(e950) homozygotes are 
more easily mis-scored than dpy-5(e61) homozygotes due to their ability to move 
forward well, which may render this p value less accurate than the value from dpy- 
5(e61). Also, the method for working out the recombination frequency in this cross is
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more simplified than before because of the spe-9(hc88) homozygotes among the wild 
type progeny. Therefore the dpy-5(e61)+/+w4 two-factor cross is probably still more 
accurate for the map position of the w4 allele although there may be errors in both 
methods of calculating p.
To conclude, the mapping data all agrees on an area within chromosome I but 
the absolute position appears to vary between crosses. The dpy-5(e61)+/+w4 two-factor 
cross gives a value of 9.9+0.527 although other positional information obtained suggests 
that w4 is closer to dpy-5(e61) and between dpy-5(e61) and unc-75(e950). It is still 
possible that w4 is a small deletion and this would result in inconsistent recombination 
frequencies when mapping the locus. Further map data could be obtained using STS 
mapping (Williams, 1992; section 5.3.2) when more mapped Tel sites are available on 
chromosome I.
4.4. Attempt to clone the wild type copy of the w4 mutant gene
4.4.1. Background of DNA transformation
The C.elegans physical map is represented by overlapping cosmid, lambda and 
yeast artificial chromosome (YAC) clones covering almost the entire genome. It is also 
well aligned with the genetic map using genetically mapped sequences of cloned genes 
and as the sequencing project nears completion, the accuracy of the alignment continues 
to increase. Newly characterised genes that have been mapped finely to an area of the 
genome will be contained within cosmid or other clone sequences covering that region. 
An extremely useful tool available when working with C.elegans is the ability to 
generate transgenic strains (Fire et al., 1986; Mello et a l, 1991). This can be achieved 
by injecting DNA molecules into hermaphrodite gonads as these molecules can 
recombine and be inherited as transgenic arrays in a small fraction of the progeny of the 
injected worms (Mello et a l , 1991). In each of these transgenic lines, the 
extrachromosomal array will be transmitted at a certain frequency, specific to each line, 
and so the proportion of transformed animals can be estimated at every generation. In 
order to clone a gene, it is possible to inject worms homozygous for a mutation with 
cosmids covering the region of the genome to which the mutant gene has been mapped. 
The wild type copy of the gene will often rescue the mutant phenotype when present as
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part of an extrachromosomal array and so the gene can be identified from the rescuing 
cosmid or cosmids. When the mutation under study is lethal, balanced heterozygotes 
can be injected and the transformed homozygous descendants examined. It is known 
that homologous recombination is important for driving transgenic array assembly 
(Mello et al., 1991) and so when searching for a gene in a certain region, it is the usual 
practice to inject groups of overlapping cosmids from this region which have shared 
areas of homology. This also increases the likelihood of rescue as some genes may 
traverse two cosmids. Each transformed line containing a transgenic array has a 
characteristic frequency of array transmission from generation to generation. In order to 
follow the transmission of arrays between generations, plasmid containing a dominant 
mutation resulting in a clear visible phenotype is injected with the test DNA molecules. 
I used the semi-dominant mutation rol-6(su!006) contained in the plasmid pRF4 (Mello 
et al., 1991) which results in a helically twisted cuticle causing transformed animals to 
move in an obvious circular manner. Because DNA molecules have been shown to 
recombine when injected together, it is assumed that animals carrying the marker 
plasmid also carry the test DNA molecules on the same array (Mello et a l 1991), . To 
ensure that the effect of all injected DNA has been studied, several lines should be 
examined from each set of injections as all test DNA molecules may not be present in 
all arrays.
4.4.2. Attempted rescue of the w4 m utant phenotype
In an attempt to clone the w4 gene, I determined whether cosmid(s) from the 
region to which w4 was mapped could rescue the mutant phenotype. I first constructed 
a balanced strain which would show an obvious change in phenotype if rescue occurred. 
The previously mentioned strain, spe-9(hc88)/w4 unc-75(e950), is well balanced as spe- 
9(hc88) homozygotes are sterile and w4unc-75(e950) homozygotes arrest as embryos. 
The strain is therefore maintained by the natural selection of heterozygotes. There will 
be recombination events between w4 and unc-75(e950) but the strain was scored for the 
presence of around 25% steriles and a very small number of recombinant Uncs at each 
generation. Recombination resulting in an unc-75(e950)/w4spe-9(hc88) genotype was 
easily detected if the ratio of Uncs increased to around 25% and there were very few
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spe-9(hc88) homozygotes. If the w4 phenotype was rescued, there would be an increase 
in Uncs to a percentage equivalent to the transgene array transmission frequency which 
is estimated from the proportion of rolling animals (Rollers) in each generation of a 
transmitting line. Conversely, these rescued Uncs (w4unc-75(e950)/w4unc-75(e950) 
[rescuing array]) would segregate dead embryos with the w4 phenotype at an equivalent 
proportion to the loss of the rescuing array. If the increased proportion of Uncs was due 
to recombination rather than rescue, then unc homozygotes would segregate 25% death 
(w4unc-75(e950)/unc-75(e950)) or, on rare occasions, no death (unc-75(e950)/unc- 
75(e950)). Another indication of rescue rather than recombination is to check the extra 
Uncs to see if they are rollers or non rollers - this can be seen in Uncs from the twisting 
of their cuticle. If the extra Uncs are rescued w4 death then they should all be rollers.
I injected 93 adult hermaphrodites from the balanced strain with a purified mix 
of nine cosmids from the region of chromosome I to which w4 was mapped (Figure 
4.11) along with pRF4 containing the marker mutation rol-6(sul006) and a plasmid, 
pTAG, to aid recombination between non-overlapping cosmids (see section 2.14.1). 
This was necessary as there were gaps between some of the injected cosmids where 
overlapping clones were not available. 68 FI rollers were obtained from the injections 
and these were plated out in groups of 2. I obtained 5 transmitting lines from these FIs 
and F2 rollers were plated out clonally in order to score the phenotypes of the progeny 
(Table 4.6). All the F2 rollers plated out from 4 of the lines were sterile. This was 
completely unexpected and is statistically different from the expected ratio of 25% 
(p<0.001,x2 test, ld.f, n=73). However, one of the transmitting lines was fertile and was 
scored for the different phenotypes (Appendix 4.4). The line had a transmission 
frequency of around 13% (n=1131) and showed no evidence of rescue, with a mean of 
2.67±0.78 % Uncs per brood (n=32 broods).
Table 4.6 Transmitting lines of w4 cosmid injections
Line number of F2 Rollers plated out F2 progeny phenotype
1 25 F2s all sterile
2 11 same proportions of different phenotypes 
as untransformed lines (Appendix 4.4)
3 25 F2s all sterile
4 13 F2s all sterile
5 20 F2s all sterile
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Figure 4.11
Schematic diagram showing relative positions of cosmids which were injected in an 
attempt to rescue the w4 mutant phenotype
A section of the physical map of the right arm of Chromosome I is shown with relative 
positions of the injected cosmids. Parallel vertical lines indicate breaks in the physical 
map which have not yet been sequenced. The nearest cloned genes are shown with their 
genetic map positions for reference. At the time of injections, the section indicated with 
a star was not present in the AceDB physical map (Thierry-Meig and Durbin, 
unpublished software) and so it was thought that W02B9 was the next cosmid to F28D9 
available in the physical map. The cosmids shown are not to scale although overlaps are 
indicated by overlapping lines. Cosmids T02A8 and AA2  have not been sequenced 
completely to date and so their actual size is unknown.
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A problem with interpreting this is that a negative result may arise for many 
reasons and is not very informative. It does not indicate conclusively that the cosmid 
containing the wild type w4 gene was not present in the mix although this would be one 
reason for a negative result. Some of the injected cosmids contained deletions 
undetected at the time of injections as the full sequence data for the cosmids under study 
was not available and so the restriction digest patterns could not be accurately analysed. 
At the time of writing, 3 of the cosmids: T02A8, AA2 and C17D12 still had unfinished 
sequences. Also, I do not know whether all cosmids were present in the transmitting 
array, in fact a low transmission frequency often indicates a small array size. Since the 
concentration of some of the cosmids may not have been accurate due to incorrect OD 
readings at low concentrations, I cannot be certain that equivalent amounts of each was 
added to the mix and if there was a large variation among concentrations, this may also 
result in some cosmids not forming part of the array. Another possible reason for a 
negative result is that there were many gaps in this region of the cosmid map at the time 
of injecting and the wild type w4 gene may have been present within a gap, or traverse 
an injected cosmid and a gap, or indeed, traverse an injected cosmid and an overlapping 
cosmid not in the same mix. Further lines from the same mix and other overlapping 
cosmids from the same region would obviously have to be injected before any 
conclusions about rescue could be drawn.
A high incidence of sterile F2s could be explained if recombination had occurred 
at an early stage in the injection process and if the injected cosmids did rescue w4. 
Injection tends to give all-or-nothing results and quite often most of the transgenic lines 
are obtained from a very small number of injected animals. The injected adults were 
progeny of a correctly scored adult so a small proportion of these will be unc- 
75(e950)/spe-9(hc88)w4 recombinants, and if  a few recombinant adults were injected 
well and gave a high proportion of transmitting FIs, this would cause further selection 
for recombinants. The phenotypes were not scored again until the F2 progeny (F3 
generation). However, even if these lines were recombinant and rescued, this does not 
explain why all F2 rollers were sterile.
In conclusion, the wide region that the gene was mapped to due to the lack of 
marker genes, the many gaps present in the physical map at the time of attempted 
rescue, and possible recombination events made results difficult to interpret. Therefore
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I decided to terminate the characterisation of this mutant and attempt to characterise 
other mutant alleles which lie in better regions of the genome.
4.2.5. Discussion
w4 homozygotes arrest either as embryos with a ruptured ventral posterior 
surface or lumpy-dumpy L is with a detached buccal cavity. Looking at markers for 
many tissue types, it can be seen that the homozygous L is and the intact regions of 
arrested embryos have relatively normal muscle, basement membrane, hypodermal 
fusions, muscle-hypodermal connections, and also secrete a cuticle. The most likely 
cause of the homozygous embryonic phenotype is a failure of hypodermal cells to 
enclose normally at the posterior ventral surface. This results in internal tissues being 
squeezed out through the hypodermal ‘hole’ as elongation contractions occur in the 
hypodermis.
Both hypodermal enclosure and elongation are disrupted when actin filament 
function is inhibited (Priess and Hirsh, 1986; Williams-Masson et al., 1997) which 
indicates that genes in the same pathway are controlling both processes. This may 
explain the percentage of lumpy-dumpy LI homozygotes of w4. It is possible that there 
are hypodermal defects present other than that of abnormal enclosure which would not 
be noticed when examining the more severe phenotype. The L is clearly do not elongate 
normally and have bulges on the dorsal and ventral sides. This, coupled with 
abnormally branched alae and a detached pharynx strongly points to a further defect in 
hypodermal function. MH27 shows that fusions appear normal but other aspects of 
elongation i.e. the actin cytoskeleton may not be.
The hmr-1 mutant phenotype described in the introduction shares several aspects 
with the w4 mutant phenotype. Most hmr-1 or w4 homozygotes arrest without 
elongating normally and with a substantial rupture of their internal organs. In hmr-1, 
and the progeny of viable Hmp mutants, hypodermal cells fail to enclose at the anterior 
region of the ventral surface and may also have small enclosure defects at the posterior 
ventral surface also. w4 unhatched homozygotes appear to be predominantly defective 
in posterior ventral enclosure although very occasionally a w4 homozygote is seen with 
a ruptured anterior. Interestingly, hmr-1 maps to the same region of chromosome I as 
w4 and is rescued by the cosmid W02B9 which was one of the cosmids I injected in my
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attempt at cosmid rescue. Due to the similarity in the phenotypes and map positions, It 
is possible that w4 is an allele of hmr-1. It would be interesting to attempt cosmid 
rescue with W02B9 to test this idea, or look at complementation with another hmr-1 
allele.
w4 produces an interesting phenotype connected with aspects of hypodermal 
development such as enclosure and elongation. When more sequence data is made 
available it would be beneficial to the understanding of these processes to clone this 
gene and examine the role of the encoded protein.
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Chapter 5 
Characterisation of a deficiency, ijDJ2
5.1. Introduction
5.1.1. Genetic mutant screens
ijDf2 and ijDfl (see next chapter) are mutants that were obtained by Ethyl 
methanesulphonate (EMS) mutagenesis of a stable transgenic C.elegans strain, IA023 
(IJohnstone, pers.comm.). IA023 contains an integrated copy of a dpy-7 
promoter::GFP transgene. As discussed in chapter 3, dpy-7 is a cuticular collagen gene 
which is expressed specifically in the hypodermis and therefore the GFP expression 
pattern in IA023 was used to facilitate the identification of mutants with hypodermal 
defects. As dpy-7 is normally expressed at the beginning of elongation, the dpy-7\\GFP 
expression pattern indicates the developmental maturity of the hypodermis. The GFP 
expression pattern also allows a rapid estimation of the stage of mutant embryo 
elongation using a dissecting microscope with a UV source, prior to selecting mutants 
for more detailed phenotypic characterisation. Both ijDf2 and ijDfl were selected for 
study as they expressed dpy-7 v.GFP but failed to elongate normally.
5.1.2. Gastrulation in C.elegans
Gastrulation is the process whereby descendants of the founder blastomeres E, 
MS, AB and P2 (C, D and P4) migrate towards the centre of the embryo allowing novel 
cell contacts which are important for the specification of cell fates. Without normal 
gastrulation, later developmental processes including enclosure of hypodermal cells (see 
section 4.1.2) and morphogenesis are blocked although gastrulation failure itself does 
not prevent individual tissues from differentiating to their terminal states (Knight and 
Wood, 1998). Gastrulation in C.elegans has been described in wild type embryos using 
Nomarski microscopy to follow the movements of individual cells. Several different 
mutants have been discovered which disrupt gastrulation and these, together with laser 
ablation studies, have aided in the understanding of many essential requirements of this 
process. However, there are still many aspects of C.elegans gastrulation, including its
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control, which are not understood and it is hoped that the isolation of further 
gastrulation-defective mutants and information from other organisms will increase the 
body of knowledge about this process.
5.1.2.1. Cell movements and divisions before and during gastrulation in C.elegans
The E blastomere is one of the descendants of the EMS founder cell and 
generates only intestine, resulting in a total of 20 gut cells in the adult (Sulston et a l , 
1983). Between the 8 and 15 cell stages of development, E divides generating two 
daughter cells, Ea, to the anterior and Ep, to the posterior. These cells are present on the 
ventral surface and contact the vitelline membrane which surrounds the embryo within 
the eggshell. At around the 24 cell stage of development, a basic blastocoele is formed 
in the centre of the embryo and at the 26 cell stage, gastrulation is initiated by the 
movement of Ea and Ep away from the vitelline membrane towards the blastocoele. 
The migration of Ea and Ep towards the centre of the embryo creates a fissure, known as 
the ventral cleft, through which other cells subsequently migrate. At the end of their 
migration, around the 44 cell stage, Ea and Ep divide once in a left/right orientation and 
afterwards continue to divide further until a rudimentary gut is formed at the 180 cell 
stage. P4 is the next cell after Ea and Ep to migrate through the ventral cleft and 4 
granddaughters of MS follow from an anterior position. At around the 100 cell stage, 
the ventral cleft widens and myoblasts derived from the C and D founder cells enter 
from the posterior. After this, AB derived pharyngeal precursors enter the ventral cleft 
from the anterior and the cleft closes. Internal cell movements continue as the 
myoblasts are positioned between the gut and the hypodermis and eventually the gut and 
pharyngeal precursors lie in a central tube surrounded by MS-, C- and D-derived 
myoblasts.
5.1.2.2. Mutants showing specific defects in gastrulation
Maternal effect mutations in any of the genes gad-1, emb-5, emb-13, emb-16, 
emb-23 or emb-31 cause failure of either the initiation or the later stages of gastrulation 
(Knight and Wood, 1998; Denich et al., 1984; Nishiwaki et a l , 1993). In all of the 
mutants, the Ea and Ep divisions occur prematurely and often in an anterior/posterior
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rather than the normal left/right orientation. In the temperature sensitive mutation gad- 
1, this premature division results in a complete lack of gastrulation movements and this 
suggests that the control of cell cycle timing and spindle orientation in the E lineage at 
this stage may be important for normal gastrulation (Knight and Wood, 1998). gad-1 
encodes a protein which has a series of WD repeats similar to Gp proteins. G-protein 
signalling is one of several mechanisms controlling spindle orientation, and mutations in 
the gbp-1 gene, which encodes the Gp subunit in C.elegans, result in randomised spindle 
orientations in early embryos (Zwaal et al., 1996). O f the emb genes, the only one to be 
molecularly characterised to date, emb-5, has been shown to encode a protein similar to 
the STP6 protein of Saccharomyces cerevisiae which is thought to regulate transcription 
by controlling chromatin assembly (Nishiwaki et al., 1993). It has previously been 
shown that inhibition of RNA polymerase II using RNA interference also causes 
premature Ea and Ep divisions and prevents gastrulation initiation (Powell-Coffman et 
al., 1996). This would suggest that one or more zygotically transcribed genes are 
essential for the initiation of gastrulation and that these are regulated by the matemal- 
effect genes described here. There are several zygotically transcribed genes, end-1 and 
rrs-1, which result in gastrulation defects although they do not block its initiation and so 
it appears that there remains a zygotically transcribed gene or genes involved in the 
initiation of gastrulation as yet undiscovered (Ferguson et al., 1996; Zhu et al., 1997).
5.1.2.3. The involvement of cell adhesion in gastrulation
It has been proposed that Ea and Ep initiate their inward movements by reducing 
adhesive contacts with neighbouring cells (Junkersdorf and Schierenberg, 1992). 
Although none of the genes already known to affect gastrulation have been shown to 
encode proteins involved in adhesion, it seems likely that cell adhesion would play a 
role in this stage of gastrulation. In Drosophila, gastrulation also involves the inward 
movements of mesoderm and endoderm precursors although there are two regions of 
invagination, the ventral furrow through which mesodermal precursors invaginate, and 
the posterior midgut invagination through which endodermal precursors invaginate 
(Sweeton et al., 1991). Another difference to C.elegans gastrulation is that the 
invaginating cells in Drosophila undergo shape changes although those in C.elegans do 
not (Sweeton et a l, 1991; Oda et al., 1998). In Drosophila, the DE-cadherin-catenin
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system which comprises DE-cadherin, Armadillo (p-catenin), and Z)a-catenin, is 
involved in cell shape changes, motility and adhesion in the invaginating mesoderm via 
changes in localisation and adherens junction formation within the cells (Oda et al., 
1998). However, while genes encoding homologues of a-catenin, Armadillo and 
classical cadherin in C.elegans, hmp-1, hmp-2 and hmr-1 respectively, are involved in 
cell shape change during morphogenesis, they do not appear to be required for general 
cell adhesion, polarity or the formation of adherens junctions (Costa et al., 1998). 
Mutants of these genes show no gastrulation defects and phenotype is only observed in 
later stages of embryogenesis. These results would seem to suggest that if there are cell 
adhesion processes acting during C.elegans gastrulation to enable the migration of cells, 
then they involve different components to the cadherin-catenin systems seen in other 
species during embryonic development.
5.1.3. Hypodermal enclosure
After gastrulation is completed, hypodermal cells, which arise on the dorsal 
surface of the embryo migrate laterally and eventually meet and fuse at the ventral 
midline, completely encasing the embryo in an outer monolayer of hypodermis (Sulston 
et al., 1983). Hypodermal enclosure and its role in subsequent morphogenetic processes 
mediated by the hypodermis is discussed in detail in section 4.1.2.
5.2. Phenotypic characterisation
ijDf2 was outcrossed four times before phenotypic characterisation was 
attempted and all mutant embryos described are ijDf2 homozygous progeny of an ijDf2 
heterozygote mother. At 20 °C, 100% of ijDf2 homozygotes arrest as unhatched 
embryos with a complete absence of elongation (Figure 5.1a). They have a lumpy shape 
and do not appear to secrete a cuticle which was initially thought to be a possible cause 
of the phenotype seen. However, the phenotype manifests itself much earlier than the 
time of cuticle secretion (see below). No difference was seen in the phenotype at 16° C 
or 25°C (Figure 5.1b,c) and no maternal effect was observed. From time-course 
studies, the embryo develops as normal apparently until just prior to the precomma 
stage of development (Figure 5.2a). Then, as wild type embryos develop to the
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Figure 5.1
DIC images of i)Df2 homozygote terminal arrest phenotypes at 
various different temperatures.
The anterior o f all images is to the left. Arrows point to the buccal cavity 
in all images
a 20°C arrest. The arrowhead indicates the maternal pole cell 
b 16°C arrest, 
c 25°C arrest.
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Figure 5.2
DIC images of ijDJ2 homozygote and wild type embryos during 
development
All embryos are positioned with the anterior to the top o f the image and 
embryos b and c have the dorsal region to the right o f the image. Images b and 
c are wild type embryos and image a is an ijDf2 homozygote which is 
approximately the same age as the wild type embryo in image b.
i Embryos a and b are at the precomma stage o f development while embryo c 
is at the comma stage
ii 60 mins after i. Note the loose cells in mutant embryo a indicated with an 
arrow. Embryo a has not elongated at all while embryo b has progressed to the 
comma stage.
iii 95 mins after i. Embryo b has reached the 1.5-fold stage while embryo a 
still has not begun morphogenesis and the shape o f the mutant embryo has 
become more irregular.
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comma and 1.5-fold stages, ijDf2 mutant embryos begin showing an irregular outline 
with surface cells rounding up and not forming tight boundaries with neighbour cells 
(Figure 5.2b). Wild type embryos then elongate rapidly while the mutant embryos 
develop into a much more amorphous shape without elongating at all (Figure 5.2c). 
Most of the ijDf2 embryos observed showed some rupture or ‘oozing’ of cells into the 
eggshell cavity and they remained flaccid and lumpy until the end of embryogenesis. 
These observations ruled out the absence of a cuticle as the cause of the observed 
phenotype as the initial defect was seen long before the time of normal cuticle secretion.
Very few tissues or structures can be distinguished within the ijDfl mutant 
embryos using DIC microscopy. In most embryos, the central canal of the pharynx can 
be seen running through the anterior midsection of the embryo and occasionally the 
buccal cavity can be seen (Figure 5.1 arrows). However, a recognisably normal 
pharyngeal structure appears to be completely absent. I found it impossible to orientate 
the dorsal and ventral surfaces of the mutants, and was only able to distinguish between 
anterior and posterior by assuming the position of the underdeveloped pharynx was 
towards the anterior and that gut autofluorescence was towards the posterior. The 
mutant embryos show irregular muscle twitching although there are no large scale 
movements.
Because of the lack of information from DIC observations, I used several 
reagents to view different structures and tissues. Terminal markers of muscle, basement 
membrane, muscle-hypodermis attachments as well as several pharyngeal components 
and markers of hypodermal and cuticle development were used to determine aspects of 
the ijDfl phenotype. In a mutant with such an abnormal end phenotype, the terminal 
pattern of marker reagents may be misleading and possibly the more important 
information to be obtained from these markers is the presence or absence of a specific 
expression pattern, tissue, or structure. Antibody staining, or GFP expression, patterns 
would be very informative at the time when the phenotypic defect is first manifested. 
Unfortunately, at the precomma stage of development most of the hypodermal and other 
marker antibodies I used have very faint patterns which are difficult to interpret. Also, 
it is very difficult to detect mutant embryos at an early stage in a mixed slide of wild 
type and mutant embryos after the antibody staining process.
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5.2.1. Hypodermis
MH27 is a monoclonal antibody which recognises a protein component of the 
adherens junctions between the apical surfaces of hypodermal cells and within the 
intestine (Priess and Hirsh, 1986; Waterston, 1988). In ijDf2 mutants the hypodermal 
cell boundaries are completely disorganised compared to wild type embryos (Figure 
5.3a-c). There are clusters of very small cells and larger areas without internal 
boundaries which probably correspond to the seam and P mononucleate cells compared 
to the large multinucleate syncytia of hyp7. In order to examine whether the large blank 
areas were regions lacking hypodermal cells, or whether they were large hypodermal 
syncytia, I co-stained with the anti-LIN-26 polyclonal antibody which recognises LIN- 
26, a nuclear protein present in all hypodermal cells (Labouesse et al., 1996). The co- 
staining indicated that hypodermal cells did cover the surface of ijDf2 homozygotes and 
that both syncytia and mononucleate cells are present (Figure 5.3d). It is difficult to 
determine whether they are in the right positions relative to one another as the embryo is 
so amorphous. There are clusters of mononucleate cells, presumably the lateral seam 
and P cells, although they do not appear to lie in the same positions in each mutant 
although this may be due to stained embryos lying in various different orientations. 
Wild type embryos tend to lie on their lateral sides during elongation as the shape of the 
embryo promotes this orientation. ijDf2 embryos do not have the dorsal bend seen in 
early wild type embryos and so there is no constraint against lying on the dorsal or 
ventral sides. Because the hypodermis is so disorganised and the embryos are orientated 
in different positions, it was difficult to observe the number of mononucleate cells 
present and the numbers of nuclei in the syncytia. There are large syncytia present with 
many nuclei present and smaller cells just with 2 or 3 nuclei. However, the overall 
number of hypodermal cells (multinucleate and mononucleate) was determined for 5 
embryos and appears to be well below the normal number of 4^) possibly indicating 
hyperfusion of cells (Table 5.1).
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Figure 5.3
Hypodermal cell shapes and positions in ijDf2 homozygotes and wild type embryos
Embryos were stained with the monoclonal antibody MH27 to visualise the adherens 
junctions between hypodermal cells (images a-e) and the polyclonal antibody anti-LIN- 
26 to visualise hypodermal cell nuclei (images d and e). wild type embryos are 
positioned with the anterior to the left and the dorsal surface to the top of the image. 
ijDf2 homozygotes are positioned with the anterior either to the right or left although the 
actual orientation could not be determined. DIC images are shown in column i and 
antibody staining of the two lateral sides of the embryo is shown in columns ii and iii.
a ijDf2 homozygote stained with MH27 showing very disorganised hypodermal 
cells.
b wild type embryo at the 1.5-fold stage stained with MH27
c wild type embryo at the 3-fold stage stained with MH27
d ijDfl homozygote stained with MH27 and anti-LIN-26 showing the presence of
mononucleate (arrow) and multinucleate (arrowhead) hypodermal cells 
e wild type embryo at the comma stage stained with MH27 and anti-LIN-26.
Hypodermal cells have not fused into syncytia at this stage.
1
•  •
11
•  •  •  
111
190
Table 5.1
Total number of hypodermal cells in five different ijDf2 homozygote embryos
ijDf2 homozygous embryo Total number of 
hypodermal cells
Comments
A 27 Some cells were much smaller than 
normal seam or P cells
B 31
C 36 Some cells were much smaller than 
normal seam or P cells
D 23
E 30
5.2.2. Cuticle
The expression patterns of two cuticular collagens were visualised by crossing 
the ijDf2 mutant strain into two stains containing an integrated copy of either a col-12 
promoter::GFP (IA022) or a dpy-7 promoter::GFP (IA105) transgene. These collagens, 
dpy-7 and col-12 are two of the structural proteins which form the cuticle and are 
synthesised within hypodermal cells, dpy-7 expression begins in wild type embryos at 
around the comma stage (Johnstone and Barry, 1996). Conversely, col-12 is among the 
last group of collagens to be expressed and normal expression is not seen until after the 
C.elegans embryo has completed elongation. The constructs used were nuclear localised 
for easier examination of the pattern, although the nuclear localisation is much clearer 
with the dpy-7 construct.
ijDf2 homozygotes express both dpy-7 and col-12 collagen::GFP reporter 
transgenes although the col-12 expression pattern is irregular (Figure 5.4). A striking 
difference is that the terminal pattern of the dpy-7 ::G FP reporter construct shows a clear 
pattern of hypodermal cells which does not vary widely between embryos (Figure 5.4a) 
but the co/-72::GFP reporter construct is only present in several areas of each embryo 
and the pattern is not consistent between embryos (Figure 5.4c). The dpy-7 v.GY'? 
reporter construct expression pattern also shows clearly that hypodermal nuclei are 
present over all of the embryo surface. The presence of co/-72::GFP reporter construct 
expression indicates that at least some hypodermal cells have developed to a
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Figure 5.4
Expression of cuticular co!lagen::GFP constructs in the hypodermis of ijDf2 
homozygotes and wild type 3-fold stage embryos
All embryos are positioned with the anterior to the left o f the image. DIC images 
are shown in column i and UV images showing collagen::GFP expression are 
shown in column ii.
a ijD fi homozygote showing the expression o f a dpy-7 ::GFP nuclear localised 
transgene
b wild type 3-fold stage embryo showing dpy-7 ::GFP expression
c ijDf2 homozygote showing the expression o f a nuclear localised col-12:: GFP
transgene
d wild type 3-fold stage embryo showing col-12 ::GFP expression. This 
transgenic line had a very weak expression pattern so the expression shown is 
faint.
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terminal stage with respect to collagen synthesis. However, the localised regions of col- 
12::GFP reporter construct expression are very different to normal and may indicate 
some abnormality in hypodermal function at this time.
The monoclonal antibody DPY7-5a, which recognises the carboxy terminal of 
the cuticular collagen DPY-7 (Chapter 3), was used to test for the presence of a cuticle 
with anti-LIN-26 antibody used as a marker of proper permeabilisation and fixing 
(Figure 5.5). No secreted cuticle was observed in the majority of ijDf2 homozygotes 
although in rare cases there are very small patches of staining at the surface. In wild 
type embryos, intracellular staining of DPY-7 is much fainter than secreted DPY-7 
staining but this did not appear to be present within ijDf2 homozygotes at all. The very 
patchy staining on mutant embryo surfaces is apparently artefactural as it was only seen 
on a small number of specimens, and so it could be concluded that DPY-7 was not 
produced in these mutants which would be surprising as the GFP reporter construct 
shows that dpy-7 is transcribed. Another possibility is that DPY-7 is produced within 
the hypodermal cells but is not secreted normally resulting in subsequent rapid 
degradation of the intracellular collagens and therefore a complete, or near complete, 
absence of DPY7-5a staining. As it is almost impossible to distinguish fixed early ijDf2 
embryos, at the time when DPY-7 should be present intracellularly, from precomma 
stage wild type embryos, it would be very difficult to test whether DPY-7 is indeed 
synthesised within hypodermal cells but not secreted.
5.2.3. Muscle
DM5.6 is a monoclonal antibody which recognises a component of the body 
wall muscle myosin heavy chain- myosin A (Miller et al., 1983; Hresko et al., 1994 and 
Moerman et al., 1996). Clear DM5.6 staining is present in ijD fl mutant embryos and 
the pattern is completely irregular, although there appears to be a general organisation 
into sarcomeres in some ijDfl homozygotes (Figure 5.6). In other ijD fl mutant 
embryos, the bright DM5.6 staining branches throughout the entire embryo. It is 
evident from the pattern, however, that the muscle is positioned internally and so the 
cells have migrated inward at some point during development.
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Figure 5.5
Localisation of a cuticular collagen, DPY-7, in ijDf2 homozygotes and 
wild type 3-fold stage embryos indicating the presence or absence of a 
cuticle
Embryos were stained with the monoclonal DPY7-5a antibody and the 
polyclonal anti-LIN-26 antibody. Only one side view o f the embryos is 
shown. The anterior o f the ijD fl homozygous embryo (on the left) is 
towards the top o f the image and the anterior o f the wild type 3-fold embryo 
(on the right) is facing downwards at the centre o f the image, 
a DIC image
b DPY7-5a staining showing a secreted cuticle on the wild type 3-fold stage 
embryo to the right but shows no staining above background in the ijD fl 
embryo indicating that no DPY-7 protein is present. Faint green spots are the 
bleed through from the anti-LIN-26 nuclei staining.
c anti-LIN-26 staining showing that both embryos are sufficiently fixed and 
permeabilised
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Figure 5.6
Position of muscle sarcomeres in i]Df2 homozygotes and wild type 
embryos
Embryos were stained with the monoclonal antibody DM5.6 to visualise 
myosin A within the muscle sarcomeres. The embryo in column b is 
positioned with the anterior to the left o f the image. The anterior o f the 
embryo in column a is either to the right or left but the actual orientation could 
not be determined. DIC images are shown in row i and DM5.6 staining o f the 
two lateral views o f the embryo muscle sarcomeres is shown in rows ii and iii. 
a ijDf2 homozygote showing very disorganised muscle sarcomeres 
b wild type 3-fold stage embryo showing the wild type position o f the muscle 
sarcomeres
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5.2.4. Muscle-hypodermis attachments and basement membrane
MH4 is a monoclonal antibody which recognises areas of the hypodermis 
(intermediate filaments) which are associated with underlying body wall muscle cells 
and also recognises regions of the pharynx, the excretory cell, and amphid sensory 
neurons (Francis and Waterston, 1991). In ijDf2 mutants, MH4 staining is clearly 
present with a completely irregular staining pattern (Figure 5.7a). Hypodermal and 
pharyngeal staining could be distinguished although both staining patterns were 
completely incomparable to the wild type patterns (Figure 5.7b and Figure 5.9e). 
Hypodermal staining was not organised into bands but was widespread and in some 
cases radiated out from dark patches. It looked threadlike in appearance.
MH3 is a monoclonal antibody which recognises several isoforms of the 
basement membrane component UNC-52, a homologue of perlecan (Francis and 
Waterston, 1991). It is present in the junctions between muscle cells and between 
muscleihypodermis connections. Again, MH3 is present in ijDf2 embryos showing a 
pattern completely divergent to the wild type pattern (Figure. 5.8). Despite the 
disorganised pattern, there seems to be some organisation of muscle into separate 
sarcomeres as in wild type. Perlecan is required in wild type animals for sarcomere 
organisation and attachment of muscle cells (Moerman et al., 1996). MH3 staining 
appears more organised than the MH4 pattern which is surprising as MH3 indicates 
junctions between muscle and hypodermal cells and MH4 is usually present in 
hypodermal cells overlying muscle cells. Because of this the patterns produced by the 
two antibodies should be quite similar. The more organised MH3 pattern may be due to 
muscle:muscle junctions as it follows the DM5.6 staining pattern much more closely. A 
very disorganised MH4 pattern could arise from a completely disorganised hypodermis 
although it has been shown previously that when body muscle cell precursors are 
ablated, the hypodermal cells that would have been in contact with them do not show 
MH4 staining, and so the pattern does seem to be dependent on underlying muscle cells 
(Hresko et al., 1994).
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Figure 5.7 
Association of the hypodermis and underlying muscle in ijDf2 
homozygotes and wild type embryos
Embryos were stained with the monoclonal antibody MH4 which recognises 
intermediate filaments, part o f the hemidesmosomes in hypodermal cells 
overlying the muscle sarcomeres. The embryo in b is positioned with the 
anterior curving down to the bottom centre o f the image and facing right. The 
embryo in a is positioned with the anterior facing either right or left but the 
actual orientation could not be determined. DIC images are shown in row i 
and MH4 staining o f two lateral views is shown in rows ii and iii. 
a ijDf2 homozygote showing a very disorganised pattern o f MH4 staining 
b wild type 3-fold embryo showing the normal organisation o f MH4 in the 
hypodermis. Bands o f hypodermal staining are indicated using arrowheads.
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Figure 5.8
Positions of muscle:muscle and musclerhypodermis junctions in ijDf2 
homozygotes and wild type embryos
Embryos were stained with the monoclonal antibody, MH3, which 
recognises several isoforms o f the protein UNC-52 present in the basement 
membrane between adjacent muscle cells and between muscle cells and the 
hypodermis. In image b the anterior o f the embryo is to the left In image a, 
the anterior o f the embryo is facing towards either the left or the right but the 
actual orientation o f the embryo could not be determined DIG images are 
shown in row i and antibody staining is shown in rows ii and iii 
a ijDf2 homozygote showing a completely disorganised MH3 staining 
pattern
b wild type 3-fold stage embryo showing the normal MH3 pattern
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5.2.5. Pharynx and intestine
The monoclonal antibody 3NB12 was used to detect pharyngeal muscle 
precursors and other structures were visualised by MH27 (adherens junctions) and MH4 
(filaments in marginal cells). Pharyngeal muscle cell precursors were present, but 
showed neither elongation nor differentiation of the pharynx (Figure 5.9a,b). The 
staining was present internally in the mid region of the embryo. Adherens junctions 
could also be seen in this area, although again were distinct from wild type patterns 
(Figure 5.9c,d). As mentioned above, MH4 staining was present but it did not show any 
structures comparable to a wild type pharynx (Figure 5.9e,f). Internal MH4 staining 
was different in nature to the threadlike hypodermal staining seen and was completely 
diffuse. It seemed to be of a more disorganised nature than either 3NB12 or MH27 
staining of the pharynx.
Gut auto fluorescence could be seen in ijDf2 embryos towards the mid posterior 
and adherens junctions were present between intestinal cells indicated by MH27 
staining (Figures 5.9c, 5.10).
5.3. Mapping
ijDf2 was mapped using various different methods. Initially, before I realised 
that the mutation was the result of a deficiency, classical genetic methods were used to 
map this lesion. I also used the PCR-based method involving polymorphisms in the 
genome known as Sequence-Tagged Sites (STS). This enables a gene to be mapped 
finely by carrying out one or two simple crosses and then testing the progeny for the 
presence or absence of these polymorphisms (Williams, 1992 and materials and 
methods section). STS mapping is explained in more detail below.
After several lines of evidence indicated, unexpectedly, that ijDf2 was a 
deficiency, a molecular approach was used to determine the position of the end points 
on the physical map. As has been mentioned, the genome of C.elegans is represented 
by overlapping clones including cosmids which comprise the physical map. In order to 
position a deficiency in the physical map as well as the genetic map, these maps must be 
aligned by equating the genetic map positions of previously cloned genes and the 
physical location of the cosmid sequences they are contained within. I tested for
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Figure 5.9
Pharynx and intestine position and shape in ijDJ2 homozygotes and 3-fold wild 
type embryos.
Embryos were stained with the monoclonal antibodies 3NB12, MH4 and MH27 (see 
text for details). DIC images are in the left column (i) and UV images showing 
antibody staining are shown in the column to the right (ii). In images except b, the 
anterior is towards the left. In image b, the anterior is facing to the right. In all images 
except images a and e, arrowheads denote the four main regions of the pharynx. In 
images a and e, the main regions of the pharynx cannot be distinguished and so an 
arrow indicates the entire pharyngeal structure.
a ijDf2 homozygote
ii 3NB12 staining of the mutant embryo showing the position of pharyngeal muscles 
which indicates a completely underdeveloped and unelongated pharynx, 
b 3-fold wild type embryo
ii 3NB12 staining of the 3-fold embryo showing the normal position of pharyngeal 
muscles.
c ijDf2 homozygote
ii MH27 staining of the mutant embryo showing the position of pharyngeal and 
intestinal adherens junctions which appear to be differentiated into four main regions 
but are still very abnormal and unelongated. The intestine is much shorter than normal, 
d 3-fold wild type embryo
ii MH27 staining of the 3-fold embryo showing the normal position of pharyngeal and 
intestinal adherens junctions. Intestinal adherens junctions are indicated with an arrow, 
e ijDf2 homozygote
ii MH4 staining showing the position of intermediate filaments within the marginal 
cells of the mutant embryo pharynx. These structures appear completely disorganised 
and are not differentiated into a recognisable pharynx, 
f 3-fold wild type embryo
ii MH4 staining of the 3-fold embryo showing the normal position of intermediate 
filaments within the marginal cells of the mutant embryo pharynx.
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Figure 5.10
Position o f the intestine in ijDf2 homozygotes and wild type embryos as 
indicated by gut granule autofluorescence.
DIC images are shown in column i and UV images showing gut 
autofluorescence in column ii. Embryos are positioned with the anterior to 
the left o f the image. An arrow points to the gut autofluorescence in each 
embryo.
a ijDf2 homozygote
The intestine position is towards the posterior in the correct area o f the 
embryo. Autofluoresence appears to be brighter than in the wild type, 
probably because the intestine is restricted to a much smaller space in the 
unelongated mutant.
b wild type 3-fold stage embryo showing the normal position o f the 
intestine.
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the presence or absence of various cosmid sequence markers (CSM) corresponding to 
the region of the deficiency in ijDf2 homozygote embryos. A PCR-based method was 
used with primers specific to a small region of each cosmid sequence, the CSM, using 
sequences from cloned genes where available. The molecular extent of the deficiency 
were mapped in this way. An overlapping deficiency was mapped and characterised in 
a similar manner. This deficiency, sDf30, also results in embryonic arrest when 
homozygous but the embryos have a more elongated terminal phenotype, arresting at 
around the 2-fold stage. From these results, I focused on a region deleted by ijDf2 but 
not sDf30. The deletion of this region is what appears to cause the earlier defect seen in 
ijDf2 homozygotes and is therefore likely to contain a gene or genes involved with 
events prior to, or at the initiation of, elongation.
5.3.1. Chromosomal assignment - classical genetic mapping
A classical genetic cross was first used to map the ijDf2 mutation to a 
chromosome. Males carrying the ijDf2 deficiency were crossed into the triply mutant 
strain MT465 (dpy-5 (e61)l; bli-2(e768)11; unc-32(el89) III). Approximately 50% of 
outcrossed FI animals, heterozygous for each marker gene, carried ijDf2 and this 
transmission of the deficiency via males, which posses only one X chromosome, 
indicated that it was not linked to the X chromosome. F2 Recombinants were picked as 
in section 4.3.1, and scored for the presence or absence of ijDf2 death among the 
progeny (Table 5.2).
Table 5.2
Percentage of F2 recombinant animals from the MT465 mapping cross carrying 
the ijDf2 mutation.
Recombinant
phenotype
carrying ijDf2 
mutation
not carrying 
ijDf2 mutation
Total number of 
recombinants
Percentage
carrying
i/Df2
Unc-non-Dpy-
non-Bli
20 16 36 56
Bli-non-Dpy-
non-Unc
5 3 8 62
Dpy-non-Unc-
non-Bli
12 3 15 80
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If the mutation is unlinked to the marker gene then 2/3 of recombinants will be 
carriers of ijDf2. None of the results above are significantly different from this expected 
ratio, although the numbers of blister recombinants are very small and the result could 
be misleading. There was therefore no evidence for linkage of ijDf2 to chromosomes I, 
II, or III.
5.3.2. Chromosome assignment - STS mapping
Further chromosomal assignment mapping, and finer mapping was done using 
Sequence-Tagged Site (STS) mapping (Williams et al, 1992). The principle of STS 
mapping is that the presence or absence of polymorphisms at specific chromosomal 
locations in different strains can be detected using PCR assays. The polymorphisms are 
therefore being utilised as genetic markers. The strain carrying the mutation to be 
mapped is crossed into a strain carrying multiple STS markers at specific sites and the 
DNA from the outcrossed progeny is scored for their presence or absence. The 
observed ‘phenotype’ in this cross are bands on a gel and so large numbers of mutant 
progeny can be tested from a single cross and the mutant gene finely mapped.
STS mapping in C.elegans utilises copies of the transposable element, Tel 
which is easily identified and is present in a widely different copy number in the two 
major C.elegans strains: Bristol and Bergerac (Williams, 1995). The Bergerac strain 
has around 500 or more copies of Tel while the Bristol strain, the strain used 
universally as the wild type, has only around 30 copies (Brenner, 1974). These cloned 
Tel polymorphisms can used as genetic STS markers as they can be amplified easily 
using PCR with primers specific to each site. Therefore, by performing one cross 
between a Bristol strain (containing the mutation to be mapped) and a Bergerac strain 
(carrying Tel genetic markers present at sites specific to the Bergerac strain), F2 
progeny exhibiting the mutant phenotype under examination can be tested for 
recombination by looking for the presence or absence of the STS markers. If the 
mutation is tightly linked to an STS, it should rarely, or never, recombine with the 
mutant chromosome and so should never be detected in F2 animals homozygous for the 
mutation. The Bergerac strain used most commonly for STS mapping is RW7000 
(Williams, 1992). RW7000 is a mutator strain with active germline Tel transposition 
and because of this spontaneous mutations can occur at a relatively high rate (Moerman
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and Waterston, 1984). A spontaneous lethal mutation may result in dead RW7000 
embryos which will be positive for all STS markers tested (Williams, 1995). This can 
lead to confusing results and must always be kept in mind when mapping lethal 
mutations.
A chromosome carrying ijDf2 was crossed into an RW7000 strain and the 
outcrossed FI hermaphrodites were allowed to self. ijDf2 homozygote embryos 
produced in the F2 generation were picked, lysed and tested for the presence or absence 
of STS markers. I used primers specific to each site and internal to the Tel 
polymorphism to amplify bands of certain sizes which could be determined from a gel 
(see section 2.12)(Williams, 1992). A specimen gel is shown in Figure 5.11b. If the 
mutation is unlinked to a chromosome then the STS marker chosen for that chromosome 
should be present in 75% of arrested embryos because it behaves as a dominant marker. 
The more tightly linked a mutation is to an STS marker, the fewer ijDf2 homozygote 
embryos will carry the marker. The results for the chromosomal assignment PCR are
shown in Table 5.3 and Appendix 5.2a.
From these results it was clear that ijDf2 was linked to Chromosome V and was
probably very close to the bpl marker.
Table 5.3 
STS Chromosomal assignment cross
Chromosome STS marker No. of
embryos with 
marker
Total no. of 
animals tested
Percentage of 
animals with 
marker
I hP4 32 47 68
II maPl 33 47 70
III mgP21 34 47 72
IV sP4 35 47 74
V bPl 1* 47 2
*The number of bPl bands may have been underestimated - see appendix 5.2.
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Figure 5.11
STS mapping of Deficiency ijDf2 on chromosome V.
a Positions of STS markers and several genes on the physical and genetic maps of 
chromosome V (Williams et al., 1992). The physical map is shown on the top with the 
genetic map underneath.
b Representative gel showing positions of STS markers from the right of chromosome 
V. Lanes 1,3,4, and 5 contain DNA from ijDfl homozygote embryos while Lane 2 is a 
control containing DNA from an RW7000 embryo. STS markers are scored as present 
for each embryo if a band of the correct size is present:
Lane 1 - markers stP128, stP6, stP105, stP108 andbPl are present
Lane 2 - control, contains all markers
Lane 3 - markers stP128, stP6, stP105 and stP108 are present
Lane 4 - markers stP128, stP105 and stP 108 are present
Lane 5 - markers stP128 and stP105 are present
c
i Proposed recombination events between the RW7000 chromosome V (top line) and 
the ijDf2 chromosome V (bottom line) which produces the classes A-F:
class A (n=5 mutant embryos), class B (n=15), class C (n=7), class D (n=9), class 
E(n=5) and class F(n=l). This places ijDf2 in a position between stP3 and bPl.
ii Proposed recombination events between the RW7000 chromosome V (top line) and 
the ijDf2 chromosome V (bottom line) in pools of 10 embryos which produces classes 
A-G: class A (n=5 embryo pools), class B (n=3), class C (n=8), class D (n=2), class E 
(n=4), class F (n=2) and class G (n=6). This accounts for more rare recombination 
events and places ijDf2 between stP3 and stP23.
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5.3.3. Fine mapping of ijDf2 - STS mapping
The ijDf2 chromosome was crossed into the RW7000 strain and F2 embryos 
homozygous for ijDf2 were lysed in the same way as for the chromosome assignment 
mapping. I used a set of 9 STS markers from chromosome V to map ijDf2 more finely 
(Figure 5.11a; Williams, 1992). Two groups of markers were tested separately, one 
group corresponding to the left of chromosome V and another group corresponding to 
the right of chromosome V. Results are shown in representative gel, Figure 5.11b, 
Appendices 5.2b-d and Figure 5.11c. From the results I concluded that ijDf2 was tightly 
linked to stP192 and stp23.
5.3.4. Complementation test
I crossed ijDf2 heterozygotes with dpy-ll/+  males in order to map ijDf2 more 
finely and test for complementation with dpy-11. dpy-11 maps to position 0 on 
Chromosome V, very close to stP192 (-0.01±0.11). I found that around 25% of FI 
males and hermaphrodites were dumpy (47/213) which indicated that ijDf2 was either 
allelic to dpy-11 or was a deficiency which deletes dpy-11, the latter proving to be the 
case.
5.3.5. Deficiency end-point mapping
To confirm that ijDf2 was indeed a deficiency, I designed primers specific to a small 
region of the genomic sequence contained in cosmid clones F44C4, which contains 
stP 192 and K04A8 (Figure 5.12a) in order to use a PCR-based approach to test for their 
presence or absence on a gel. I will use the term cosmid sequence marker (CSM) to 
denote this amplified region from the genomic sequence contained within each cosmid 
clone tested. Genomic DNA from wild type and mutant embryos was obtained in the 
same way as for STS mapping (see section 2.12). Both CSMs were present in wild type 
controls but absent in ijDf2 homozygous embryos (Figure 5.12b) and so it was obvious 
that certain sequences are deleted in ijDf2 homozygotes. I had already mapped ijDf2 to 
a region of the genetic map but in order to obtain information about genes deleted by
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Figure 5.12
Physical mapping of ijDf2 using Cosmid Sequence Markers (CSMs)
a Schematic map of the centre of Chromosome V showing the positions of
cosmids used to map deficiency ijDf2 relative to one another on the physical 
map. CSMs K04A8 and F44C4 were the first markers tested and are highlighted 
in red. Two of the STS polymorphisms are shown with their positions on the 
genetic map in map units.
b Gels showing DNA amplified from ijDf2 homozygote and wild type embryos.
Each band represents a CSM from the cosmid named on the gel. Lanes 
containing DNA from ijDf2 homozygote embryos are marked with asterisks, all 
other lanes represent wild type embryos.
The DNA marker used is 50bp ladder (Gibco) and representative bands are marked with 
arrows. The marker bands are all 50bp apart.
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ijDf2 I used this CSM molecular approach to estimate the molecular extent of the 
deficiency. Primers were designed similarly towards other cosmid sequences in this 
region and ijDf2 homozygote embryos were lysed again tested for the presence or 
absence of these CSMs using PCR. All results are shown on Figure 5.12. One of the 
main problems encountered when testing for presence or absence of CSMs was that, 
when the primers were very effective, faint bands could be seen in ijDf2 embryos while 
very bright bands were amplified in N2 embryos. Since control CSMs from different 
chromosomes showed equivalent bands in N2 and ijDf2 homozygote embryos, and 
certain other primer pairs that worked less well came up clearly in N2 and not at all in 
ijDf2 homozygotes, I propose that primer pairs which worked very effectively can 
amplify DNA from pole cells within ijDf2 homozygote embryos. Pole cells are seen in 
terminal arrest ijDf2 embryos (Figure 5.1a) and in wild type embryos at the three fold 
stage and so it is possible that a very sensitive PCR system could detect DNA from 
these cells in mutant embryos. However, there was a clear difference between the faint 
bands amplified from the deficiency homozygotes and the bands from wild type 
embryos, and also between CSMs that were known to be present or absent in the 
deficiency embryos because of data from cloned genes. Positive and negative controls 
were used along with test cosmids for each individual embryo, as the DNA was divided 
among several reactions (see section 2.13). The results showed that ijDf2 comprises a 
large deficiency which deletes around 2.16Mb of the genome. The approximate left end 
point of the deficiency lies between cosmids M03E7 and C35A11 and the approximate 
right end point lies between C12D5 and T05B11. Aligning these end points with the 
genetic map proved to be difficult as there are few cloned genes in this region. The 
right end point is near the polymorphism stP23 which has a position of 0.7 on the 
genetic map. The left end point, however, is not near any cloned genes, but the next 
polymorphism much further to the left, eP74, has a position of -2.46 on the genetic map 
of Chromosome V. An overlapping deficiency was characterised and similarly mapped 
in order to narrow down the deleted region which results in the amorphous, unelongated 
phenotype of ijDf2.
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5.4. Characterisation of an overlapping deficiency, sD/30
5.4 1. Phenotypic characterisation of sDf30
sDflO is a deficiency which is predicted to significantly overlap ijDf2 from 
genetic data (Rosenbluth et al, 1985). The genetic data predict the sDflO endpoints as - 
0.89 and 0.68 (Rosenbluth et al, 1985; ACeDB). The sD/30 deficiency was outcrossed 
from the balanced strain once, and further outcrossed twice before any observations 
were made. I have found that animals homozygous for the sDf30 deficiency arrest as 
embryos with a terminal elongation of 1.5 to 2-fold and all appear to have a large 
indentation at the site of the buccal capsule (Figure 5.13). I carried out a time course of 
the embryonic development of sD/30 homozygotes using Nomarski optics and found 
that development was relatively normal until comma stage and then the mutant embryos 
began to grow at a slower rate and exhibit abnormal morphology. Many elongated to 2- 
fold or over but then slowly regressed to a terminal phenotype of around 1.5-fold. I saw 
no evidence of embryos rupturing or loose cells within the egg which indicates that 
hypodermal cells seem to have enclosed the embryo sufficiently. The regression of the 
homozygote embryos to a 1.5-fold stage may have been due to the secretion of an 
inadequate cuticle. Because of the difference in phenotype between sDf30 and ijDfl, I 
mapped the end points of the sDflO deficiency to narrow down the region deleted by 
ijDfl alone which must contain genes involved in the initiation of elongation or earlier.
5.4.2. Physical Mapping of sD/30 end-points
The end points of the sDflO deficiency were physically mapped using the CSM 
approach in the same way as the ijDf2 deficiency. The presence and absence of the test 
CSMs in sDf30 homozygotes is shown in Figure 5.14. The molecular overlap of the 
two deficiencies is shown in Figure 5.15. It can be seen that sDf30 almost completely 
overlaps ijD fl but there is a region to the right of the ijD fl deficiency which is deleted 
by it alone and possibly also a region to the left of the deficiency between the last two 
CSMs tested. Because ijDfl homozygotes show defects from an earlier stage in 
embryogenesis than sDflO homozygotes, a gene or genes involved in processes prior to,
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Figure 5.13
DIC images of mutants homozygous for deficiencies i]Df2 or sDf30
Both embryos are positioned with the anterior to the left and the embryo in 
image b also has the dorsal surface to the top o f the image.
a ijD fl homozygote which arrests without any elongation, 
b sDflO  homozygote which arrests at around the 2-fold stage o f elongation
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Figure 5.14
Physical mapping of sDf30 using Cosmid Sequence Markers (CSMs)
a Schematic map of the centre of Chromosome V showing the positions of
cosmids used to map deficiency sD/30 relative to one another on the physical 
map. Two of the STS polymorphisms are shown with their positions on the 
genetic map in map units.
b Gels showing DNA amplified from sDf30 and wild type embryos. Each
band represents a CSM from the cosmid named on the gel.
Lanes containing DNA from sDf30 homozygote embryos are marked with 
asterisks, all other lanes represent wild type embryos.
The ladder used is 50bp ladder (Gibco) and representative bands are marked 
with arrows. The marker bands are all 50bp apart.
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Figure 5.15
Comparison of deficiencies ijDf2 and sDf30 in the centre of chromosome V
Representative cloned genes or polymorphisms are shown to indicate the approximate 
position in map units of the deficiencies on the genetic map. There are no cloned genes 
or polymorphisms to the left of gad-1 within the deficiencies, however the left point of 
sDf30 has been quoted as -0.9 from genetic data. The dashed areas of the deficiencies 
are regions between the last deleted cosmid and the first undeleted cosmid. The 
deficiency endpoint lies somewhere within this region.
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or at the beginning of, elongation may therefore be present within these regions of the 
genome. Because the approximate left end points of both deficiencies are relatively 
close, it is possible to use genetic map information from sDf30 to infer an approximate 
map position for ijDf2 also. The left end point of sDf30 is cited as -0.89 (ACeDB) 
which agrees with the left end point of ijDf2 being much further right than eP74 (-2.46).
5.5. Discussion
ijDf2 is a deficiency around 2.2Mb in size, deleting cosmids from between 
C35A11 and M03E7 to the left, to between C12D5 and T05B11 to the right. This 
corresponds to the genetic map of chromosome V from a left end position of 
approximately -0.9 to a right end position of approximately 0.7 map units. Animals 
homozygous for this deficiency arrest as embryos, showing abnormalities as early as 
270 mins post fertilisation, before the precomma stage of development. Very high 
magnification studies of early development were not carried out and so abnormalities in 
cell movements before this time may not have been detected. Although there is no body 
morphogenesis, markers of muscle, basement membranes and hemidesmosomes are 
present. However, the pattern of all of these is very abnormal. The hypodermis is also 
present around the entire embryo with an approximately normal number of nuclei 
although there appears to be a smaller number of hypodermal cells than normal 
indicating possible hyperfusion of cells. The embryos express both dpy-7 and col-12 
collagen::GFP reporter transgenes in the hypodermis which indicates that the 
hypodermis is developmentally mature with respect to collagen synthesis as it is 
executing certain aspects of a terminal fate. The ijDf2 homozygotes do not secrete a 
cuticle incorporating DPY-7, however, and there is no evidence of intracellular DPY-7 
staining. Intestinal and pharyngeal cells are also present but in a very underdeveloped 
form. Most of the embryos show some rupture with loose cells present within the cavity 
between the embryo and the eggshell.
These embryos share several phenotypic aspects with gastrulation defective 
mutants. They show abnormalities prior to the comma stage of development, the gut is 
positioned towards the posterior and the end phenotype is a misshapen ball even though 
many tissues have developed to their terminal stage (Bucher and Seydoux, 1994; Knight 
and Wood, 1998). However, in mutant embryos which fail to gastrulate normally, the
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gut primordia and founder cells of other tissues fail to migrate inwards and instead 
develop at the surface of the embryo, whereas in ijDf2 homozygotes the underdeveloped 
gut and pharynx seem to be positioned towards the centre of the embryo and muscle is 
also present internally. This is an interesting phenotype as there is a complete failure to 
elongate even though the hypodermis is present around the entire embryo and expresses 
collagen genes which are normally expressed at the very end of embryogenesis. The 
organisation of the hypodermal cells is very abnormal, as is the organisation of body 
wall muscle cells and the attachments between the two tissues. A possible explanation 
for the phenotype is that some aspect of cell adhesion has been disrupted which would 
account for the early defects seen at around AVz hours post fertilisation when cells appear 
to be less tightly packed around the edges and resemble a cluster of grapes. 
Hypodermal boundaries are also completely disorganised within the embryo which 
would be another indication of subnormal cell adhesion, but there are multinucleate as 
well as mononucleate cells so hypodermal cell fusion is occurring. In fact, there appear 
to be fewer hypodermal cells than normal which would indicate hyperfusion. As 
previously mentioned, elongation does not normally begin as an active process until the 
comma stage when the hypodermal cells have completely enclosed the embryo which 
could suggest that the phenotype in ijDf2 shows a pre-elongation defect. However, if 
the dorsal hypodermal cells do not interdigitate normally then the embryo will not form 
this characteristic shape and it may be that earlier abnormalities in the positioning or 
interactions between hypodermal cells are preventing ijDf2 mutant embryos from 
elongating. This could result from a possible cell adhesion defect. It is also an 
interesting point that hypodermal cells express cuticular collagen genes that are 
normally produced at the beginning (dpy-7) and end (col-12) of elongation when the 
organisation of these cells relative to one another appears to be so disorganised. 
However, there is no evidence for the presence of these collagens either within cells or 
secreted as a cuticle. It is possible that such a disorganised hypodermis may produce 
collagens intracellularly but be unable to secrete them, leading to their degradation 
within the cells as is thought to happen with unsecreted mutant collagens (see chapter 
3). Because every structure or tissue type seems to be affected to some extent, the 
phenotype does appear to be a general abnormality. A cell adhesion defect would affect 
not only the hypodermis, but any cell type that relies on cell-cell interactions for some 
or all of its development. This would include all the tissues and structures visualised in
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the phenotypic characterisation and could have effects as early as late gastrulation when 
adhesion between cells is an essential precursor to embryogenesis and would disrupt 
processes such as enclosure which relies both on correct termination of gastrulation and 
the adhesion of hypodermal cells migrating around the embryo (Williams-Masson et a l, 
1997; George et a l,  1998).
From comparison with the sDf30 deficiency it is clear that ijDf2 deletes one or 
more genes which when present allow the embryo to elongate to 1.5- or 2-fold. sDf30 
does not seem to show the irregular cell contacts or rupture phenotypes seen in ijDf2 
and so, if a gene involved in cell adhesion is deleted in ijDfl homozygotes, it would 
presumably be present in sDflO homozygotes. As can be seen from Figure. 5.15, sDflO 
is almost completely contained within ijDfl although the left end-points of both 
deficiencies have not been mapped more finely. Both delete M03E7 and do not delete 
C35A11, so there is a region of 200Kb within which the endpoints of both deficiencies 
lie. The right end of ijDfl extends beyond sD/30 to the interval between C12D5 and 
T05B11 (a distance of 37Kb) while sDflO ends between F10G2 and C12D5 (323Kb 
apart). Further endpoint mapping and an attempt at cloning the genes involved in this 
elongation defect was not carried out because of the complexity of the phenotype and 
the lack of any other deficiency overlapping the regions which sDflO did not delete. As 
mentioned above, it is likely that the phenotype seen in ijDfl is due to the deletion of a 
gene or genes involved in a general role in embryogenesis, possibly cell adhesion. 
There may or may not also be another gene deleted which is specifically involved in the 
onset of morphogenesis as the correction of a cell adhesion defect alone may be enough 
to allow elongation to a certain stage. Although normal cell adhesion is vital in the 
process of morphogenesis, a gene controlling general cell adhesion would not be 
specifically involved in elongation and so may not facilitate the understanding of 
elongation as much as other more related genes. Another very important point is that, in 
this region of the genome, there is a large cluster of essential genes and so reducing the 
deleted genes to a subset which are involved in gastrulation, cell adhesion, or 
morphogenesis may be extremely difficult.
The study of deficiencies can uncover relationships between genes that would 
otherwise go unnoticed and may be a more valuable tool than is currently thought, 
although with very large deficiencies, so many genes may be knocked out and the 
phenotype produced may be a combinatorial affect of this large scale knock-out.
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Discovering which deleted genes are responsible for the observed phenotype and which 
are non-essential or give no observed phenotype can be examined by RNAi, for 
example, and may reveal redundancies and pathway similarities previously unknown. If 
more time was available, it is possible that the ijDf2 deficiency could unearth 
developmental genes that are important in the initiation or execution of morphogenesis.
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Chapter 6 
Characterisation of a deficiency, ijD fl
6.1. Introduction
6.1.1. Elongation of the C.elegans embryo
Contraction of the hypodermal actin cytoskeleton is thought to drive the cell 
shape changes involved in the elongation of the C.elegans embryo (Priess and Hirsh, 
1986). Actin microfilaments and microtubules in the hypodermal cytoplasm form a 
meshwork which is not oriented in any direction until ventral enclosure and dorsal 
intercalation are complete or nearing completion (Williams-Masson et al., 1998). 
Microtubules appear to begin aligning circumferentially in the hypodermis at the final 
stages of ventral enclosure and actin microfilament bundles become circumferentially 
oriented shortly after this. Microtubules and actin microfilament bundles are aligned 
parallel in the apical region of the dorsal and ventral hypodermis. However, in the 
lateral hypodermis, microtubules do not become circumferentially oriented but instead 
remain in a complex network throughout the cytoplasm (Priess and Hirsh, 1986). Actin 
microfilament bundles do align circumferentially in the lateral hypodermal cells as well 
as in the dorsal and ventral hypodermis, although the microfilaments in the dorsal and 
ventral hypodermis appear to be closely associated with the plasma membrane while the 
lateral microfilaments are not (Costa et al., 1997). Actin microfilament bundles also 
seem to be anchored to the adherens junctions at either side of the hypodermal cell they 
traverse while microtubules appear to terminate before these junctions (Priess and Hirsh, 
1986; Costa et al., 1998). Studies using actin and microtubule inhibitors, cytochalasin 
D and nocodazole respectively, showed that actin microfilaments are essential for the 
initiation and maintenance of elongation until the embryo is fully elongated and while 
microtubules are not essential for elongation, they are necessary for the normal 
elongation process (Priess and Hirsh, 1986). Embryos that had been treated with a 
microtubule inhibitor continued to elongate but did not elongate fully and developed 
many surface abnormalities. Priess and Hirsh (1986) proposed that the actin 
microfilament bundles were contractile and that their apical contraction caused an 
asymmetrical change in the shape of the hypodermal cells. They suggested that this
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shape change creates pressure on the internal cells of the embryo and ultimately results 
in elongation. The idea that actin microfilaments are contractile is further strengthened 
by observations on mutant embryos homozygous for hmp-1 or hmp-2, which encode 
homologues of a-and (3-catenin respectively, in which the actin microfilaments detach 
from the adherens junctions at either side of the dorsal hypodermal cells (Costa et al., 
1998). The detached actin microfilaments become shorter and thicker indicating that 
they are contractile. The mechanism of actin microfilament bundle contraction has not 
been elucidated although observations of other contractile systems and evidence from 
several elongation defective mutants suggest that there is a myosin component involved 
(Ridley and Hall, 1992; Allen and Walsh, 1994; Wissmann et al., 1997). The change of 
hypodermal cell shape can be seen clearly during elongation using an antibody, MH27, 
which recognises a component of adherens junctions in hypodermal cells (Priess and 
Hirsh, 1986; Waterston, 1988). There is also an obvious pressure exerted on the internal 
cells of the embryo during elongation as seen in mutant embryos which do not enclose 
completely and in embryos which have lesions created in the hypodermis by a laser 
microbeam (Priess and Hirsh, 1986; Costa et al., 1998; Chapter 4). Prior to elongation, 
no cells are exuded from the embryo. However, after the onset of elongation, internal 
cells squeeze through any openings in the hypodermal sheet and the embryos rupture. 
The internal pressure which creates this rupturing, is prevented by treatment with 
cytochalasin D which interferes with actin filaments (Priess and Hirsh, 1986). This 
evidence indicates that the actin microfilaments produce the internal pressure observed.
The microtubules are thought to provide a relatively rigid support to the 
hypodermal cells which helps to distribute the mechanical stresses produced from 
microfilament contraction (Priess and Hirsh, 1986). It can be seen that the 
circumferential margins of the lateral hypodermal cells, which do not possess 
circumferentially oriented microtubules, decrease much more in width than the dorsal 
and ventral hypodermal cells with their microtubule support. Another feature of the 
embryo which is thought to play a part in elongation is the hypodermal sheath. This 
sheath has not been extensively characterised but is an extracellular layer which is 
secreted over the surface of the hypodermis prior to elongation and eventually forms the 
outer cortical layer of the first secreted cuticle at the end of elongation (Priess and Hirsh, 
1986; Costa et al., 1997). When lesions were produced in this sheath during elongation 
using trypsin, embryos ceased elongating normally and developed abnormal
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constrictions on the surface (Priess and Hirsh, 1986). These constrictions are thought to 
be due to microfilament contraction as they didl not develop in the presence of 
cytochalasin D. It is thought that the sheath could play a role in transmitting the 
mechanical stress from microfilament contraction longitudinally across the embryo 
during elongation and thus provide an additional support for the hypodermal cells 
(Priess and Hirsh, 1986).
6.1.2. Pharyngeal development during embryonic elongation
Another structure which undergoes elongation and differentiation during 
embryogenesis is the pharynx which is discussed in more detail in section 1.7.5.5. 
Although it has been shown that the embryo can elongate in the absence of a pharynx, 
pharyngeal and body shape morphological defects often occur together (Schnabel and 
Schnabel, 1990; Mango et al., 1994a; Wissmann et a l , 1997; McKeown et al., 1998). 
The active process of body morphogenesis may also pull the pharynx out into its 
elongated shape and so animals which are defective in elongation may consequently 
have much shorter pharynxes. Conversely, an absent or abnormal pharynx may lead 
indirectly to morphogenetic defects even when hypodermal cells seem normal, as the 
pharynx normally fills the anterior third of the developing embryo (Schnabel and 
Schnabel, 1990).
In this chapter I will describe the characterisation of the ijDfl deficiency which 
has defects primarily in body morphogenesis but also shows abnormal pharyngeal 
development. It was generated as described in section 5.1.1.
6.2. Phenotypic characterisation of ijDfl
A strain heterozygous for the ijDfl deficiency was outcrossed four times before 
phenotypic observations were made. ijDfl heterozygotes are healthy, fertile animals 
and all embryos studied were ijDfl homozygotes segregated from an hermaphrodite 
heterozygous for ijDfl. ijDfl homozygotes are embryonic lethals which arrest at the 
1.5-fold stage of elongation. While this is a very uniform arrest, there are two main 
classes of shape which are commonly seen (Figure 6. la  and b). The percentage of total
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Figure 6.1
DIC images showing terminal arrest phenotypes of ijDfl homozygous mutants
All embryos in a are orientated with the anterior to the left and the dorsal region to the 
top of the page. In b the embryo anterior is facing to the left at the top centre of the 
image and in c and d the anterior is curving around the bottom left of the image with the 
dorsal surface to the top and right.
a ijDfl 1.5-fold homozygotes
i Usual terminal phenotype of ijDfl homozygotes
ii Variations of the usual terminal phenotype showing a mutant with a kinked 
anterior (top) with an arrow pointing to the anterior tip, and a mutant with a 
more uneven outline (bottom) with a very pointed tail indicated with an arrow.
b ijDfl 1.5-fold ‘Long posterior’ homozygote
The buccal cavity is indicated with an arrow, 
c 3-fold wild type embryo
The buccal cavity is indicated with an arrow, 
d ijDfl 1.5-fold homozygote showing the shortened pharynx.
The grinder and the anterior basement membrane are indicated by arrowheads 
but the four main regions can not be seen distinctly. This is typical for most 
ijDfl homozygotes where the pharynx is visible
1
•  •
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ijDfl homozygotes made up by each of these phenotypic variations is shown on Table 
6 . 1 .
Table 6.1 
Phenotypic variations in body shape among ijDfl homozygotes
Phenotype
name
Distinguishing phenotypic features Percentage of total 
ijDfl homozygotes 
(n=291)
1.5-fold 
(Figure 6.1a)
Arrest at 1.5-fold. Relatively smooth 
outline although a proportion have a 
‘kinked’ anterior or a more irregular 
outline with a very pointed tail.
A small number of embryos arrest 
slightly longer, some getting to around 
1.75 fold.
88
Long posterior 
(Figure 6.1b)
Arrests at around 1.5-1.75 fold stage of 
elongation but anterior is very short 
while posterior is much more elongated 
than normal 1.5-fold phenotype and curls 
around the anterior.
12
Both these phenotypes were seen at terminal arrest and subsequent phenotypic 
characterisation showed that all observations and antibody staining patterns were very 
similar for both phenotype classes. Because of this, I will only give detailed 
descriptions of the 1.5-fold embryo phenotype. From DIC microscopy, the buccal 
cavity is seen in some mutant embryos (Figure 6.1b arrow), and a very underdeveloped 
pharynx is also apparent in most embryos which does not appear to pump (Figure 6.Id). 
From time-course observations, ijDfl homozygote embryos appear to reach the comma 
stage of development at an equivalent time to wild type embryos but they then elongate 
very slowly only to 1.5 or 1.75 fold while wild type embryos rapidly elongate to the full 
length in just over 2 hours. There is no evidence of rupture or loose cells within the 
mutant eggshells and so it appears that hypodermal cells have enclosed the embryo 
normally. These embryos show defects only after the active process of elongation has
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been initiated and therefore there is evidence to suggest that genes involved in the active 
process of elongation have been deleted by the ijDfl deficiency. Movement is seen in 
ijDfl homozygotes although it is often ‘jerky’ with the mutant embryos constantly 
twitching. No clear differences in either of the terminal phenotypes of the ijDfl 
homozygotes were observed at 16°C, 20°C or 25°C (Figure 6.2).
In order to examine the mutant embryos in more detail, I used fluorescent 
markers of several tissues and structures including the hypodermis, cuticle, muscle, 
muscle hypodermis attachments, basement membrane, pharynx and intestine.
6.2.1. Hypodermis
Hypodermal cells are joined at their apical junctions by specialised adherens 
junctions and the monoclonal antibody MH27 recognises a protein component of these 
junctions (Priess and Hirsh, 1986; Waterston, 1988). In ijDfl homozygote embryos, the 
MH27 pattern is very similar to the wild type embryo pattern at the same stage of 
elongation (Figure 6.3a,b). Normally large numbers of hypodermal cells fuse in wild 
type embryos between the 1.5-fold stage and the 3-fold stages (Podbilewicz and White 
1994). Some ijDfl homozygous embryos arrest without completing these fusions 
indicating that the hypodermis has not reached its terminal stage of development (Figure 
6.3a, arrow).
Observations of the pattern of the hypodermal nuclear protein, LIN-26 using the 
anti-LIN-26 polyclonal antibody, indicate that there are an approximately wid type 
number and position of hypodermal nuclei in ijDfl homozygotes (Labouesse et al., 
1996). Co-staining with anti-LIN-26 polyclonal, and MH27 monoclonal antibodies 
shows that the mutant hypodermal nuclei appear to be in relatively wild type positions, 
and this can be shown most clearly by comparisons with a wild type embryo at the 1.5- 
fold stage of elongation (Figure 6.4).
6.2.2. Cuticle
Cuticular collagens that are synthesised by hypodermal cells are expressed in 
temporally distinct waves throughout elongation starting with the expression of dpy-7 at 
the comma stage of development and ending with the expression of col-12 after
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Figure 6.2
DIC images showing terminal arrest phenotypes of ijDfl 
homozygotes at various temperatures
a 16°C 
b 20°C 
c 25°C
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Figure 6.3
Hypodermal cell shapes and positions in ijDfl mutant embryos and wild 
type embryos
Embryos were stained with the monoclonal antibody MH27 to visualise the 
adherens junctions between hypodermal cells. In all images, the anterior is to 
the left and the dorsal region is to the top. DIC images are shown in column i. 
A seam cell is indicated with an arrowhead in image ii of all embryos, 
a ijD fl homozygote
ii and iii MH27 staining showing lateral views o f the hypodermis. The 
hypodermal cells appear to be o f approximately wild type shape and position 
although they are not as elongated as a wild type 3-fold embryo and fewer 
hypodermal fusions have occurred in the dorsal region o f the embryo as shown 
by extra hypodermal cell boundaries (indicated with an arrow in images aii 
and bii).
b 1.5-fold wild type embryo
ii and iii MH27 staining showing lateral views o f the hypodermis 
c 3-fold wild type embryo
ii and iii MH27 staining showing lateral views o f the hypodermis
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1Figure 6.4
Position of hypodermal nuclei in ijD fl mutant embryos and 1.5-fold wild 
type embryos
Embryos were stained with the monoclonal antibody MH27 and the polyclonal 
antibody anti-LIN-26 which recognise hypodermal cell boundaries and 
hypodermal nuclei respectively. Column i shows DIC images and column ii 
shows MH27 and anti-LIN-26 staining. All embryos are positioned with the 
anterior to the left and the dorsal region to the top o f the page.
a ijD fl homozygote showing that the seam cells are mononucleate as expected 
(one is indicated by an arrowhead) and that dorsal hypodermal cells are mostly 
multinucleate syncytia (indicated by an arrow). Hypodermal nuclei seem to be 
in approximately wild type positions.
b 1.5-fold stage wild type embryos showing the normal positions o f the 
hypodermal cells and nuclei. A mononucleate seam cell is indicated with an 
arrowhead and a multinucleate dorsal hypodermal cell with an arrow as in a.
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elongation has been completed (Johnstone and Barry, 1996). Because of this, the 
expression patterns of constructs consisting of collagen promoters fused to GFP within 
mutant embryos provide temporal markers of the stage of hypodermal development with 
respect to cuticle synthesis. ijDfl homozygotes express both dpy-7 and co/-72::GFP 
reporter constructs (Figure 6.5a,c). The intensity of col-12::GFP transgene expression 
in ijDfl is equivalent to the transgene expression in wild type embryos although the 
expression pattern did not appear as uniform as wild type. The expression of this 
transgene was very faint in wild type as well as ijDfl homozygote embryos in all lines 
obtained from injecting the pMW0003 col-12::GFP construct (Figure 6.5d). Because 
col-12 is expressed after elongation and just prior to cuticle secretion and hatching in 
wild type embryos, the expression of the col-12::GFP transgene in ijDfl homozygote 
embryos suggests that hypodermal cells have reached the terminal stage of development 
regarding the synthesis of cuticular collagens (Johnstone and Barry, 1996).
To determine whether ijDfl homozygote embryos actually secreted a cuticle, I 
used a monoclonal antibody, DPY7-5a, described in chapter 3, which recognises the 
carboxy terminus of the DPY-7 cuticular collagen. A cuticle is clearly secreted in ijDfl 
embryos and it has the same pattern as secreted wild type cuticle seen in embryos at the 
end of elongation (Figure 6.5e,f). The circumferentially orientated furrows, or annulae 
of the cuticle are much closer together than wild type which would be expected from an 
unelongated embryo, and this makes the antibody appear much brighter in mutants than 
in wild type. Costa et al., 1997 suggest that the pattern of the annulae, or furrows, seen 
in the cuticle coincides with the pattern of actin filament bundles in the underlying 
hypodermis. The presence of these parallel furrows in ijDfl homozygotes, albeit much 
more closely packed together than in elongated wild type embryos, suggests that at 
some stage during embryogenesis, actin fibres in the hypodermis of these mutant 
embryos become circumferentially orientated as in normally elongating embryos prior 
to elongation.
6.2.3. Muscle
Myosin A is a component of body wall muscle which is recognised by the 
monoclonal antibody DM5.6 (Miller et a l, 1983; Hresko et a l, 1994; Moerman et a l, 
1996). The overall pattern of DM5.6 staining in ijDfl homozygotes is the same as wild
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Figure 6.5
Expression of cuticular collagen:: GFP constructs in the hypodermis and 
localisation of the cuticular collagen, DPY-7, in ijDfl homozygotes and wild type 
embryos
Column i shows DIC images while column ii shows UV images of collagen: :GFP 
transgene expression (a-d) or DPY7-5a antibody staining (e, f). The monoclonal 
antibody, DPY7-5a, recognises the cuticular collagen DPY-7. In all images, except 
image f, the anterior of the embryos is to the left and in images a, c and e the dorsal 
region of the embryos is towards the top of the page, 
a ijDfl homozygote
ii dpy-7v.GFP transgene expression in the mutant embryo.
This shows that the transgene is clearly expressed in the mutant embryo 
although mutant embryos at the terminal phenotype often showed a diffuse 
transgene expression in the hypodermis. 
b 3-fold wild type embryo
ii Normal pattern of the dpy-7::G FP nuclear localised transgene expression in the 
3-fold wild type embryo 
c ijDfl homozygote
ii col-12\:GFV nuclear localised transgene expression in the mutant embryo.
The expression of this particular col-12 GFP transgene in the lines observed was 
faint in mutant and wild type embryos. It can be seen that the col-12: :GFF 
transgene is expressed in mutant embryos 
d 3-fold wild type embryo
ii Normal pattern of the col-12: :GFF nuclear localised transgene expression in 
the 3-fold wild type embryo although this was very faint in the lines observed, 
e ijDfl homozygote
ii Staining pattern of the monoclonal antibody, DPY7-5a in the mutant which 
shows an extracellular localisation indicating that a cuticle has been secreted, 
f 3-fold wild type embryo
ii Normal extracellular localisation of the DPY7-5a antibody in a 3-fold wild 
type embryo showing a secreted cuticle
HnfiHSotIssotI
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type embryos showing four regions of sarcomere staining in parallel rows (Figure 6.6). 
However, the fine structure of these sarcomeres seems to be slightly more disorganised 
in ijDfl mutants compared to wild type embryos, appearing more branched and diffuse 
(Figure 6.6a). This may reflect a real difference of muscle organisation in ijDfl mutants 
or it may be a result of abnormalities in other associated tissues. It is also possible that 
the unelongated phenotype of ijDfl embryos results in slight changes in the pattern of 
these tissues as they are present in a much shorter space than normal.
6.2.4. Muscle-hypodermis attachments and basement membrane
UNC-52 is a component of the basement membrane between the hypodermis 
and body wall muscle (Rogalski et al. ,1993). It is a homologue of perlecan and 
functions to organise muscle sarcomeres and anchor myofilaments to the cuticle through 
the hypodermal cells (Moerman et al., 1996). Several of the isoforms of this protein are 
recognised by the monoclonal antibody MH3 which indicates both muscleihypodermis 
and muscle:muscle boundaries(Francis and Waterston, 1991). The MH3 pattern in ijDfl 
homozygotes is organised essentially as wild type (Figure 6.7).
Hemidesmosomes are regions of the hypodermis associated with the attachment 
of underlying body wall muscle. A component of hemidesmosomes, the intermediate 
filaments, are recognised by a monoclonal antibody, MH4, which also recognises 
regions of the pharynx, the excretory cell, and amphid sensory neurons (Francis and 
Waterston, 1991). In ijDfl homozygote embryos, there is MH4 staining in the pharynx, 
excretory cell, and amphid sensory neurons but no staining at all apparent in the 
hypodermis (Figures 6.8 and 6.9e). It has been found that hypodermal cells under 
which the body wall muscle has been ablated do not show MH4 staining (Hresko et al., 
1994). However, in ijDfl homozygotes there is both muscle staining and staining of the 
basement membrane at muscle:muscle, and/or muscle:hypodermal junctions. Muscle 
attachment is normally mediated by a region of the basement membrane and the 
hemidesmosomes (Hresko et al., 1994). It is possible that a component of the 
intermediate filaments in the hypodermis recognised by MH4 is encoded by a gene 
which is deleted by ijDfl.
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Figure 6.6
Position of muscle sarcomeres in ijD fl mutants and wild type 
embryos
Embryos were stained with the monoclonal antibody DM5.6 to visualise 
myosin A within the muscle sarcomeres. In both images, the anterior is to 
the left and in image a the dorsal region is to the top o f the image. DIC 
images are shown in row i. 
a ijD fl homozygous mutant
ii and iii DM5 .6 staining showing different views of the mutant 
embryo muscle sarcomeres. Sarcomeres appear to be organised in 
an approximately wild type manner, 
b 3-fold wild type embryo
ii and iii DM5.6 staining o f the 3-fold embryo showing two views 
o f the normal positions o f the muscle sarcomeres.
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Figure 6.7
Positions of muscle:muscle and muscle:hypodermis junctions in ijD fl 
homozygous mutants and wild type embryos
Embryos were stained with the monoclonal antibody MH3 which recognises 
several isoforms o f the protein UNC-52 present in the basement membrane 
between adjacent muscle cells and muscle:hypodermal cells. In all images 
the anterior is to the left and the dorsal region is to the top and right DIC 
images are shown in row i. 
a ijD fl homozygous mutant
ii and iii MH3 staining pattern at the two sides o f  the mutant 
embryo MH3 staining is equivalent to the wild type pattern, 
b 3-fold wild type embryo
ii and iii Normal MH3 staining pattern at two sides o f the 
wild type embryo.
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Figure 6.8
Association of the hypodermis and underlying muscle in ijD fl 
mutants and wild type embryos
Embryos were stained with the monoclonal antibody MH4 which 
recognises intermediate filaments, part o f the hemidesmosomes, present 
in hypodermal cells overlying muscle sarcomeres. Bands o f MH4 
staining are denoted with arrowheads on image bii. The ijD fl embryo in 
a is positioned with the anterior to the left o f the image and the dorsal 
region to top o f the image. The wild type embryo in b is positioned with 
the anterior towards the bottom centre o f the image. MH4 also stains 
regions o f the pharynx which can be seen on a more internal focal plane. 
DIC images are shown in column i. 
a unhatched w4 mutant
ii and iii MH4 staining showing the absence o f intermediate 
filaments in the hypodermis o f the mutant embryo. MH4 staining o f 
a sensory neuron can be seen and is indicated with an arrow, 
b 3-fold wild type embryo
i and ii MH4 staining showing normal hemidesmosome positions 
at one side o f the wild type embryo.
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6.2.5. Pharynx and intestine
The pharynx is a structure made up of many cell types including muscle, 
epithelial and nerve cells. The main regions of the wild type pharynx are shown in 
Figure 1.4c. In order to examine the pharynx, I used the monoclonal antibodies, 
3NB12, which recognises pharyngeal muscle precursor cells, MH27, which recognises 
adherens junctions within the pharynx and intestine, and MH4, which recognises 
intermediate filaments in pharyngeal epithelial cells in regions adjacent to pharyngeal 
muscle cells (Priess and Hirsh, 1986; Waterston, 1988; Francis and Waterston, 1991; 
Hresko et al., 1994; Mango et a l, 1994a). The pharynx of ijDfl embryos has not 
elongated to the terminal pharyngeal length, possibly as a result of the much shortened 
body, and staining of some cell types that make up the pharynx indicate that it is 
underdeveloped (Figure 6.9a,c,e). The 3NB12 pattern appears shorter and less 
differentiated than a wild type pharynx at the 3-fold stage of development which 
indicates that the pharyngeal muscles are more underdeveloped than in the fully 
elongated wild type embryo (Figure 6.9a,b). The MH27 staining pattern also shows the 
pharynx to be shorter than a 3-fold stage embryo but otherwise appears to show 
differentiation into the four main regions (Figure 6.9c,d). The MH4 staining pattern 
looks shorter and possibly less differentiated than in a 3-fold stage embryo (Figure 
6.9e,f). It is possible that the apparent defects seen in these different pharyngeal tissue 
groups is due mostly to the unelongated body of the mutant embryos causing the 
pharynx to occupy a much shorter space and therefore appear abnormal.
Gut autofluorescence is present approximately in the correct position and is 
equivalent to a wild type embryo at the same stage of elongation (Figure 6.10). From 
MH27 staining, intestinal adherens junctions also appear to be intact and in 
approximately the correct position. Compared to wild type embryos, they are possibly 
closer to the pattern of fully elongated embryos rather than 1.5-fold elongated wild type 
embryos (Figure 6.9g-l). This may suggest that unlike the pharynx, the intestine has 
reached a further stage of development possibly even developing to completion.
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Figure 6.9
Pharynx and intestine position and shape in ijDfl homozygote mutants and 3-fold 
wild type embryos.
Embryos were stained with the monoclonal antibodies 3NB12, MH4 and MH27 (see 
text for details). DIC images are in the left column (i) and UV images showing 
antibody staining are shown in the column to the right (ii). In all images except image f 
the anterior is towards the left and in images of mutant embryos (a, c, and e) the dorsal 
region is to the top. In image f  the anterior is curving down to the bottom centre of the 
image pointing to the right. In all images, arrowheads denote the four main regions of 
the pharynx.
a ijDfl homozygote mutant
ii 3NB12 staining of the mutant embryo showing the position of pharyngeal 
muscles which appears to show less differentiation and elongation of the 
pharynx compared to wild type, 
b 3-fold wild type embryo
ii 3NB12 staining of the 3-fold embryo showing the normal position of 
pharyngeal muscles, 
c ijDfl homozygote mutant
ii MH27 staining of the mutant embryo showing the position of pharyngeal and 
intestinal adherens junctions which appears differentiated as wild type but shows 
much shorter structures, 
d 3-fold wild type embryo
ii MH27 staining of the 3-fold embryo showing the normal position of 
pharyngeal and intestinal adherens junctions, 
e ijDfl homozygote mutant
ii MH4 staining showing the position of intermediate filaments within the 
marginal cells of the mutant embryo pharynx. These structures appear possibly 
less developed than in the wild type and are not as elongated, 
f 3-fold wild type embryo
ii MH4 staining of the 3-fold embryo showing the normal position of 
intermediate filaments within the marginal cells of the mutant embryo pharynx.
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Figure 6.10
Position of the intestine in ijDfl homozygote mutants and wild type 
embryos as indicated by gut granule autofluorescence
DIC images are shown in column i and UV images showing gut 
autofluorescence in column ii Embryos in all images are shown with the 
anterior to the left and the dorsal region to the top and right o f the image. An 
arrow points to the gut autofluorescence in each embryo 
a ijD fl homozygote mutant embryo
The gut autofluorescence appears as wild type. It appears slightly brighter than 
a 3-fold wild type embryo which is probably due to the shortened overall body 
length.
b 1 5-fold stage wild type embryo 
c 3-fold stage wild type embryo
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6.3. Mapping
I mapped ijDfl using a mixture of classical genetic crosses, the sequence-tagged 
site (STS) PCR-based method explained in section 5.3.2, complementation tests, and the 
cosmid sequence marker (CSM) method explained in section 5.3.5.
6.3.1. Chromosomal assignment
Hermaphrodites heterozygous for the ijDfl deficiency were crossed with wild 
type males and the resulting FI males were crossed into several mapping strains. The 
F2 outcrossed hermaphrodites never contained ijDfl and since it could not be 
transferred through males, I deduced that the mutation was most likely linked to the X 
chromosome. Males contain only one X chromosome whereas hermaphrodites have 
two, therefore a male carrying an embryonic lethal allele on the X chromosome will 
arrest as an embryo.
6.3.2. Fine mapping of ijDfl - STS mapping
The principles of STS mapping are explained in section 5.3.2. The same 
Bergerac strain, RW7000, containing Tel markers at specific sites (the STS markers), 
was used in the crosses, although the initial crosses had to be carried out in a different 
way as the mutation was linked to the X chromosome. Firstly, RW7000 hermaphrodites 
were crossed with wild type males and the resulting FI males, all carrying the maternal 
RW7000 X chromosome, were crossed into hermaphrodites heterozygous for ijDfl. 
The outcrossed hermaphrodites from this cross, all carried one RW7000 X chromosome 
and 50% of them carried the ijDfl deficiency X chromosome. These hermaphrodites 
were allowed to self and the resulting ijDfl homozygous embryos were lysed and tested 
for the presence or absence of the STS markers using PCR. I used 6 STS markers from 
the X chromosome to map ijDfl (Figure 6.11a, Appendix 6.2; Williams et al., 1992). 
A representative gel showing the marker bands is shown in Figure 6.11b and the full 
results are given in Appendix 6.2 and Figure 6.1 lc. The results showed that ijDfl lies to 
the far right of the X chromosome, to the right of stP72. As explained in section 5.3.2,
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Figure 6.11
STS mapping of Deficiency ijDfl on the X chromosome.
a Positions of STS markers and several genes on the physical and genetic maps of the 
X chromosome (Williams et al., 1992). The physical map is shown on the top and 
genetic map underneath.
b Representative gel showing positions of STS markers from the right of chromosome 
V. Lanes 1-15 contain DNA from ijDfl homozygote embryos except Lane 7 which is a 
control containing DNA from an RW7000 embryo. Lanes 9-11 and Lane 14 are either 
failed reactions or contain none of the STS markers. STS markers are scored as present 
for each embryo if a band of the correct size is present:
Lane 1 - markers stP33, stP40, stP41 and stP129 are present
Lane 2 - markers stP33, stP40 and stP41 are present
Lane 3 - markers stP40, stP41, stP129 and stP72 are present
Lane 4 - markers stP40 and stP41 are present
Lane 5 - markers stP40 and stP41 are present
Lane 6 - markers stP40 and stP41 are present
Lane 7 - control, all markers are present
Lane 8 - markers stP33, stP40, stP41, stP129 and stP72 are present 
Lane 12 - markers stP33, stP40 and stP41 are present 
Lane 13 - markers stP40 and stP41 are present 
Lane 15 - markers stP33, stP40 and stP41 are present
c Proposed recombination events between the RW7000 X chromosome (top line) and 
the ijDfl X chromosome (bottom line) which produces the classes A-E: 
class A (n=30 mutant embryos), class B (n=45), class C (n=28), class D (n=17) and 
class E(n=4). This places ijDfl in a position to the right of stP72 as shown on the 
bottom chromosome.
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spontaneous lethal mutations may result from Tel insertion in the RW7000 strain 
leading to arrested embryos testing positive for all STS markers (Williams, 1995).
6.3.4. Complementation tests
ijDfl was crossed into strains carrying marker genes in this region of the X 
chromosome in order to map the mutation more finely. Crossing with a strain carrying 
lin-15(n309) at position 22.30 on X and separately with a strain, SP219 carrying unc- 
3(el51) at 18.56 on X gave non-complementation. Hermaphrodites homozygous for the 
recessive temperature-sensitive allele, lin-15 show a multivulva (Muv) phenotype and 
hemizygous males can only mate at the permissive temperature of 15°C. After mating 
had occurred at 15°C between males hemizygous for lin-15 and hermaphrodites 
heterozygous for ijD fl, the worms were moved to 25°C and I observed that around 50% 
of FI hermaphrodites showed the Muv phenotype. 14 Muv and 14 non-Muv FIs were 
left to self separately at 25°C and while all the Muv hermaphrodites carried ijD fl, none 
of the non-Muv hermaphrodites did. Similarly, I crossed males hemizygous for unc- 
3(el51), and carrying the mnDpl duplication (X;V) which covers unc-3 to allow 
mating, with hermaphrodites heterozygous for ijDfl. Around 25% of FI 
hermaphrodites were Unc as 50% of all FIs would be carrying the mnDpl duplication, 
and after cloning out 15 Unc and non-Unc FIs it was found that all the Unc FIs carried 
ijDfl while none of the non-Unc FIs did. It was concluded that ijDfl must be a 
deficiency which deletes both unc-3 and lin-15 and the region between these genes.
6.3.5. Deficiency physical end-point mapping
In order to investigate the extent of the deficiency, I tested ijDfl homozygote 
genomic DNA for the presence or absence of cosmid sequence markers (CSMs) from 
this region of the X chromosome. As before, primers were designed specific to a region 
of the genomic sequence contained in each cosmid clone tested and the presence or 
absence of a particular band on a gel indicated if the cosmid sequence had been deleted 
or not. I had the same problem as that mentioned in section 5.3.5 when executing this 
method. Several primer pairs worked very effectively on wild type embryos and gave 
much fainter bands within ijDfl homozygote embryos. This was seen with several
237
CSMs corresponding to the region close to and between the genes unc-3 and lin-15 
which were already known to be deleted in ijDfl from the complementation tests. As 
mentioned in section 5.3.5,1 propose that primer pairs that worked very effectively can 
amplify DNA from polar bodies within ijDfl homozygote embryos which can be seen 
clearly at terminal arrest (Figure 6.13a, arrowhead). It was difficult to get PCR 
conditions optimum for each primer set so that bands were seen from zygotic genomic 
DNA only. However, each PCR was repeated at least four times and the end point 
results obtained were reproducible. Results are shown in Figure 6.12. The end point 
mapping showed that the ijDfl deficiency deletes around 1.6Mb, stretching from 
between cosmids F54E4 to F42D1 (around 125Kb apart) on the left to between cosmids 
F52E10 and C11G6 (around 34Kb apart) on the right. These approximate end points 
correspond to a region of the genetic map between position 18 and 23.5 on the X 
chromosome, a distance of approximately 5.5 map units.
6.4. Characterisation of overlapping deficiencies, mnDfl 7 and mnDf43
This region of the genetic map is well characterised and there are many 
deficiencies which have been genetically mapped using information about genes which 
they do or do not delete. Several of these deficiencies overlap ijDfl and after 
preliminary characterisation of their phenotypes, two were selected with a view to 
identifying a region of the genome deleted by ijDfl which is involved in the elongation 
process.
6.4.1. Phenotypic characterisation of mnDfl 7 and mnDf43
These deficiencies, mnDfl 7 and mnDf43 appeared to overlap ijDfl significantly 
using the genetic data available (Meneely and Herman, 1981; ACeDB). Embryos 
homozygous for mnDfl 7 arrest at an equivalent stage of elongation to ijDfl 
homozygotes with quite a similar phenotype (Figure 6.13b). In contrast, embryos 
homozygous for mnDf43 appear to elongate much further, to originally around 2.5 fold, 
but they retract to just over 2-fold and there are loose cells and areas of rupture within 
the eggshell (Figure.6.13c). These embryos have a more elongated pharynx than the 
ijDfl pharynx which also appears possibly more differentiated from DIC microscopy.
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Figure 6.12
Physical mapping o f the ijDfl deficiency using Cosmid Sequence Markers (CSMs)
a Schematic diagram representing the mapped region of the X chromosome
showing the positions of cosmids from the region of the deficiency relative to 
one another and corresponding cloned genes with their positions on the genetic 
map (where known) in map units. Cosmids used in ijDfl mapping are shown in 
green.
b Gels showing the presence or absence of each CSM used in mapping. Lanes
containing DNA amplified from ijDfl homozygote embryos are marked with an 
asterisk, all other lanes contain DNA from wild type embryos.
The DNA marker used was 50bp ladder (Gibco) and a representative marker band is
noted in each gel picture. Each of the bands is 50bp apart.
ae lt-3 d e l-l imc-3 imc-7 lin-15 let-2
18.56 20.36 22.30 23.77
b
E03G2
F52E10F54E4
F10G12T10B10
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Figure 6.13
DIC images of the arrest phenotypes of mutants homozygous for 
deficiencies ijDfl, m nD fl 7 or mnDf43
All embryos are positioned with the anterior to the left and dorsal regions to the 
top o f the image.
a ijD fl homozygote which arrests at the 1.5-fold stage. An arrow indicates the 
position o f the maternal pole cell.
b m nD fl 7 homozygote which arrests at around the 1.5- to 1.75-fold stage 
c mnDf43 homozygote which arrests at just over the 2-fold stage. An arrow 
points to loose cells floating outside the embryo within the eggshell.
240
The rupture could be caused by abnormal enclosure of the hypodermis, abnormal 
hypodermal cell junctions or the secretion of an abnormal cuticle which has weak areas. 
This would result in tissue bursting through the regions with abnormal hypodermal 
coverage or cuticle and a retraction of embryo length. Because both of these 
deficiencies overlap ijD fl, it seems possible that the same deleted region is responsible 
for the severe elongation defect seen in ijDfl and mnDfl 7 embryos. This region would 
not be deleted by mnDf43 allowing embryos homozygous for this deficiency to elongate 
much further, although mnDf43 appears to also delete a gene involved in either 
enclosure of the embryo or cuticle secretion which may or may not be deleted in 
mnDfl 7 and ijDfl. mnDf43 appears to have a better developed pharynx than mnDfl 7 or 
ijDfl although this may be due to the increased length of mnDf43 homozygotes. The 
important aspect of the mnDf43 phenotype is that embryos homozygous for the 
deficiency can elongate significantly over 2-fold even if they subsequently rupture or 
retract, while in mnDfl 7 and ijD fl, the embryos never elongate past 1.5- to 1.75-fold. 
Because ijDfl and mnDfl 7 homozygote embryos arrest at an equivalent stage of 
elongation while mnDf43 homozygotes have the ability to elongate past 2-fold, it is 
likely that there is a gene or genes involved in elongation deleted by both ijDfl and 
mnDfl 7 but not by mnDf43. In order to locate the region of the genome where this gene 
or genes could lie, I mapped the end points of these deficiencies on the physical map 
using the CSM method as before.
6.4.2. Physical mapping of m nD fl 7 and mnDf43 endpoints
Available genetic map data for mnDfl 7 and mnDf43 from complementation tests 
with strains carrying point mutations in cloned genes, indicate that mnDfl 7 extends 
from around 15.44 to 22.48 on X and mnDf43 extends from 15.44 to 21.53 on X 
(ACeDB). Both deficiencies delete let-4 (17.44) and not unc-84 (13.44) to the left, but 
their left end-points have not been further defined. The right end points on the genetic 
map are between let-10 (22.46) and let-14 (22.49) for mnDfl 7, and between exc-1 
(21.24) and dyn-1 (21.39) for mnDf43. In order to compare the molecular extent of 
these deficiencies with ijD fl, I had to physically map them using the same method. The 
presence or absence of the CSMs used to physically map these deficiencies is shown in 
Figures 6.14 and 6.15. From this end point mapping, it became clear that there was a
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Figure 6.14
Physical mapping of the mnDfl 7 deficiency using Cosmid Sequence Markers
(CSMs)
a Schematic representation of the region of the X chromosome to which the
deficiency maps. Positions of cosmids relative to one another on the physical 
map are shown above and cloned genes from the genetic map are shown below 
the chromosome line with their approximate positions (where known) in map 
units. Cosmids highlighted in green are those used in the end-point mapping of 
mnDfl 7.
b Gels showing the presence or absence of CSMs used to map mnDfl 7 in mutant
and wild type embryos. Lanes containing DNA amplified from mnDfl 7 
homozygote embryos are denoted with an asterisk and all other lanes contain 
DNA from wild type embryos.
The marker used was 50bp ladder (Gibco) and a representative marker band is indicated
in each gel picture. Each of the bands is 50bp apart.
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Figure 6.15
Physical mapping of the mnDf43 deficiency using Cosmid Sequence Markers
(CSMs)
a Schematic representation of the region of the X chromosome to which the
deficiency maps. Positions of cosmids relative to one another on the physical 
map are shown above and cloned genes from the genetic map are shown below 
the chromosome line with their approximate positions (where known) in map 
units. Cosmids highlighted in green are those used in the end-point mapping of 
mnDf43.
b Gels showing the presence or absence of CSMs used to map mnDf43 in mutant
and wild type embryos. Lanes containing DNA amplified from mnDf43 
homozygote embryos are denoted with an asterisk and all other lanes contain 
DNA from wild type embryos.
The marker used was 50bp ladder (Gibco) and a representative marker band is indicated
in each gel picture. Each of the bands is 50bp apart.
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possible region deleted by ijDfl which is also deleted by mnDfl 7 and not mnDf43 
between the CSMs for F39D8 and ZK662 and this is supported by the genetic data. The 
molecular overlaps of all three deficiencies are shown in Figure 6.16. mnDf43, which is 
around 1.8Mb in length, deletes an area further left than m nD fl7 (1.4Mb long) or ijDfl. 
This region may contain the gene or genes, which when deleted result in the rupture 
seen in many mnDf43 homozygotes. To the right of the deficiencies, mnDf43 and 
mnDfl7 delete the F39D8 CSM and not the ZK662 CSM while both CSMs are deleted 
in ijDfl. This area is indicated by arrows in Figure 6.16. The genetic data shown above 
indicates that mnDfl 7 extends further right in this region than mnDf43 and so this is an 
ideal region in which to search for the gene or genes which when deleted result in the 
1.5-fold arrest, but when present allow elongation past 2-fold. The next step was to 
attempt to rescue the early elongation defect seen in ijDfl by injecting genomic DNA 
from this region and clone the gene or genes involved.
6.5. Cosmid rescue of the early elongation defect in ijDfl
Overlapping cosmid, lambda and yeast artificial chromosome (YAC) clones are 
represented in the C.elegans physical map and cover the entire genome, with the 
exception of a few very small gaps (The C.elegans sequencing Consortium, 1998). The 
X chromosome has excellent alignment between the genetic and physical maps due to 
the high proportion of cloned genes and the alignment is increasing further as more 
genes are investigated. The ability of injected DNA molecules to recombine and form 
heritable extrachromosomal transgenic arrays within C.elegans hermaphrodites 
constitutes a valuable tool which enables the study of mutations and cloning of genes 
(Fire et al., 1986; Mello et al., 1991). DNA transformation is discussed in more detail 
in section 4.4.1.
In the case of ijD fl, I did not expect to achieve complete rescue of the mutant 
phenotype. ijDfl is a large deficiency deleting many genes and it is probable that a 
number of these are essential. By injecting cosmids from the region between F39D8 
and ZK662, I was adding back a small proportion of wild type genes into animals 
homozygous for a large deficiency and so I was simply looking for transformed 
homozygotes of ijDfl which arrested at a much later stage of elongation, possibly 
equivalent to the elongation phenotype seen in mnDf43. For simplicity, I will refer to a
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Figure 6.16
Schematic diagram showing the overlaps of the deficiencies ijD fl, mnDfl 7 and 
mnDf43 on the right arm of the X chromosome
Cosmid positions are drawn relative to one another although these are not to scale, and 
cloned genes are also shown with their positions on the genetic map in map units as 
reference points. Solid black lines indicate areas that deficiencies delete with dashed 
black lines representing the region from the last absent CSM to the first present CSM 
where the endpoints have not been more finely mapped. The area of the genome 
between the red arrows possibly contains a region which is deleted by mnDfl 7 and ijDfl 
but not mnDf43. Because of the different phenotypes of embryos homozygous for each 
deficiency, a gene or genes involved in early elongation may be present within this 
region. The region denoted by the green star may contain the gene which, when deleted 
in mnDf43 results in hypodermal rupture. The scale bar refers to the lines indicating the 
extent of the deficiencies and not to the cosmids.
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quantitative increase in the degree of elongation at arrest as rescue. Because I was 
looking for differences between transformed and non-transformed arrested embryos, I 
needed to inject a marker visible in embryos along with the cosmid and pRF4 
(containing the rol-6(sul006) mutation) DNA. I selected the plasmid pMW0002, 
containing the promoter region of the collagen gene, dpy-7 fused to, and in frame with, 
the GFP gene (I.Johnstone, pers.comm.). This plasmid did not interfere with 
embryogenesis when injected alone and it was known that dpy-7 was expressed in ijDfl 
homozygotes (see section 6.2.2). When viewed under UV light, embryos containing the 
pMW0002 marker plasmid fluoresce and so they can be distinguished readily from 
embryos which do not contain the plasmid. Both pMW0002 and pRF4 were included as 
markers in all the injection mixes described below.
6.5.1. Rescue achieved with groups of cosmids
Initially, while mapping of the deficiencies mnDfl 7 and mnDf43 was in 
progress, I injected 15 overlapping cosmids (Figure 6.17a) between the genes unc-7 
(position 20.36) and lin-15 (position 22.30) into hermaphrodites of a partially balanced 
strain with the genotype +,ijDfl/unc-84,+. Two lines were obtained from these 
injections and both showed rescue of the early elongation phenotype (Figure 6.18a and 
Table 6.2). This rescue phenotype showed elongation to over the 2-fold stage with no 
apparent rupturing of tissues and usually quite a narrow anterior. The pharyngeal 
grinder was also generally more conspicuous with the entire pharynx appearing much 
more similar to a wild type pharynx. By this stage of the rescue experiments, I had 
mapped the end-points of mnDfl7 and mnDf43 further right and so it reduced the 
number of cosmids in the target region to 11, C11G10-C02D4 on the left being placed 
outside the region of interest. Two subgroups of 6 overlapping cosmids from within 
these 11 cosmids were then injected (Figure 6.17b,c). The cosmids from F59D12 to 
C02C6 were positioned as Figure 6.17b at the time of injections but more recently their 
positions have been amended to the order in 6.17c. These subgroups were towards the 
right of the 15 cosmid group as mapping by this stage had uncovered the region from 
F39D8 to ZK662 as being important. Only one line was obtained from each subgroup 
and while the subgroup to the ‘left’ of the region, from C33A11 to H08J19, gave no 
rescue, the subgroup to the ‘right’ of the region, from F59D12 to C02C6 gave rescue
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Figure 6.17
Schematic diagram showing groups of cosmids used in rescue injections of ijDfl
a Original group of 15 overlapping cosmids on the X chromosome with
approximate position of cloned genes on the genetic map in map units. Double 
lines represent gaps in the physical map. The cosmids highlighted in red in Figure 
6.16 are also highlighted in red here for position reference. The distance from 
Cl 1G10 to ZK678 is approximately 670kb.
b, c Subgroups of 6 cosmids representing the ‘left’ and ‘right’ of the area. Cosmids 
in blue were present in the ‘left’ group only, cosmids in pink were present in the 
right group only, and cosmids in purple were present in both groups, b shows the 
positions of the cosmids as they were placed at the time of injections and c shows 
the revised positions of the cosmids at the time of writing. Double lines represent 
gaps in the physical map. The distance between cosmids C33A11 and ZK678 is 
approximately 470kb.
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Figure 6.18
DIC images showing rescue phenotypes of ijDfl homozygous mutants 
transformed with various combinations of cosmids
All embryos are positioned with the anterior to the left and the dorsal region 
to the top o f the image. Column i shows the anteriors o f the embryos while 
column ii shows the posteriors. In all images o f column i, the anterior tip of 
the head is indicated with an arrowhead and in all images o f column ii, the 
posterior tip o f the tail is indicated with an arrowhead, 
a 15 cosmid rescue 
b 6 cosmid rescue
c Ambiguous phenotype o f  some o f the embryos from the K09A9 1 Ong 
injections
d 5 cosmid rescue (as b but without K09A9)
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equivalent to that obtained with the 15 cosmid injections (Figure 6.18b). As these 
subgroups were formed at the time when the cosmid positions were shown as Figure 
6.17b, they were thought to contain 6 overlapping cosmids, except for the group to the 
right which also included ZK678 by mistake. These results coincided with the physical 
and genetic mapping data that the area of interest is to the right of F39D8.
Table 6.2 Rescue achieved with groups of cosmids and single cosmids
Injected cosmids Number of lines Number of lines 
showing rescue
15 cosmid group (see section 6.5.1) 2 2/2
6 cosmid group L (see section 6.5.1) 1 0/1
6 cosmid group R (see section 6.5.1) 1 1/1
F29D12 2 0/2
H08J19 6 0/6
K09E9 (lOng/pl) 2 0/2
K09E9 (5ng/gl) 2 0/2
K09A9 (lOng/gl) 2 ?/2 1
K09A9 (5ng/pl) 11 0/11
C02C6 4 0/4
ZK678 2 3 0/3
5 cosmid group (see section 6.5.1) 1 1/1
K09E9 plus K09A9 3 0/3?3
K09A9 plus C02C6 7 7 /74
K09E9 plus C02C6 5 5/5
1 These lines gave a variable phenotype: some transformed embryos were as ijDfl 
homozygotes, some were over 2-fold and a small proportion had narrow anteriors. 
Overall, rescue was not observed in any way comparable to rescue with 15 cosmids
2 ZK678 was added as a mistake to the 6R group of cosmids and so was subsequently 
tested alone to make sure it was not contributing to the rescue seen.
3 Around half the transformed embryos were as ijDfl 1.75fold embryos but none had 
narrow anteriors. They did not look like the rescued phenotype.
4 There were occasional 1.5-fold transformed embryos with much narrower anteriors 
than ijDfl homozygotes
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6.5.2. Single cosmid injections from within the rescuing groups
I subsequently began injecting each cosmid singly (at a concentration of 
1 Ong/pl) from the rescuing group of 6 cosmids (shown in pink and purple in Figure 
6.17b,c). The cosmids that had been included in both mixes were also tested as they 
may not have been present in the non-rescuing line from the ‘left’ group of cosmids. 
From this point on, ijDfl/+ hermaphrodites were used for injections as there was too 
much recombination in the +,ijDfl/unc-84, + strain to make its use beneficial. None of 
these cosmids rescued alone although I obtained ambiguous results from K09A9 with 
some of the transformed embryos resembling rescue (Figure 6.18d, Table 6.2). K09A9 
was injected singly again at a concentration of 5ng/pl as this was the concentration of 
each of the cosmids in the rescuing group of 6. At this concentration, K09A9 showed 
no rescue and so the ambiguous effects seen with this cosmid seem to be concentration 
dependent. In the rescue seen with other groups of cosmids, all transformed embryos 
showed the rescue phenotype. This result indicated that the rescue seen in the original 
group of 6 cosmids was not due to K09A9 alone. To further test the effect of the 
K09A9 cosmid, I injected a mix of all of the cosmids in the original rescuing group of 
6, except K09A9. Interestingly, this group of 5 cosmids rescued the phenotype as 
before (Figure 6.18d and Table 6.2).
6.5.3. Rescue achieved with two groups of two cosmids
Because none of the cosmids in this mix rescued the phenotype when they were 
injected alone, either the gene causing rescue in the mix was present across two 
cosmids, or there was more than one gene contributing to the rescue seen. Groups of 
two overlapping cosmids were injected from the original rescuing group of 6 starting 
from the left of the 5 overlapping cosmids: C02C6, K09A9, K09E9, H08J19, and 
F59D12 (new amended positions). The first group injected: C02C6 and K09A9 did 
rescue the phenotype as completely as the group of 6 (Figure 6.19a; Table 6.2). 
Injecting K09A9 along with K09E9 the cosmid which overlaps it on the right gave no 
rescue. From information available with the sequence data, there is only one gene 
spanning the intersection of the genomic sequences contained within cosmids K09A9 
(accession number Z79601) and C02C6 (accession number Z79596), dyn-1, but as this
250
Figure 6.19
DIC images showing rescue phenotypes of ijD fl homozygous mutants 
transformed with cosmid C02C6 plus either cosmid K09A9 or K09E9
The embryo in a is positioned with the anterior facing downwards at the left 
o f the image and the dorsal surface to the top and right o f the image. The 
embryo in b is positioned with the anterior facing right at the bottom left o f 
the image and the dorsal surface towards the top o f the image. Arrowheads 
point to the anterior tip o f the head in i, the pharyngeal grinder in ii, and the 
posterior tip o f the tail in iii.
a Rescue achieved with cosmids C02C6 and K09A9 
b Rescue achieved with cosmids C02C6 and K09E9
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was contained in its entirety in C02C6 alone, it did not seem to be a good candidate for 
rescue on its own. This suggested that the rescue seen may have been due to two or 
more genes in C02C6 and K09A9. Information available with the sequence data of 
K09A9 and K09E9 (accession number Z79602) also predicts two genes, K09A9.1 and 
K09A9.2, contained entirely within the overlap of genomic sequences contained within 
these cosmids and although the above results show that they do not rescue on their own, 
it seemed possible that either of them in conjunction with C02C6 may achieve rescue. 
Because of this, I looked at the effect of injecting C02C6 along with K09E9 and found 
that this combination did indeed give rescue (Figure 6.19b; Table 6.2). However, this 
result did not remove the possibility that there may be a separate gene contained within 
K09A9 and K09E9 which gives rescue in conjunction with a gene in C02C6. In order 
to investigate whether the genes in the K09A9/K09E9 genomic sequence overlap were 
contributing to rescue, and if so, which of them were involved, I cloned the genes 
separately into plasmids to inject along with C02C6 without the rest of the genomic 
sequences within the K09A9 or K09E9 cosmids.
6.6. Cloning and injection of genes in the overlap of cosmids K09A9 and K09E9
The predicted genes, K09A9.1 and K09A9.2, were subcloned from K09A9 into 
pBluescript SK- to form the plasmids pKAl and pKA2. pKAl contains a 4.7kb PvuW- 
Kpnl fragment of K09A9 containing the predicted gene K09A9.1 (3.3kb) along with 
0.8kb upstream and 0.6kb downstream flanking sequence and pKA2 contains a 4.5kb 
BamHl-Xhol fragment of K09A9 containing the predicted gene K09A9.2 (1.3kb) along 
with 0.9kb upstream and 2.3kb downstream flanking sequence (Figure 6.20). The 
diagnostic digests for pKAl and pKA2 are shown in Figure 6.21. The pKAl and pKA2 
digests appear to show the correct positions of bands although there was a dip in the gel 
which made size comparisons more difficult. Lanes 5 and 6 are shown as additional 
size markers (see Figure 6.21 legend). In order to ensure that the correct fragment was 
cloned for both pKAl and pKA2, I tested the plasmids with primers specific to 
K09A9.1 and K09A9.2 respectively (Table 2viii, primers K09A9.1-T3 and -T7, 
K09A9.2-T3 and -T7; Figure 6.22). From the PCR it is clear that the correct predicted 
gene is present in both plasmids and in the case of K09A9.1, the primers amplified the 
entire sequence of the predicted gene (Table 2viii, primers K09A9.2-T3 and T7).
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Figure 6.20
Subcloning of genes K09A9.1 and K09A9.2 from genomic sequence contained 
within the cosmid K09A9
a A representation of the C.elegans Genomic DNA contained within the 
cosmid K09A9 showing the GENEFINDER predicted genes, K09A9.1- 
K09A9.6. K09A9.1 and K09A9.2 are shown as blue arrows and the other genes 
are shown as orange arrows. Restriction sites used to cleave the gene-containing 
sequence from the genomic DNA are shown in purple. K09A9.1 was cut out 
using Kpnl and Pvull restriction enzymes resulting in a 4.7kb fragment shown 
below the K09A9 genomic map. K09A9.2 was cut out using BamHl and Xhol 
restriction enzymes resulting in a 4.5kb fragment shown below the K09A9 
genomic map.
b Plasmid pKAl consisting of a pBluescript SK- backbone (purple) and the 4.7kb
insert (grey) containing predicted gene K09A9.1 (blue arrow) as detailed in a. 
Cloning sites are shown in purple. pBluescript SK- was cut with Kpnl and 
EcoRV as there are two Pvull sites in pBluescript SK-, both outwith the 
polylinker (see section 2.16.1.1).
c Plasmid pKA2 consisting of a pBluescript SK- backbone (purple) and the 4.5kb
insert (grey) containing predicted gene K09A9.2 (blue arrow) as detailed in a. 
Cloning sites are shown in purple.
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Figure 6.21
Restriction maps and diagnostic digests of plasmids pKAl and pKA2
a pKAl restriction map
b pKA2 restriction map
purple shading: vector DNA (pBluescript SK-)
grey shading: C.elegans genomic DNA
blue arrows: Coding sequence of gene K09A9.1 or K09A9.2
The plasmids have been linearised and positions of restriction sites are in base pairs 
from the origin of the pBluescript SK- plasmid as given in the published sequence 
(accession number: X52324).
c Gel showing diagnostic restriction digests for pKAl and pKA2.
Lanes 5 and 6 are included as size markers
Sail digest of pKAl - 7.62kb band
Xhol digest of pKAl - bands of 950bp and 6.67kb
Pvull digest of pKA2 - bands of 842bp, 1.50, 2.51 and 2.54kb
Xbal digest of pKA2 - bands of 844bp and 6.56kb
Lane5: bands of 3.8 and 6.8kb
Lane6: bands of 4.4 and 6.4kb
lkb ladder band sizes are given to the right of the gel in kb. The gel dips on the right 
hand side so the lkb ladder bands at the left do not match up exactly with those on the 
right. The contrast was enhanced for bands under lkb in size to enable them to be seen 
more clearly.
All bands were as expected for plasmid digests.
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Figure 6.22
Gel showing the presence of coding sequences from predicted genes 
K09A9.1 and K09A9.2 in plasmids pKAl and pKA2
The K 09A 9.1 lane contains a 1.45kb fragment o f the coding sequence o f 
the predicted gene K09A9.1 amplified from the plasmid p K A l. The 
K09A9.2 lane contains the entire coding sequence o f the predicted gene 
K09A9.2 (1.38kb) amplified from the plasmid pKA2.
This shows the presence o f  each gene in the correct plasmid.
Sample marker bands from lkb ladder are shown to the right o f the gel in 
kb. Above the 2kb band, all subsequent higher bands differ by lkb in size 
up to the largest band o f 12kb which is shown.
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ijDfl/+ hermaphrodites were injected with a mix containing pKAl, pKA2 and 
C02C6 as well as the marker plasmids. The subclones were injected at a concentration 
of lng/pl as previous injections at a higher concentration had yielded many FI 
transformants but no lines which is an indication that one or more of the plasmids are 
toxic at a high copy number. C02C6 was injected at a concentration of 5ng/pl. The 
results are shown in Table 6.3. This combination of DNA molecules did not give rescue 
which was a surprising result that suggested rescue was due to a different gene in each 
of K09A9 and K09E9 after all. However, non-rescue can be due to many factors. Even 
though an upstream region of 769bp and 908bp were included for K09A9.1 and 
K09A9.2 respectively (see Figures 6.20 and 6.21), this may not be enough to include the 
entire promoter sequence. It is possible that the promoter for each predicted gene lies 
within the coding region of the other although this may be unlikely. If this was the 
problem, however, the entire promoter regions for each gene could be restored when the 
two predicted genes were injected together as they may recombine in the region of 
overlap. The GENEFINDER program is used by the C.elegans sequencing consortium 
to predict genes and these predictions are often inaccurate. If the 5' ends of these genes 
were actually further upstream than predicted, then even less of the upstream flanking 
sequence would be present in the subclone plasmids. To check whether it was the 
overlap contributing to rescue or another gene in each cosmid, I subcloned the entire 
overlap region and, the genes contained in the non-overlap region of the K09E9 cosmid.
Table 6.3 
Rescue obtained from injection of the C02C6 cosmid plus regions of the K09A9 
and K09E9 cosmids
Injected cosmids, plasmids 
and deleted cosmids
Number of lines Number of lines showing 
rescue
pKAl ,pKA2,C02C6 6 0/6
pKEO and C02C6 10 4/10
pKENO and C02C6 3 possibly 2/3 (see text)
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6.7. Subcloning and injecting the overlap and non-overlap regions of K09E9
The overlap and non-overlap regions were subcloned in a different way to the 
predicted genes K09A9.1 and K09A9.2. I chose restriction enzymes to cut out the 
regions of the genomic DNA that were unwanted and re-ligated the remaining genomic 
DNA, complete with the original cosmid backbone, Lorist B. Unfortunately, careful 
examination of initial digests of K09E9 and K09A9 indicated that large areas of the 
genomic sequence contained in these cosmids were deleted. I had previously been 
preparing cosmid DNA from at least two colonies and comparing the restriction digest 
patterns as an assay for intact cosmids. However, when I examined the cosmids I had 
used in the rescue injections accurately, many of them had deletions which had not been 
noticed before. I was unaware of the extent of cosmid deletions and in consequence, it 
is possible that some cosmids may have failed to rescue due to the presence of these 
deletions. The implications of the K09A9 and K09E9 deleted regions on previous 
results is discussed in section 6.8. I subsequently received an undeleted version of the 
K09E9 cosmid and used this for further subcloning. pKEO contained the K09E9 Lorist 
B backbone and genomic sequence specific to the region in the K09A9/K09E9 overlap. 
It was constructed by deleting a 29kb region between AvrW sites from 8312bp to 
37447bp (Figure 6.23a) and re-ligating the remainder of the cosmid, forming a subclone 
of 10.2kb containing the genes K09A9.1 and K09A9.2, plus the Lorist B backbone 
(Figure 6.23b). pKENO contained the K09E9 Lorist B backbone and genomic sequence 
specific to the region of K09E9 not contained in the K09A9/K09E9 overlap. It was 
formed by deleting a region from BamRl at 478bp to Pmel at 6992bp containing genes 
K09A9.1 and K09A9.2 (Figure 6.23a) and blunt-end ligating the remainder of the 
genomic DNA, forming a subclone of 32.7kb plus the Lorist B backbone (Figure 6.23c). 
Diagnostic digests of these subclones are shown in Figure 6.24.
ijDfl/+ hermaphrodites were injected with DNA mixes containing either pKEO 
or pKENO plus the C02C6 cosmid. Results are shown in Table 6.3. 4 out of 10 lines 
from the C02C6 plus pKEO injections did indeed result in rescue as complete as with 
the initial cosmid group (Figure 6.25a,b) but the other 6 lines showed no rescue at all. 
The most likely explanation for this is that the 4 rescuing lines contained both cosmids 
but the other lines only contained one, or neither of them and therefore did not give 
rescue. When C02C6 and pKENO were injected together, however, two of the lines
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Figure 6.23
Subcloning of ‘overlap’ and ‘non-overlap’ genomic sequences from within the
cosmid K09E9
a Schematic diagram of the C.elegans genomic DNA contained within the cosmid
K09E9 showing the GENEFINDER predicted genes: K09A9.1 and K09A9.2 
present within the K09A9/K09E9 overlap genomic sequence (blue arrows), and 
K09E9.1-K09E9.3 present within the K09E9 non-overlap genomic sequence 
(green arrows). The restriction sites used in creating the subclones are shown. 
AvrR was used to cut out the non-overlap genomic sequence of K09E9 so that 
only the overlap sequence and the vector backbone (shown in purple in b and c) 
remained after re-ligation. PmeI and BamHl were used to cut the overlap 
sequences from the K09E9 cosmid so that only the non-overlap sequence 
remained along with the vector backbone.
b Plasmid pKEO showing the Lorist B vector backbone in purple, genomic
sequence in grey and the genes present in the K09A9/K09E9 overlap as blue 
arrows. The site of AvrH re-ligation is shown.
c Plasmid pKENO showing the Lorist B vector backbone in purple, genomic
sequence in grey and the genes present in the K09E9 non-overlap genomic 
sequence as green arrows. The site of the PmeVBamRl ligation is shown.
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Figure 6.24
Restriction map and diagnostic digests of deleted cosmids pKEO and pKENO
a pKEO restriction map
b pKENO restriction map
purple shading: vector DNA (Lorist B)
grey shading: C.elegans genomic DNA
blue arrows: predicted genes K09A9.1 and K09A9.2
green arrows: predicted genes K09E9.1 -K09E9.3
The deleted cosmids have been linearised and positions of restriction sites are in base 
pairs from the origin of the Lorist B vector as given in the published sequence 
(accession number: X98613) added to the deleted genomic DNA contained within the 
K09E9 cosmid from the origin stated in the published sequence (accession number: 
Z79602).
c Gels showing diagnostic restriction digests for pKEO and pKENO
i pKEO diagnostic digests:
Xhol digest of pKEO - 3 bands of 950bp, 3.9kb and 10.7kb.
Sail digest of pKEO - 2 bands of 6.3 and 9.3kb.
ii pKENO diagnostic digests:
iscoRI digest of pKENO - showing 8 bands of 1.2, 1.4, 2.3, 3.1, 3.7, 4.9, 
10.2, and 10.8kb. Not shown are lower bands of 302 and 196bp as these 
were very faint and diffuse.
BgEl digest of pKENO - showing 8 bands of 650bp, 968bp, 1.7, 2.1, 2.3, 
3, 5.9, and 21kb. Not shown is a band of 61bp which could not be seen 
on the gel.
lkb ladder band sizes are given to the left of the pKEO gel in kb and selected bands are 
indicated to the left of the pKENO gels in ii.
All bands were as expected for the plasmid digests.
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DIC images showing phenotypes of ijD fl homozygous mutants 
transformed with various cosmid groups or subciones
All embryos are positioned with the anterior to the left and the dorsal 
surfaces to the top o f the images. In column i, an arrowhead indicates the 
anterior tip o f the head and in column ii, an arrowhead indicates the posterior 
tip o f the tail.
a Original 15 cosmid rescue 
b pKEO plus cosmid C02C6 rescue
c Phenotype achieved by pKENO plus cosmid C02C6 injections
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also showed an effect even though this was not as pronounced as the previous cosmid 
group rescue (Figure 6.25c). These results point to the genes in the overlap as being 
involved in rescuing the elongation defect along with a component of C02C6 but there 
may also be another aspect of K09E9 and possibly K09A9 which can also contribute 
partially to rescue. Since the genes in the overlap of the genomic sequence of these two 
cosmids do not share any significant homology with any genes outwith the genomic 
overlap, it seems that the partial rescue effect resulting from the pKENO plus C02C6 
injections differs from the rescue effect resulting from the pKEO plus C02C6 injections. 
It appears that more than one set of genes can affect this mutant phenotype and it 
therefore seems that the elongation defect is a complex compound effect.
6.8. Implications of partially deleted K09A9 and K09E9 cosmids on previous 
results.
The large deletions in the genomic sequences contained within the K09A9 and 
K09E9 cosmids were not detected until after the cosmid rescue injections had been 
completed and the K09A9.1 and K09A9.2 genes had been subcloned. It has already 
been mentioned above that PCR was used to ensure that the correct genes were present 
within pKAl and pKA2, and the same primers were used to detect these ‘overlap’ genes 
in the partially deleted K09A9 and K09E9 cosmids (Figure 6.26). The overlap genes 
were found to be present in both partially deleted cosmids which may be a significant 
result as the deleted cosmids also achieved rescue along with cosmid C02C6 which was 
present in an undeleted form. The presence of other genes outside the K09A9/K09E9 
genomic sequence overlap were not tested in the partially deleted K09A9 and K09E9 
cosmids. I also examined the restriction digest pattern of the deleted cosmids using 
different restriction endonucleases and deduced that the region of deletion was outwith 
the overlap between the genomic sequences contained within the K09A9 and K09E9 
cosmids. To summarise, although rescuing cosmids K09A9 and K09E9 were injected 
in a partially deleted form, the genes from the genomic overlap between these two 
cosmids were present in the injected cosmids. They were also shown to be present in 
the plasmids pKAl and pKA2 which did not give rescue in any combination along with 
cosmid C02C6. For simplicity I will henceforth use the cosmid name to denote the 
C.elegans genomic sequences contained within that cosmid.
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Figure 6.26
Gel showing the presence of coding sequences from genes K09A9.1 and 
K09A9.2 in deleted cosmids K09E9 and K09A9
K 09A 9.1 lanes contain a 1.45kb amplified fragment o f the coding sequence 
o f the predicted gene K09A9.1. K09A9.2 lanes contain the entire coding 
sequence o f the predicted gene K09A9.2 (1.38kb). AK09E9 lanes contain 
DNA amplified from the deleted K09E9 cosmid and AK09A9 lanes contain 
DNA amplified from the deleted K09A9 cosmid.
The gel shows the presence o f both genes in both deleted cosmids although 
the K09A9.1 band in the deleted K09E9 cosmid is faint.
Sample marker bands from lkb ladder are shown to the right o f the gel in kb. 
Above the 2kb band, all subsequent higher bands differ by lkb in size up to 
the largest band o f 12kb which is shown.
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6.9. RNA interference of genes within the K09A9/K09E9 overlap and the cosmid 
C02C6
6.9.1. Background of RNA interference
A relatively new reverse genetic tool in C.elegans is that of RNA interference 
(RNAi) which can specifically inhibit the function of the gene under study and allow the 
‘null’ phenotype of the gene to be observed. This is achieved by injecting double 
stranded RNA, corresponding to the gene in question, into an adult hermaphrodite and 
then examining the progeny of that animal for any effect. It was first reported that 
antisense RNA towards specific genes in C.elegans could phenocopy a null mutation in 
a gene when expressed from a transgene and that sense transcripts were also effective in 
producing the targeted phenotype (Fire et al., 1991). This effect was also found by Guo 
and Kemphues in 1995 during attempts to use antisense RNA to block gene expression 
in the maternal germ line. They observed that injecting both antisense and sense RNA 
separately into adult hermaphrodites induced phenocopies of a mutation in the target 
gene in the progeny of the injected animals. Many subsequent studies have shown that 
double stranded RNA (dsRNA) is much more potent at causing interference than either 
single strand alone and it is thought that the presence of tiny amounts of dsRNA present 
in single stranded RNA preparations may actually be the cause of the interference seen 
(Fire et a l, 1998). RNAi has shown to be specific when tested for many genes for 
which the null phenotype is known, for example, unc-22 and mec-3 (Fire et al., 1998). 
Several aspects of RNAi are unusual. Firstly, interference can cross cell boundaries as 
injection of dsRNA into the gonads and the intestine produce the same effects and more 
recently it was found that simply soaking the worms in dsRNA could induce specific 
interference of the essential maternal gene pos-1 (Tabara et al., 1998). Secondly, 
interference can not only be observed in the injected animal but can frequently be seen 
in a high proportion or in all of its progeny. It has also been found that the DNA 
template used to produce the RNA can be genomic and that the presence of intronic 
sequences seem to have no effect on interference although it is vital that exon sequence 
is present. The mechanism of this process is not fully understood as yet. Only a few 
molecules of dsRNA are required per cell to induce an effect which suggests that there 
may be an amplification or catalytic step in the interference process. It is known that
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RNA transcripts of a target gene fail to accumulate after RNAi and in some cases of 
RNA-mediated co-suppression in plants, gene silencing correlates with an increased 
turnover of both the transgenic and endogenous gene transcripts (Jacobs et al., 1997). It 
is possible that there is a role for RNA-associated gene silencing in the wild type system 
as a defence against invading viruses or as a method to switch off specific genes in 
response to physiological or developmental cues (Jorgensen et al., 1998; Montgomery 
and Fire, 1998).
6.9.2. RNAi of genes in the K09A9/K09E9 cosmid overlap and in the C02C6 
cosmid
As a final test to examine the predicted genes in the overlap of cosmids K09A9 
and K09E9 and in C02C6,1 decided to produce dsRNA towards a region of each gene 
and then inject the dsRNAs in different combinations to observe their effects. Even 
though a combination of these genes were enough to rescue the early elongation defect 
in ijDfl, this does not mean that their deletion alone is sufficient to create the phenotype 
seen. dsRNA was prepared for the predicted overlap genes: K09A9.1 and K09A9.2, and 
for the genes in C02C6: CQ2C6.\{dyn-l), and predicted genes, C02C6.2 and C02C6.3, 
as detailed in section 2.17. Figure 6.27 shows the positions of the genomic sequence 
used to generate RNA in the 5 genes and the sizes of the single stranded and double 
stranded RNA prepared for each gene. The combinations of dsRNA were injected into 
wild type hermaphrodites which were then transferred singly to new plates at regular 
intervals in order to examine the brood phenotypes and look for any resulting lethality. 
Table 6.4 details the combinations of dsRNA injected and the resulting phenotype seen. 
I found that if  I injected dsRNA of every gene except dyn-1, there was no overall 
phenotype produced, but if dyn-1 dsRNA was injected alone, I observed over 80% 
embryonic death in the progeny of the injected animals and the other 20% were very 
small, dumpy and slow growing, dyn-1 encodes a homologue of vertebrate dynamin 
which is required for endocytosis, acting to pinch vesicles off from the plasma 
membrane (Clark et a/., 1997; Labrousse et al, 1998). The dead embryos from dyn-1 
RNAi were variable, but the vast majority arrested as amorphous lumps of cells with no 
distinguishing features or tissues (Figure 6.28a). The most likely explanation for this is 
that dyn-1 RNAi inhibits both maternal and zygotic dyn-1 function resulting in a more
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Figure 6.27
RNA interference (RNAi) using genes in the genomic overlap of K09A9 and K09E9 
cosmids, and in cosmid C02C6
Positions of primers used to generate DNA fragment templates for RNA interference 
(RNAi) and single and double stranded RNA fragments corresponding to these 
templates for each target gene
Details of the RNAi protocols are given in section 2.17.
a Schematic diagram of the complete genomic sequence contained within cosmid 
K09A9 with the positions of the 6 predicted genes indicated as arrows. Genes from the 
K09A9/K09E9 genomic overlap are denoted by blue arrows and the positions of the 
primers used to amplify the DNA fragment templates for RNA in the RNAi experiments 
are shown in pink.
b Schematic diagram of the complete genomic sequence contained within cosmid 
C02C6 with the positions of the 3 predicted genes indicated as blue arrows. Positions of 
the primers used to amplify the DNA fragment templates for RNA in the RNAi 
experiments are shown in pink.
c Agarose gel showing the single stranded RNA (T3 and T7 lanes) and double 
stranded RNA (ds lanes) generated from the amplified DNA fragments from each gene. 
The gene name is above the lanes containing corresponding RNA.
Sizes of DNA fragments amplified from each gene (which will correspond to the size of
the generated RNA):
K09A9.1: 1.45kb
K09A9.2: 1.38kb
C02C6.1: 1.48kb
C02C6.2: 1.03kb
C02C6.3: 1.77kb
a K.09A9.2-T7
K09A9.5 K09A9.3
K09A9.6 K09A9.4
X = H = >
K09A9 42016 bp
K09A9.2-T3 
I K09A9.1-T3
K09A9.1-T7
K09A9.1
K09A9.2
C02C6.3-T3 
C02C6.3-T7 
C02C6.2-T7\
\  C02C6.3
C02C6.2
C02C6.1-T3
C02C6.1-T7
C02C6 43379 bp C02C6.1
c
K09A9.1 K09A9.2 C02C6.I C02C6.2 C02C6.3
lkbT 3  T7 ds T3 T7 ds T3 T7 ds T3 T7 ds T3 T7 ds lkb
Figure 6.28
DIC images of phenotypes obtained from dyn-1 RNAi and phenotypes of 
dyn-1 (ky51) and dyn-1 (cq4) homozygotes.
In images b and d, the anterior is towards the left of the image.
a An embryo from an wild type hermaphrodite injected with double stranded RNA
corresponding to a region of sequence from the dyn-1 gene.
b Larvae from an wild type hermaphrodite injected with double stranded RNA
corresponding to a region of sequence from the dyn-1 gene. The larvae are 
trapped in their old cuticle, indicated with arrows in both images. Scale bar is 
lOjim in both cases.
c Terminal arrest phenotype of an embryo produced from a dyn-1 (ky51)
homozygote which was raised and maintained at 25°C.
d Terminal arrest phenotype of a dyn-1 (cq4) homozygous embryo.
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severe phenotype than that seen in ijDfl homozygotes where maternal dynamin will be 
present from the heterozygous parent.
Table 6.4
Results of RNAi for genes K09A9.1, K09A9.2, C02C6.1 {dyn-1), C02C6.2 and 
C02C6.3 injected into wild type hermaphrodites
dsRNA injection 
combinations
Concentration 
of dsRNA 
injected 
(ng/jxl)
Phenotypes seen in FI 
generation
If lethality, arrest 
phenotypes seen
C02C6.1 {dyn-1) 300 78% embryonic 
lethality (n=1277), 
other progeny small, 
dumpy, slow growing. 
Some Egl
82% amorphous, 
lumpy ‘blobs’
7% irregular 3-fold 
11% irregular 2-fold 
(n=194)
C02C6.1 {dyn-1) 30 70% embryonic 
lethality (n=1253), 
other progeny small, 
slow growing, dumpy, 
Egl*
91% amorphous, 
lumpy ‘blobs’
3% irregular 3-fold 
6% irregular 2-fold 
(n=211)
K09A9.1 and .2, 
C02C6.2 and .3
300 each <1% dead embryos and 
slightly lumpy larvae. 
No definite phenotype
variable
All combinations 
including 
C02C6.1 {dyn-1)
300 each as C02C6.1 alone* as C02C6.1 alone
All combinations 
not including 
C02C6.1 {dyn-1)
300 each <1% dead embryos and 
slightly lumpy larvae. 
No definite phenotype
variable
* In the RNA combinations including C02C6.1 {dyn-1), it was noted that a high 
proportion of larvae were mid-moult, seemingly trapped in their shed cuticle (Figure 
6.28b). They appeared lethargic or paralysed
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In order to check that the dyn-1 RNAi embryos were the result of removing both 
maternal and zygotic dynamin, I observed the temperature-sensitive allele dyn-1 (ky51) 
and a null allele of dynamin, dyn-1 (cq4) kindly sent to me by A.van der Bliek. dyn- 
l(ky51) homozygotes are paralysed when transferred to the restrictive temperature and 
this paralysis is reversible (Clark et al., 1997). This is due to the high demand on 
endocytosis at neuron synapses from the recycling of synaptic vesicles. At the 
restrictive temperature, the amount of dynamin present is significantly reduced and 
endocytosis is therefore halted. I raised dyn-l(ky51) homozygotes at the restrictive 
temperature of 25°C and then observed the phenotype of their progeny produced at the 
same temperature which would have no, or a greatly reduced amount of, maternal or 
zygotic dynamin. These hermaphrodites produced a small brood including embryonic 
lethals as well as other small, lethargic progeny. The majority of embryos arrested at 
the same stage as dyn-1 RNAi embryos (Figure 6.28c). Dynamin functions maternally 
in endocytosis of the yolk proteins which provide essential nourishment for the 
developing embryos (B.Grant, pers. comm.). In contrast, animals homozygous for the 
dyn-l(cq4) null arrest as 3-fold embryos or LI stage larvae (Figure 6.28d). I then 
performed RNAi with the predicted genes K09A9.1 and K09A9.2 in hermaphrodites 
heterozygous for dyn-1 (cq4) and subsequently examined their homozygous dyn-1 (cq4) 
progeny for any effects. I did not observe any difference between the dyn-1 (cq4) null 
homozygous progeny of the injected dyn-1 (cq4) null heterozygotes, and homozygote 
dyn-1 (cq4) null embryos from non-injected heterozygote animals.
6.9. Discussion
ijDfl is a deficiency which deletes around 1.6Mb of the genome and extends 
from around position 18 to position 23.5 on the X chromosome,. Animals homozygous 
for the deficiency arrest as 1.5-fold stage embryos with an underdeveloped pharynx and 
a limited degree of movement. The basement membrane between the muscle and 
hypodermis appears to be as wild type and myosin staining shows that muscle 
sarcomeres are in the correct position, although the organisation of myosin within each 
sarcomere seems less uniform than wild type. This could reflect an actual defect or 
simply be the result of the presence of fully developed muscle in a much shorter space 
than wild type due to the lack of elongation in ijDfl mutant embryos. MH4 staining,
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however, is absent from the hypodermis which would seem to indicate some defect in 
the intermediate filaments of the hypodermis which mediate muscle-cuticle attachment 
from around the 2-fold stage. In fact there is a predicted gene deleted by ijDfl present 
across cosmids W10G6 and F52E10 which encodes an intermediate filament protein 
(Dodemont et al., 1994). It is possible that this protein is the target of the MH4 
antibody in the hypodermis. The presence of basement membrane between the 
hypodermis and muscle however show that these tissues are properly aligned and 
closely apposed. As normal muscle function is required for proper elongation, this 
apparent defect in the muscle-hypodermis association may contribute to the elongation 
defect seen in ijDfl homozygotes (Waterston, 1989; Williams and Waterston, 1994). 
Another possible role for intermediate filaments is the anchorage of the 
circumferentially oriented actin filament bundles in the hypodermis during elongation 
(Costa et al., 1998). If intermediate filaments were necessary to maintain proper actin 
microfilament organisation during elongation then the absence of an intermediate 
filament structural protein may prevent full elongation. It is possible that the deletion of 
the W10G6.3 gene which encodes an intermediate filament protein could prevent 
significant elongation past 2-fold in ‘rescued’ ijDfl homozygotes. Another gene 
thought to be involved in intermediate filament function is jam-1 which encodes the 
protein recognised by the MH27 monoclonal antibody (M.Koeppen, pers. comm.). This 
gene encodes a protein homologous to human trychohyalin which organises 
intermediate filaments and RNAi experiments with jam-1 produce embryos which arrest 
at the 2-3-fold stage. The hypodermis undergoes fusions, almost to the terminal stage 
but often the hypodermal fusions are not complete. ijDfl mutants synthesise and secrete 
cuticle with essentially the same pattern as fully elongated wild type embryos, and the 
furrows seen in the cuticle may reflect circumferential orientation of actin fibres during 
embryogenesis as in wild type embryos (Costa et al., 1997). The secretion of a cuticle 
in these ijDfl homozygotes suggests that completed hypodermal fusions are not 
necessary for this process.
The study of overlapping deficiencies uncovered a possible region of ijDfl 
containing genes involved in this early elongation process and subsequent injection of 
cosmids from this region partially rescued the phenotype so that transformed embryos 
arrest at a much later stage in elongation. The rescue phenotype was an arrest at around 
2.5-fold elongation, often associated with a very narrow anterior and an apparently more
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developed pharynx than ijDfl homozygotes. There are aspects of this phenotype which 
are similar to mnDf43 homozygotes, although ijDfl rescued embryos do not rupture 
suggesting that mnDf43 deletes a gene or genes involved in enclosure/cuticle synthesis 
which ijDfl does not delete. The smallest area that rescued this phenotype was the 
overlap of the two cosmids K09E9 and K09A9 plus the cosmid C02C6. The non­
overlap region of K09E9 plus C02C6 also gave a partial rescue effect although this was 
not as pronounced.
From the published sequences of the C.elegans genomic DNA contained within 
cosmids K09A9 and K09E9, two genes are predicted within the genomic overlap of the 
two cosmids: K09A9.1 which is similar to a serine/threonine kinase, and K09A9.2 
which is similar to the rat RAS-related gene, Rab-14. C02C6 contains two genes 
predicted by GENEFINDER, C02C6.2 and C02C6.3 (containing sequences similar to 
leucine-rich repeats), and a cloned gene C02C6.1, or dyn-1 which encodes a homologue 
of mammalian dynamin, an lOOkDA GTPase necessary for clathrin-mediated 
endocytosis (Clark et al., 1997). There are several possible connections between these 
various genes. Dynamin regulates endocytic coated-vesicle formation and is expressed 
in neurons primarily and also in the pharynx, intestine and reproductive tissues. The 
abundance of dynamin in neurons is thought to reflect the need for a high rate of 
endocytosis due to the recycling of synaptic vesicles (Labrousse et al.. ,1998). Dynamin 
expression has not been observed in the hypodermis although it is thought to be 
expressed ubiquitously as it appears to be the only dynamin gene in C.elegans (Clark et 
al., 1997). There is a dynamin-related gene, drp-1, also present in C.elegans which 
encodes a protein with 32% identity to dynamin (A.Labrousse, pers comm). This 
identity is distributed over most of the proteins except for a few highly divergent 
domains which may confer functional specificity, and DRP-1 is thought to regulate 
mitochondrial morphology. My observations that dyn-1 RNAi can result in animals 
‘trapped’ in their cuticle may indicate that it has some function in moulting which is 
thought to involve coated-pit mediated endocytosis (Yochem et al., 1999). Rab proteins 
are small GTPases regulating membrane traffic in eukaryotic cells and recently an 
epithelial-specific member of this family, Rab 17, has been identified which may be 
involved in transcellular transport between the apical and basolateral surfaces of 
polarised cells (Liitcke et al, 1993; Zacchi et al, 1998). Interestingly, another member of 
the family, rab-3 also appears to be involved in the trafficking of synaptic vesicles and
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another three rab genes in C.elegans, rab-5, rab-7 and rab-11, are thought to be 
involved in receptor-mediated endocytosis (Iwasaki et a l , 1997; Y.Zhang, pers. 
comm.). However, it is difficult to say how these findings fit into the mechanism of 
elongation and it may be possible that the genes responsible for rescue of the early 
elongation defect in these cosmids have unique functions in morphogenesis which have 
not been uncovered as yet.
A possible role for the predicted K09A9.2 gene in embryonic elongation is in the 
organisation of the actin cytoskeleton. Small GTPases from the Rho subfamily of the 
Ras superfamily have been implicated in the regulation of actin cytoskeleton 
organisation in many different cells and organisms (Hall, 1998; Schmidt and Hall, 
1998). In vitro studies on vertebrate fibroblasts have shown that the activation of Rho 
results in the assembly of contractile actin-myosin filaments called stress fibres; 
activation of Rac, another member of the Rho family, results in the production of actin- 
rich lamellipodia; and activation of Cdc42, a third member of the Rho family, stimulates 
the production of actin-rich filopodia (Ridley and Hall, 1992; Ridley et al., 1992; 
Kozma et a l , 1995; Nobes and Hall, 1995). It has also been found that there is 
significant interaction between these GTPases as Ras and Cdc42 can activate Rac, and 
Rac can activate Rho (Ridley et a l , 1992; Nobes and Hall; 1995). As discussed in 
section 1.7.5.3, the contractile actin microfilaments of C.elegans appear to be anchored 
at the adherens junctions of hypodermal cells by a putative catenin-cadherin system 
which mediates elongation (Costa et al, 1998). It has been found that Rho and Rac are 
required for the establishment of cadherin-mediated cell-cell adhesion in human 
epithelial cells and for the actin reorganisation necessary for the stabilisation of 
cadherins at intercellular junctions (Braga et al., 1997). It seems quite likely therefore 
that small GTPases may also play a role in the circumferential organisation of actin 
microfilaments in the C.elegans embryo and possibly in the anchoring of these 
microfilaments at adherens junctions in hypodermal cells.
It is interesting that genes contained in the K09E9/K09A9 overlap and C02C6 
are sufficient to rescue the early elongation defect (and underdeveloped pharyngeal 
defect) in ijDfl but the RNAi results indicate that only one of these genes, dyn-1 shows 
a phenotype when its function is disrupted. Firstly, it must be remembered that RNAi is 
a new and not well understood tool for phenocopying a gene knock-out and although 
results for many genes have been shown to be specific and reproducible (Fire et al.,
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1998), a negative result is not very informative. The results for the dyn-1 RNAi 
phenotype were shown to be comparable to the phenotype obtained when maternal and 
zygotic dynamin were removed, or greatly reduced, in the temperature shift experiment, 
but there could be many aspects of the sequences used for the other genes which 
prevented the production of an actual null phenocopy. Also, the methods used to 
produce dsRNA may not have worked uniformly for all genes and so there could have 
been differences in the injected concentrations of the different RNAs. If the RNAi 
results were an actual indication of the null phenotypes of these genes, then I would 
expect the deficiency to remove other similar genes which, in wild type worms, would 
compensate for the ‘knock-out’ of the rescuing genes by RNAi. Using the WU-Blast 
1.4 blastn sequence homology search, I searched for sequence alignment between the 
genes contained in C02C6 and in the K09A9/K09E9 overlap and other sequences 
contained within the ijDfl deficiency and no significant homology was found. WU- 
Blast 1.4 is based on NCBI-Blast version 1.4 (Gish and States, 1993; Altschul and Gish, 
1996). This leads me to believe that either the RNAi results were not indicative of the 
null phenotypes of the genes examined, except dyn-1, or that the phenotype seen in 
ijDfl homozygotes is the result of an extremely complex compound effect of many 
deleted genes. This may be the reason why there was also some degree of cosmid 
rescue with the non-overlap rescue of K09E9 plus C02C6. It is possible that the 
disruption of several pathways is responsible for the ijDfl phenotype and that, while 
replacing genes in some of these pathways gives significant repair, the removal of these 
genes alone is not sufficient to create the phenotype observed.
The relationships between genes that have emerged from the characterisation of 
this deficiency are much more complex than expected. I can not discard the possibility 
that other cosmids may also have rescued the phenotype to the same extent if they had 
been injected in their entirety rather than in the deleted forms discovered in retrospect. 
It is possible that a process necessary for the initiation of elongation or for terminal 
differentiation of the pharynx, requires the proper function of a common pathway with 
several gene components. There may also be a degree of redundancy which has been 
seen so often in C.elegans with various genes compensating for the loss of others 
(Culotti et a l , 1981; Johnson et al., 1988; Ferguson and Horvitz, 1989). This could 
explain why more than one combination of genes can repair the ijDfl early elongation 
defect. No clear cut explanation of rescue has arisen from this characterisation other
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than the fact that more than one gene is required for rescue, and the common factor in 
all rescue combinations has been an element of the cosmid C02C6. Because the 
K09A9/K09E9 overlap in combination with C02C6 is sufficient to rescue the early 
elongation defect, it would be of interest to check the predicted positions of the genes 
contained therein and to subclone them again with a larger upstream flanking region in 
each clone. The injections of these clones along with C02C6 may show which gene is 
involved in the rescue, if it is only one of these genes, and further injections with 
subclones of the genes in C02C6 could possibly provide rescue at the gene level. 
Although the removal of these genes may not be sufficient to cause the ijDfl phenotype, 
the study of rescuing genes could give an insight into how several aspects of elongation 
are controlled and unearth complex interactions that would otherwise have remained 
hidden.
273
Chapter 7 
Concluding discussion
7.1. Summary of results
The work presented in this thesis is concerned with embryonic and 
postembryonic shape change and maintenance in the nematode Caenorhabditis elegans. 
I have shown that many different factors are involved in these processes as well as 
elucidating some of these factors through the characterisation of mutants and the 
observations of an antibody localisation pattern. The characterisation of three 
embryonic lethal mutants defective in elongation suggests that the presence of a 
seemingly correctly fused hypodermis is not enough to drive normal elongation and that 
there are factors such as cell adhesion or the presence of certain GTPases or protein 
kinases which are involved in the dynamic process of embryonic shape change. The 
localisation of DPY-7, a cuticular collagen necessary for postembryonic shape 
maintenance, has been analysed using the monoclonal antibody, DPY7-5a. This has 
shown where DPY-7 is localised within hypodermal cells before secretion, when it is 
first translated, when it is secreted, and has given an indication of the position of DPY-7 
within the multilayered structure of the cuticle. The comparison of localisation patterns 
in wild type animals and in strains producing only mutant DPY-7 has given an 
indication of the cause of the mutant phenotype and the comparison of DPY7-5a 
staining patterns between wild type and non-dpy-7 mutants may yet uncover further 
collagen interactions.
7.2.1. Embryonic lethal mutations causing defective morphogenesis
Three mutants, that had been generated in two separate genetic screens for 
embryonic lethal mutants defective in morphogenesis, were phenotypically and 
genetically characterised. Two of these mutations were shown to be the result of 
deficiencies, ijDfl in the X chromosome, and ijDf2 in chromosome V. The third, w4 
was mapped genetically to an area of chromosome I between dpy-5 and unc-75 although 
it was not established if this mutation was the result of a point mutation or a deletion.
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ijDf2 homozygotes arrest as amorphous lumps of cells prior to any elongation 
and many of these arrested embryos have loose cells floating about inside the eggshell. 
Certain components of muscle, basement membrane, intestine, pharynx and 
muscle:hypodermis attachment structures are present at arrest and the embryos twitch in 
an uncontrolled manner. Defects in embryogenesis were seen before the precomma 
stage as ijDf2 homozygote embryos showed loose aggregations of cells rather than the 
tightly packed spheroid of cells seen before enclosure in the wild type embryo. For this 
reason, it was suggested that ijDf2 may delete a gene or genes involved in general cell 
adhesion, and this defect in turn would disrupt hypodermal morphogenesis when 
hypodermal cells are migrating around the embryo during enclosure and in the processes 
of body elongation and hypodermal cell fusion. Hypodermal cells were shown to be 
present around the surface of the embryo although they were completely disorganised 
and it was not clear if there were gaps in this hypodermal coverage. There were mono- 
and multi-nucleate hypodermal cells present and a seemingly correct total number of 
hypodermal nuclei. These cells were not organised into wild type positions, however, 
and the total number of hypodermal cells was less than the normal number at hatch, 
indicating a possible hyperfusion defect in the hypodermis. Although the ijDf2 
homozygote phenotype resembled gastrulation-defective embryos in several respects, 
some components of the pharynx and intestine were present internally, as were the body 
wall muscles and so this indicated that gastrulation had occurred to some extent (Knight 
and Wood, 1998). It is possible that gastrulation is not completed normally in ijDf2 
homozygotes, possibly due to a cell adhesion defect, although it is initiated and the 
internalisation of a number of cells has occurred. The ijDf2 deficiency was mapped 
both genetically and molecularly and was shown to delete 2.2Mb at the centre of 
chromosome V from around position -0.9 to position 0.7 on the genetic map. A 
deficiency, sDf30, that almost completely overlaps ijDf2, shows apparently normal 
gastrulation and enclosure of hypodermal cells and arrests at the 1.5- to 2-fold stage of 
elongation. It is apparent therefore that the gene or genes involved in the earlier, 
possible cell adhesion role, are present in the area of the genome that is deleted by ijDfl 
but not by sDflO.
ijDfl homozygotes appear to develop normally until the comma stage of 
embryogenesis. At this stage they appear to halt the elongation process while wild type 
embryos of the same age elongate normally to the 3-fold stage. ijDfl homozygotes
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arrest at the 1.5-fold stage of elongation with an apparently normal number of 
hypodermal nuclei. Some ijDfl homozygotes appear to have arrested with too few 
fusions in the dorsal hypodermis although all of them express collagen genes and 
secrete a cuticle. Components of the pharynx, intestine, basement membrane and 
muscles were shown to be present at arrest and the embryos twitch actively inside the 
eggshell although the movement is ‘jerky’ and uncontrolled. The monoclonal antibody, 
MH4, recognises intermediate filaments which are components of hemidesmosomes, 
specialised hypodermal structures which anchor muscle cells to the cuticle. The MH4 
staining pattern was shown to be absent from the hypodermis and, interestingly, the 
ijDfl deficiency does delete a predicted gene, W10G2.3, which encodes an intermediate 
filament protein (Dodemont et al., 1994). The ijDfl deficiency was mapped to the right 
arm of the X chromosome from position 18 to position 23.5, and deletes 1.6Mb of the 
genome. Two overlapping deficiencies, mnDfl7 and mnDf43, were characterised and 
compared to ijD fl, and a region of the physical map was implicated as a likely region to 
contain the gene or genes involved in the early elongation process. It was found that 
two groups of two cosmids from this region could rescue the early elongation defect and 
produce embryos that arrested at over the 2-fold stage of elongation. One of these 
cosmids in each rescue pair was C02C6 and the other rescuing cosmid was either 
K09A9 or K09E9. The genomic sequence contained within these two latter cosmids 
overlapped and this overlap contained two predicted genes, encoding a serine/threonine 
kinase-like protein, and a Ras-like GTPase respectively. It was found that this overlap 
alone injected with C02C6 also gave rescue of the early elongation defect and so one or 
both of these genes was involved in restoring the elongation defect of ijDfl.
It was proposed that, since GTPases of the Ras superfamily have been 
implicated in actin cytoskeletal organisation and the production of contractile stress 
fibres in fibroblasts, the Ras-like GTPase may be a likely candidate for a gene involved 
in the elongation process (Hall, 1998). There are three predicted genes in C02C6 but 
only one of these dyn-1 encodes a protein with significant homology to any known 
protein (Clark et al., 1997). DYN-1 is a homologue of vertebrate dynamin which is a 
small GTPase involved in coated pit endocytosis. It does not appear to be expressed in 
the hypodermis although the absence of any close homologues in C.elegans suggests 
that the protein should be present ubiquitously. The main role of dynamin in C.elegans 
is in the recycling of synaptic vesicles and it is present at high levels in neurons (Clark
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et a l, 1997; Labrousse et a l , 1998). It has also been suggested that dynamin is 
involved in endocytosis of yolk proteins necessary for nourishment of the developing 
embryo (B.Grant pers. comm.). It is possible that dynamin is present in hypodermal 
cells and has as yet remained undetected there. However, the role that dynamin plays, if 
any, in the rescue of the early elongation phenotype of ijDfl is unknown. The predicted 
gene encoding the intermediate filament protein is present outwith the area targeted for 
rescue of the early elongation phenotype. However, it is very possible that this gene has 
a role to play in the later stages of elongation as correct muscle-hypodermis attachment, 
mediated by the intermediate filaments, is an essential prerequisite to complete 
elongation.
Both ijDfl and ijDf2 were zygotic lethal mutations isolated from an EMS 
genetic screen for mutants defective in embryonic elongation carried out in our 
laboratory (I.Johnstone, pers.comm.). Genetic mapping and molecular data 
subsequently showed both these mutations to be very large deficiencies, ijDfl deleting 
1.6Mb and ijDf2 deleting 2.2Mb of the genome. This was unexpected considering the 
previous data both in C.elegans and in other organisms where over 90% of EMS 
mutation events resulted in a single G/C-»A/T substitution (Anderson, 1995; Li et al., 
1998). The purpose of our mutant screens was to select for embryonic lethal mutations 
affecting morphogenesis, which has been shown to be a complex process depending on 
the normal functioning of several different tissues. There are reports of very few single 
genes which have been mutated to completely disrupt elongation. It is very possible 
that severe elongation disruptions may be caused by mutations in several different gene 
combinations and by selecting for these defects, we have automatically been biasing our 
search towards deficiencies. The larger the deficiency, the more likely it is that it will 
delete two genes involved in the elongation process and thus produce an elongation 
defective phenotype. Between 15% and 30% of the 19,099 predicted genes in the 
genome are thought to be essential (Johnsen and Baillie, 1997). Selecting for 
embryonic lethal mutants in a screen may bias the outcome towards a higher possibility 
of obtaining deficiencies. Also, two genes which would produce viable phenotypes if 
deleted separately may produce a lethal phenotype when deleted together.
The third elongation defective mutant which was characterised was given to us 
from a screen carried out by Joel Rothman. w4 was mapped to the right arm of 
chromosome I, between dpy-5 and unc-75 and closer to unc-75 but a more precise
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location was not determined. The majority of w4 homozygotes, around 75%, arrest as 
embryos with a pronounced rupture of internal tissues at the lower ventral surface. 
Since this is the point of ventral closure of the hypodermal cells in wild type embryos, it 
seems that the w4 hypodermis does not enclose properly at this point and as elongation 
begins, internal tissues are forced out through the ventral opening. From time-course 
studies it can be seen that the amount of exuded tissue increases greatly after the comma 
stage until, at arrest, the embryo is very ruptured. The pharynx, muscles, basement 
membrane, intestine and hemidesmosomes all appear to be present in their correct 
positions and seem equivalent to wild type, except that the internal structures often 
extend outwith the embryo at the site of rupture. Hypodermal cells are present in 
approximately the correct number with an apparently wild type number of nuclei, 
however the site of rupture suggests that the most ventral hypodermal cells, the P cells 
do not form proper junctions with their contralateral neighbours. These homozygotes 
do secrete a cuticle which can be seen under Nomarski microscopy, and when using an 
antibody, DPY7-5a, which recognises the DPY-7 cuticular collagen. Around 25% of 
w4 homozygotes elongate to around 2.5 fold and hatch as lumpy-dumpy larvae. Most 
of these hatched mutants have dorsal and ventral bulges, especially at the anterior, a 
detached and fused buccal cavity, branched alae at the level of the bulges, and 
occasionally a blocked rectum. These mutants move slowly across a surface and die 
within 2-3 days of hatching without growing any larger, presumably due to starvation. 
Interestingly, Costa et al. (1998) characterised mutations in a gene, hmr-1 which maps 
to between dpy-5 and unc-75 on chromosome I and encodes a homologue of classical 
cadherin. hmr-1 homozygotes arrest as embryos and appear to be defective in 
hypodermal enclosure also, although the rupture appears to be towards the anterior in 
these embryos. A very small proportion (around 2%) of hmr-1 homozygotes enclose 
but do not elongate normally, arresting with dorsal bulges. It is possible that w4 is an 
allele of hmr-1 although cosmid rescue of the w4 phenotype was not obtained by 
injecting a group of cosmids including one containing the wild type hmr-1 gene.
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7.2.2. Characterisation of the staining pattern of DPY7-5a, a monoclonal antibody 
specific to the cuticular collagen DPY-7
The control of body morphogenesis is taken over by the multilayered cuticle at 
the 3-fold stage of embryonic elongation and the cuticle is responsible for maintaining 
shape change for the rest of the life cycle. The structural components of the cuticle are 
synthesised in the hypodermis and proteins known as collagens make up the majority of 
these components. Genetic studies have shown that some cuticular collagens are 
essential for maintaining shape as null mutants of the genes encoding these collagens 
have an altered postembryonic shape. Null mutations in other collagens do not produce 
a detectable phenotype under laboratory conditions, although mutant forms of these 
collagens can disrupt the organisation of the cuticle and cause an abnormal body shape. 
DPY-7 plays an significant role in the function of the C.elegans cuticle and the absence 
of DPY-7 in the cuticle results in a dumpy animal which is much shorter and broader 
than wild type, dpy-7 is also among the earliest group of collagen genes to be expressed 
in the hypodermis at each stage of the life cycle, beginning embryonically at the 
precomma stage. A novel monoclonal antibody, DPY7-5a, which is specific to the 
carboxy terminal domain of DPY-7 was generated by I. Johnstone in our laboratory and I 
observed the spatial and temporal staining of this antibody embryonically and 
postembryonically. The DPY7-5a antibody was shown to be specific to DPY-7 by 
staining dpy-7(qm63) homozygotes which have the dpy-7 locus deleted. These mutants 
showed no DPY7-5a staining at all. DPY7-5a showed an intracellular localisation of 
DPY-7 in hypodermal cells of the embryo from the precomma stage to around the 2.5 
fold stage of development. This result coincided with the previous finding that dpy-7 
was expressed at the precomma stage of embryonic development (Johnstone and Barry, 
1996). Staining was cytoplasmic and appeared to be present throughout the whole cell, 
although most of the staining was subapical, and it was absent from the nucleus. All 
hypodermal cells appeared to contain DPY7-5a staining although the seam cells 
appeared to show a less bright signal in some embryos. From the 2.5 fold stage to the 3- 
fold stage there was a switch from an intracellular to an extracellular location of the 
DPY7-5a antibody and at the 3-fold stage, staining was present extracellularly in 
circumferentially arranged bright bands, except over the seam cells where there was a 
complete absence of staining. These bright circumferentially arranged bands of DPY7-
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5a staining coincided exactly with the annular ridges of the cuticle. This suggests that 
the DPY-7 collagen is in the cortical layer of the cuticle as this is the only layer to be 
patterned into annulae, and that DPY-7 is localised to a region of the annular ridges 
(Cox et al., 1981a; Costa et al., 1998). The intracellular pattern of localisation was only 
examined thoroughly during embryogenesis as in later stages, the secreted cuticle makes 
internal observation difficult. However, in stages where internal staining was observed 
postembryonically, it appeared to follow the same intracellular pattern and was present 
in hypodermal cells as expected. Extracellular staining of DPY7-5a was seen in all 
stages. In LI and adult stages, there is a clear absence of DPY7-5a staining from above 
the seam cells and staining is only seen to either side of the alae, the cuticular structures 
which run longitudinally above the seam. In L2-L4 stages however, the annulae 
staining appears to traverse the borders of the seam cells and, in many cases, the annulae 
almost interdigitate above the seam. Since it has been reported that annulae are absent 
from above the seam cells at all stages, this may indicate some movement of the DPY-7 
collagen over cell boundaries. It appears that the DPY-7 protein is only completely 
absent or undetectable over the seam cells at stages where there are alae present.
All collagens have conserved blocks of Gly-X-Y repeats, and point mutations 
which cause glycine substitutions in these repeats in collagens essential for the 
maintenance of shape usually result in shape defects when homozygous. It was 
previously thought that these mutant phenotypes were due to the absence of the wild 
type collagen in the cuticle rather than the presence of the mutant collagen as the 
mutations are recessive and the phenotypes are very similar to the null phenotype of 
each particular collagen gene (Johnstone et al., 1992; Johnstone, 1994; Kramer, 1997). 
I examined the pattern of the DPY7-5a antibody in mutants homozygous for the 
dpy7(e88) mutation which results in a Gly-X-Y repeat glycine substitution. The internal 
staining pattern during embryogenesis was as wild type, but when the intracellular- 
extracellular switch occurred there was a noticeable decrease in the amount of DPY-7 
collagen secreted into the cuticle. There was some extracellular DPY7-5a staining, 
however, which indicates that a proportion of the mutant collagen does enter the cuticle. 
This observation suggests that although the dumpy phenotype produced in this mutant 
may be due mostly to the absence of wild type DPY-7 collagen in the cuticle, there still 
may be a component of the phenotype which is due to the presence of mutant DPY-7 
collagen in the cuticle. To ensure that this reduction in extracellular DPY7-5a staining
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was not simply a facet of the dumpy phenotype, I stained dpy-13(e458) homozygotes. 
DPY-13 is another collagen essential for postembryonic shape maintenance and the dpy- 
13(e458) homozygotes represent the null phenotype. Intracellular DPY7-5a staining 
was as wild type in dpy-13(e458) homozygote embryos and the intracellular- 
extracellular switch occurred as normal. Extracellular staining of all larval stages and 
the adult stage was in the same pattern as wild type except that the bands of staining, 
representing annulae, were much closer together, around half the distance apart of wild 
type annulae. Costa et a l (1997), reported that it is the circumferentially aligned actin 
microfilaments within hypodermal cells that pattern the cuticle, giving rise to annulae. 
Since these actin microfilaments are independent of the cuticle, it would seem likely 
that there would be the same amount of actin filaments and thus annulae in a wild type 
and a dumpy animal. For this reason, the annulae should be closer together in the 
dumpy animal, and the shorter the animal, the closer together the annulae should be. I 
found that this indeed appeared to be true when comparing dpy-13(e458) homozygotes 
with wild type animals of the same stage.
The DPY7-5a antibody is a useful tool when examining postembryonic shape 
change as it may give an indication of the reason for particular phenotypes and the 
organisation of the cuticle in wild type worms. It may also shed some light on the 
temporal expression of collagen genes in the hypodermis by staining collagens that are 
expressed at the same time and those expressed in the later temporal waves.
7.2. Future work
7.2.1. Cosmid rescue of ijDf2 early enclosure/cell adhesion defect
In order to identify precisely which gene or genes are deleted by ijDf2 to 
produce the unelongated arrest phenotype, the endpoints of the ijDf2 and sDf30 
deficiencies would have to be mapped more finely on the physical map. ijDf2 extends 
further right than sDf30 and may also extend further to the left. It is possible that the 
gene or genes of interest are deleted by a region of ijDf2 which is deleted by it and not 
sDf30. Overlapping groups of cosmids corresponding to this area could be injected into 
ijDf2 heterozygotes with the same markers used for indicating transgenic larvae and 
embryos as were used in the cosmid rescue of ijDfl (section 6.5). The resulting rescue
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should produce ijDf2 homozygote embryos that elongate to an equivalent length to 
sDf30 homozygotes. This may give a clearer indication of what process is being 
affected in ijDf2 homozygotes and how it relates to morphogenesis.
7.2.2. Rescue of the ijDfl early elongation phenotype at the gene level
I showed that the overlap of genomic sequence between the cosmids K09A9 and 
K09E9 along with the cosmid C02C6 produced rescue of the ijDfl early elongation 
defect. Rescue was not obtained, however, when the two predicted genes contained in 
this overlap were subcloned and injected together with the C02C6 cosmid. This may 
have been for several reasons, one of which being that there may not have been enough 
upstream flanking sequence contained along with the gene coding sequence in the 
subclones. In order to narrow down the number of genes involved in this early 
elongation process, it would be beneficial to subclone these two predicted genes again, 
with larger flanking sequences, and to try to achieve the early elongation defect rescue 
at the gene level. This would show which of these predicted genes was involved in this 
process, or that both were involved. There are three predicted genes in C02C6 and so 
these could be subcloned also and different combinations of genes could be injected in 
an attempt to rescue the early elongation phenotype using gene subclones.
7.2.3. The involvement of an intermediate filament component coding gene in the 
elongation process
Although the cosmid W10G6 was not in the region targeted for rescue of the 
early elongation phenotype, there is a strong possibility that it could influence the later 
stages of elongation as it contains the gene W10G6.3 which encodes an intermediate 
filament component. Intermediate filaments are important components of 
hemidesmosomes, structures in the hypodermis which function in the attachment of 
muscles through the hypodermis to the cuticle. Muscle attachment to the hypodermis 
has been shown to be an important feature in the elongation process from 2- to 3-fold 
and mutants defective in muscle:hypodermis attachments usually arrest as lumpy, 
improperly elongated embryos (Rogalski et a l , 1993; Williams and Waterston, 1994; 
Gupta et al., 1997). Staining ijDfl homozygotes with the MH4 antibody, which
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recognises an unknown component of hemidesmosomes, showed a complete absence of 
staining in the hypodermis although the staining patterns of this antibody in other 
structures were present. This indicates some defect in the hypodermal muscle 
attachment structures, probably due to the absence of W10G6.3 gene, and so may have 
an effect on the later stages of ijDfl homozygote elongation. In order to investigate this, 
the cosmids W10G6 and F52E10, or the subcloned W10G6.3 gene could be injected 
into ijDfl heterozygotes along with the K09A9/K09E9 overlap plus C02C6 cosmids 
which are known to rescue the early elongation defect seen, and the resulting 
transformed ijDfl homozygotes could be observed for changes in the degree of rescue.
7.2.4. Testing whether w4 is an allele of hmr-1
The theory that w4 may be an allele of hmr-1 because of the proximity of the 
loci and the similarity of the phenotypes produced by homozygous mutants, could be 
tested by a complementation test or by attempting to rescue the w4 phenotype by 
injection of an hmr-1 subclone. Attempted rescue using the W02B9 cosmid or an hmr-1 
subclone would be carried out by injecting w4 heterozygotes using the same marker 
genes as in section 6.5 and then monitoring transformed lines for any rescue of the 
embryonic lethal phenotype. If the injected DNA rescues the embryonic lethal 
phenotype, then the co-injected dpy-7::GFP fusion construct marker would not be 
present or expressed in dead embryos, but if  the injected DNA did not rescue the 
embryonic lethal phenotype then expression of the dpy-7 v.GFP transgene would be 
present in a percentage of arrested embryos equivalent to the transformation frequency 
of the line.
7.2.5. Electron microscopy of the cuticle of hatched w4 homozygotes
In order to investigate whether the defects seen in w4 homozygotes are purely 
due to hypodermal abnormalities, an investigation of the cuticle of hatched 
homozygotes could be undertaken. w4 hatched homozygotes have branched alae and a 
lumpy, short appearance with dorsal and ventral bulges so the cuticle may be weak or 
defective in certain areas. Serial sections of the cuticle at these areas of abnormal body 
shape would help to elucidate whether these abnormalities simply reflected defects in
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the underlying hypodermal cells or whether they are due to actual structural defects in 
the cuticle.
7.2.6. Determining the precise point of DPY-7 secretion during embryogenesis
It is known that the cuticle is secreted at the 3-fold stage of embryogenesis but 
analysis of the actual process of secretion of the DPY-7 cuticular collagen may help to 
elucidate the stages of this process. Synchronised embryonic cultures can be obtained 
by cutting open gravid hermaphrodites and selecting 2-cell stage embryos. These 
synchronised cultures could be left to develop until the 2-fold stage of embryogenesis in 
an appropriate buffer and then sample specimens taken every 10 minutes, fixed and 
stained with the DPY7-5a monoclonal antibody. In this way, the precise time of cuticle 
secretion, estimated from the secretion of the DPY-7 collagen, can be observed and the 
transition from intracellular to extracellular staining could be monitored much more 
closely. Once the secretion time is known more accurately, embryos could be stained at 
smaller time points and the secretion process could be observed more clearly. This 
analysis would indicate whether there is a specific area where cuticle secretion begins, 
or whether it is a more uniform process, it would also elucidate whether DPY-7 collagen 
is secreted along an annular ridge at various points at the same time or whether there is a 
focal point from which cuticle secretion spreads.
7.2.7. Precise subcellular localisation of DPY-7 collagen in the hypodermis
I have reported the intracellular localisation of DPY-7 as observed using 
immunofluorescence microscopy but a much more accurate subcellular localisation 
could be obtained using electron microscopy. Serial sections of embryos throughout the 
stages of elongation stained with the DPY7-5a monoclonal antibody may show subtle 
changes in the position of DPY-7 within cells, from the time of translation to the time of 
secretion. Electron microscopy would indicate which organelles DPY-7 co-localises 
with and if this changes throughout embryonic development. This may elucidate 
aspects of the cuticle formation process and could even indicate a route from the 
intracellular position of the DPY-7 collagen to the apical surface in preparation for 
secretion.
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7.2.8. DPY7-5a staining pattern in collagens expressed at the same time during 
development
Many aspects of cuticular collagen synthesis and organisation are still unknown 
including whether collagen trimers are made up of collagen chains from only one or 
more than one collagens. It is known that collagen genes are expressed in temporal 
waves during development but the reason for this organisation still remains unclear 
(Johnstone and Barry, 1996). dpy-7 is expressed at the same time as several other 
collagen genes, including dpy-2 and dpy-10 and so it would be interesting to look at the 
DPY7-5a staining pattern in embryos homozygous for dpy-2 or dpy-10 null alleles 
(J.Muriel, pers comm.). This may indicate previously hidden interactions between 
collagens expressed at the same time and may help provide an explanation as to why 
collagens are expressed in this manner.
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Appendices
Appendix 3.1
Measurements of the distance between annu!ae/DPY7-5a bands in N2 and CB458 
strains in pm
N2
young adults:
A)
1.178 1.149 1.157 1.157 0.930 1.178 1.149 1.178 1.140 1.283
1.178 1.053 1.283 1.283 1.053 1.178 1.538 1.157 1.283 1.283
1.283 1.178 1.029 1.140 1.183 1.140 1.140 1.183 1.183 1.178
1.157 1.538 1.149 1.178 1.302 1.410 1.404 1.178 1.428 1.140
0.723 0.818 0.903 0.639 0.723 0.903 0.723 0.723 0.818 0.723
0.818 0.723 0.639 0.998 0.998 0.542 0.818 0.903 0.639 0.818
0.903 0.818 0.818 0.998 0.903 0.639 0.818 1.029 0.818 0.818
0.903 0.723 0.818 1.098 0.903 1.029 1.098 0.818 0.972 0.542
1.098 0.972 0.571 0.818 0.808 0.818 0.639 0.930 0.745 0.903
0.930
C)
0.972 0.903 0.903 0.930 0.894 0.894 0.651 1.149 1.029 0.808
0.894 1.022 0.808 1.029 1.157 0.688 0.930 1.022 0.651 0.903
1.149 0.777 0.903 1.029 0.930 1.149 1.022 0.808 0.777 0.894
0.808 0.903 1.157 0.777 0.894 1.029 0.651 0.903 1.178 1.149
0.903 0.930 0.894 0.894 0.930 0.894 0.903 1.029
1.083 1.178 1.091 0.930 1.091 0.977 1.083 1.178 0.977 0.903
0.930 0.977 1.029 1.178 0.857 1.083 1.091 0.977 1.083 1.178
1.029 1.083 1.157 1.091 1.083 1.178 1.091 1.083 1.083 0.977
1.091 0.930 0.977 1.083 0.903 0.977 1.303 0.894 1.258 1.083
1.083 1.142 1.022 0.930 1.091 1.283 0.857 1.142
1.029 0.930 1.083 1.029 1.178 1.083 1.157 1.211 1.083 0.930
1.333 1.283 1.178 1.303 1.178 1.083 1.333 1.157 1.178 1.333
1.083 0.972 1.553 1.178 1.178 1.211 1.083 0.903 1.303 1.091
1.083 1.083 1.083 1.083 1.178 1.178 1.091 1.178 1.091 0.972
1.178 1.083 1.083 0.930 1.211 1.178 1.083 1.091
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Appendix 3.1 (continued)
Measurements of the distance between annulae/DPY7-5a bands in N2 and CB458 
strains in pm
N2 old adults
A)
1.498 1.459 1.431 1.639 1.379 1.669 1.378 1.639 1.431 1.741
1.379 1.669 1.431 1.741 1.431 1.498 1.384 1.379 1.493 1.547
1.431 1.547
1.778 1.456 1.376 1.494 1.494 1.778 1.456 1.494 1.376 1.302
1.778 1.333 1.580 1.315 1.580 1.580 1.580 1.494 1.494 1.660
1.456 1.615 1.778 1.456 1.543 1.428 1.615 1.543 1.494 1.376
1.660 1.778 1.456 1.376 1.494 1.580 1.376 1.315 1.494 1.494
1.660 1.580 1.494 1.660 1.494 1.376 1.714
1.660 1.494 1.899 1.737 1.778 1.859 1.778 1.954 1.600 1.899
1.615 1.778 1.494 1.615 2.063 1.376 1.806 2.063 1.494 1.302
1.899 1.660 1.428 2.019 1.580 1.494 2.182 1.737 1.456 2.141
1.737 1.456 1.859 1.737 1.580 1.615 1.737 1.859 1.494 1.704
1.553 1.615 1.580 1.778 1.615 1.778 1.615
CB458 [dpy-13(e458)\ adults 
A)
0.746 0.572 0.572 0.746 0.640 0.859 0.746 0.859 0.462 0.859
0.572 0.572 0.405 0.689 0.859 0.820 0.746 0.640 0.462 0.923
0.640 0.640 0.543 0.724 0.724 0.820 0.640 0.640 0.543
0.689 0.572 0.820 0.810 0.746 0.859 0.859 0.746 0.810 0.859
0.746 0.820 0.689 0.572 0.820 0.640 0.859 0.820 0.640 0.746
0.820 0.572 0.572 1.000 0.746 0.859 0.820 0.640 0.572 0.746
0.820 0.746 0.820 1.208 0.572 0.923 0.746 0.689 0.923 0.859
0.859 0.653 0.810 0.689 0.689
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Appendix 4.1
Percentage of LI and embryonic death in broods from heterozygous w4/+ 
hermaphrodites. All broods maintained at 20°C except where stated.
Within each brood Within dead progeny
Number of
dead
embryos
Number of 
dead L is
Number of
viable
progeny
Percentage
death
Percentage 
LI death
Percentage
embryonic
death
91 28 0 100* 24 76
34 10 124 26 23 77
35 18 130 29 34 66
32 8 99 29 20 80
40 10 92 35 20 80
31 18 110 31 37 63
32 5 91 29 13 86
20 2 46 32 9 91
23 2 49 34 8 92
11 0 55 17 0 100
22 2 59 29 8 92
16 1 51 25 6 94
20 4 57 30 16 84
11 1 24 33 8 92
7 1 27 23 12 88
27 2 78 27 7 93
17 6 72 24 26 74
12 10 82 21 45 55
36 11 89 35 23 77
17 15 90 26 47 53
18 4 59 27 18 82
12 4 38 30 25 75
6 3 39 19 33 67
11 7 38 32 39 61
15 5 82 20 25 75
21 7 69 29 25 75
24 10 86 28 29 71
8 7 27 36 47 53
7 8 32 32 53 47
6 6 38 24 50 50
8 11 28 40 58 42
14 4 57 33 22 78
12 12 68 26 50 50
7 1 48 14 12 88
*Parent hermaphrodite was maintained at 13°C as incubator was not working properly 
and so a w4 homozygote must have escaped death. This brood was not included when 
calculating the average percentage death.
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Appendix 4.2
ZE316 MT465 cross - raw data:
F2 recombinants
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A ppendix 4.3
dpy-5+unc-l 01/+w4 + three-factor cross raw data
Brood
number
Dpy-non-Unc recombinants Unc-non-Dpy recombinants
number of
dead
progeny
number o f
living
progeny
percentage
death
number of
dead
progeny
number o f
living
progeny
percentage
death
1 0 ND 0 0 ND 0
2 16 60 21 9 63 13
3 15 42 26 0 ND 0
4 22 82 21 30 91 25
5 0 ND 0 0 ND 0
6 11 52 17 0 ND 0
7 17 31 35 9 44 17
8 0 ND 0 20 47 30
9 0 ND 0 0 ND 0
10 15 68 18 0 ND 0
11 0 ND 0 0 ND 0
12 9 29 24 33 72 31
13 14 75 16 0 ND 0
14 12 30 29 0 ND 0
15 20 51 28 21 63 25
16 24 91 21 0 ND 0
17 0 ND 0 15 47 24
18 15 50 23 0 ND 0
19 20 57 26 9 21 30
20 0 ND 0 0 ND 0
21 7 39 15 0 ND 0
22 10 24 29 0 ND 0
23 12 44 21 0 ND 0.
24 5 23 18 0 ND 0
25 4 12 25 0 ND 0
26 15 46 25 0 ND 0
27 5 24 17 7 17 29
28 8 52 13 0 ND 0
29 0 ND 0 24 58 29
30 5 12 29 19 54 26
31 0 ND 0 16 42 28
32 0 ND 0 18 52 26
33 15 32 32 14 26 35
34 0 ND 0 0 ND 0
35 25 69 27 19 40 32
36 0 ND 0
37 0 ND 0
38 27 64 30
39 18 74 20
40 18 78 19
41 19 63 23
42 16 60 21
43 14 50 22
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Appendix 4.4a
F2 progeny phenotypes from Line2 of w4 cosmid injections
Brood number of
dead
embryos
Total
number of 
larvae
number of 
Uncs
number of 
Rollers
percentage
Uncs
A 29 84 1 9 0.9
B 49 91 0 8 0
C 29 58 1 9 1.1
Appendix 4.4b
F3 progeny phenotypes from Line 2 of w4 cosmid injections
Brood number of
dead
embryos
Total
number of 
larvae
number of 
Uncs
number of 
Rollers
percentage
Uncs
Al sterile adult
A2 27 95 2 21 1.6
A3 sterile adult
A4 44 98 4 7 2.8
A5 32 102 1 27 0.7
A6 sterile adult
A l sterile adult
A8 26 63 2 9 2.2
A9 31 78 2 32 1.8
B1 17 50 2 17 3.0
B2 17 66 2 7 2.4
B3 sterile adult
B4 sterile adult
B5 sterile adult
Cl 13 32 0 4 0
C2 sterile adult
C3 sterile adult
C4 sterile adult
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A ppendix 4.4c
F4 Progeny phenotypes from F3s including Uncs from Line2 o f  w4 cosmid injections
brood no Roller
phenotype
number of
dead
embryos
Total
number of 
larvae
number of 
Uncs
percentage
Uncs
A l.l yes sterile adult
A1.2 yes sterile adult
A1.3 yes sterile adult
A1.4 yes 47 84 2 1.5
A1.5 yes 27 47 0 0
A1.6 yes sterile adult
A luncl no 13 48 N/A N/A
A2.1 yes 33 70 2 1.9
A2.2 yes sterile adult
A2.3 yes sterile adult
A2.4 yes 20 101 0 0
A2.5 yes sterile adult
A2uncl no 30 122 N/A N/A
A2unc2 yes 23 101 N/A N/A
A2unc3 no 29 96 N/A N/A
A3.1 yes 31 129 5 3.1
A3.2 yes 24 114 4 2.9
A3.3 yes 36 103 4 2.8
A3.4 yes 25 59 0 0
A3.5 yes sterile adult
A4.1 yes 55 116 4 2.3
A4.2 yes sterile adult
A4.3 yes 30 93 2 1.6
A4.4 yes 29 80 2 1.8
A4.5 yes sterile adult
A4uncl no 20 59 N/A N/A
A5.1 yes 31 61 3 3.3
A5.2 yes 54 108 3 1.9
A5.3 yes 30 78 5 4.6
A5.4 yes 34 83 3 2.6
A5.5 yes 25 68 2 2.2
A5uncl yes 28 71 N/A N/A
B l.l yes sterile adult
B1.2 yes 19 48 3 4.5
B2.1 yes sterile adult
B2.2 yes 39 106 4 2.8
B2.3 yes 45 97 3 2.1
B2.4 yes 32 68 2 2.0
B2.5 yes 25 101 2 1.6
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A ppendix 5.1
Percentage death in 33 broods from ijDfl heterozygote hermaphrodites. All broods 
were maintained at 20°C.
Number of dead 
embryos
Number of viable 
LI larvae
Total progeny Percentage death
33 75 108 30
32 76 108 30
28 72 100 28
29 63 92 32
24 58 82 29
12 54 66 18
16 52 68 24
33 61 94 35
14 42 56 25
25 84 109 23
24 86 110 22
36 73 109 33
28 71 99 28
39 96 135 29
20 69 89 22
16 65 81 20
15 59 74 20
20 64 84 24
17 56 73 223
18 56 74 24
24 81 105 23
17 78 95 18
23 53 76 30
11 50 61 18
19 71 90 21
26 68 94 28
23 58 81 28
28 57 85 33
25 50 75 33
20 66 86 23
30 88 118 25
15 76 91 16
28 75 103 27
Average death = 25.5±0.88%
Total number of progeny scored = 2971
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Appendix 5.2a
Tabulated representation of chromosomal assignment STS multiplex PCR gels for 
ijDfl.
In all cases, 1 indicates the presence of the STS marker band, and 0 indicates its 
absence. Each lane on the gel represented one embryo._______________________
embryo hP4
(LG I)
maPl 
(LG II)
mgP21 
(LG III)
sP4
(LG IV)
bPl
(LG V)
1 1 0 0 1 0
2 0 0 1 1 0
3 1 0 1 0 0
4* 1 1 0 1 1
5 1 1 1 1 0
6 1 1 0 0 0
7 1 1 0 1 0
8 0 0 1 1 0
9 1 1 1 1 0
10 0 1 1 1 0
11 0 1 0 1 0
13 1 0 0 1 0
14 0 1 1 1 0
15 1 0 1 1 0
16 1 0 1 1 0
17 1 0 1 1 0
21 1 1 1 1 0
22 0 1 1 1 0
23 1 1 1 0
24 1 1 1 1 0
25 1 1 1 1 0
26 1 1 1 1 0
27 1 1 1 1 0
28 1 1 1 0
29 1 1 1 1 0
30 1 1 0 0 0
31 0 1 1 1 0
32 1 1 0 1 0
33 1 1 0 1 0
34 1 1 1 1 0
35 0 1 1 0 0
36 0 1 0 1 0
37 0 1 1 1 0
38 1 1 0 0
39 1 1 1 1 0
40 0 1 0 0
41 0 1 1 0
42 1 1 1 1 0
43 1 1 0 1 0
44 1 1 0 0
45 1 1 1 1 0
46 1 1 1 0 0
47 1 1 0 0 0
48 1 1 1 1 0
49 0 1 1 0 0
50 0 1 0 0 0
51 0 1 1 1 0
TOTAL 32/47 33/47 34/47 35/47 1/47
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Appendix 5.2a continued
Reactions: 12, 18, 19 and 20 failed.
The number of bPl bands may have been underestimated as on some gels, the control 
bPl band was quite faint. On gels with clear bPl controls, however, the band was only 
seen once (* embryo 4). The ijDf2 mutation is still clearly linked to Chromosome V 
comparing the incidence of bPl bands with STS markers from the other chromosomes 
which were all present in approximately 75% of embryos (corresponding to 35 out of 47 
embryos).
Appendix 5.2b
Tabulated representation of gels showing chromosome V mapping data for ijDf2 using 
STS markers on the right and centre of chromosome V.
1 indicates the presence of a STS marker band, and 0 indicates the absence of the band. 
STS markers are placed in the order that they appear on chromosome V, from left to 
right (stP192 being the farthest left in this group). Each lane on the gel represented one 
embryo.
embryo stP192 bPl stP6 stP108 stP105 stP128
1 0 0 0 1 1 1
2 0 0 0 0 1 1
3 0 0 0 1 1 1
4 0 0 0 1 1 1
5* 1 1 1 1 1 1
6 0 0 0 1 1 1
7 0 1 1 1 1 1
8 0 0 0 1 1 1
9 0 0 0 0 1 1
10 0 0 0 1 1 1
11 0 0 0 0 1
12 0 0 0 0 1 1
13 0 0 0 0 1 1
14 0 0 0 1 1 1
15 0 0 0 1 1 1
16 0 1 1 1 1 1
17 0 0 1 1 1 1
18 0 0 0 1 1 1
19 0 0 0 0 1 1
29 gel lanes contained no bands either due to a failed PCR reaction or absence of the 
STS markers tested in the embryo.
*embryo 5 was probably a dead RW7000 embryo as it had all STS markers in the 
region, (from later results I know that stP192 is deleted in ijDf2). Occasionally, the 
RW7000 strain gives death or sick larvae due to the high number of Tel insertions.
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A ppendix 5.2c
Tabulated representation of gels showing chromosome V mapping data for ijDf2 using 
STS markers on the left and centre of chromosome V.
1 indicates the presence of a STS marker band, and 0 indicates the absence of the band. 
STS markers are placed in the order that they appear on chromosome V, from left to 
right (stP3 being the farthest left in this group). Each lane on the gel represented one 
embryo.
embryo stP3 stP192 bPl stP6 stP18
1 1 0 0 0 0
2 1 0 0 0 0
3 0 0 0 0 1
4 0 0 0 1 1
5 0 0 0 0 1
6 0 0 0 1 1
7 0 0 0 1 1
8 0 0 0 1 1
9 0 0 0 1 1
10 0 0 0 0 1
11 1 0 0 0
12 0 0 0 0 1
13 0 0 0 1 1
14 0 0 0 0 1
15 1 0 0 0
16 0 0 0 1 1
17 0 0 0 1 1
18 0 0 0 1 1
19 0 0 0 1 1
20 0 0 0 1 1
21 1 0 0 0
22 0 0 0 1 1
23 0 0 0 1 1
24 0 0 0 0 1
137 gel lanes contained no bands either due to a failed PCR reaction or absence of the 
STS markers tested in the embryo.
296
Appendix 5.2d
Tabulated representation of gels showing chromosome V mapping data for ijD fl using 
STS markers on chromosome V.
1 indicates the presence of a STS marker band, and 0 indicates the absence of the band. 
STS markers are placed in the order that they appear on chromosome V, from left to 
right (stP3 being the farthest left in this group). Each lane on these gels represented a 
pool of 10 embryos.
embryo
pool
stP3 stP192 stP23 bPl stP6 stP128
1* 1 1 1 1 1 1
2 1 0 0 1 1 1
3 0 0 0 0 1
4 0 0 0 1 1 1
5 0 0 0 1 1 1
6 1 0 0 0 1
7 0 0 0 0 1 1
8§ 1 0 1 1 1 1
9§ 1 0 1 1 1 1
10 0 0 0 1 1 1
11 1 0 0 1 1 1
12 1 0 0 0 1
13 0 0 0 0 1
14 0 0 0 1 1 1
15 0 0 0 0 1 1
16 0 0 0 1 1 1
17 0 0 0 1 1 1
18 1 0 0 0 1 1
19 0 0 0 0 1 1
20 0 0 0 0 1
21 1 0 1 1 1 1
22 1 0 1 1 1 1
23 1 0 1 1 1 1
24 1 0 0 1 1 1
25 0 0 0 1 1 1
26 1 0 0 0 1 1
27 0 0 0 0 1
28 0 0 0 0 1 1
29 0 0 0 1 1 1
30 0 0 0 0 0 1
31 0 0 0 0 0 1
3 lanes contained bands which were too faint to distinguish properly.
*The pool of 10 probably an RW7000 death as all STS markers are present
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Appendix 6.1
Percentage death in 33 broods from ijDfl heterozygote hermaphrodites. All broods 
were maintained at 20°C.
Number of dead 
embryos
Number of viable 
LI larvae
Total progeny Percentage death
35 89 124 28
32 86 118 27
30 80 110 27
13 40 53 24
16 45 61 26
17 40 57 30
13 42 55 24
16 36 52 31
15 48 63 24
12 36 48 25
21 43 64 33
25 43 68 37
14 53 68 20
14 39 53 26
22 38 60 37
18 53 71 25
14 49 63 22
20 49 69 29
46 134 180 26
32 65 97 33
29 51 80 36
21 48 69 30
16 47 63 25
15 52 67 22
18 58 76 24
14 43 57 24
29 59 88 33
18 68 86 21
17 52 69 25
15 46 61 24
11 37 48 23
25 69 94 26
29 67 96 30
Average death = 27.2±0.79%
Total number of progeny scored = 2488
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Appendix 6.2
Tabulated representation of gels showing mapping data for ijDfl using STS markers on 
the X chromosome, (continued on the next two pages)
1 indicates the presence of a STS marker band, and 0 indicates the absence of the band. 
STS markers are placed in the order that they appear on the X chromosome, from left to 
right (stP41 being the farthest left). Each lane on the gel represents one embryo.
Embryo stP41 stP40 stP33 stP129 stP72 stP2
1 1 1 0 0 0 0
2 1 1 1 0 0 0
3 1 1 0 0 0 0
4 1 1 0 0 0 0
5 1 1 1 1 0 0
6 1 1 1 1 0 0
7 1 1 1 0 0 0
8* 1 1 1 1 1 1
9 1 0 0 0 0
10 1 1 0 0 0 0
11 1 1 0 0 0 0
12 1 1 0 0 0 0
13 1 1 1 0 0 0
14 1 1 0 0 0 0
15 1 1 1 0 0 0
16 1 1 0 0 0 0
17 1 1 0 0 0 0
18 1 1 1 1 1 0
19 1 1 1 1 1 0
20 1 1 1 0 0 0
21* 1 1 1 1 1 1
22 1 0 0 0 0
23 1 1 0 0 0 0
24 1 1 0 0 0 0
25 1 1 0 0 0 0
26 1 1 0 0 0 0
27 1 1 0 0 0 0
28 1 1 0 0 0 0
29? 1 0 0 0 1
30 1 0 0 0 0
31 1 1 0 0 0 0
32 1 1 1 0 0 0
33 1 1 1 1 1 0
34 1 1 1 0 0 0
35 1 0 0 0 0
36 1 1 0 0 0 0
37 1 1 1 1 0 0
38* 1 1 1 1 1 1
39 1 0 0 0 0
40 1 1 1 1 0 0
41 1 1 1 1 0 0
42 1 1 1 0 0 0
43? 1 1 0 1 1 0
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Embryo stP41 stP40 stP33 stP129 stP72 stP2
44 1 1 0 0 0 0
45 1 1 0 0 0 0
46 1 1 0 0 0 0
47 1 1 1 1 1 0
48 1 1 1 0 0 0
49 1 1 0 0 0 0
50 1 1 1 0 0 0
51 1 1 1 1 0 0
52 1 1 0 0 0 0
53 1 1 0 0 0 0
54 1 0 0 0 0
55 1 0 0 0 0
56 1 1 0 0 0 0
57 1 1 0 0 0 0
58 1 0 0 0 0
59 1 1 1 1 0 0
60 1 1 1 0 0 0
61 1 1 1 1 0 0
62 1 1 0 0 0 0
63 1 1 1 1 0 0
64 1 1 0 0 0 0
65 1 1 0 0 0 0
66 1 0 0 0 0
67 1 1 1 0 0 0
68 1 0 0 0 0
69 1 1 1 0 0 0
70 1 1 1 0 0 0
71 1 1 1 0 0 0
72 1 1 0 0 0 0
73 1 1 1 1 0 0
74 1 0 0 0 0
75 1 1 0 0 0 0
76 1 1 0 0 0 0
77 1 1 0 0 0 0
78 1 1 1 0 0 0
79 1 1 1 0 0 0
80 1 1 1 0 0 0
81 1 1 0 0 0 0
82 1 1 0 0 0 0
83 1 0 0 0 0
84 1 1 1 0 0 0
85* 1 1 1 1 1 1
86 1 1 1 0 0 0
87 1 1 0 0 0 0
88 1 1 1 1 0 0
89 1 1 1 0 0 0
90 1 1 0 0 0 0
91 1 0 0 0 0
92 1 0 0 0 0
93 1 1 1 0 0 0
94 1 1 1 0 0 0
95 1 1 0 0 0 0
96 1 1 1 1 0 0
97 1 1 0 0 0 0
98 1 1 1 0 0 0
99 1 1 0 0 0 0
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Embryo stP41 stP40 stP33 stP129 stP72 stP2
100 1 0 0 0 0 0
101 1 1 1 0 0 0
102 1 1 1 0 0 0
103 1 1 0 0 0 0
104 1 1 0 0 0 0
105 1 0 0 0 0 0
106 1 1 1 1 0 0
107 1 0 0 0 0 0
108 1 0 0 0 0 0
109 1 1 1 1 0 0
110 1 0 0 0 0 0
111 1 1 1 0 0 0
112? 1 1 1 0 0 1
113 1 0 0 0 0 0
114 1 0 0 0 0 0
115 1 1 1 1 0 0
116 1 0 0 0 0 0
117 1 0 0 0 0 0
118 1 1 1 1 0 0
119 1 0 0 0 0 0
120 1 0 0 0 0 0
121 1 0 0 0 0 0
122 1 1 0 0 0 0
123 1 0 0 0 0 0
124 1 1 0 0 0 0
125 1 1 0 0 0 0
126 1 0 0 0 0 0
127 1 1 0 0 0 0
128 1 1 1 0 0 0
129 1 0 0 0 0 0
130 1 1 1 1 0 0
131 1 0 0 0 0 0
* may be RW7000 homozygotes which have died as embryos. RW7000 animals are 
very slow growing and there is occasional embryonic and larval lethality.
? These are strange combinations of markers which could only be explained by double 
recombination events or the embryos carrying two recombinant chromosomes, each 
with different STS markers.
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